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Abstract 
Background 
Adults with intellectual disabilities experience equivalent or higher rates of obesity in 
comparison to the general population. This increases the risk for health conditions associated 
with adverse weight gain including cardiovascular disease and type II diabetes. Clinical 
guidelines on the management of obesity recommend multi-component interventions which 
include an energy deficit diet (EDD) of 600 kcal per day, support to increase physical activity 
and key behaviour change techniques including goal setting and self-monitoring to facilitate 
these healthy lifestyle changes. However, the current evidence base and provision of health 
services on the management of obesity in adults with intellectual disabilities is limited. A 
systematic review of multi-component weight management interventions was conducted and 
identified only seven randomised controlled trials of weight management interventions in 
adults with intellectual disabilities and obesity. The intervention components primarily 
focussed on a health education approach including diet, physical activity, and behaviour 
change techniques. However, no intervention adhered to clinical recommendations in terms 
of including an EDD, a weight maintenance intervention or investigating the long term 
efficacy of the intervention at 12 months. Meta-analyses revealed that post intervention 
(Weighted mean difference; WMD: -0.92kg; 95% CI -2.11kg, 0.28kg; p = 0.13) and at 12 
months (WMD: -1.15 kg (95% CI -4.15 kg to 1.86 kg; p = 0.45), current multi-component 
weight management interventions are not more effective than no treatment. The results of 
this review illustrate that the current evidence base is insufficient to support multi-
component weight management interventions focussed on a health education approach and 
therefore, future studies should investigate the efficacy of an alternative approach and the 
inclusion of an EDD to examine the efficacy of this approach to the management of obesity 
in adults with intellectual disabilities.  
 
Methods 
The primary aim of this thesis was to add to the limited evidence base on multi-component 
weight management interventions in adults with intellectual disabilities by examining the 
feasibility of conducting a full-scale trial of a multi-component intervention, TAKE 5. 
TAKE 5 adheres to clinical recommendations on weight management and was specifically 
designed for adults with intellectual disabilities, and where applicable implemented with 
support from carers. The study design was a single blind cluster randomised controlled trial 
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comparing two active interventions. The comparator intervention, WWToo, was based on a 
health education approach and consisted of multiple components focussed on diet, physical 
activity and behaviour change techniques. A multi-point recruitment strategy was piloted. 
Participants were recruited from multiple organisations, from specialist intellectual 
disabilities services, provider organisations and local day centres. Additional feasibility 
outcomes included retention rates and the fidelity and implementation of the intervention. 
The primary efficacy outcome was change in body weight at 12 months. Additional 
secondary outcomes included anthropometric outcomes (BMI, waist circumference, 
percentage body fat), objective measure of physical activity (time spent in light, moderate to 
vigorous intensity and total physical activity) and sedentary behaviour and health related 
quality of life. 
 
Results 
The multi-point recruitment strategy was shown to be feasible and 50 participants were 
successfully recruited to the study. This study design was shown to be acceptable to adults 
with intellectual disabilities as retention to both interventions was high with 90% of 
participants completing the intervention. The TAKE 5 multi-component weight management 
intervention with support from carers led to significant reductions in weight, BMI, waist 
circumference and percentage body fat at six and 12 months. Furthermore, 50% of the 
participants in the TAKE 5 intervention achieved a clinically significant weight loss of 5% 
or greater of initial body weight in comparison to 21% of the participants in the WWToo 
intervention. Significant improvements in the above outcomes were not found in participants 
completing the WWToo intervention. A limitation of both interventions was the inability to 
engage participants in physical activity, reduce the sedentary lifestyle behaviours and 
improve health related quality of life of this population group. Both interventions were 
implemented as intended, and both interventions were shown to be feasible and accessible 
to all adults with varying levels in intellectual disabilities due to the social support provided 
by carers in implementing the interventions.  
 
Conclusion 
This study is the first ever randomised controlled trial of a weight management intervention 
that adheres to clinical recommendations in adults with intellectual disabilities. This study 
provided evidence on the feasibility of this study design in adults with intellectual disabilities  
and demonstrated the acceptability of the EDD approach tailored to meet the needs of adults 
with intellectual disabilities. Furthermore, this study has provided preliminary evidence that 
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an EDD may be an efficacious approach to weight management, and provided further 
evidence that current service provision based on health education approach is ineffective in 
the treatment of obesity in adults with intellectual disabilities. On the basis of these findings 
a future full-scale randomised controlled trial is necessary to confirm these findings and 
provide evidence on the optimum approach to weight management in this population group.  
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_______________________________________________________________________ 
Chapter 1: Background 
_______________________________________________________________________ 
 
1.1 Introduction 
This chapter will provide an overview of the global burden of obesity. Followed by a review 
of the evidence of the burgeoning obesity epidemic and determinants of obesity for adults with 
intellectual disabilities. Current guidelines on the management of obesity will be presented, 
followed by research guidance on developing and evaluating complex interventions. This 
chapter will provide a summary of the research conducted prior to this PhD, based on the TAKE 
5 multi-component weight management intervention for adults with intellectual disabilities. 
Finally, this chapter will conclude with how this thesis aims to enhance our knowledge of the 
field, and address any gaps identified in the current research base.   
 
1.2 Definition of obesity 
Obesity is a major public health concern internationally [World Health Organisation (WHO), 
2004]. Obesity is characterised by an excessive quantity of body fat, that negatively impairs 
health (WHO, 2004). The WHO reported rates of obesity have more than doubled since 1980, 
and in 2014 it was estimated that 1.9 billion adults (≥ 18 years) were overweight and of these, 
600 million were obese (WHO, 2016). Obesity rates are projected to continue to increase in 
prevalence with conservative estimates of rates of 2.16 billion and 1.12 billion adults expected 
to be overweight and obese, respectively, by 2030 (WHO 2016).  The extent of the obesity 
epidemic in the United Kingdom (UK), is illustrated by the findings reported in the Health 
Survey for England (Department of Health, 1998) and Scottish Health Surveys (Scottish 
Executive, 2006). In 2014, 41% of men and 33% of women in England were overweight, and 
26% of men and 24% of women clinically obese (Health Survey England, 2014). Prevalence 
rates in Scotland, in a more recent update in 2015, revealed even higher rates, with 65% of 
adults classified as overweight, including 29% classified as obese (Health Survey Scotland, 
2015). 
 
The burden of obesity on health is well recognised, increasing the risk of chronic diseases 
including type II diabetes (Mokdad, Ford, Bowman, Dietz, Vinicor, Bales, & Mark, 2003), 
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cardiovascular disease (Wilson, D'Agostino, Sullivan, Parise, & Kannel, 2002) and some 
cancers (Hu, Tuomilehto, Silventoinen, Barengo, Peltonen, & Jousilahti, 2005).  
 
Body mass index (BMI) is the most commonly used measure to classify obesity and is 
calculated as the ratio of weight in kilograms (kg) divided by height in meters (m) squared 
(kg/m2). Obesity is classified as a BMI ≥ 30 kg/m2 and is subdivided into level of severity of 
obesity, with each level associated with increased risk of chronic diseases. The classification 
of weight status for adults by BMI is presented in Table 1.1.  
 
Table 1.1. The International Classification of adult underweight, overweight and obesity 
according to BMI. (Adapted from the WHO, 2004). 
Classification of weight status Body Mass Index (kg/m2) 
Underweight < 18.5 
Normal Weight 18.5 – 24.9 
Overweight > 25.0 
Pre-obese 25.0 – 29.9 
Obese Class 1 30.0 – 34.9 
Obese Class 2 35.0 – 39.9 
Obese Class 3 (Morbid obesity) ≥ 40.0 
 
The aetiology of obesity is multi-factorial and thought to be influenced by many factors such 
as genetic disorders, psychological and environmental factors (WHO, 2004). The primary 
determinants of obesity in the general population are thought to be related to modern day 
lifestyle factors, such as readily available, energy dense food, promoting dietary indulgence 
and increased energy intake; the technological advances in transport; and more sedentary jobs 
leading to limited physical activity participation and reduced energy expenditure. This creates 
a physiological imbalance within the body. Energy intake exceeds energy expenditure resulting 
in an increase in body weight (Catenacci, Hill, & Wyatt, 2009). In order to prevent a positive 
imbalance resulting in weight gain, interventions have focused on the prevention and 
management of body weight through modifiable determinants of diet and physical activity, 
aiming to change these behaviours and adoption of healthier lifestyle habits. The determinants 
of obesity consistent with the general population and specific to adults with intellectual 
disabilities will be further discussed in section 1.7.  
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1.3 Economic cost of obesity 
The increasing prevalence of obesity and its associated health inequalities is a burgeoning 
financial burden in the UK (Murray, Richards, Newton, Fenton, Anderson, Atkinson, & 
Braithwaite, 2013). It is reported that health conditions associated with overweight/obesity cost 
the National Health Service (NHS) greater than £5 billion per year (Scarborough, Bhatnagar, 
Wickramasinghe, Allender, Foster, & Rayner, 2011). Quantifying the economic costs of obesity 
is difficult due to the numerous health inequalities associated with obesity. The Foresight report 
(Butland, Jebb, Kopelman, McPherson, Thomas, & Mardell, 2007) is the most widely cited 
report on UK obesity trends, which predicted that greater than half of the UK population could 
be obese by 2050 and that associated total costs could increase to £50 billion per year. It is now 
thought that as obesity prevalence has continued to increase that these figures are conservative 
and the true burden of obesity in the future could be even more extreme.   
 
The current estimates of the cost of obesity to the NHS in Scotland are attributed to prescribed 
medication (60%); hospital care (30%) and General Practitioner consultations (10%). In total, 
it is estimated that this corresponds to £223 million (accounting for inflation). However, the 
cost of obesity on health care is only part of the economic burden, other expenditures include 
societal costs including community support services, travel expenses to appointments and 
absences from employment. Research on prevention and management strategies are therefore 
a priority to reduce the associated cost of obesity on society. 
 
1.4 Individuals with intellectual disabilities 
1.4.1 Definition of intellectual disabilities 
Intellectual disabilities is defined by the American Association of Intellectual and 
Developmental Disabilities (AAIDD) as, “significant limitations both in intellectual 
functioning and in adaptive behaviour as expressed in conceptual, social, and practical adaptive 
skills. This disability originates before age 18” (Schalock et al., 2010, pg.1). 
 
Intellectual disabilities is currently the most widely accepted term internationally (WHO, 
2007). Other terms used simultaneously and interchangeably with intellectual disabilities 
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include learning disabilities, developmental disabilities and also mental retardation. There has 
been a lot of confusion over the application of these terms and classification used to define 
intellectual disabilities has been debated over recent years as sometimes the above terms are 
used to mean different populations with disabilities. For example, in the UK the term learning 
disabilities is used concurrently with intellectual disabilities. However, this does not meet the 
definition used in the United States of America (USA), which denotes learning disabilities as 
distinct from intellectual disabilities. Furthermore, the term developmental disabilities is used 
in the USA. This is an overarching term that encompasses cognitive and/or physical disabilities 
and includes intellectual disabilities. Other examples of developmental disabilities include 
cerebral palsy which is characterised as a physical disability or fetal alcohol syndrome which 
has both physical and intellectual impairments.  
 
In addition, acceptability of terms has also changed over recent years. Previous terms have also 
included moron and mentally handicapped, however these are considered to be offensive and 
no longer deemed acceptable to describe individuals with intellectual disabilities (Schalock, 
Luckasson, & Shogren, 2007). This is also currently applicable to the utility of the term mental 
retardation. Although this is still currently used by the WHO International Classification of 
Diseases (ICD), recent publications from the WHO no longer used this term (Schalock et al., 
2007). 
 
Despite differences in the terminology and definitions, the classification of intellectual 
disabilities is generally consistent based on the following three main criteria: 
 
1) limitation in intellectual functioning;  
 
2) limitations in adaptive behaviour, specifically related to conceptual skills (e.g., 
language and literacy, money, time, and number concepts; and self-direction), Social 
skills (e.g. interpersonal skills, social responsibility, problem solving and ability to 
understand/follow rules and laws) and practical skills (e.g., daily living activities such 
as personal care and healthcare, occupational skills, travel and transportation); 
 
3) the onset of the disability prior to 18 years (Schalock et al., 2010, WHO, 2007). 
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In keeping with current practice this thesis will use the term intellectual disabilities throughout, 
based on the above definition and classification. 
 
1.4.2 Level of intellectual disabilities 
The level of intellectual disabilities can be categorised into four groups, mild, moderate, severe 
and profound using the intelligence quotient (IQ) testing. An IQ < 70, (or 2 standard deviations 
(SD) below the mean) is indicative of a limitation in intelligence. The IQ scores used to identify 
level of intellectual disabilities are presented in Table 1.2. 
 
Individuals with intellectual disabilities are a heterogeneous population and have a large range 
of abilities with some individuals’ dependent on a higher level of support from carers than 
others. For example, adults with mild intellectual disabilities in general can communicate 
effectively, can live independently and require minimum support. Adults with moderate 
intellectual disabilities are not fully independent and require additional support needs, with 
communication, everyday activities such as accessing services in the community, self-care and 
decision making. Adults with more severe or profound intellectual disabilities require full time 
support from carers, can have problems with mobility and communication. Adults with an 
increased severity of disabilities can also require assistance with personal care, and may be 
fully reliant on others to make decisions. 
 
Table 1.2.  Level of intellectual disabilities  
Level of intellectual disabilities IQ Score 
Mild 50-69 
Moderate 35-49 
Severe 20-34 
Profound <20 
 
1.4.3 Genetic syndromes  
There are a number of genetic syndromes associated with intellectual disabilities, including 
Prader–Willi syndrome, Cohen syndrome and Bardet–Biedl syndrome (Allison, Packer-
Munter, Pietrobelli, Alfonso, & Faith, 1998; Farooqi & O'Rahilly, 2005). Specific 
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characteristics of these genetic disorders include high rates of obesity, developed from early 
onset. Individuals with genetic syndromes and obesity represent only a small proportion of the 
intellectual disabilities population and require intensive support for weight management 
including prescription of a low calorie diet, restricted access to food and in some cases 
pharmacological intervention (Goldstone, Holland, Hauffa, Hokken-Koelega, & Tauber, 
2008). Therefore, this review will only focus on research on individuals without the above 
genetic syndrome as their origin of intellectual disabilities with the exception of adults with 
Down syndrome.  
 
1.4.3.1 Down syndrome 
Down syndrome is the most common genetic condition in individuals with intellectual 
disabilities. It is characterised by an extra chromosome on chromosome 21 and often referred 
to as Trisomy 21. Individuals with Down syndrome have distinct characteristics such as short 
stature, low muscle tone and poor cardiorespiratory fitness (Rimmer, Heller, Wang, & Valerio, 
2004). Unlike the syndromes described above, individuals with Down syndrome do not have a 
genetic cause of obesity, however, there is evidence to support that individuals with Down 
syndrome have higher rates of obesity than participants without Down syndrome as their origin 
of intellectual disabilities (Bhaumik, Watson, Thorp, Tyrer, & McGrother, 2008; Hsieh, 
Rimmer, & Heller, 2014; Melville, Cooper, Morrison, Allan, Smiley, & Williamson, 2008).  
The inclusion of adults with Down syndrome in weight management interventions is also a 
priority for this subpopulation of adults with intellectual disabilities. Adults with Down 
syndrome have been included in previous weight management interventions and shown to be 
able to make healthy lifestyle choices and reduce body weight (Melville et al., 2011; Spanos, 
Melville, & Hankey, 2013a). 
 
1.5 Prevalence of obesity in individuals with intellectual 
disabilities  
Estimates of the prevalence of obesity in adults with intellectual disabilities is important due 
to the prevalence of a wide -range of serious health complications associated with obesity (Hu 
et al., 2005; Mokdad et al., 2003; Wilson et al., 2002). To highlight the severity of the problem, 
studies comparing prevalence estimates of obesity with the general population will be 
discussed. The available evidence on prevalence rates of obesity in national and international 
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studies has been reviewed by Rimmer & Yamaki, (2006) and Melville, Hamilton, Hankey, 
Miller, & Boyle, (2007). The latter review systematically examined the available evidence on 
rates of obesity in studies conducted between 1985 and 2006. The results revealed that 
prevalence rates of obesity varied across studies from 2% to 31% in males and 15% to 51% in 
females and that there was a trend for obesity to increase with time. However, caution in the 
interpretation of these results was advised, as the authors reported limitations in the results such 
as whether or not the samples studied were representative of adults with intellectual disabilities 
and the diverse geographical locations of those studied, which made it difficult to compare 
prevalence rates. Overall, this review found that despite the small samples size of studies, 
prevalence rates of obesity were greater than in the general population. 
 
Studies of UK prevalence rates of obesity in adults with intellectual disabilities have been 
compared to the general population from national surveys. Melville et al., (2008) compared a 
cross-sectional study of 945 adults with intellectual disabilities identified through primary care 
settings with the general population based on data obtained from the Scottish Health Survey 
2003 (Scottish Executive 2006). The main results of this study were that the prevalence of 
obesity in women (39.3%) and men (27.8%) with intellectual disabilities was greater than 
women (25.1%) and men (22.7%) in the Greater Glasgow Health board sample from the 
Scottish Health Survey. Bhaunik et al., (2008) also found that in a sample of 952 adults with 
intellectual disabilities (≥ 25 years), women with intellectual disabilities (32%) were more 
likely to be obese in comparison to women in the general population (23%). This finding was 
not replicated in men with intellectual disabilities, reporting lower rates of obesity in 
comparison to the general population, 15% and 19%, respectively. Adults with intellectual 
disabilities were identified from an epidemiological health register and the comparison sample 
on the general population from the Health Survey for England (Department of Health 1998). 
 
In agreement with the above studies, data on the prevalence of obesity for adults with 
intellectual disabilities (≥16 years) was obtained in primary care general practices in Bristol, 
UK (Gale, Naqvi, & Russ, 2009). Comparison of 688 adults with intellectual disabilities with 
evidence from the general population in the South West of England (National Centre for Health 
Outcomes Development, 2008) revealed that the difference in prevalence estimates of obesity 
was nearly 10% greater in adults with intellectual disabilities, 33% and 24%, respectively. A 
recent study by Robertson, Emerson, Baines, & Hatton, (2014), utilised methods of self-report 
of intellectual impairment obtained from the secondary analysis of the Understanding Society 
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survey (McFall & Garrington, 2011) to assess prevalence rates of obesity in adults with 
intellectual disabilities in the UK. Data on BMI was self-reported in the first  wave of the survey 
and collected by trained nurses in the second. In both methods of data collection, adults with 
intellectual disabilities were reported to have higher rates of obesity in comparison to 
individuals without intellectual disabilities participating in the same survey, 27% vs 17% and 
41% vs 26%, respectively.  
 
In agreement with the evidence published based on UK studies, international studies have also 
reported high rates of obesity in adults with intellectual disabilities. For example, studies 
conducted in the USA, New Zealand and the Netherlands. In a large longitudinal study 
conducted in the USA by Hsieh et al., (2014) data on the prevalence of intellectual disabilities 
obtained from the Longitudinal Health and Intellectual Disabilities Study (Hsieh, Rimmer, & 
Heller, 2012) were compared to data on the general population from the 2010 National Health 
Interview Survey. The results from 1450 adults with intellectual disabilities (≥18 years), 
reported higher prevalence of obesity in comparison to the general population, 38% and 28%, 
respectively. Furthermore, a greater proportion of adults with intellectual disabilities were at 
risk of morbid obesity in comparison to the general population (7% and 4%, respectively). 
 
Prevalence rates of obesity in adults with intellectual disabilities receiving services from an 
intellectual disabilities provider in New Zealand were compared to the general population in a 
small (n = 141), single geographical setting study (Stedman & Leland, 2010). Results 
illustrated that adults with intellectual disabilities also showed the higher rates of obesity in 
comparison the general population (p < 0.001). This finding was also replicated in the 
Netherlands in adults (> 50 years) with intellectual disabilities in the study by de Winter, 
Bastiaanse, Hilgenkamp, Evenhuis, & Echteld, (2012). Data available from 945 participants 
mean age 61 (range 50-93 years), participating in the ‘Healthy Ageing and Intellectual 
Disabilities’ (HA-ID) study demonstrated that obesity levels (measured by BMI, assessed 
through objective measurements of weight and height) were significantly higher for adults with 
intellectual disabilities (25.6%, 95% Confidence Interval (CI) 22.8%–28.5%) in comparison to 
the general population (9.6%, 95% CI 8.7%–10.6%). 
 
The above research provides an overview of the high prevalence rates of obesity in adults with 
intellectual disabilities in comparison to the general population. However, comparison of 
prevalence rates of obesity between studies in adults with intellectual disabilities should be 
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interpreted with caution due to methodological limitations in conducting epidemiological 
research, particularly in this population (Leonard & Wen, 2002). Issues affecting the robustness 
of the evidence-base in reviewed studies include, variability in the definition and classification 
of intellectual disabilities with some studies using self-report measures (Hsieh et al., 2014; 
Robertson et al., 2014), which also extends to the estimate of BMI (Hsieh et al., 2014; 
Robertson et al., 2014) used to classify participants as overweight or obese. Self-report 
measures are subject to reporting error and recall bias and should be interpreted with caution. 
In summary, the findings from the available research illustrate that adults with intellectual 
disabilities have a high prevalence of obesity, at least equivalent to or greater than the general 
population. This raises concern as obesity has shown to have a negative impact on the health 
of this population group, increasing the prevalence of obesity related co-morbidities including 
type II diabetes and cardiovascular disease and therefore highlights the need for further 
research in the treatment of obesity in adults with intellectual disabilities. 
 
1.6 Prevalence of obesity related co-morbidities in adults 
with intellectual disabilities 
Obesity is shown to have a negative impact on health and health care resources due to the wide 
range of associated comorbidities. Obesity has shown to increase the risk of numerous health 
conditions including cardiovascular disease, type II diabetes, some cancers, and 
musculoskeletal conditions (NICE, 2014; SIGN, 2010). Furthermore, obesity and these 
associated comorbidities have also shown to have a negative impact on health related quality 
of life in adults with intellectual disabilities, through contributing to further disability posed by 
exacerbating existing mobility restrictions, and thus reducing individuals’ capacity to 
participate in social and leisure activities (Rimmer & Yamaki, 2006) This can also extend to 
increasing mental health problems including depression (Morris, Koehn, Happell, Dwyer, & 
Moxham, 2010). Evidence on the extent of the adverse effects of obesity on health is illustrated 
in Table 1.3. This section will focus on the most predominant health conditions associated with 
obesity, cardiovascular disease, and type II diabetes (Loveman et al., 2011; WHO, 2004). 
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Table 1.3. Health conditions associated with obesity. Adapted from the WHO (WHO, 2004). 
High increase in risk 
(relative risk >3)* 
Moderate increase in risk 
(relative risk 2-3)* 
Slight increase in risk 
(relative risk 1-2)* 
Type II diabetes Coronary heart disease Cancer (breast cancer in 
postmenopausal women, 
endometrial cancer, colon 
cancer) 
Gallbladder disease Hypertension Reproductive hormone 
abnormalities 
Insulin resistance Osteoarthritis (knee joints) Polycystic ovary syndrome 
Breathlessness Hyperuricaemia and gout Impaired fertility 
Sleep apnoea  Low back pain due to 
obesity 
  Increased risk of anaesthesia 
complications 
  Fetal defects associated with 
maternal obesity 
*Relative risk values are approximate.  
 
 
1.6.1 Cardiovascular disease 
Cardiovascular disease is an overarching term that encompasses conditions including coronary 
heart disease, peripheral artery disease and cerebrovascular disease. Cardiovascular disease is 
one of the leading causes of mortality in individuals with intellectual disabilities (Emerson & 
Banes, 2011). There is limited available evidence that make a direct comparison between 
prevalence rates of cardiovascular disease in adults with intellectual disabilities and the general 
population. However, in a study of 66 adolescents with intellectual disabilities conducted in 
Sweden, Wallén et al., (Wallén, Müllersdorf, Christensson, Malm, Ekblom, & Marcus, 2009) 
found than in comparison to a sample of 34 adolescents without intellectual disabilities, 
adolescents with intellectual disabilities had more severe cardiovascular disease risk factors. 
The mean age of participants in this study was 18.6 (SD 1.3) and therefore the results may not 
be generalizable to older adults with intellectual disabilities. However, this is concerning that 
the risk factors for cardiovascular disease already exist at this young age and have shown to 
11 
 
increase throughout adulthood (Draheim., 2006). Risk factors in adults with intellectual 
disabilities have shown to include sedentary behaviour, elevated cardiometabolic factors 
including glucose and lipoprotein profiles and overweight and obese (Wallace & Schluter, 
2008).  
 
1.6.2 Type II diabetes 
Type II diabetes is a common condition associated with obesity and has also shown to increase 
the risk of developing cardiovascular disease (Draheim, 2006; Heslop, Blair, Fleming, 
Hoghton, Marriott, & Russ, 2014). The available evidence on the prevalence of type II diabetes 
in adults with intellectual disabilities is limited. Two systematic reviews have investigated the 
prevalence of diabetes in individuals with intellectual disabilities (MacRae et al., 2015; 
McVilly, McGillivray, Curtis, Lehmann, Morrish, & Speight 2014). Both reviews identified a 
paucity of evidence of the prevalence of this condition in adults with intellectual disabilities. 
Moreover, the prevalence rates of type II diabetes are uncertain as all but one study (Butler, 
Whittington, Holland, Boer, Clarke, & Webb, 2002), identified in both reviews, provided a 
clear distinction between diabetes classification (type I and type II). However, this study was 
conducted in individuals with Prader-Willi syndrome in which obesity is associated with 
genetic abnormalities. Therefore, prevalence rates cannot be generalised to all adults with 
intellectual disabilities. 
 
The prevalence of combined diagnosis of diabetes (type I and type II) was reported by both 
reviews to be higher in individuals with intellectual disabilities in comparison to the general 
population MacRae et al., (2015). The uncertainty in accurate assessment of the prevalence of 
type II diabetes is concerning due to the high risk factors associated with the development of 
this condition in adults with intellectual disabilities, including obesity, unhealthy diet, and high 
levels of physical inactivity and sedentary behaviour (Bartlo & Klein, 2011; McGuire etal., 
2007).  Research should therefore aim to develop interventions to target these risk factors in 
particular management of obesity in order to help reduce the risk of obesity associated 
comorbidity and improve the health of this population group. 
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1.7 Determinants of obesity in adults with intellectual 
disabilities 
The aetiology of obesity in adults with intellectual disabilities is complex and multi-factorial. 
The determinants of obesity in this population group can be categorised into modifiable and 
non-modifiable factors. Identifying and understanding of the determinants of obesity, in 
particular related to lifestyle, is vital to the development of effective weight management 
interventions. 
 
1.7.1 Non-modifiable determinants 
1.7.1.1 Age 
In the general population, there is a strong linear relationship between increase in BMI with 
age (Flegal, Carroll, Ogden, & Curtin, 2010; Rennie & Jebb, 2005). However, the relationship 
between increasing age and weight gain in adults with intellectual disabilities is unclear. This 
is perhaps confounded by the heterogeneous population of adults with intellectual disabilities 
and the high prevalence of underweight in adults within this population group. This is 
particularly evident in adults with more severe and profound intellectual disabilities (Emerson, 
2005) the reduced life expectancy of this population group (Bittles, Petterson, Sullivan, 
Hussain, Glasson, & Montgomery, 2002).  
 
The age of onset of obesity in individuals with intellectual disabilities is reported to be lower 
than that of the general population (Emerson, 2005; Melville et al., 2008; Hsieh et al., 2014). 
Melville and colleagues (2008) reported that for all age categories up to the age of 74 in women 
and greater than 75 in men (with the exception of age category 65-74), adults with intellectual 
disabilities reported greater prevalence rates of obesity in comparison to the general population.  
Furthermore, the prevalence rates of obesity in adults (18-86 years) with intellectual disabilities 
in a study conducted in the USA (Hsieh et al., 2014) increased with age between subgroups; 
36.9% of adults aged 18-39 years, 42.2% of adults ages 40-59 years and decreased slightly to 
33.6% in adults aged ≥ 60 years. The most concerning finding from this study was the 
prevalence of morbid obesity (BMI ≥ 40 kg/m2) in the subgroup of adults aged 18-39 years, 
which was almost double the prevalence rates reported in the general population for the 
equivalent age range. This is of concern as the development of obesity in early adulthood has 
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been shown to continue throughout life and exacerbate the already reduced life expectancy of 
adults with intellectual disabilities (Cooper, Melville, Morrison, 2004). 
 
1.7.1.2 Gender 
Studies comparing the prevalence estimates of obesity by gender have continuously reported 
that women with intellectual disabilities are at greater risk of obesity in comparison to men 
with intellectual disabilities (Melville et al., 2008; Bhaumik et al., 2008). Bhaumik and 
colleagues (2008) examined the prevalence of obesity in adults with intellectual disabilities 
using objective measures of BMI assessed through measurement of height and weight of a 
cohort of 1119 adults (≥ 20 years) obtained from the Leicestershire Learning Disabilities 
Register in the UK. Rates of obesity were reported to be almost double in women with 
intellectual disabilities (29%) in comparison to men (15%) (p < 0.001). This finding is 
consistent with the evidence of studies comparing prevalence rates of obesity in men and 
women in the general population. For example, Melville et al., (2008) reported that in their 
comparison sample of adults without intellectual disabilities (obtained from Scottish Health 
Survey), there is a greater prevalence of obesity for women (39.3–26.0%) than men (27.8–
22.4%). 
 
The extent of the gender effect is further highlighted by comparison studies investigating 
prevalence rates of obesity in adults with intellectual disabilities with the general population. 
Bhaumik et al., (2008) reported that compared with data from the general population obtained 
from the Health Survey for England (Department of Health 1998), women with intellectual 
disabilities had higher prevalence of obesity than women in the general population, 32% and 
23%, respectively.  
 
The findings of UK studies of the effect of gender are in agreement with the prevalence in 
international studies. For example, a study conducted in the Netherlands in older adults 
reported that female participants have a higher prevalence of obesity in comparison to females 
in the general population (38.0% vs 14.8%, respectively (de Winter et al., 2012). 
 
In addition, results from a systematic review of the comparison of the prevalence rates in 
women with intellectual disabilities to women in the general population is consistently reported 
to be greater (Melville et al., 2007), with the degree of difference ranging from 18% to 30%. 
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An explanation for the effect of gender in adults with intellectual disabilities is uncertain. It is 
postulated that this may be due to evidence illustrating the differences in lifestyle determinants 
such as physical activity levels between men and women with intellectual disabilities, with 
men shown to engage in higher levels of total physical activity and moderate to vigorous 
physical activity (Phillips & Holland, 2011). 
 
1.7.1.3 Level of intellectual disabilities 
Research has consistently shown that the prevalence of obesity varies with level of intellectual 
disabilities, with individuals with mild to moderate intellectual disabilities shown to have 
higher prevalence than individuals with severe to profound intellectual disabilities (Melville et 
al., 2007). In a sample of 540 adults with intellectual disabilities living in different residencies, 
village communities, residential campuses and dispersed housing schemes Robertson 
Robertson, Emerson, Gregory, Hatton, Turner, Kessissoglou, & Hallam (2000) reported that 
obesity was more prevalent in adults classified as being more able (OR = 2.25, p = <0.001). 
This is further supported, by a relatively large scale study of 1542 adults with intellectual 
disabilities, conducted in the UK by Emerson, (2005). Results illustrated that individuals 
defined as the most able (OR = 2.5, p < 0.001) and moderately able (OR = 1.8, p = 0.01) were 
significant predictors of risk of obesity. In the study by Heish et al., (2014) rates of obesity 
were significantly higher for individuals with mild and moderate intellectual disabilities (41% 
and 44%, respectively) compared to individuals with severe or profound intellectual disabilities 
(26%). These findings are in agreement across different sample populations of adults with 
intellectual disabilities (Emerson, 2005; Melville et al., 2008; Stancliffe, Lakin, Larson,  
Engler,  Bershadsky, Taub, & Ticha, 2011), reporting that risk of obesity is reduced as level of 
intellectual disabilities increases in severity.  
 
Possible explanations for the differences in obesity prevalence across level of intellectual 
disabilities, is thought to be due to a number of factors including environmental factors, 
autonomy and individual skills in self-care and decision making. Individuals with severe and 
profound intellectual disabilities typically reside in institutional settings which are supported 
by care staff in a more structured routine.  There is often less freedom of choice than for 
individuals with mild/moderate intellectual disabilities living in their own home or supported 
family home (Lakin, Doljanac, Byun, Stancliffe, Taub, & Chiri, 2008). Individuals with more 
mild intellectual disabilities are shown to have more autonomy over everyday choices than 
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individuals with more severe intellectual disabilities (Lakin et al., 2008). An increased ability 
to make choices is associated with unhealthy lifestyle choices such as physically inactive 
lifestyles and unhealthy food choices (Rimmer & Yamaki, 2006). Furthermore, limited ability 
in self-care such as additional support needs with eating and drinking is also thought to be a 
potential explanation for the lower prevalence rates in adults with increased severity of 
intellectual disabilities.  
 
1.7.2 Modifiable determinants 
1.7.2.1 Environmental factors 
Reviews of environmental determinants of obesity in adults with intellectual disabilities have 
explored the effect of living arrangements and obesity in adults with intellectual disabilities 
(Rimmer & Yamaki, 2006; Melville et al., 2007). It has been reported that individuals who live 
in less restrictive environments are associated with increased risk of obesity (Rimmer & 
Yamaki, 2006; Melville et al., 2007). In addition, persons who live in more restrictive 
environments such as supported group homes are less likely to be obese compared with 
individuals who live independently or in family homes (Robertson et al., 2000).  
 
Hsieh et al., (2014) investigated type of residence, categorised into three levels based on level 
of support received.  Living in their own home or supported living was categorised as least 
supported; living with a family member or relative/welfare guardian was categorised as 
moderately supported and living in a care or group home was categorised as a high level of 
support. Results illustrated that although there were no significant differences in rates of 
obesity between the type of residence, the highest prevalence rates were reported in adults 
considered to live in less supported environments (41.7%). This was followed by adults living 
in moderate supported living (37.3%) and those in receipt of high support in care homes 
(35.3%). The effect of the environment as a risk factor for obesity is further supported by a 
study examining prevalence rates at the time of discharge from an institutional resident setting 
to follow up assessments at one year when resident the community. Obesity prevalence 
increased by 5% in women and 6% in men over the one year period (Bryan et al., 2000). 
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In summary, the influence of the environment on the development of obesity includes living in 
a less restricted setting, such as living in the community where there is an increased availability 
of food. Individuals with intellectual disabilities living independently in the community have 
less support from carers, and therefore choose uninformed lifestyle choices. This inability to 
manage their own environment is due to a limited cognition and understanding of the 
consequences of obesity (Smyth & Bell, 2006). Individuals with intellectual disabilities are 
often excluded from education and health promotion strategies (Emerson & Bains, 2011) and 
therefore adopt uninformed decisions in particular, unhealthy food choices which are easily 
available and the adoption of sedentary behaviours (Rimmer & Yamaki, 2006).  
 
1.7.2.2 Physical activity 
There is a general consensus in the available research that adults with intellectual disabilities 
engage in lower levels of physical activity and lead more sedentary lifestyles in comparison to 
the general population (Bartlo & Klein., 2011; Temple & Walkley., 2003). This is thought to 
be due to the increased barriers in engaging in an active lifestyle experienced by adults with 
intellectual disabilities which include a lack of support, finances and transportation (Hawkins 
& Look, 2006; Bodde & Seo, 2009). Population level data on physical activity in adults with 
intellectual disabilities has been in general obtained by indirect measures of physical activity 
such as questionnaires, either reported by the individual with intellectual disabilities or by 
proxy responses from carers. Comparisons of physical activity levels with the general 
population have continuously reported lower levels of physical activity in adults with 
intellectual disabilities, with these findings consistently reported across national and 
international studies.  
 
Robertson et al., (2000) assessed levels of physical activity during the previous four weeks 
prior to interviews with adults with intellectual disabilities and their carers. Assessment of 
physical activity levels was based on physical activity questions from the Health Survey for 
England 1993 (Department of Health, 1998). Physical activity was categorised based on the 
definitions of the Health Survey for England 1993; ‘frequency-intensity activity level’ (defined 
as the number of occasions of moderate or vigorous activity) and physical inactivity was 
defined as participating in less than 12 bouts of moderate or vigorous physical activity in the 
previous four weeks. Based on these definitions it was reported that a high proportion of 
participants, 53% or men and 64% of women were defined as physically inactive, with this 
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level of physical inactivity shown to be an independent risk factor for cardiovascular disease 
(Ekblom-Bak, Hellénius, Ekblom, Engström, & Ekblom, 2010). Comparison of these results 
with the general population data (from Health Survey for England 1996) revealed that 
irrespective of residential setting both men and women with intellectual disabilities were 
overall more likely to lead physically inactive lifestyles. 
 
Physical activity levels of adults with intellectual disabilities were compared with the general 
population in a large-scale study of 1458 adults with intellectual disabilities in England 
(Emerson, 2005). Comparison data of adults with intellectual disabilities was obtained from 
Health Survey for England 2001 (National Centre for Social Research, 2003). Physical activity 
levels were assessed using the same methodological approach as by Robertson et al., (2002). 
Both men and women with intellectual disabilities were reported to participate in less physical 
activity in comparison to the general population (p < 0.001). Moreover, only 8% of participants 
described as being physically able to engage in physical activity were considered to be active. 
 
McGuire, Daly, & Smyth, (2007) examined the physical activity levels of adults with 
intellectual disabilities in Ireland. Although the Irish Health Department recommendations are 
consistent with UK physical activity guidelines, the measurement tool utilised was the National 
Survey of Lifestyle, Attitudes and Nutrition (SLAN; Kelleher et al., 2003) to compare adults 
with intellectual disabilities with the general population defined physical activity as 20 minutes 
of mild exercise four or more times per week. Comparison of physical activity levels in adults 
with intellectual disabilities with the general population reported that the only 29.5% of 
participants with intellectual disabilities met the physical activity recommendations in 
comparison to 59% in the general population. 
 
Finlayson et al., (2009) conducted a large prospective cohort study, assessing physical activity 
levels in 433 adults with intellectual disabilities. Assessment of physical activity was through 
a semi-structured interview addressing physical activity questions on the type, the duration and 
the frequency of physical activity undertaken by adults with intellectual disabilities. The results 
of the interview were defined into intensity of physical activity, vigorous, moderate and light 
and combined with the data obtained on frequency and duration into summary categories of 
physical activity based on the Scottish Health Survey 2003 (Scottish Executive 2006). The 
results reported that most popular type of physical activity in adults with intellectual disabilities 
was walking. However, only 5.6% of men and 4.5% of women met the physical activity 
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recommendations set by the Scottish Health Survey 2003 (Scottish Executive 2006). 
Comparison of physical activity levels of this sample population with the general population 
was only available for moderate intensity physical activity. Adults with intellectual disabilities 
spent a significantly less mean amount of time walking at a moderate physical activity level 
per week (15 minutes) in comparison to adults in the general population (162 minutes), 
respectively. 
 
Comparison between studies conducted internationally is difficult due to the different 
definitions of physical activity recommendations. However, the trend in low levels of physical 
activity in this group is commonplace and has been agreed internationally. For example, a 
systematic review by Temple & Walkley, (2003) reported that across studies, only 17.5% to 
33% of participants met current physical activity recommendations. 
 
Walking is a common form of physical activity in adults, and recent attention has been made 
in health promotion initiatives to encourage this form of physical activity by setting activity 
goals such as the 10 000 steps/day monitored with the use of a pedometer. This is thought to 
be consistent with the recommendations for health benefits of 30 minutes of moderate to 
vigorous physical activity (Donnelly, Blair, Jakicic, Manore, Rankin, & Smith, 2009). Only a 
few studies have examined the validity of this target, though it has increasingly gained 
acceptance as a public health goal/message. Stanish & Drahiem, (2005) investigated the 
walking activity of 103 adults with intellectual disabilities using pedometers. The mean daily 
step counts ranged from 6590 (SD 4652) steps to 9548 (SD 9865) across days of the week. 
Furthermore, only approximately 21% of participants achieved the recommended step count. 
 
It is important to note that the above assessments of physical activity although providing 
assessment of physical activity in large populations, are subject to limitations. This is 
particularly relevant for adults with intellectual disabilities due to their cognitive abilities to 
recall physical activity participation, acquiescence and the level of understanding of this 
population group (Finlay & Lyons, 2001). The assessment of physical activity across studies 
in terms of validity varies from direct assessment from observational or accelerometer 
methodologies to indirect assessment from pedometers and self-report or informant report data 
(Esliger & Tremblay, 2007). Accelerometers are considered the criterion method of measuring 
physical activity (Lee, Williams, Brown, & Laurson, 2015) as they can provide additional 
information on energy expenditure and time spent in levels of physical activity. Only a few 
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studies have utilised this methodology in adults with intellectual disabilities. For example, 
Frey, (2004) investigated the physical activity habits of 22 adults with intellectual disabilities 
in the USA using the Actigraph 7164 model. Direct comparison of physical activity levels was 
made with two groups of age and gender matched adults without intellectual disabilities defined 
as sedentary (< 3 days per week of 30 minutes of moderate to vigorous physical activity) or 
active (> 3 days per week of 30 minutes of moderate to vigorous physical activity) based on 
self-reported physical activity. Adults with intellectual disabilities engaged in the less moderate 
to vigorous physical activity (19.7± 17.6 minutes/day), in comparison to sedentary (31.6 ± 21.8 
minutes/day) and active (55.9 ± 18.2 minutes/day) adults without intellectual disabilities.  
 
Studies that have measured physical activity with accelerometers have in general been limited 
by small sample sizes. However, a large-scale study of 152 individuals (age range 12 to 70 
years) with intellectual disabilities (including 79 participants with Down syndrome) conducted 
by Phillips & Holland, (2011) in the UK objectively assessed physical activity with 
accelerometers (Actigraph GT1M). The results are consistent with previous research and 
demonstrated that overall adults with intellectual disabilities engage in high levels of physical 
inactivity and time spent in sedentary behaviour (608.1 mins/day). Furthermore, no participant 
engaged in enough moderate to vigorous physical activity to the level required to be considered 
to meet physical activity recommendations for adults (Department of Health, 2011). In this 
overview of the evidence of physical activity levels, irrespective of methodological assessment, 
adults with intellectual disabilities have consistently been shown to engage in low levels of 
physical activity that do not meet current physical activity recommendations.  
 
1.7.2.3 Diet 
The extent of available evidence on nutritional habits and the quality of dietary intake (adhering 
to dietary recommendations on a healthy balanced diet) of adults with intellectual disabilities, 
is limited. This is primarily due to the difficulties in accurately and reliably assessing dietary 
intake in adults with intellectual disabilities. Studies in adults with intellectual disabilities have 
utilised a range of methodologies such as. 24 hour recall, food frequency questionnaires, 
weighed dietary intake, and food diaries (Humphries, Traci, & Seekins, 2009). The most 
common methodological approach in population based studies involved nutrition 
questionnaires which require recall of dietary intake. 
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Robertson et al., (2000) investigated the nutritional intake of adults with intellectual disabilities 
sampled from different residential settings. Data were obtained from proxy respondents by 
carers using the recommendations on a healthy balanced diet by Tameside and Glossop Health 
Needs Survey (Turner, 1997). The results reported that across settings adherence to a healthy 
balanced diet was low (7-8%) and that only 16-22% of participants consumed a sufficient 
intake of fruit and vegetables. 
 
McGuire et al., (2007) investigated the nutritional status of adults with intellectual disabilities 
living in residential settings or in family settings. Assessment was made by proxy respondent 
by carers completing a questionnaire based on a modified version of the National SLAN 
(Kelleher et al., 2003). Information on 157 adults with intellectual disabilities was obtained. 
Nutritional assessment was based in the ‘Food Pyramid’ which examined intake of food groups, 
fruit and vegetables, carbohydrates, dairy products, protein, and foods high in sugars and fats. 
Comparison of nutritional intake with the general population revealed that the percentage of 
participants with intellectual disabilities (42.4%) meeting guidelines on the recommended 
portion of daily fruit and vegetables (> 4 portions) intake was less in comparison to the general 
population (72%) completing the survey.  
 
These findings were reinforced by a study of adults with intellectual disabilities in Australia 
(Koritsas & Iacono, 2015). This study examined the nutritional status and food choices of 68 
adults (age range 19 to 73 years) with intellectual disabilities. A questionnaire was developed 
which included a screening tool for malnutrition, The Australian Nutrition Screening Initiative 
checklist (Lipski, 1996). The questionnaire was administered by health professionals ranging 
from GPs, nurses to disability care workers supporting adults with intellectual disabilities. The 
results reported that the mean score on the screening tool was associated with moderate risk 
(38.2% of participants) of malnutrition, with a further 42.6% of participants at minimum risk 
and 17.6% at high risk. It was postulated by the authors, that due to the high rates of overweight 
and obesity that the result of malnutrition may be due to the new paradox prevalent in the 
general population of over-nutrition (Tanumihardjo, Anderson, Kaufer-Horwitz, Bode, 
Emenaker, Haqq, & Stadler, 2007). Over-nutrition occurs when the quantity of energy intake 
is sufficient or exceeds energy expenditure.  However, it is often limited in the quality of 
nutritional content to provide a healthy balanced diet and may not meet micronutrient 
requirements (Taumihardjo et al., 2007). The results reported that the majority of adults with 
intellectual disabilities, exercised little choice on their dietary intake (60.3%).  The 
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consumption of takeaway foods was considered to be low with the mean frequency of 
takeaways reported to be less than once per week (range 0 to 3.5 times per week). The 
participant population was reported to be predominately adults with severe to profound 
intellectual disabilities, therefore, the results may not be generalizable to adults with more mild 
to moderate intellectual disabilities who have shown to have more autonomy (Lakin et al., 
2008).  Exploring the cause of the results of this study are important. Due to the limited choice 
over dietary intake and the high prevalence of malnutrition in adults with intellectual 
disabilities in this study, the authors implied that this was probably due to the lack of knowledge 
or informed choice for a healthy diet by carers supporting this population group. These findings 
are in agreement with previous research showing that carers had poor knowledge of nutrition 
recommendations (Melville, Hamilton, Miller, Boyle, Robinson, Pert, & Hankey, 2009) and by 
Humphries et al., (2009) reporting that the nutritional quality of the diets of adults with 
intellectual disabilities living in the community was poor due to undertrained staff responsible 
for the preparation of meals.  
 
The association between consuming an unhealthy diet and the risk of obesity in adults with 
intellectual disabilities has not been extensively investigated due to the difficulties in accurately 
measuring dietary intake. One study by Draheim, Williams, & McCubbin, (2002) investigated 
the health status of 145 adults with intellectual disabilities. Two food frequency questionnaires 
were administered to participants, with support from carers. The Block Screening 
Questionnaire intake (Block, Clifford, Naughton, Henderson, & McAdams, 1989) and the and 
the Behavioral Risk Factor Surveillance System, Fruit and Vegetable Module (Serdula,  Coates, 
Byers, Mokdad, Jewell, Chavez, & Block, 1993) both of which aimed to assess intake of food 
groups, fat, fruit and vegetables . The results demonstrated only 36.6% of participants met the 
dietary recommendations (> 5 portions per day) for fruit and vegetable intake and 64.1% of 
participants consumed above average fat intake (≥35% of total dietary intake). Participants who 
were thought to consume a fat intake above the recommended were more likely to have 
abdominal obesity. However, this finding is not supported by other studies by Cunningham, 
Gibney, Kelly, Kevany, & Mulcahy, (1990) & Braunschweig, Gomez, Sheean, Tomey, Rimmer, 
& Heller, (2004). The latter study investigated the dietary intake of 48 adults with Down 
syndrome resident in group homes in the USA. Assessment of dietary intake was made by 
proxy-response by carers using the same Block screening food frequency questionnaire as used 
by Draheim et al., (2002). Although participants’ diet was shown to not meet recommendations 
on a healthy balance diet it was not associated with increased body weight. 
22 
 
 
Overall comparison of dietary intake in adults with intellectual disabilities across studies is 
difficult due to the limited validity and diverse methodology utilised. No studies have validated 
a measure of dietary intake due to similar barriers previously discussed in completing physical 
activity questionnaires including challenges with comprehension, memory and communication 
of adults with intellectual disabilities. Proxy-respondents for dietary assessment are also 
subject to limitations due to carers not being present at every meal, and food choices made by 
individuals when out of their care could not be accounted for. Furthermore, difficulties in 
comparison of dietary assessment also occur due to the heterogeneity in the sample of 
participants studied.  A systematic review of nutrition in adults with intellectual or 
developmental disabilities by Humphries et al., (2009) revealed that there is an apparent 
disparity in the quality of nutritional intake in adults with intellectual disabilities resident in the 
community or more supported institutional settings. It is reported that the nutritional intake of 
individuals in institutional residences generally correlates with acceptable nutrition 
recommendations for a healthy balanced diet (Cunning et al., 1990).  However, this acceptable 
diet has not been replicated in a community setting (Bryan, Allan, & Russell, 2000; Robertson 
et al., 2000). This is supported by evidence when participants transition from institutional 
settings into the community and is associated with a decline in estimated dietary quality and 
increase in BMI (Bryan et al., 2000). 
 
In summary, the available literature illustrates that current methods are not sufficiently accurate 
or reliable to assess dietary intake in adults with intellectual disabilities. This prevents firm 
conclusions to be drawn on the nutritional assessments of this population group.  However, the 
majority of studies report nutritional intakes that are insufficient and do not meet national 
recommendations for a healthy balanced diet. It is known that consumption of energy dense 
foods can increase energy intake and result in an energy imbalance and increased body weight 
(Catenacci et al., 2009).  Interventions aimed at weight loss should therefore target this lifestyle 
behaviour in order to control fluctuations in body weight that could result in weight gain. Where 
individuals with intellectual disabilities are dependent on carers it is important that appropriate 
education and support is provided so that carers are actively involved in facilitating healthy 
dietary intake.   
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1.7.2.4 Obesogenic medication 
Mental health problems have often been shown to be more prevalent in adults with intellectual 
disabilities in comparison to the general population (Smiley et al., 2007; Deb, Thomas, & Bright, 
2001) and have shown to include mood disorders and anxiety resulting in problem behaviours, 
attention deficit hyperactivity disorder (ADHD), bipolar affective disorder and schizophrenia 
(Devine & Taggart, 2008). A cause and effect relationship between obesity and mental health is 
proposed, as individuals who are overweight and obese may have a poorer quality of life and thus 
at increased risk of depressive symptoms (Markowitz, Friedman, & Arent, 2008; Morris et al., 
2010). Depression can often lead to adverse weight gain by influencing unhealthy lifestyle 
behaviours in overeating or a reduced motivation for engagement in physical activity (Morris et 
al., 2010). Furthermore, the treatment of these conditions through prescribed medication, 
especially that prescribed on a long term basis, is a contributing factor to weight gain. Studies 
in the general population (Domecq et al., 2015; Leslie, Hankey, & Lean, 2007) and specific to 
adults with intellectual disabilities (Cohen, Glazewski, Khan, & Khan, 2001; Bokszanska, 
Martin, Vanstraelen, Holt, Bouras, & Taylor, 2003) have reported increased body weight in 
particular in response to antidepressants, antipsychotics and antiepileptic medications.  
 
Bokszanska et al., (2003) examined the side effects of two widely prescribed atypical 
antipsychotics (Olzapine and risperidone) in fifty adults with intellectual disabilities. Although 
both medications were shown to be effective in treating the symptoms designed to target, 
adverse weight gain occurred at three months and continued to be increased at 12 months of 
administration of these medications. Hsieh et al., (2014) explored the modifiable factors 
associated with obesity after adjusting for non-modifiable risk factors in adults with intellectual 
disabilities. Forty-five percent of adults were taking medication associated with weight gain 
and this was significantly associated with obesity (OR 1.80; 95% CI 1.38 to 2.37; p  < 0.001).  
 
Due to the high prevalence of obesity in adults with intellectual disabilities it is important that 
alternative medications that do not increase body weight are considered wherever possible. 
Furthermore, weight management interventions that improve health behaviours such as diet 
and physical activity should be implemented in some circumstances to reduce medication use, 
for example in the treatment of obesity related comorbidities. 
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In summary adults with intellectual disabilities are reported to have higher rates of obesity in 
comparison to the general population. Non-modifiable risk factors for obesity in this population 
group include being female, Down syndrome as the origin of intellectual disabilities and 
increasing prevalence with aging. Modifiable determinants include, in some circumstances, 
taking obesogenic medication, and unhealthy lifestyle habits such as diet and physical activity. 
These risk factors have a cumulative effect on the risk of obesity in adults with intellectual 
disabilities and interventions should aim to modify these risk factors associated with adverse 
weight gain. 
 
1.8 Management of obesity 
1.8.1 Clinical guidelines 
Treatment of overweight and obesity is initially managed within primary care settings and 
founded on clinical guidance. The first guidelines on weight management of overweight and 
obese adults were established by the Scottish Intercollegiate Guidelines Network (SIGN; SIGN 
1996). The guidelines were the first ever worldwide, and aimed to improve the effectiveness 
of the prevention and management of obesity. These recommendations have since been updated 
and revised guidelines in adults were published in 2010 (SIGN, 2010). In addition to the 
guidelines from SIGN, are the clinical guidelines on the management of obesity published in 
the UK (England and Wales) by the National Institute of Clinical Excellence (NICE; NICE 
2006; NICE 2014). Both guidelines aim to improve the care provided to individuals with 
obesity and are formed from evidence synthesis of systematic reviews and the highest quality 
research. This thesis will focus on the UK clinical guidelines only, as the studies carried out for 
the purpose of this thesis were conducted in Scotland and the therefore both the UK guidelines 
are considered relevant.  
 
The recommendations from these current clinical guidelines state that overweight and obese 
adults should aim for a sustainable weight loss of 0.5-1 kg [1-2 pounds (lb)] per week, with an 
overall aim to achieve a clinically significant/important weight loss of 5-10% (~5-10 kg) of 
initial body weight. This is supported by both guidelines; however, SIGN provides further 
guidance based on differentiation between BMI categories and advocates, largely through 
evidence from clinical opinion, that in individuals with a higher BMI of > 35 kg/m2, greater 
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weight loss of the order of 15-20% (~15-50 kg) may be required to facilitate improvements in 
health risk factors. 
 
1.8.2 Multi-component weight management interventions 
To achieve clinical improvements in health, multi-component weight management 
interventions are recommended as the optimal treatment approach. Recommendations state that 
“weight management programmes should include behaviour change strategies to increase 
people’s physical activity levels or decrease inactivity, improve eating behaviour and the 
quality of the person’s diet and reduce energy intake” (NICE 2014). 
 
The supporting evidence for the recommendation of multi-component weight management 
interventions is based on a meta-analysis of five studies, comparing interventions including a 
combination of diet, physical activity and behaviour change techniques to single component 
dietary interventions. Meta-analysis of the results reported that median weight change was -
4.60 kg (range -3.33 kg to -5.87 kg) for the multi-component interventions in comparison to -
0.48 kg (range -2.40 kg to 0.53 kg) for the dietary interventions (NICE 2006). 
Recommendations on the content of the intervention components; diet, physical activity and 
behaviour change strategies are also provided and will be discussed along with the supporting 
evidence. 
 
1.8.2.1 Diet 
To facilitate a healthy sustainable weight loss, a negative energy balance created through 
modification in primarily the quantity of dietary intake has been recommended. To achieve a 
weight loss of 0.5 kg per week, an energy deficit of 3500 kilocalories (kcal) week, equivalent 
to 500 kcal per day is required (Lean & James, 1986). In practice 600 kcal energy deficit diet 
(EDD) is recommended to ensure this deficit is achieved. Consideration of lower EDD (800-
1800 kcal//day) and very low EDD (< 800 kcal/day) are also recommended in certain 
circumstances, to be associated with a clinical important weight loss (≥5-6%).  However, 
caution over the nutritional adequacy of this approach is warranted and current advice suggests 
these lower energy approaches should only be undertaken with medical supervision. 
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1.8.2.2 Physical activity 
The current physical activity recommendations for moderate to vigorous physical activity of 
30 minutes on five or more days of the week are based on the amount of physical activity 
required to achieve benefits in health risk factors including reducing the risk of type II diabetes 
and cardiovascular disease.  The ‘dose’ of physical activity to  prevent and increase in body 
obesity is recommended to be equivalent to 225-300 minutes/week of moderate to vigorous 
physical activity (Donnelly et al., 2009). This may be achieved through regular physical 
activity, five sessions per week of moderate intensity for 45 to 60 minutes. This is equivalent 
to an energy expenditure of approximately 1800 to 2500 kcal/week. Further increases in 
physical activity levels of 60 to 90 minutes are advocated for those who have lost weight and 
want to maintain weight and avoid weight regain. Clinical recommendations advocate that this 
dose can be accumulated in multiple bouts of ten minutes over the course of a day.  
 
1.8.2.3 Behaviour change techniques 
To support these changes in diet and physical activity, behaviour change techniques should also 
be incorporated and include the following to be used flexibly where applicable: 
• self-monitoring of behaviour and progress 
• stimulus control  
• goal setting 
• slowing rate of eating 
• ensuring social support 
• problem solving 
• assertiveness 
• cognitive restructuring (modifying thoughts) 
• reinforcement of changes 
• relapse prevention 
• strategies for dealing with weight regain.  
 
In addition to these intervention components, it is recognised that multi-component weight 
management interventions need to be tailored to an individual’s needs and support to enable 
this should be provided, if necessary. The need for multi-component weight management 
interventions to be adapted to the specific requirements of individuals, including individuals 
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with intellectual disabilities is further highlighted in the updated recommendations by NICE, 
(2014) including guidance on adapting resources and communicating at a level that will 
facilitate understanding. 
 
In order to examine the effectiveness of a multi-component weight management intervention, 
a duration of at least 12 months has been recommended, including the intervention and follow 
up period is required. Furthermore, the distinction between weight loss and weight maintenance 
should be emphasised at six and nine months of treatment, incorporating the development of 
skills essential to each stage of weight management. 
The above guidance on weight management is focussed on previous research of multi-
component weight management interventions in the general population. However, there is a 
limited evidence base for the treatment of obesity in adults with intellectual disabilities. 
 
1.8.3 Weight management services 
In the UK, current weight management services are based on clinical guidance (NICE 2014; 
SIGN 2010). The Glasgow and Clyde Weight Management Service (GCWMS) is an example 
of a weight management service available to the general population living in Greater Glasgow 
and Clyde (GGC). It was developed in 2004, to offer evidence based treatment approaches to 
support individuals to achieve a clinically significant weight loss, in response to the first SIGN 
obesity guidance. The GCWMS is part of a hierarchical approach offered by the NHS in this 
area of Scotland for weight management. The services available are based on severity of 
obesity, according to BMI and range from primary prevention (BMI ≥ 18.5-24.9 kg/m2), local 
authority (community based interventions, BMI ≥ 25 kg/m2), specialist services (GCWMS, 
BMI ≥ 35 kg/m2 or ≥ 30 kg/m2 with co-morbidities) and surgery (following completion of the 
GCWMS programme). The GCWMS is the third treatment option under specialist services not 
delivered in the community. The GCWMS delivery uses a multi-disciplinary team of health 
professionals including dietitians, psychologists and physiotherapists.  
 
The service comprises three structured phases delivered approximately over a two year period: 
• Phase 1: Weight loss – Multi-component intervention (diet, physical activity, 
psychology – behaviour change techniques, motivational enhancement) 
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• Phase 2: Continued weight loss – Lower calorie diet or pharmacological treatment 
approach 
 
• Phase 3: Weight maintenance – Learning to keep the weight off, through using support 
systems in place in the local community such as those available in tier two of the overall 
approach to weight management. 
 
A prospective cohort study was conducted in order to evaluate the first phase of the GCWMS. 
The study was conducted between 2004 to 2007 and published by Morrison and colleagues in 
2012 (Morrison, Boyle, Morrison, Allardice, Greenlaw & Forde, 2012). Evaluation of the 
intervention at the end of phase three and approximately 12 months from baseline, was reported 
based on last observation carried forward (LOCF).  Patients significantly lost weight mean 
change was -3.6 kg (95% CI -3.9 kg to -3.3 kg) and 24% lost a clinically important weight loss 
of greater than 5% (Logue, Allardice, Gillies, Forde, & Morrison, 2014). Therefore, based on 
the above evaluation the service was considered an effective approach supporting individuals 
to achieve a clinically significant weight loss.  
 
1.8.4 TAKE 5 multi-component weight management intervention 
Prior to this study it was identified that there was a gap in service provision for weight 
management for adults with intellectual disabilities in the UK. This was supported by a review 
of the evidence on lifestyle interventions for obesity management in this population group 
(Hamilton, Hankey, Miller, Boyle, & Melville, 2007; Spanos et al.,2013a). In particular, it was 
identified that no interventions had been developed that met clinical recommendation on multi-
component weight management in the general population (NICE 2014; SIGN 2010). An 
attempt to fill the gap in the evidence base for weight management for adults with intellectual 
disabilities and obesity, the TAKE 5 multi-component weight management intervention was 
developed (Melville et al., 2011; Spanos, Hankey, & Melville, 2015). TAKE 5 was developed 
in collaboration with NHS GCWMS (Morrison et al., 2012). The intervention satisfied 
evidence-based recommendations for weight management interventions within current clinical 
guidelines, and was designed to be used with support from carers, or significant others, 
wherever possible. 
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Melville and colleagues initially conducted pilot investigations into the feasibility and 
acceptability of the intervention to individuals with intellectual disabilities. This study also 
provided preliminary results on any clinical benefits of the intervention, worthy of conducting 
further evaluations, as recommended by the Medical Research Council (MRC) research 
framework (MRC, 2000; MRC, 2008). A single-stranded feasibility study of the TAKE 5 
intervention was conducted (Melville et al. 2011). Fifty-four individuals met the criteria for 
inclusion and consented to participate in the pilot study. Of the individuals, three dropped out, 
and four did not complete the intervention within the study period. Therefore, retention to the 
intervention was high with forty-seven (87.0%) participants completing the intervention. The 
study reported a significant decrease in participants’ body weight (mean difference – 4.47kg; 
p<0.001), with seventeen participants (36.2%) losing 5% or more of initial body weight.  TAKE 
5 also found significant results in other health risk factors including an increase in daily time 
spent in physical activity (mean difference 1.87%; p<0.05) and a decrease in daily time spent 
sedentary (mean difference -2.60%; p<0.05). 
 
The second phase of the TAKE 5 intervention consisted of a 12 month weight maintenance 
phase (Spanos et al., 2015). Participants who completed the weight loss phase and achieved a 
minimum 3% weight loss of initial body weight were invited to continue to maintain their 
weight loss. Thirty-one participants were eligible to participate, however two participants 
withdrew from the study and one participant died, leaving twenty-eight participants who took 
part and completed (90.3%) the weight maintenance phase. There were no statistically 
significant changes in anthropometric outcomes (weight, BMI or waist circumference) or 
physical activity post intervention, at 12 months. However, 50.4% of participants maintained 
their body weight (mean weight change -0.5 kg, SD 2.2 kg) and 21.6% of participants continued 
to lose weight (mean weight change -8.0 kg, SD 3.0 kg). 
 
1.8.5 Role of carers 
 
Social support from family or paid carers has been highlighted by previous studies as playing 
an important role in supporting adults with intellectual disabilities to lose weight (Fox, 
Rosenberg, & Rotatori, 1985; Hamilton et al., 2007; Spanos et al., 2013a). The roles of carers 
involved in weight management and lifestyle interventions has ranged from encouragement 
and reinforcement of key healthy lifestyle messages to actively participating in physical 
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activities such as walking with adults with intellectual disabilities and decision making on 
consumption of a healthy balanced diet. (Fox et al., 1985; Matthews et al., 2016; Spanos et al., 
2013b). The level of carer involvement is dependent on the individual needs of adults with 
intellectual disabilities and research has recommended that weight management interventions 
should aim to involve carers to facilitate changes in body weight in this population. 
 
A qualitative study was also conducted which aimed to explore the role and experiences of 
carers and the identification of barriers and facilitators in implementing the TAKE 5 
intervention and supporting adults with intellectual disabilities and obesity to make healthy 
lifestyle choices. Semi-structured interviews were conducted with 24 carers (Spanos et al., 
2013b). This was a purposive recruited sample of carers: 16 paid and eight family carers who 
supported participants who achieved a 5% weight loss (n = 12) or did not (n = 12). All carers 
completed the interviews, however, data from two interviews were of insufficient quality to be 
analysed qualitatively. Therefore, twenty-two participant interviews (91.6%) were included in 
the analysis. Carers reported the need for ongoing support and opportunities for training from 
health professionals. They also reported that lack of communication between staff in a team, 
supporting a participant, was an important barrier in their efforts to support weight loss. Carers 
of participants who did not lose weight described barriers associated with the complexity of 
some aspects of the intervention, including the prescribed diet.   
 
1.9 Research guidance on developing and evaluating 
complex interventions 
For a complex weight management intervention to be implemented into clinical practice, it 
needs to have undertaken a comprehensive research process. The MRC framework provides 
best practice guidance on the development, evaluation and implementation of complex 
interventions (MRC, 2000; MRC, 2008). The framework aims to identify the ‘active 
ingredients’ of an intervention in order to provide an understanding of the causal mechanisms 
which are essential for replicating an intervention in different contexts and for developing 
future effective interventions. The MRC framework provides an outline of key stages of this 
complex process, from exploratory stages of research, addressing issues in design to an 
evaluation stage and finally long-term implementation. The key stages of this process and 
activities to be undertaken at each stage are illustrated in Figure 1.1. These include: 
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Development of an evidence-based intervention; feasibility and piloting; evaluation of the 
intervention and implementation. 
 
 
 
Figure 1.1. Key stages in developing and evaluating complex interventions. Adapted from 
MRC, (2008). 
 
1.9.1 Development of an evidence-based intervention 
The MRC guidelines on developing and evaluating complex interventions advocate that prior 
to the development of an intervention it is important to identify the existing evidence through 
conducting a systematic review. In cases where current systematic reviews exist it is important 
to update these as the evaluation of the evidence evolves, prior to any implementation of 
recommendations. This is essential to developing the relevant theory on which the intervention 
will be founded upon. An intervention based on theory will allow the effective components of 
the intervention to be identified in order to attribute the causes of the changes in outcomes 
observed. 
 
1.9.2 Feasibility and piloting 
Examining the feasibility of an intervention prior to a full-scale trial is important to provide 
essential information on the design of the intervention and also the evaluation process. This 
stage involves testing procedures associated with conducting clinical trial research such as the 
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acceptability of recruitment strategies, retention of participants and the acceptability of patient 
centred outcome measurements. Pilot studies prior to full-scale trials also provide valuable 
information on the sample size requirements for such a trial in order to include enough 
participants to detect a statistically significant effect, and try to avoid inconclusive findings 
(type II error). At this stage, it is also recommended that a number of studies may be carried 
out either simultaneously such as the investigation into the process evaluation and feasibility 
measures of an economic evaluation. 
 
1.9.2.1 Process evaluation 
Process evaluations of complex interventions was conducted as early as the 1960s. In 
Suchman’s (1967) textbook on program evaluation, process evaluation was defined: 
 
“In the course of evaluating the success or failure of a program, a great deal can be learned 
about how and why a program works or does not work. Strictly speaking, this analysis of the 
process whereby a program produces the results it does is not an inherent part of evaluation 
research. An evaluation study may limit its data collection and analysis simply to determine 
whether or not a program is successful… However, an analysis of process can have both 
administrative and scientific significance, particularly where the evaluation indicates that a 
program is not working as expected. Locating the cause of the failure may result in modifying 
the program so that it will work, instead of its being discarded as a complete failure [p. 66].”  
 
This description at the time was not coined process evaluation, however, it is still used as the 
definition that current concepts and frameworks are modelled on today. The evolution of 
research over the years has led to more comprehensive definitions and concepts (Baranowski 
& Stables, 2000; Linnan & Steckler, 2002). Process evaluation can be conducted for a number 
of reasons including the interpretation of successful and unsuccessful components, monitoring 
of the fidelity of the intervention (i.e. whether delivery of the intervention is consistent with 
that planned from the outset) and assessing the influence contextual factors could have on 
intervention outcomes (Linnan & Steckler, 2002; Saunders, Evans, & Joshi, 2005). There is no 
comprehensive approach or gold standard for a process evaluation. It may be conducted 
formatively to provide feedback during a complex intervention to inform the researchers or in 
a summative manner to provide information on the causality of outcomes. Both these 
evaluations can be applied to all stages of the research process whether it is at the feasibility 
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and piloting stage to assist in redefining the intervention and modelling to inform future trials 
(Linnan & Steckler, 2002) or at the implementation stage to assist with the adoption and 
translation of the intervention into routine practice (Glasgow, Vogt, & Boles, 1999). The 
importance of conducting process evaluations has recently been emphasised by the publication 
of distinct guidelines from outcome evaluations, aimed at consolidating the available literature 
(Moore et al., 2015). 
 
1.9.2.2 Economic evaluation 
In addition to the benefits of conducting a process evaluation to gain insight into the 
implementation process, the inclusion of an economic evaluation can also provide important 
insights into the study design, the components of the intervention and the resources necessary 
to implement the intervention. Economic evaluations can be conducted at any stage of 
developing and evaluating complex interventions. Economic evaluation at the feasibility and 
pilot stage will help identify data collection methods (i.e. staff costs, intervention resources) 
and limitations in the cost-effectiveness which could be refined prior to a full-scale trial. An 
economic evaluation will also generate pilot data to inform the sample size required for a full-
scale trial to provide enough power to detect economically important differences in cost-
effectiveness. Furthermore, economic evaluation conducted concurrently to evaluating the 
effectiveness of an intervention will make the interpretation of the results more informative for 
decision and policy makers. This could for example help provide estimates on funding 
requirements and whether or not an intervention is viable for implementation into practice. 
 
1.9.3 Evaluation of the intervention 
In order to examine the efficacy of an intervention it is recommended, where possible, that a 
randomised controlled trial design be implemented. Randomised controlled trials represent the 
gold standard approach to examining the efficacy of healthcare interventions (MRC, 2008). 
Randomised controlled trials aim to eliminate risk of bias. The main sources of bias in 
conducting clinical trial research can be categorised into six classifications; selection bias 
(sequence generation and allocation concealment), performance bias, detection bias, attrition 
bias, reporting bias and other potential risks of bias (Higgins et al., 2011). A description of each 
risk of potential bias is illustrated in Table 1.4. 
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Table 1.4. Classification of bias in clinical trials. Adapted from the Cochrane Handbook 
(Higgins et al., 2011). 
Bias Description Risk of bias domains 
Selection bias Systematic differences 
between baseline 
characteristics of the 
groups that are compared. 
Sequence generation 
Allocation concealment 
Performance bias Systematic differences 
between groups in the care 
that is provided, or in 
exposure to factors other 
than the interventions of 
interest. 
Blinding of participants 
and researchers 
Detection bias Systematic differences 
between groups in how 
outcomes are determined. 
Blinding of outcome 
assessment 
Attrition bias Systematic differences 
between groups in 
withdrawals from a study. 
Incomplete outcome data 
Reporting bias Systematic differences 
between reported and 
unreported findings. 
Selective reporting of 
outcomes 
Other bias Systematic differences not 
specified by the above i.e. 
in relation to study design, 
such as recruitment bias, 
or incorrect analysis. 
Other potential sources of 
bias (e.g. related to study 
design, contamination of 
interventions, related to 
clinical setting) 
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Advantages of conducting randomised controlled trials are that they allow the investigation of 
causal associations between interventions and outcomes, which is not permitted with other 
types of study designs such as observational studies (cross-sectional or longitudinal studies). 
The random allocation of participants to each treatment arm of a trial, permits that all factors 
will be equal and the only factors which differentiate between groups are the interventions they 
received. Associations can be investigated in observational studies however, due to 
confounding factors, causality cannot be inferred. Therefore, randomised controlled trials are 
the most powerful research method for providing robust evidence on the efficacy of an 
intervention. 
 
1.9.4 Implementation of the intervention 
There is not a clear pathway for implementing interventions and the evidence for this process 
remains limited (Grimshaw et al., 2004). However, adherence to the guidelines discussed above 
provides a strong evidence base for interventions. Reporting of findings at all stages of the 
research process, and dissemination and translation of findings to a large audience such as 
service users, stakeholders, and policy makers is imperative. The authors of the MRC research 
framework, have highlighted a lack of available evidence on the key processes of 
implementation research, and advocate that future research is necessary to help facilitate the 
move from interventions conducted in controlled research settings into routine practice. 
Furthermore, they suggested that long term follow up of studies may assist in providing 
valuable insight into whether the short term changes and benefits that occur in the original 
study are persistent over time, thus providing findings more generalizable to real world 
situations.  
 
In summary, complex interventions are widely used in health care research. Weight 
management interventions can be defined as complex interventions due to the multiple-
components including, diet, physical activity and behaviour change techniques in the treatment 
of obesity. In order to examine the efficacy of a multi-component weight management 
intervention effectively it has to go through a series of research studies which continuously aim 
to redefine the intervention components and develop effective evaluation methods. The MRC 
framework for developing and evaluating complex interventions is based on best practice 
guidelines. The initial stages of this framework, that assessed feasibility and piloting methods, 
are particularly relevant for this thesis which will examine the feasibility of a full-scale trial of 
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the TAKE 5 weight management intervention for adults with intellectual disabilities and 
obesity. This stage involves testing methodological procedures for their acceptability, including 
testing recruitment strategies, and estimating rates of recruitment and retention, the 
acceptability of patient centred outcomes and providing estimates of sample sizes for future 
trials. 
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_______________________________________________________________________ 
Chapter 2: Aims of thesis and research questions 
_______________________________________________________________________ 
 
2.1 Aims 
The aims of this thesis were formulated based on the existing literature discussed in chapter 
one and in accordance to current research recommendations on developing and evaluating 
complex interventions. 
 
The overall aim of this thesis was to examine the effectiveness of multi-component weight 
management interventions for adults with intellectual disabilities and to inform the 
development of a future randomised controlled trial.  
 
This aim was addressed by conducting two studies which aimed  
1. To systematically review the available literature on randomised controlled trials of 
multi-component weight management interventions for adults with intellectual 
disabilities and obesity. 
 
2. To examine the feasibility of a full-scale clinical trial of the TAKE 5 multi-component 
weight management intervention in comparison with an active comparator intervention.       
 
2.2 Research questions 
In order to address the above aims of this thesis, the following research questions were 
developed. The research questions (1-4) in relation to the first aim were addressed in chapter 
three, by undertaking a systematic review of the literature. The research questions (5-10) in 
relation to the second aim were addressed in chapters four to six, through conducting a pilot 
randomised controlled trial. 
 
1. What are the components included in weight management interventions for adults with 
intellectual disabilities? 
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2. Do multi-component interventions adhere to clinical guidelines on weight 
management? 
 
3. What is the intervention effect of multi-component interventions on body weight in 
comparison to a control or comparator intervention? 
 
4. Did participants achieve a clinically significant weight loss of 5-10% of initial body 
weight?  
 
2.2.1 Feasibility  
 
5. Can adults with intellectual disabilities and obesity be recruited to a randomised study 
of the TAKE 5 intervention, versus a comparator health education intervention? 
 
6. What attrition rates are observed at six and 12 months post-randomisation? 
 
2.2.2 Potential efficacy  
 
7. Did participating in the weight management interventions result in a clinically 
important weight loss of 5-10% of initial body weight? 
 
8. Were there between group differences in secondary outcomes: arthrometry; physical 
activity and sedentary behaviour; and health related quality of life? 
 
2.2.3 Process evaluation  
 
9.  Were the weight management interventions implemented as intended? 
 
10. Were there any effective and ineffective components of the interventions? 
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_______________________________________________________________________ 
Chapter 3: The effects of multi-component weight 
management interventions on body weight loss in 
adults with intellectual disabilities and obesity: A 
systematic review and meta-analysis of 
randomised controlled trials 
_______________________________________________________________________ 
 
3.1 Introduction 
Chapter one highlighted the extent of the obesity epidemic in adults with intellectual disabilities 
and the clinical and research processes relevant to the management of obesity. This chapter will 
present a review of the available evidence on multi-component weight management 
interventions in adults with intellectual disabilities and obesity. This review will aim to expand 
on previous knowledge of lifestyle interventions for the treatment of obesity in adults with 
intellectual disabilities and systematically review the ‘active ingredients’ of the current 
literature to inform the successful components in supporting adults with intellectual disabilities 
to lose weight. 
 
3.2 Systematic review of weight management interventions 
The available literature on the management of obesity in adults with intellectual disabilities has 
been previously reviewed (Hamilton et al., 2007; Jinks, Cotton, & Rylance, 2011; Spanos et 
al., 2013a). Hamilton and colleagues (2007) identified eight studies focussed on behavioural, 
physical activity and health promotion interventions for weight loss. The role of carers in 
supporting weight management was also explored. The involvement of carers in the 
intervention was associated, in some studies, with increased weight loss and adherence to the 
intervention sessions. Subsequent to this review, Jinks et al., (2011) conducted an integrative 
systematic review, including both quantitative and qualitative studies. Twelve studies were 
identified and complied with the study definitions of intervention components of Hamilton et 
al., (2007). Although both of these reviews concluded the interventions were successful in 
supporting short term weight loss or changes in BMI, they reported a key limitation was the 
small sample sizes of the studies. The most recent review by Spanos et al., (2013a) identified 
studies characterised as single component lifestyle interventions that focused on diet, physical 
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activity or behaviour change, but also identified eight interventions that were characterised as 
multi-component interventions (comprising all three lifestyle components). This review 
provided further evidence for the vital role of carers in supporting adults with intellectual 
disabilities to make healthy lifestyle choices. 
 
Limitations with the current available evidence included the limited use of systematic 
methodology to effectively examine the available evidence (Hamilton et al., 2007; Jinks et al., 
2011). Hamilton et al. (2007) did not provide eligibility criteria for the inclusion of studies in 
their review, therefore selection of studies could have been biased, based on subjective and 
individual judgement on the study selection process. Although, Jinks et al. (2011) used 
systematic search methods, the identification of searches was limited in range to studies 
published after 1998, which may have excluded important findings from earlier studies. A 
limitation identified in all of the above reviews was the inclusion of heterogeneous study 
designs which are subject to bias and associated with reverse causality. To facilitate decisions 
on the most effective approach for weight management for adults with intellectual disabilities, 
it is important that systematic reviews are based on randomised controlled trials in order to 
provide a more accurate estimate of the effect of the intervention. 
 
The identification of intervention components was based on information from the study titles 
and methods of the primary studies and not based on standardised terminology. Recent research 
has been conducted to assist in the accurate reporting and identification of the ‘active 
ingredients’ of complex interventions through the development of standardised definitions of 
intervention components and behaviour change techniques (Abraham & Michie, 2008; Michie, 
Ashford, Sniehotta, Dombrowski, Bishop, & French, 2011; Michie et al., 2013). The 
identification of effective behaviour change techniques associated with changes in lifestyle 
outcomes would help inform the development of future interventions. Michie and colleagues 
have been at the forefront of research developing behaviour change taxonomies. The 40 item 
Coventry Aberdeen LOndon REfined (CALO-RE) taxonomy has been used to reliably classify 
behaviour change techniques to help people change their physical activity levels and eating 
behaviours and therefore is particularly relevant to examining the intervention components of 
multi-component weight management interventions (Michie et al., 2011). This review 
systematically coded the behaviour change techniques reported in the primary studies of multi-
component interventions to provide greater insight into the effective components in supporting 
adults with intellectual disabilities and obesity to lose weight. 
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3.3 Research questions 
The overall aim of this study was therefore to systematically review the available literature on 
randomised controlled trials of multi-component weight management intervention for adults 
with intellectual disabilities and obesity. Specific research questions to be addressed in this 
chapter were: 
 
1. What are the components included in weight management interventions for adults with 
intellectual disabilities? 
 
2. Do multi-component interventions adhere to clinical guidelines on weight 
management? 
 
3. What is the intervention effect of multi-component interventions on body weight in 
comparison to a control or active comparator intervention? 
 
4. Did participants achieve a clinically significant weight loss of 5-10% of initial body 
weight? 
 
3.4 Methods 
This study was conducted in accordance with the guidelines of the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) (Moher, Liberati, Tetzlaff, & Altman, 
2009). The guidelines included a flow diagram of the phases to be reported in conducting a 
systematic search (identification, screening, eligibility and inclusion of primary studies in the 
review) and a 27 item checklist of items to be reported throughout each stage of the review 
process. 
 
3.4.1 Search strategy 
A systematic search strategy was conducted which aimed to identify published studies, 
systematic reviews, research theses, and abstracts from conference proceedings in order to 
increase the identification of relevant studies. An electronic literature search was preformed of 
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six bibliographic databases; Medline, Embase, Cochrane Central Register of Controlled Trials 
(CENTRAL), Cumulative Index of Nursing and Allied Health Literature (CINHAL), 
PsychINFO and Education Resource Information Centre (ERIC) from 1946 to and including 
January 2016. The International Standard Randomised Controlled Trial Number (ISRTCN) 
trials registry was also searched to identify current relevant trials. The search strategy consisted 
of MeSH subject headings and keywords or phrases such as intellectual disabilities, diet, 
physical activity and behaviour change interventions and obesity. The full Medline search 
strategy is in Appendix i and was adapted for the other databases. Hand searching of key 
journals, previous systematic reviews and the reference lists of identified studies was also 
conducted.  
  
3.4.2 Eligibility criteria 
Studies were assessed for their eligibility. Studies were included in this review if they met the 
following inclusion criteria: 
• Participants diagnosed with intellectual disabilities 
• Adults (≥ 18 years) 
• Randomised controlled trial (based on the definition and criteria by the Cochrane 
Collaboration, i.e. the study explicitly states that the interventions compared in the 
study were established by the procedure of random allocation (Higgins & Green, 2011) 
• Multi-component intervention (diet, physical activity, behaviour change) 
• Study included obese participants, BMI ≥ 30 kg/m2 
• Report objective measure of body weight or BMI at baseline and follow up. 
 
Studies excluded from this review were: 
• Studies published in non-English language journals 
• Surgical or pharmacological interventions 
• Participants with the following genetic syndromes Prader-Willi Syndrome, Cohen 
Syndrome or Bardet-Biedl syndrome as discussed in section 1.4.3 Genetic syndromes 
• Special Olympic athletes due to the higher levels of physical activity in the sub-
population. 
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3.4.3 Data collection and analysis 
3.4.3.1 Selection of studies 
Assessment of identified studies obtained from the search was conducted by screening 
information provided in the title and abstract (performed by LH). Obviously irrelevant studies 
were excluded at this stage for example not involving adults with intellectual disabilities or 
focused on weight management. Titles and abstracts that obtained information relevant to this 
review such as the investigation of a multi-component weight management intervention, 
including participants with intellectual disabilities, and studies of randomised controlled trial 
design were considered for further assessment of the full text. In cases where there was 
uncertainty about a studies eligibility, the full text of the article was obtained for further 
investigation. Full texts articles were then assessed for their eligibility, meeting the above 
criteria. Full text screening was performed independently, by two researchers (LH, CM). 
Consensus on included studies was agreed and the final list of studies included in this review.  
 
This review categorised studies by research design into studies that examined the efficacy of a 
multi-component weight management intervention against a control intervention (no treatment/ 
treatment as usual) and studies that utilised an active comparator intervention. The 
interventions in the latter study design typically involved two multi-component interventions, 
one with additional intervention components and for the purpose of this review defined as a 
more comprehensive multi-component weight management intervention, and a less intense 
active comparator intervention. 
 
3.4.3.2 Data extraction 
Data extraction was conducted to obtain relevant data for this review. This included general 
study details such as the author, title, and year of publication; participant characteristics; 
research objectives; intervention components (i.e., duration and frequency of the intervention 
sessions); quantitative outcome measures of body weight, and/or BMI, and result statistics such 
as means and standard deviations of pre and post and change in body weight. In cases where 
there were duplicate publications or a protocol paper had been published all versions of the 
study were considered to maximise the extraction of all available information. The 
identification of behaviour change techniques was conducted independently by two reviewers 
(LH, CH) who then compared ratings and discussed any discrepancies to come to a consensus 
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and final score. The methodology section of studies detailing intervention components was 
screened against the CALO-RE taxonomy (Michie et al., 2011). If a behaviour change 
technique was identified it was coded ‘yes,’ if the technique was absent or there was insufficient 
detail to determine if a technique was utilised it was coded ‘no’. 
 
3.4.4 Risk of bias 
Risk of bias assessment for the reporting of included studies was conducted using the Cochrane 
Collaboration’s tool for assessing risk of bias (Higgins et al., 2011). The tool examined six 
classifications of bias: selection bias; performance bias; detection bias; attrition bias; reporting 
bias; and other potential risks of bias (Table 1.4). The bias is then categorised into seven 
corresponding domains which aim to address the following questions: 
 
Selection bias: Was the allocation sequence adequately generated? Was allocation adequately 
concealed? Performance bias: Was knowledge of the allocated interventions adequately 
prevented during the study? Detection bias: Was knowledge of the allocated intervention 
adequately prevented by outcome assessors? Attrition bias: Were incomplete outcome data 
adequately addressed? Reporting bias: Are reports of the study free of suggestion of selective 
outcome reporting? Other bias: Was the study apparently free of other problems that could put 
it at a risk of bias? Each bias was rated as low, unclear or high risk of bias based on the criteria 
by the Cochrane Collaboration (Higgins et al., 2011). Two reviewers independently assessed 
the primary studies for risk of bias (LH, CH) and consensus agreed as described above. 
 
3.4.5 Publication bias 
Publication bias was examined visually by funnel plots of the Weighted Mean Difference 
(WMD) against the standard error of the WMD of the included studies and investigated 
statistically using linear regression (Egger, Smith, Schneider, & Minder, 1997). This test 
investigates the association between the WMD and the standard error for each individual study. 
Evidence of publication bias was present at a significance level, p < 0.05. 
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3.4.6 Data analysis 
3.4.6.1 Effect size calculation 
Meta-analysis was performed using Comprehensive Meta-Analysis (Version 3.0 for Windows: 
Biostat, Englewood, Colorado, USA). The effect size for each study was calculated as the 
difference in the mean change in body weight in the multi-component intervention minus the 
mean change in body weight in the control or comparator intervention (Borenstein, Hedges, 
Higgins, & Rothstein, 2009). In the studies that reported mean change in body and SD of the 
change, these values were included directly in the meta-analysis. For studies that reported pre 
and post data on body weight, the SD of the mean change was calculated using the following 
equation: 
 
• SD change = √ (SD pre 2 + SDpost2 - (2 x r x SD pre x SDpost) 
  
To calculate the SD, a correlation coefficient (r) of 0.98 was used based on studies where data 
on the variance of pre and post intervention mean body weight and mean change in body weight 
were reported (Beeken et al.,2013; Beeken et al., 2015; Bergström, Hagströmer, Hagberg, & 
Elinder, 2013; Fox, Haniotes, & Rotatori, 1984; McDermott et al., 2012).  
 
• r = (SDpre2 + SDpost2 – SDchange2) / (2 x SDpre x SDpost) 
 
The pooled effect size WMD for studies comparing a multi-component intervention to a non-
active control group and studies comparing the multi-component intervention to an active 
comparator are analysed and reported separately using a random effects meta-analysis 
(DerSimonian & Laird, 1986). 
 
3.4.6.2 Assessment of heterogeneity 
Cochrane’s Q statistic was used to assess heterogeneity, with a significance level of p < 0.05 
indicating evidence of statistical heterogeneity. The I2 statistic was also used to assess the 
degree of heterogeneity, with I2 ≥ 50% indicating substantial heterogeneity (Higgins, 
Thompson, Deeks, & Altman, 2003).  
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3.4.6.3 Clinical effectiveness 
Defining changes in weight loss is important to determine if the magnitude of the change is 
consistent with clinical improvements in health. For the purpose of this review and throughout 
this thesis, a clinically important weight loss will be defined as a weight loss of ≥ 5% of initial 
body weight. A weight loss of less than 3% will be consider a small weight fluctuation 
following the recommendation by Stevens, Truesdale, McClain, & Cai, (2006). Successful 
weight maintenance will be achieved if participants maintain ± 2.9% of their weight loss 
achieved at the end of the weight loss phase.  
 
3.5 Results 
3.5.1 Literature search 
The search resulted in a total of 3008 studies. Duplicates (401 studies) were removed and the 
remaining studies titles and abstracts were screened. Two thousand, five hundred and sixty-
seven studies were excluded as they were obviously irrelevant (i.e., did not implement a multi-
component intervention, were single stranded studies or did not include participants with 
intellectual disabilities). Forty potentially relevant studies were assessed for their eligibility. 
Thirty-three studies were excluded due to the reasons illustrated in Figure .1 and nine studies 
were included for discussion in this review. 
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Figure 3.1. Study search results and selection process. 
MCWMI = Multi-component weight management intervention; RCT = Randomised 
controlled trial 
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3.5.2 Study characteristics 
Of the seven studies, five studies were conducted in the USA (Fox et al., 1984; Fisher, 1986; 
McDermott et al., 2012; Marks, Sisirak, & Chang, 2013; Pett, Clark, Eldredge, Cardell, Jordan, 
Chambless, & Burley, 2013), one study in Sweden (Bergström et al.,2013), and one study in 
the UK (Beeken et al., 2013; Beeken et al., 2015). The mean duration of the active intervention 
period across studies was 4.5 months (range: 2-15 months), with participant follow ups 
scheduled at three, six and 12 month time points. Two studies did not conduct further follow 
ups after post intervention measures (Bergström et al., 2013; Marks et al., 2013). Sessions 
lasted between 60 and 90 minutes and were conducted between one and three times per week. 
All studies were conducted in a group setting with small numbers of participants led by health 
professionals including dietitians (Beeken et al., 2013; Beeken et al., 2015), recreation 
specialists (Fox et al., 1984) and a health educator (McDermott et al., 2103). Carers and 
community staff also received training and delivered intervention components (Bergström et 
al., 2013; Marks et al., 2013; Pett et al., 2013). A summary of the study characteristics are 
presented in Table 3.1. 
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Table 3.1. Summary of study characteristics of multi-component weight management interventions 
Reference Study Population Duration of 
active 
intervention  
(follow up) 
Interventions Attrition 
Beeken et al., 
(2013/2015) 
 
 
Shape UP-LD 
intervention  
N = 25 
Age: > 18 years 
BMI:  > 25 kg/m2 
ID: Mild/Moderate  
 
 
 
Control 
Treatment as usual 
N = 25 
Age: > 18 years 
BMI:  > 25 kg/m2 
ID: Mild/Moderate 
12 weeks  
(3 months/6 
months) 
Session duration: 90 
minutes 
 
Session frequency: 
1/week 
 
Delivery: Sessions 
conducted in groups 
by a health 
professional 
 
 
Shape UP-LD 
Enrolled: N = 
25 
Completed: N = 
22 
 
Control: 
Enrolled: N = 
25 
Completed: N = 
17 
 
Attrition rate: 
22% 
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Bergström et al., 
(2013) 
Intervention 
N = 73 
Age: 36.2 (10.1) years 
BMI: 30.0 (7.6) kg/m2 
Gender: Male n = 27 
(42.2%) Female n = 37 
(57.8%) 
ID: Mild/Moderate 
 
 
Control 
Waiting list control 
N = 66 
Age: 39.4 (11.3) years 
BMI: 28.5 (6.6) kg/m2 
Gender: Male n = 29 (43.9%) 
Female n = 37 (56.1%) 
ID: Mild/Moderate 
 
12-15 months Session duration: 90 
minutes  
 
Session frequency: 
Not specified 
 
Delivery: Sessions 
conducted by care 
staff after a period of 
training 
Intervention 
Enrolled: N = 
73 
Completed: N = 
63 
 
Control 
Enrolled: N = 
66 
Completed: N = 
66 
 
Attrition rate: 
7.2% 
Fisher et al., 
(1986) 
Behaviour Self-control 
plus physical activity 
intervention N = 8 
Age: > 20 
Behaviour Self-control 
intervention  
Comparator intervention 
N = 9 
Age: > 20 
8 weeks 
(4 weeks) 
Session duration: 
60 minutes 
 
Session frequency:  
2/week  
 
Attrition rate: 
0% 
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Weight status: Obese, 
20% above desired weight 
for height 
Gender: Female 
ID: Mild/Moderate 
 
Weight status: Obese, 20% 
above desired weight for 
height 
Gender: Female 
ID: Mild/Moderate 
 
Delivery: Sessions 
were delivered in 
groups. 
Fox et al., 
(1984) 
Behaviour Therapy + 
Buddy Reinforcement 
N = 8 
Age: 27.5 (5.4) years 
Weight status: % 
overweight 34.7 (18.5) % 
Gender: Male n = 4 (50%) 
Female n = 4 (50%) 
IQ: 46.3 (12.1) 
 
 
 
Behaviour Therapy 
Comparator intervention 
N = 8 
Age: 29.5 (7.2) years 
Weight status: % overweight 
44.4 (35.4) %  
Gender: Male 3 Female 5 
IQ: 42.1 (8.4) 
 
15 weeks  
(12 months) 
Session duration: 
60 minutes 
 
Session frequency: 
2/week for 10 weeks 
weight loss, followed 
by 1/week for 5 
weeks weight 
maintenance 
 
Delivery: Sessions 
conducted in groups 
by a recreational 
therapist 
Attrition rate: 
0% 
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Marks et al.,  
(2013) 
Intervention 
N = 32 
Age: 42.6 (7.4) years 
Weight status: 
Underweight-Obese 
Gender: Male N = 16 
(50%) 
Female N = 16 (50%) 
ID: Mild/Moderate 
 
 
Control 
No treatment 
N = 35 
Age: 47.6 (7.0) years 
Weight status: 
Gender: Male N = 16 (46%) 
Female N = 19 (54%) 
ID: Mild/Moderate 
 
12 weeks Session duration: 60 
minutes 
 
Session frequency: 
3/week 
 
Delivery: Sessions 
were conducted in 
groups by community 
based organisation 
staff. 
Total Enrolled: 
67 
Total 
Completed: 60 
(1 drop out, 6 
not complete 
specified 
number of 
sessions) 
 
Attrition rate: 
10.4% 
 
McDermott et 
al., (2012) 
 
STYH intervention  
N = 216 
Age: 39 (range: 19-65) 
years 
BMI: 32.5 (range: 18.5 -
71.3) kg/m2  
Control 
No treatment 
N = 216 
Age: 39 (range: 19-65) years 
BMI: 32.5 (range: 18.5 -71.3) 
kg/m2  
8 weeks 
(12 months) 
Session duration: 90 
minutes 
 
Session frequency: 
1/week. 
 
Total Enrolled: 
443 
Total 
Completed: 196 
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Gender: Male n = 218 
(49.2%) Female n = 225 
(50.8%) 
ID: Mild/Moderate 
Gender: Male n = 218 (49.2%) 
Female n = 225 (50.8%) 
ID: Mild/Moderate 
Delivery: Sessions 
were conducted in 
groups by a health 
educator. 
 
Attrition rate: 
55.8% 
Pett et al.,  
(2013) 
Intervention with young 
adults  
N = 12 
Age: 23.6 (3.1) years 
BMI: 39.0 (8.0) kg/m2 
Gender: Male n = 4 
(36.4%) Female n = 7 
(63.6%) 
ID: Mild/Moderate 
 
 
 
Intervention with young 
adults + parents 
Comparator intervention 
N = 11 
Age: 25.6 (4.8) years 
BMI: 37.3 (5.2) kg/m2 
Gender: Male n = 5 (45.5%) 
Female n = 6 (54.5%) 
ID: Mild/Moderate 
 
12 weeks 
(3 months) 
Session duration: 90 
minutes 
 
Session frequency: 
2/week 
 
Delivery: Sessions 
were conducted in 
groups by recreational 
centre staff 
Young adults 
Enrolled: 12 
Completed:11 
 
Young adults 
+ parents 
Enrolled:11 
Completed: 11 
 
Attrition rate: 
4.3% 
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Change in body weight was a primary outcome in four studies (Fox et al., 1984; Fisher, 
1986; Beeken et al., 2013; Beeken et al., 2015; Pett et al., 2013).  McDermott et al., (2012) 
included BMI as a primary outcome, aiming to limit weight gain and Bergström et al., 
(2013), and Marks et al., (2013) included BMI as a secondary outcome. As BMI is calculated 
from the following equation; body weight (kg) divided by height2 (m) and due to the limited 
number of studies providing quantitative data on changes in BMI for analysis, the authors 
reporting BMI were contacted to request data on change in body weight. This allowed 
inclusion of these studies in the meta-analysis on body weight. All studies focused on 
reduction in weight and only one study included a weight maintenance period following 
weight loss (Fox et al., 1984). 
 
Four studies compared the efficacy of the weight management treatment against no 
treatment, control intervention (Beeken et al., 2013; Beeken et al., 2015; Bergström et al., 
2013; McDermott et al., 2012; Marks et al., 2013) and three studies used an active 
comparator intervention to examine the efficacy of the intervention (Fox et al., 1984; Fisher, 
1986; Pett et al., 2013). These foregoing studies included additional components to the 
intervention for example a more comprehensive physical activity programme (Fisher, 1986), 
or the addition of social support from carers (Fox et al., 1984; Pett et al., 2013). The studies 
that had the most comprehensive intervention component were used to subtract the mean 
change on body weight of the less-inclusive comparator intervention in order to calculate 
the effect size (see section 3.4.6.1 Effect size calculation). 
 
3.5.3 Participant characteristics 
A total of 755 participants were randomised into the studies. The sample size of studies 
ranged from 12 to 443 participants. The mean age range of participants was from 20 to 45 
years. Four studies included adults with overweight and obesity, BMI > 25 kg/m2 (Fox et al., 
1984; Fisher, 1986; Beeken et al., 2013; Beeken et al., 2015; Pett et al., 2013). Three studies 
included participants with varying weight status, classified as underweight, normal weight, 
overweight, and obese (Bergström et al., 2013; McDermott et al., 2012; Marks et al., 2013). 
The authors of the studies by Bergström et al., (2013) and McDermott et al., (2012) provided 
raw data and therefore, meta-analysis of participants with obesity only was conducted. The 
majority of participants in the study reported by Marks et al., (2013) were reported as 
overweight (40.5%) and obese (36.7%). The gender distribution of studies included male 
and female participants with the exception of one study including female participants only 
(Fisher, 1986). Studies included participants diagnosed with mild to moderate levels of 
55 
 
intellectual disabilities. One study included participants with Down syndrome (Pett et al., 
2013). A summary of study and participant characteristics is presented in Table 3.2. 
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Table 3.2. Summary of multi-component weight management intervention components 
Reference Intervention components Control/Comparator 
intervention 
 Diet Physical Activity Behaviour change  
Beeken et 
al., 
(2013/2015) 
 
 
Health education – food 
groups/ portions, eating 3 
meals & healthy snacks, 
shopping & cooking. 
 
Health education  
 
Behaviour change theories: 
Social cognitive theory, control 
theory 
 
Behaviour change techniques: 
6. Goal setting (outcome)  
8. Barrier identification/problem 
solving 11. Prompt review of 
outcome goals  
16. Prompt self-monitoring of 
behaviour 
 21. Provide instruction on how to 
perform the behaviour 26. Prompt 
practice  
35. Relapse prevention/coping 
planning  
Control 
Usual care, 1 off session 30-45 
minutes duration, plus health 
booklet and healthy eating and 
exercise DVD. 
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36. Stress management/emotional 
control training  
39. General communication skills 
training 
 
Bergström 
et al., 
(2013) 
Health Education plus 
opportunity to try foods 
Health Education plus 
opportunity to try physical 
activity 
 
 
Behaviour change theories: 
Social cognitive theory 
 
Behaviour change techniques: 
1. Provide information on 
consequences of behaviour in 
general  
26. Prompt practice 
 
Waiting list control 
Fisher 
(1986) 
 
 
Health education – 
healthy balanced diet, 
portion control, reducing 
snacking. 
 
Walking – 10 minute 
target at the beginning of 
the intervention, increase 
by 5 minutes every 2 
Behaviour change theories: 
Control theory 
 
Behaviour change techniques: 
7. Action planning  
Diet identical to Behaviour Self-
control plus physical activity 
intervention. 
 
Behaviour change techniques: 
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Eating techniques – 
practice eating slowly 
 
 
weeks until a target of 30 
minute was achieved). 
 
 
 
13. Provide rewards contingent 
on successful behaviour  
16. Prompt self-monitoring of 
behaviour  
17. Prompt self-monitoring of 
behavioural outcome  
19. Provide feedback on 
performance  
21. Provide instruction on how 
to perform the behaviour  
22. Model/demonstrate the 
behaviour  
26. Prompt practice  
29. Plan social support/social 
change 
 
 
13. Provide rewards contingent 
on successful behaviour  
16. Prompt self-monitoring of 
behaviour  
17. Prompt self-monitoring of 
behavioural outcome  
19. Provide feedback on 
performance  
21. Provide instruction on how 
to perform the behaviour  
22. Model/demonstrate the 
behaviour  
26. Prompt practice  
29. Plan social support/social 
change 
 
Fox et al., 
(1984) 
 
Health education – 
healthy balanced diet, 
Calisthenics (e.g., jumping 
jacks) and aerobic 
exercises at least two 
Behaviour change theories: 
Control theory 
 
Behaviour Therapy 
intervention 
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 portion control, reducing 
snacking. 
 
Eating techniques – 
practice eating slowly 
times a day. Lifestyle 
activities (e.g., walk 
instead of riding to work; 
using stairs). 
Behaviour change techniques: 
5. Goal setting (behaviour)  
6. Goal setting (outcome) 
7. Action planning  
8. Barrier identification/problem 
solving 9. Set graded tasks  
10. Prompt review of behavioural 
goals  
11. Prompt review of outcome 
goals  
12. Prompt rewards contingent on 
effort or progress  
13. Provide rewards contingent on 
successful behaviour  
14. Shaping  
16. Prompt self-monitoring of 
behaviour  
17. Prompt self-monitoring of 
behavioural outcome  
Diet and physical activity 
components and behaviour 
change techniques identical in 
both interventions.  
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19. Provide feedback on 
performance  
20. Provide information on where 
and when to perform behaviour  
21. Provide instruction on how to 
perform the behaviour  
22. Model/demonstrate the 
behaviour  
24. Environmental restructuring 
 26. Prompt practice  
27. Use of follow-up prompts  
29. Plan social support/social 
change  
40. Stimulate anticipation of 
future rewards 
 
Additional social support from 
peers with intellectual disabilities. 
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Marks et 
al., (2013) 
Knowledge of healthy 
foods, meals and snacks 
Review importance of 
physical activity 
components including 
flexibility, strength, 
endurance 
Behaviour change theories: 
Social cognitive theory 
 
Behaviour change techniques: 
1. Provide information on 
consequences of behaviour in 
general  
2. Provide information on 
consequences of behaviour to the 
individual  
5. Goal setting (behaviour) 
6. Goal setting (outcome)  
7. Action planning  
8. Barrier identification/problem 
solving 9. Set graded tasks  
10. Prompt review of behavioural 
goals  
11. Prompt review of outcome 
goals  
Control: 
No treatment 
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12. Prompt rewards contingent on 
effort or progress  
13. Provide rewards contingent on 
successful behaviour  
16. Prompt self-monitoring of 
behaviour  
17. Prompt self-monitoring of 
behavioural outcome  
20. Provide information on where 
and when to perform behaviour  
21. Provide instruction on how to 
perform the behaviour  
22. Model/demonstrate the 
behaviour  
24. Environmental restructuring 
26. Prompt practice  
29. Plan social support/social 
change  
35. Relapse prevention/coping 
planning 
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39. General communication skills 
training 
 
McDermott 
et al., 
(2012) 
 
 
Health education – 
emphasise on fruit, 
vegetables, wholegrains 
and portion sizes. 
Provided healthy snacks. 
 
Health education plus 
optional brisk walk. 
 
Behaviour change theories: 
Social cognitive theory 
 
Behaviour change techniques: 
1. Provide information on 
consequences of behaviour in 
general  
8. Barrier identification/problem 
solving 18. Prompting focus on 
past success  
21. Provide instruction on how to 
perform the behaviour  
26. Prompt practice  
36. Stress management/emotional 
control training  
39. General communication skills 
training 
Control: 
Participants attended the same 
number of sessions. Content not 
centred on healthy lifestyle, 
focussed on hygiene and safety. 
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Pett et al., 
(2013) 
Health education – 
healthy eating, 
emphasised increased 
fruit and vegetable intake 
based on American 
Dietary guidelines 
(Dietary Guidelines 
Advisory Committee, 
2005) 
 
Physical activity based on 
guidelines by American 
College of Sports 
Medicine (American 
College of Sports 
Medicine, 2006) 
 
Mode: aerobic activity, 
muscle strength and 
endurance, and flexibility 
(activities such as walking 
or jogging outdoors or on 
a treadmill, stationary 
cycling, weight lifting and 
stretching 
 
Duration: 45 minutes 
Intensity: Based on 
individual fitness levels 
Behaviour change theories: 
Social cognitive theory/ 
Transtheoretical Model 
 
Behaviour change techniques: 
5. Goal setting (behaviour)  
7. Action planning  
8. Barrier 
identification/problem solving  
10. Prompt review of behavioural 
goals  
18. Prompting focus on past 
success  
22. Model/demonstrate the 
behaviour  
24. Environmental restructuring 
26. Prompt practice  
29. Plan social support/social 
change  
Behaviour change techniques: 
7. Action planning 
8. Barrier 
identification/problem solving  
18. Prompting focus on past 
success  
26. Prompt practice 
36. Stress 
management/emotional control 
training 
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 36. Stress 
management/emotional control 
training 
 
NOTE: Techniques colour coded in blue were consistent across both interventions. 
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3.5.4 Risk of bias 
An overview of the risk of bias for each domain, categorised per study is presented in Figure 
3.2. Selection bias was assessed by studies fulfilling the criteria on reporting sequence 
generation and allocation concealment. Three studies provided adequate details on sequence 
generation (Beeken et al., 2013; Bergström et al., 2013; Marks et al., 2013) and were judged 
as a low risk of bias. The remaining studies did not provide sufficient information to assess 
the risk of bias domain as high or low risk and were judged as unclear risk (Fox et al., 1984; 
Fisher, 1986; McDermott et al., 2012; Pett et al., 2013).  The methods of concealment of 
random allocation were in general reported as unclear with only two studies reporting 
adequate details to be judged as low risk of bias (Beeken et al., 2013; Bergström et al., 2013). 
One study was classified as high risk of bias as the community based organisations that 
delivered the intervention performed the randomisation of participants into the multi-
component intervention or waiting list control (Marks et al., 2013). 
 
All of the studies failed to report clear methods of blinding of participants, researchers, and 
personnel involved in the trial, with the exception of Marks et al., (2013) which was judged 
as high risk of bias for this domain. In the study by Marks et al. the carers were involved in 
conducting the randomisation process and therefore unblinded to the group allocation. 
Across studies detection bias was in general uncertain as there was either inadequate 
information reported, from which high or low risk of bias could be assessed. Two studies 
involved independent researchers, unaware of the intervention treatments to assess the 
outcome measures (Bergström et al., 2013; Marks et al., 2013). These studies are assessed 
as having a low risk of bias. 
 
Attrition bias was assessed as low risk of bias in five out of the seven studies. McDermott 
et al., (2012) received a high risk of bias rating, with an attrition rate of 55.8% and in the 
study by Marks et al., (2013) although only 10.4% of participants with intellectual 
disabilities did not complete the intervention and were excluded from the analysis, 22.7% 
of staff participants withdrew from the study thus increasing the total attrition. Two studies 
reported no drop outs (Fox et al., 1984; Fisher, 1986). 
 
The study by Beeken et al., (2015) had to be assessed as unclear risk of bias for reporting 
bias as data were obtained from publication of the abstract and full results are yet to be 
published. However, a study protocol has been published and contact with the author 
provided details on the change in body weight to calculate the WMD. Therefore, it is 
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believed that this will be low on receipt of full publications. The remaining studies were 
judged as low risk of bias with the exception of one study which was subject to reporting 
bias, by not reporting all outcome measures and/or not providing adequate information on 
outcome results (Fisher, 1986). 
 
The study by Prett et al., (2013) was considered to be at potential risk of other sources of 
bias. This was in relation to the study design as only two out of the three intervention groups 
were randomised. A further potential source of bias which was not accounted for in the 
majority of studies with the exception of (Fisher, 1986; Fox et al., 1984; McDermott et al., 
2012; Pett et al., 2013) was the lack of justification of the sample sizes of studies. This may 
result in underpowered studies and or certainly studies with unknown power. 
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Figure 3.2. Risk of bias assessment of studies included in the review of multi-component 
weight management interventions for adults with intellectual disabilities and obesity. 
Adapted from the Cochrane Handbook (Higgins et al., 2011).  represents low risk of 
bias;  represents unclear risk of bias and  represents high risk of bias. 
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3.5.5 Publication bias 
As only seven studies, four with a control and three with an active comparator intervention 
were identified, funnel plots asymmetry was not determined due the limited number of 
studies to provide adequate power of reliability test for presence of publication bias (Higgins 
& Green, 2011). 
 
3.5.6 Intervention components 
3.5.6.1 Diet 
The majority of studies were focussed on a health education approach, providing general 
information on healthy balanced diet including for example food groups, portion sizes, and 
healthy meals and snacks. The information was conveyed in a number of formats from 
images to food games (Beeken et al., 2013), demonstrations and tasting of foods (Bergström 
et al., 2013). 
 
3.5.6.2 Physical activity 
Three studies provided structured physical activity programmes as part of their intervention, 
involving aerobic activities, stretches to improve flexibility and strength and muscular 
endurance based activities (Marks et al., 2013; Pett et al., 2013). Participants were instructed 
to perform these activities two-three times per week. The intensity that these activities were 
to be performed at was not reported. Three studies focussed on lifestyle physical activity 
such as walking (Fisher, 1986; Fox et al., 1984; McDermott et al., 2012), with Fisher, 
prescribing daily walking targets ranging from 10 minutes at the beginning of the 
intervention to 30 minutes by the end of the intervention period. Fox et al., (1984) included 
calisthenics (e.g., jumping jacks) and aerobic exercise performed twice a week. These 
studies also provided advice on increasing energy expenditure through changes in daily 
activities such as taking the stairs, housework, and dancing. The studies by Beeken et al., 
(2013); Bergström et al., (2013) and McDermott et al., (2012) mainly focussed on increasing 
physical activity through a health education approach with Bergström et al., (2013) 
providing participants with the opportunity to try new physical activities. 
 
3.5.6.3 Behaviour change techniques 
In total 26 out of the 40 behaviour change techniques from the CALO-RE taxonomy were 
coded as being utilised across interventions. The mean number of techniques used was 11 
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(range: 2-21). The techniques identified as consistently reported in the interventions were: 
prompt practice; provide instruction on how to perform the behaviour; barrier 
identification/problem solving; action planning; model/demonstrate the behaviour; plan 
social support/social change; and prompt self-monitoring of behaviour. The techniques used 
in each intervention are also presented in summary Table 3.2 and the frequency of each 
technique across studies in Table 3.3. The 14 techniques not identified as being utilised in 
studies were: provide information about others' approval; provide normative information 
about others' behaviour; prompting generalisation of a target behaviour; teach to use 
prompts/cues; agree behavioural contract; facilitate social comparison; prompt identification 
as role model/position advocate; prompt identification as role model/position advocate; 
prompt anticipated regret; fear arousal; prompt self-talk; prompt use of imagery; 
motivational interviewing; time management; stimulate anticipation of future rewards 
 
. 
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Table 3.3. Frequency of behaviour change techniques used in the studies comparing the 
multi-component to a control or active comparator intervention. 
 
Behaviour Change Technique Control Active 
Comparator 
 N % N % 
26. Prompt practice 4 100 3 100 
21. Provide instruction on how to perform the 
behaviour 
3 75 2 67 
8. Barrier identification/problem solving 3 75 2 67 
7. Action planning 1 25 3 100 
16. Prompt self-monitoring of behaviour 2 50 2 67 
22. Model/demonstrate the behaviour 1 25 3 100 
29. Plan social support/social change 1 25 3 100 
5. Goal setting (behaviour) 1 25 2 67 
6. Goal setting (outcome) 2 50 1 33 
10. Prompt review of behavioural goals 1 25 2 67 
13. Provide rewards contingent on successful behaviour 1 25 2 67 
17. Prompt self-monitoring of behavioural outcome 1 25 2 67 
24. Environmental restructuring 1 25 2 67 
11. Prompt review of outcome goals 2 50 1 33 
36. Stress management/emotional control training 2 50  1 33 
1. Provide information on consequences of behaviour in 
general 
3 75 0 0 
39. General communication skills training 3 75 0 0 
19. Provide feedback on performance 0 0 2 67 
9. Set graded tasks 1 25 1 33 
12. Prompt rewards contingent on effort or progress 
towards behaviour 
1 25 1 33 
18. Prompting focus on past success 1 25 1 33 
20. Provide information on where and when to perform 
behaviour 
1 25 1 33 
35. Relapse prevention/coping planning 2 50 0 0 
14. Shaping 0 0 1 33 
27. Use of follow-up prompts 0 0 1 33 
72 
 
2. Provide information on consequences of behaviour to 
the individual 
1 25 0 0 
3. Provide information about others' approval 0 0 0 0 
4. Provide normative information about others' 
behaviour 
0 0 0 0 
15. Prompting generalisation of a target behaviour 0 0 0 0 
23. Teach to use prompts/cues 0 0 0 0 
25. Agree behavioural contract 0 0 0 0 
28. Facilitate social comparison 0 0 0 0 
30. Prompt identification as role model/position 
advocate 
0 0 0 0 
31. Prompt anticipated regret 0 0 0 0 
32. Fear arousal 0 0 0 0 
33. Prompt self-talk 0 0 0 0 
34. Prompt use of imagery 0 0 0 0 
37. Motivational interviewing 0 0 0 0 
38. Time management 0 0 0 0 
40. Stimulate anticipation of future rewards 0 0 0 0 
 
 
The detail in which behaviour change techniques were reported varied greatly across studies 
as did the description of intervention components (i.e., diet and physical activity) which 
made it difficult to code techniques and in some cases, it was unclear if a technique was 
present due to insufficient detail reported. For example, two studies (Fox et al., 1984; Fisher, 
1986) examined the efficacy of the multi-component weight management intervention 
originally developed by Rotatori & Fox (1981). The original intervention comprised of 14 
weeks focusing on weight loss, with participants meeting three times per week; followed by 
an additional weight maintenance period, with two sessions per week. The sessions focussed 
on healthy eating such as increased awareness of environmental conditions related to eating, 
(i.e. sitting at the dining room table and not watching television during eating), and reducing 
the rate and amount of food eaten by chewing food completely. Although both the studies by 
Fox et al., (1984) and Fisher, (1986) were founded on the study by Rotatori & Fox (1981), 
it was not clear whether the intervention content delivered in the original sessions was 
replicated. In particular, Fox et al., (1984) investigated the efficacy of a streamlined version 
of the weight management programme by reducing the intervention period to 10 weeks with 
meetings occurring twice per week and five further weeks of weekly maintenance meetings. 
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This was achieved by eliminating some of the behaviour change techniques. Furthermore, 
both studies made adaptations to the original intervention. Fox et al., (1986) aimed to 
compare two formats of the group based intervention, with and without planned social 
support from peers in the form of a ‘buddy system’. Fisher (1986) also examined a deviation 
of the original intervention in assessing the effects of the intervention to a comparator 
intervention with a more involved physical activity component. In addition to the lifestyle 
physical activity (i.e., taking the stairs) by Rotatori & Fox, (1981), Fisher, (1986) provided 
daily walking targets. In order to prevent inaccurate assumptions of the application of the 
techniques originally used by Rotatori & Fox, (1981) the only behaviour change techniques 
reported by Fox and colleagues (1984) and Fisher (1986) were coded. The difference in 
detail of reporting of techniques is illustrated as the studies were coded as utilising 21 and 
nine techniques, respectively. 
 
3.5.7 Carer involvement 
All of the studies with the exception of Fisher, (1986) and McDermott et al., (2012) involved 
the support of carers in the intervention. The level of support provided was of varying 
degrees. For example, two studies included a specifically designed component of the 
intervention for carers, which generally aimed to increase their knowledge of healthy 
lifestyle routines (Bergström et al., 2013; Pett et al., 2013). Bergstrom and colleagues 
specifically designed their complex intervention to simultaneously target adults with 
intellectual disabilities and their carers. The aim of the intervention was to improve diet and 
physical activity of adults with intellectual disabilities through increasing the knowledge of 
both the service users and staff. The intervention components directed towards improving 
the carers’ knowledge and skills included the appointment of a ‘health ambassador’ in each 
residential setting where the intervention took place and the involvement of a staff study 
circle. The role of a health ambassador is a common occurrence in residences in Sweden, 
which was built upon and involved relaying health information to colleagues and 
organisation of the health promotion activities. The study circle was based on ‘Focus Health’ 
a newly piloted manual and the principles of peer education. The manual consisted of 10 
themes which aimed to improve the carers’ knowledge and skill regarding health and health 
determinants for individuals with intellectual disabilities: 1) Health and quality of life; 2) 
Autonomy and ethics; 3) National recommendations concerning diet and health and 
information in society; 4) Healthy dietary habits; 5) Physical activity for health; 6) 
Availability and accessibility; 7) Habits and attitudes; 8) Motivation and support for 
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behavioural change; 9) Cooperation; and 10) How to sustain good work (Bergström et al., 
2013). 
 
In the study by Pett et al., (2013) parents received intervention sessions which aimed to 
improve healthy lifestyle behaviours in terms of physical activity habits of the young adults 
also participating in separate intervention sessions. Three studies also provided training for 
carers prior to the delivery of the intervention with service users in order to provide carers 
with knowledge about the intervention and to help support the participants during the 
intervention (Fox et al., 1984; Beeken et al., 2013; Beeken et al., 2015; Marks et al., 2013). 
 
3.5.8 Efficacy of the interventions 
3.5.8.1 Multi-component weight management intervention versus control 
intervention  
The summary estimates of the meta-analyses are presented in Figures 2.3 to 2.5. Four studies 
examined the efficacy of a multi-component weight management intention against a control 
intervention (Beeken et al., 2013; Beeken et al., 2015; Bergström et al., 2013; McDermott 
et al., 2012; Marks et al., 2013). Two studies reported BMI as their primary outcome, 
however, data were provided from the authors of these studies and therefore were included 
in the meta-analysis. The within group change in body weight was not significant in the 
multi-component interventions with only one study reporting a change in body weight of -
1.86 kg (SD 4.40 kg) (Marks et al., 2013). The remaining studies reported minimal changes 
(less than 1 kg) which could be attributed to fluctuations in body weight. Body weight 
remained unchanged in the control intervention (less than 1 kg change in body) with the 
exception of the study by Bergström et al., (2013) reporting weight gain of 2.36 kg (SD 4.26 
kg) in adults with intellectual disabilities and obesity. There was no significant difference in 
body weight between the multi-component interventions and control interventions post 
intervention (WMD:  -0.92 kg; 95% CI -2.11 kg to 0.28 kg; p = 0.13). Statistical 
heterogeneity was not present (Q (3) 5.3, p = 0.15; I2 = 43.4%). The study by Marks et al., 
(2013) reported a significant between group effect size (-2.13 kg; 95% CI -4.03 kg to -0.23 
kg), illustrating that the multi-component intervention was more effective than no treatment.  
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Reference Intervention Control Mean difference 
(95% CI) 
  Mean (SD) N Mean (SD) N  
Beeken et al. 
(2013)    
 
0.00 (2.79) 21 0.30 (3.49) 19 -0.30 (-2.25 to 1.65) 
 
Bergström et 
al. (2013) 
 
-0.85 (7.53) 26 2.36 (4.26) 18 
 
-3.21 (-7.06 to 0.64) 
 
Marks et al. 
(2013) 
 
-1.86 (4.40) 32 0.27 (3.52) 86 
 
-2.13 (-4.03 to -0.23) 
 
McDermott 
et al. (2012) 
 
-0.13 (2.76) 106 0.04 (3.38) 35 -1.17 (-1.03 to 0.70) 
 
Pooled Estimate 
(Random Effect) 
185  158 
 
-0.92 (-2.11 to 0.28) 
 
Tests for heterogeneity:  p = 0.15, I2 = 43.4% 
  
 
Figure 3.3. Weighted mean difference in body weight (kg) between the multi-component interventions and control interventions (Post intervention).  
 
 
 
 
 
 
 
 
  -8.00         -4.00             0             4.00            8.00 
    Favours Intervention          Favours Control 
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Reference Intervention Control Mean difference 
(95% CI) 
  Mean (SD) N Mean (SD) N  
Bergström et 
al. (2013) 
 
-0.85 (7.53) 26 2.36 (4.26) 18 
 
-3.21 (-7.06 to 0.64) 
 
McDermott 
et al. (2012) 
 
-0.58 (5.33) 56 -0.57 (4.26) 49 
 
0.00 (-1.87 to 1.86) 
 
Pooled Estimate 
(Random Effect) 
82  67 
 
-1.15 (-4.15 to 1.86) 
 
Tests for heterogeneity:  p = 0.14, I2 = 53.5% 
  
 
Figure 3.4. Weighted mean difference in body weight (kg) between the multi-component interventions and control interventions (12 month follow up).  
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Two studies examined the long term efficacy of the intervention at 12 months (Bergström et 
al, 2013: McDermott et al., 2012). Within group change in body weight in the multi-
component weight management interventions was again minimal with a change of 
approximately less than 1 kg in each intervention. The WMD was -1.15 kg (95% CI -4.15 
kg to 1.86 kg; p = 0.45). Statistical heterogeneity was present (Q (1) 2.2, p = 0.14; I2 = 
53.5%). 
 
3.5.8.2 Multi-component weight management intervention versus active 
comparator intervention 
Three studies utilised an active comparator intervention to investigate the efficacy of the 
multi-component interventions (Fox et al., 1984; Fisher, 1986; Pett et al., 2013). The studies 
included a more comprehensive intervention with additional intervention components in 
comparison to a less intense multi-component intervention. Three studies included 
additional behaviour change techniques, which primarily provided increased social support 
either from peers or carers (Fox et al., 1984; Pett et al., 2013) and one study investigated the 
effect of a more structured physical activity programme with graded targets (Fisher, 1986). 
The WMD was 0.55 kg (95% CI -2.94 kg to 2.05 kg; p = 0.70) post intervention. Statistical 
heterogeneity in effect sizes (Q (2) 0.7, p = 0.69; I2 = 0.0%). Studies reported no between 
group differences, however, the within group changes in body weight in the study by Fox et 
al., (1984) illustrated that both interventions were effective in changing body weight, with a 
weight change of -4.77 kg in both interventions. Exploration of no between intervention 
effect was primarily due to minimal changes in weight loss in both multi-component 
interventions (Fisher, 1986) and also a greater weight loss favouring the comparator 
intervention (Pett et al., 2013). 
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Reference Intervention Control Mean difference 
(95% CI) 
  Mean (SD) N Mean (SD) N  
Fisher, 
(1986) 
 
-0.60 (2.10) 8 -1.00 (2.20) 9 0.40 (-1.65 to 2.45) 
 
Fox et al. 
(1984) 
 
-4.77 (3.08) 8 -4.77 (2.56) 8 
 
0.00 (-2.78 to 2.78) 
 
Pett et al. 
(2013) 
 
-0.82 (3.72) 11 -2.72 (4.66) 11 
 
1.90 (-1.62 to 5.42) 
 
Pooled Estimate 
(Random Effect) 
27  28 
 
0.55 (-0.94 to 2.05) 
 
Tests for heterogeneity:  p = 0.69, I2 = 0.0% 
  
 
Figure 3.5. Weighted mean difference in body weight (kg) between the multi-component interventions and the active comparator interventions (Post 
intervention). 
  -8.00         -4.00             0             4.00            8.00 
    Favours Intervention          Favours Control 
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Follow up of the long term efficacy of the interventions at 12 months was only investigated 
in one study by Fox et al., (1984). Results therefore could not be pooled in a meta-analysis, 
although the within group, pre-post results revealed that participants in the multi-component 
intervention had maintained changes (±3%) in body weight from baseline with a weight loss 
of -1.87 kg (SD 6.55 kg) and in the active comparator -0.79 kg (3.39 kg).  
 
3.5.8.3 Clinical effectiveness 
None of the studies reported if participants achieved a weight loss associated with clinical 
benefits (5-10%) of initial body weight. Changes in percentage body weight pre-post 
intervention were reported for only one study, which achieved a mean clinically significant 
weight loss at the end of the active intervention period (Fox et al., 1984). Fox and colleagues 
reported that at the end of the weight maintenance phase participants in both interventions 
had achieved an average weight loss of -6.1% (SD 3.3%) and -5.9% (SD 3.0%) in the multi-
component intervention and comparator intervention, respectively. However, this was not 
maintained at 12 months, questioning the sustainability of the benefits of the intervention.  
 
3.6 Discussion 
The purpose of this study was to systematically review the available evidence on the effects 
of randomised controlled trials of weight management interventions on body weight loss in 
adults with intellectual disabilities. The identification of the successful components of multi-
component weight management interventions from high quality randomised controlled trials 
can help the inform the development of future studies. Consistent with previous reviews 
(Hamilton et al., 2007; Jinks et al., 2011; Spanos et al., 2013a), this study found that there 
are few studies designed to reduce obesity in adults with intellectual disabilities. 
 
3.6.1 Efficacy of the interventions 
The meta-analysis found that overall current studies of multi-component interventions do 
not significantly reduce body weight in comparison to no treatment control intervention. One 
multi-component intervention by Marks et al., (2013) however, did report a significant effect 
size in comparison to no treatment (-2.13 kg; 95% CI -4.03 kg to -0.23 kg). This is 
unexpected considering the limited effect of the other interventions which have been shown 
to be homogeneous in intervention components, primarily opting for a health education 
approach and the inclusion of similar behaviour change techniques. Closer inspection of the 
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primary study revealed that although the between group change in body weight was 
significant this was not reported as a key finding which raises concern over the validity of 
this result. A difference of 9.48 kg was present between the intervention group and control 
group at baseline. Although, this was not reported in the primary study to be a significant 
between group difference, it is thought that this may have confounded the results. It would 
be expected that participants with a higher baseline weight would lose more weight due to 
regression to the mean (McQueen, Cohen, St John-Smith, & Rampes, 2009). Furthermore, 
results were presented for incomplete data without justification, illustrating presence of 
attrition bias. Therefore, this result should be interpreted cautiously. The study by Bergström 
et al., (2013) contributed to the pooled effect size favouring the multi-component 
intervention in comparison to no treatment. However, the results of this study do not report 
a significant effect of the intervention on weight loss, with a minimal within group weight 
change of -0.85 kg (SD 7.53 kg) and thus not considered an effective weight management 
intervention for adults with intellectual disabilities and obesity. On the contrary, this multi-
component intervention may be considered as an approach to prevention of weight gain, as 
the participants in the control intervention gained weight. Prevention of weight gain is an 
alternative strategy to tackling the obesity epidemic and research has shown that this is also 
a priority and under researched area in adults with intellectual disabilities (Harris, Hankey, 
Murray, & Melville, 2015). 
 
3.6.2 Clinically important weight loss 
Clinical guidelines for the management of obesity recommend that for individuals with a 
BMI between 25-35 kg/m2 a 5-10% weight loss is required to reduce health risks associated 
with obesity (SIGN 2010; NICE 2014). Clinically important weight losses were not reported 
in the studies included in this review. Only one study reported to have a mean percentage 
weight loss greater than 5% in participants at the end of the 15 week intervention period 
(Fox et al., 1984). However, a clinically important weight loss was not maintained in the 
study by Fox et al., (1984) 12 months from baseline.  
 
3.6.3 Comparison of intervention components with clinical 
recommendations on weight management 
3.6.3.1 Diet 
None of the studies met the recommendations of the inclusion of an EDD, instead opting for 
a health education approach. This in part may explain the limited weight loss reported in 
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studies. A health education approach is based on non-quantitative dietary advice, which is 
not prescriptive and therefore open to more interpretation by the individual or their carer. 
Future studies should aim to examine the feasibility and acceptability of offering an EDD to 
adults with intellectual disabilities and obesity, and examine the efficacy of this approach in 
order to provide insight into the optimum approach to weight management interventions in 
this population group. 
 
3.6.3.2 Physical activity 
Physical activity is an integral component of the management of obesity due to its role in 
affecting energy balance, and the regulation of body weight through an increase in energy 
expenditure (Berk, Hubert, & Fries, 2006; Kavouras, Panagiotakos, Pitsavos, Chrysohoou, 
Anastasiou, Lentzas, & Stefanadis, 2007; McTiernan et al., 2007). Evidence based 
guidelines support an energy expenditure of 1200 to 2000 kcal per week. This is achieved 
through participation in 150-250 minutes of moderate to vigorous physical activity per week 
and is required to achieve a steady weight loss (SIGN 2010; NICE 2014). Increased levels 
of physical activity  is associated with the long term  maintenance of body weight loss 
(Catenacci & Wyatt, 2007; SIGN 2010; NICE 2014).  The physical activity components of 
studies in this review varied from a structured physical activity plan including aerobic, 
flexibility, and strength based activities to a health education approach and advice on 
lifestyle physical activity such as taking the stairs, and walking. The ‘dose’ of physical 
activity prescribed could only be quantified in three studies (Fisher, 1986; McDermott et al., 
2012; Pett et al., 2013). The weekly amount of physical activity in these studies varied from 
70 minutes to 210 minutes per week. Only one study in this review achieved the current 
physical activity recommendations for weight loss (Fisher, 1986). Adults with intellectual 
disabilities and obesity are consistently reported to have low levels of physical activity 
(Fernhall & Unnithan, 2002) with one study reporting engagement levels of only 13.1 (SD 
16.2) minutes per day in moderate to vigorous physical activity (Melville et al., 2011). It 
should be considered that the current guidelines might not be achievable for some adults 
with intellectual disabilities and obesity. Future studies should aim at looking at new ways 
to reduce the amount of time spent in sedentary behaviours and aim to gradually increase 
participation in physical activity over time to reach the amount of physical activity required 
to lose weight. This is in accordance with new consensus guidelines for beginners to exercise 
and may by applicable for this population group (O'Donovan et al., 2010). 
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3.6.3.3 Behaviour change techniques 
 The importance of the incorporation of behaviour change techniques into weight 
management interventions has been shown to be effective in supporting changes in attitudes 
and adoption of practices of healthier lifestyle habits (SIGN 2010; NICE 2014). The number 
of behaviour change techniques included in this review varied between studies, with the most 
common techniques incorporated including prompt practice; provide instruction on how to 
perform the behaviour; barrier identification/problem solving; action planning; 
model/demonstrate the behaviour; plan social support/social change; and prompt self-
monitoring of behaviour. To the author’s knowledge, this study is the first to utilise the 
CALO-RE taxonomy to assess behaviour change techniques in multi-component weight 
management interventions in adults with intellectual disabilities. However, the taxonomy 
has been applied in recent systematic reviews related to changing lifestyle habits in the 
general population and therefore relevant to draw comparison with this study. For example, 
the taxonomy has been applied to interventions improving dietary intake in older adults (Lara 
et al., 2014); increasing physical activity in obese adults (Olander, Fletcher, Williams, 
Atkinson, Turner, & French, 2013) and promoting weight loss (Hartmann‐Boyce, Johns, 
Jebb, & Aveyard, 2014). There is no clear evidence of the optimum number of behaviour 
change techniques with recent research in the general population reporting conflicting 
results. Lara et al., (2014) examined the effectiveness of behaviour change techniques in 
dietary interventions in older adults, and reported a significant trend towards greater fruit 
and vegetable intake with increased number of behaviour change techniques per study. 
Whereas, Michie and colleagues, (Michie, Abraham, Whittington, McAteer, & Gupta, 2009) 
prior to the development of the CALO-RE taxonomy reported that effectiveness was not 
increased with increased number of behaviour change techniques.  
 
Direct comparison of studies that included a more comprehensive intervention with a 
comparator intervention revealed insignificant results, suggesting that perhaps these 
techniques were not of significant magnitude to effect changes in body weight. In addition, 
goal setting and providing feedback on performance, which in the general population have 
been shown to be an effective technique in supporting weight loss, were infrequently 
implemented in the interventions (Michie et al., 2009; SIGN, 2010; NICE, 2014). However, 
it is important to note that caution is warranted over the interpretation of any comparisons 
of effective behaviour change techniques in the general population with those applied in 
adults with intellectual disabilities. As this population group may not be able to apply 
specific techniques due to limitations in their cognitive abilities and level of understanding. 
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For example, provide information on the consequences of behaviour in general has been 
shown to be an effective technique in increasing physical activity in obese adults 
(Dombrowski, Sniehotta, Avenell, Johnston, MacLennan, & Araújo-Soares,2012). However 
previous randomised controlled trials of weight management interventions in adults with 
intellectual disabilities reported that some participants did not have the capacity to 
understand the health implications of not engaging in healthy lifestyle habits (Bergström et 
al., 2013). This was further explored by Spanos et al., (2013b) investigating the acceptability 
of the single stranded TAKE 5 intervention. Carers reported that adults with intellectual 
disabilities had difficulties in understanding the health risks of obesity and healthy eating 
messages such as quantifying portion sizes. Therefore, this technique may not be applicable 
to this population group. Indeed, there has been an inconsistency in the effective techniques 
supporting behaviour change between population groups and even between obese and non-
obese adults (Olander et al., 2013). Behaviour change techniques associated with increasing 
physical activity in adults without obesity (Williams & French, 2011) were not shown to be 
effective in obese adults by Olander et al., (2013). Only four techniques across the two 
reviews were associated with increased physical activity, these included; provide 
information on consequences of behaviour in general, prompt rewards contingent on effort 
or progress towards behaviour, provide instruction on how to perform the behaviour and 
facilitate social comparison. In order to elucidate the effective techniques for weight 
management in adults with intellectual disabilities future studies are required that actively 
report the behaviour change techniques and facilitate direct comparison of intervention 
components. 
 
3.6.3.4 Weight maintenance intervention 
Weight maintenance is recognised as an integral component to the management of obesity, 
illustrating that individuals who have lost a significant amount of weight through substantial 
lifestyle changes are able to maintain changes in body weight and prevent future weight gain 
or health risks (NICE 2014; SIGN 2010). This review illustrated that research on weight 
maintenance interventions for adults with intellectual disabilities is limited. This is 
consistent with the research in the general population with studies primarily focusing on the 
development and evaluation of weight loss initiatives (Loveman et al., 2011). The 
effectiveness of weight maintenance interventions in adults with intellectual disabilities has 
not been extensively investigated. Only one study included in this review included a weight 
maintenance period (Fox et al., 1984). This was five weeks in duration and arguably not 
really a weight maintenance intervention as participants were encouraged to continue to lose 
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weight. Therefore, technically it differed little from the weight loss phase. The long term 
effects of a multi-component weight maintenance interventions require further investigation 
in adults with intellectual disabilities and obesity. 
 
3.6.3.5 Long term follow up 
Few studies investigated the long term effects of the weight management interventions at 12 
months (Fox et al., 1984; Bergström et al., 2013; McDermott et al., 2012). The meta-analysis 
illustrated no significant weight loss at 12 months post intervention in the studies comparing 
the long term effects of multi-component weight management intervention to no treatment 
control intervention. Research in the general population shows that the trend in weight 
change for most adults in the following a period of initial weight loss, is weight regain over 
time (Avenell et al., 2004). Clinical guidelines advocate a minimum 12 month study period 
(including the intervention and follow up) to examine the efficacy of the intervention. 
Therefore, future studies are required to assess the long term effect of the intervention.  
 
3.6.4 Support from carers 
It has been highlighted in previous reviews that carers play an integral role in motivating 
participants to make healthy lifestyle choices (Hamilton et al., 2007; Spanos et al., 2013a). 
The level of carer involvement in the studies included in this review varied from carers 
attending each of the intervention sessions, to individual components of the intervention 
specifically designed to involve carers to help the participants they support to achieve 
healthy lifestyle changes and ultimately weight loss. Two studies compared the effect of 
increased social support from carers on weight loss, and found insignificant results (Fox et 
al., 1984; Pett et al., 2013).  Although both interventions in the study by Fox et al., (1984) 
were shown to both be effective, the addition of a buddy system involving increased social 
support from peers did not provide any additive effect. Exploring the results of the study by 
Pett et al., (2013) in further detail revealed that the additional involvement of support from 
carers did not significantly support participants with intellectual disabilities to lose weight. 
However, this study was limited by a small sample size, and was an underpowered study.  
Furthermore, the authors reported that only eight of the carers out of 18 parent carers who 
inquired about the parent group took part. It was speculated by the authors that this was due 
to participant burden and lack of time; therefore, these reasons may have also been present 
in the carers who participated, and could be a potential explanation to the limited weight loss 
in comparison to the participant with intellectual disabilities only intervention. There was 
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also an imbalance between the number of participants with Down syndrome in the 
comparator intervention. The authors of this study reported that the presence of Down 
syndrome was a predictor of weight loss and therefore may have resulted in the increased 
weight loss in the comparator intervention. Overall, this review illustrated that there is 
insufficient evidence from direct comparisons of studies comparing the efficacy and thus 
quantifying the effect of increased support from carers on change in body weight. Clinical 
guidelines have advocated that multi-component interventions should be individualised, 
both in terms of the type of treatment suggested (with resources adapted to the cognitive 
abilities of service users) and the level of support provided (SIGN 2010; NICE 2014. 
Interventions should therefore continue to recognise the important influence carers have on 
the lives of adults with intellectual disabilities.  Interventions should aim to actively involve 
the carers in implementing session with study participants and also aim to enhance their 
knowledge and skills, in order to help facilitate healthy lifestyle choices for this population 
group.  
 
3.6.5 Intervention delivery 
All the studies delivered the intervention in a group format, with the involvement of 4-8 
participants. The effectiveness of the delivery of weight management interventions are 
uncertain and are unexplored in this population. Evidence in the general population is 
equivocal on the optimum delivery to support individuals to lose weight. A recent systematic 
review by Greaves, Sheppard, Abraham, Hardeman, Roden, Evans, & Schwarz, (2011) on 
the evidence synthesis of reviews of intervention components associated with effective 
dietary and physical activity interventions reported high quality randomised controlled trials 
(Avenell et al., 2004; Dombrowski et al., 2012; Ogilvie, Foster, Rothnie, Cavill, Hamilton, 
Fitzsimons, & Mutrie, 2007) provided evidence for individual, group and a mixture (both 
group and individual) mode of delivery in changing diet and /or physical activity behaviours. 
Furthermore, the interventions were delivered by a variety of providers, from carers to health 
professionals in physical activity and dietitians. There is a lack of evidence distinguishing 
between the effect of the delivery of the intervention between providers (Greaves et al., 
2011). Individual randomised controlled trials have provided evidence for the delivery of 
physical and dietary interventions by a variety of providers including dietitians/nutritionists, 
doctors and nurses and physical activity specialists (Greaves et al., 2011). However, a recent 
review of weight management interventions in the general population, provided evidence for 
a strong association with weight loss when interventions were delivered by a dietitian (-1.5 
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kg; 95% CI -2.9 kg to -0.2 kg) (Hartmann‐Boyce et al., 2014). This is further supported by 
evidence of the effective role of dietitians in delivering a weight management intervention 
in the general population (Laws, 2004). These data suggest a slight advantage for dietitians 
in terms of weight loss. However, future studies of multi-component weight management 
interventions should investigate the efficacy in adults with intellectual disabilities and weigh 
up the cost-effectiveness of the additional resource required to employ a full time dietitian 
over the potential benefit in terms of efficacy of the intervention. 
 
Adults with intellectual disabilities experience difficulties with communication, 
understanding, and adaptive behaviour and require varying levels of support. The studies in 
this review only included participants with mild to moderate level of intellectual disabilities. 
Obesity is not exclusive to this group of people with intellectual disabilities, it affects 
individuals with all levels of intellectual disabilities. Therefore, future studies should aim to 
take into consideration the context and experience of all adults with intellectual disabilities 
and obesity. However, this may justify a carer based approach in some cases, or an individual 
mode of delivery.  A one-to-one approach could allow the inclusion of all adults with 
intellectual disabilities, however it would be resource intensive. Furthermore, it has been 
reported that adults with intellectual disabilities can experience difficulties in accessing 
services due to transportation issues, and may rely heavily on their carers for support. An 
individualised intervention may be able to accommodate the needs specific to this population 
group and engage carers in the implementation of the intervention. The  cost-effectiveness 
of this type of delivery would be required before implementation  into routine practice 
(NICE, 2014). None of the studies in this review conducted an economic evaluation of the 
study and therefore no information was available on the cost-effectiveness of multi-
component interventions in this population group. Economic evaluation can provide an 
important insight into considerations regarding the design of the components and resources 
required to implement an intervention. Therefore, future trials should consider evaluating 
the cost effectiveness of an intervention alongside outcome evaluations (MRC, 2008). 
 
3.6.6 Quality assessment 
The internal validity of the studies was assessed by the Cochrane Collaboration risk of bias 
assessment tool. Differences in the risk of bias can help to understand the variation in the 
results of studies, with more rigorous studies (i.e., studies with a low risk of bias) more likely 
to produce results that are true. The majority of risk of bias assessment across domains for 
studies was considered as low risk. However, this was closely followed by the reporting that 
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showed an unclear risk for domains. Due to this lack of reporting of information on the 
methodology of studies, it was not possible to grade or categorise studies on their level of 
potential bias. Inclusion of these studies in this review was justified on the basis that 
including studies that had low risk of bias for all domains would have resulted in the 
exclusion of all studies. Furthermore, excluding solely studies of high risk of bias would 
produce a summary effect that was imprecise due to only a very limited number of quality 
trials considered to be eligible.  
 
Adequate description and randomisation of participants is essential to prevent an imbalance 
in participant characteristics between the intervention groups. This is particularly pertinent 
when participants are allocated to a no treatment arm / treatment as usual arm of a 
randomised controlled trial. Researchers aware of and not concealed from may enrol 
participants into the more ‘appropriate intervention.’ All the studies reported either low risk 
of bias or unclear risk of bias for this domain with the exception of Marks et al., (2013). 
High risk of bias was assessed by this study due to the fact that community based 
organisations conducting the randomisation could potentially have influenced the sequence 
of participants entered into the interventions. 
 
Blinding of participants, researchers and others involved in the study (performance bias), 
particularly those involved in the outcome assessment (detection bias) can reduce the risk of 
the identity of the intervention treatment and the potential of influencing the trial outcomes, 
respectively. The majority of studies did not address or provide sufficient details on 
performance bias. However, it is unlikely that participants/carers were blinded as this is 
usually difficult for a lifestyle intervention.  Attempts at blinding cannot ensure successful 
concealment of the treatment under investigation, and is especially obvious to personnel if 
the comparator intervention is no treatment. Detection bias is more important as the 
unblinding of the intervention allocation has been shown to exaggerate the intervention 
effect (Hróbjartsson et al., 2012). Only two studies reported blinding of outcome assessors 
(Beeken et al., 2013; Beeken et al., 2015; Marks et al., 2013), therefore future trials should 
aim to include more rigorous attempts to prevent detection bias by including single blinded 
study designs. 
 
Rates of attrition were reported in all studies. Weight management interventions in the 
general population often report high attrition rates of 30-60% (Douketis, Macie, Thabane,  
& Williamson, 2005). Only one study in this review had attrition rates comparable with the 
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highest attrition rates (55.8%) (McDermott et al., 2013). However, this study, although it 
included a randomisation process and under the definition by Cochrane Collaboration 
(Higgins & Green, 2011) met the criteria for inclusion in this review, the study design was 
more like that of a cohort study. With the exception of the above study, the attrition rates of 
included studies were much lower than studies of weight management interventions in the 
general population with two studies reporting no drop outs. The mean attrition rate for the 
studies was 14.2% (range: 0% to 55.8%). This low attrition rate may also be due to the 
duration of studies with the mean duration of 4.5 months. Investigations of weight 
management interventions in the general population include longer term interventions of 12 
month duration. Moreover, the low attrition may also be the result of interventions being 
delivered with the involvement of others, such as carers, who may be influential in securing 
attendance of participants at appointments. Future studies of longer duration are required to 
examine the acceptability of long term weight management interventions and their retention 
of participants. A further potential source of bias which was not accounted for in the majority 
of studies with the exception of (Fisher, 1986; Fox et al., 1984; McDermott et al., 2012; Pett 
et al., 2013) was the lack of justification of the sample sizes of studies. This may result in 
underpowered studies and or certainly studies with unknown power. 
 
3.6.7 Strengths and limitations 
To the authors knowledge, this is the first review to synthesis and quantify the effect of the 
available evidence of multi-component weight management interventions on change in body 
weight in adults with intellectual disabilities and obesity. The inclusion of randomised 
controlled trials provides a more valid and reliable estimate of the effect of the intervention, 
by aiming to reduce methodological errors of non-randomised trials such as imbalances 
between participant characteristics under investigation, and also un-measurable confounding 
factors and reverse causality often associated with observation studies. Furthermore, the 
behaviour change techniques were systematically identified against a standardised 
taxonomy. 
 
Sample heterogeneity in terms of the weight status of participants limits the interpretation of 
the results as one of the studies included participants across a range of BMI, classified as 
underweight, normal weight, overweight and obese (Marks et al., 2013). Although, the aim 
of this review was to examine the effect of multi-component interventions in adults with 
intellectual disabilities and obesity, the study was included in this review as a high proportion 
of participants with overweight and obesity participated. Due to the limited number of 
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studies further analysis of subgroups such as age, BMI categories of severity of obesity, and 
risk of bias could not be explored to assess the effects of these characteristics on body weight.  
 
Finally, regarding the reporting of the intervention components some of the included studies 
did not clearly define the behaviour change techniques. This made it difficult to extract the 
active techniques which were implemented to evoke the change in lifestyle. Additionally, 
different labels were used across studies which reflect the same techniques (i.e., self-
monitoring, completion of diaries). The MRC guidelines for developing and evaluating 
complex interventions have further highlighted this issue stating that clear reporting on the 
components of interventions are necessary with standard definitions to classify behaviour 
change techniques (MRC, 2008).  
 
3.7 Conclusion 
In conclusion, there is a paucity of available evidence on the management of obesity in adults 
with intellectual disabilities. The current weight management interventions did not adhere 
to clinical recommendations on the inclusion of an EDD, inclusion of a weight maintenance 
period or provided adequate follow up to examine the efficacy of the intervention. In general 
interventions were based on a health education approach, were underpowered and produced 
small insignificant effects on weight loss. The meta-analysis revealed that multi-component 
weight management interventions did not significantly reduce body weight in comparison to 
no treatment (control intervention) post intervention or at 12 months follow up. One study 
produced a significant between group effect, post intervention, in comparison to the control 
intervention. However, large variation in baseline weights between groups, with higher 
baseline body weight in the multi-component intervention, meant that under the principle of 
regression to the mean, greater weight loss is expected. 
 
The direct effect of intervention components was assessed by studies including an active 
comparator study design. Three studies compared two active weight management 
interventions, however there was no significant difference in change in body weight between 
multi-component weight management interventions. Difficulties in isolating the active 
ingredients of the weight management interventions due to lack of adequate reporting of 
behaviour change techniques and homogeneity of techniques utilised in the interventions 
limited exploration into the active processes supporting weight loss.  
 
  90 
 
The current evidence base raises questions over the efficacy of the health education approach 
to weight management. Future studies of multi-component weight management 
interventions should aim to meet clinical guidelines recommended by NICE and SIGN on 
weight management, in particular the inclusion of an EDD and social support from carers. 
Long term studies including an active weight maintenance period of at least six months 
duration and comprising a minimum 12 months intervention period overall are required to 
investigate the efficacy of this approach to weight management in supporting sustainability 
of weight loss in adults with intellectual disabilities and obesity.  
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_____________________________________________________________________ 
Chapter 4: Methods 
_____________________________________________________________________ 
4.1 Introduction 
This chapter will outline the rationale for conducting the pilot randomised trial and include 
the details of the feasibility, potential efficacy, and process outcomes which will be 
evaluated. This chapter consists of a mixed method design, utilising predominantly 
quantitative research methods, and enhanced by qualitative methods to explore in-depth the 
processes involved in conducting a randomised trial. A systematic description of the ‘active 
ingredients’ of the intervention components will also be discussed. This chapter concludes 
with a detailed statistical analysis plan (SAP). 
 
4.2 Study design 
Defining the optimum study design in behavioural change research can cause considerable 
debate, and decision balancing is often required between different methodological concepts. 
One of the major influencing factors in the choice of an active comparator intervention in 
this study was the ethical considerations of offering participants with obesity and at increased 
risk of health inequalities (Guh, Zhang, Bansback, Amarsi, Birmingham, & Anis, 2009; 
Whitlock et al., 2009) no treatment or withholding treatment for a 12 month period.  
 
There are few studies of randomised trials examining the efficacy of a multi-component 
weight management intervention in comparison to an active comparator intervention 
(chapter two). Therefore, there was limited evidence available on which to base a best 
alternative comparator intervention.  
 
Treatment as usual (TAU) in most areas in the UK for adults with intellectual disabilities and 
obesity is inconsistent, ranging from no treatment intervention to community group based 
lifestyle interventions, such as Waist Winners Too [(WWToo); Jones, Melville, Tobin, & 
Gray 2015].  This variability in treatment options was also thought to affect the validity of 
the study design, as providing a no treatment, control intervention would limit the 
differentiation between the effects of taking part in the research project and specific 
treatment effects of the intervention (McQueen et al. 2013). For the purpose of the study 
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TAU was therefore defined as an active comparator intervention, WWToo. Moreover, an 
active comparator intervention was justified as this is a relatively novel study design in adults 
with intellectual disabilities and with the feasibility of recruitment and retention uncertain, 
it was considered that recruitment and retention would be negatively affected by offering no 
treatment as an intervention. 
 
The outline of the study design is illustrated in Figure 4.1. Participants were randomised to 
either intervention for a 12 month period; a six month weight loss period (comprising of 9-
12 sessions designed to take place at between two – three weekly intervals) followed by a 
six month weight maintenance period (comprising of six sessions taking place once a 
month). At the end of the weight loss phase, if participants lost a clinically significant weight 
loss of 5% of initial body weight they continued onto the six month weight maintenance 
phase. However, if participants did not reach this weight loss target of 5% at the end of the 
weight loss period, they were advised to continue on the weight loss plan for a further three 
months, followed by a condensed three month weight maintenance period.  This allowed a 
12 month “intervention period” for all participants and mirrored the procedures conducted 
by the GCWMS. In order to prevent detection bias, outcomes measures were assessed by the 
researcher (LH) who was blinded to study group allocation at three time points, baseline, six 
months (post weight loss phase) and 12 months at the end of the intervention period. 
 
4.3 Ethical approval 
The study was conducted in accordance with the ethical guidelines of the Declaration of 
Helsinki and consistent with the principles of Good Clinical Practice. Ethical approval was 
received from the Scotland A Research Ethics committee on the 16th of December 2013 
(reference number: 13/SS/0229. Appendix ii).  
 
4.4 Recruitment 
Recruitment is an integral part in the process of conducting a randomised controlled trial as 
poor recruitment can result in an underpowered study and therefore any results that may be 
clinically important without adequately achieving the sample size may be statistically 
inconclusive. One of the main aims of this study was to investigate the feasibility of 
conducting a full-scale, multi-centre trial. Therefore, essential procedures necessary to 
coordinate a full-scale trial such as recruitment and retention to the trial were piloted. 
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There is a lack of a clear framework to inform the recruitment into intervention studies in 
the general population (Foster, Brennan, Matthews, McAdam, Fitzsimons, & Mutrie, 2011). 
Furthermore, research in adults with intellectual disabilities is made more complex due to 
ethical procedures including procedures with informed consent and the inability to directly 
approach potential participants (Cleaver, Ouellette‐Kuntz, & Sakar, 2010; Lennox, Taylor, 
Rey‐Conde, Bain, Purdie, & Boyle, 2005). To attempt to overcome the barriers often faced 
with involving participants with intellectual disabilities in research (Oliver, Piachaud, Done, 
Regan, Cooray, & Tyrer, 2002) this study utilised a multi-point recruitment strategy which 
has shown to be successful in research recruiting adults with intellectual disabilities to a 
physical activity intervention (Melville et al., 2015). This strategy was originally postulated 
in research recruiting participants into walking interventions (Foster et al., 2011). The 
framework was adapted to facilitate recruitment to this study based on the four primary 
stages. 
 
• Stage 1: Identification of potential participants 
An initial planning stage involving identification of potential participants to be recruited to 
the study. Participants were recruited from multiple organisations, from specialist 
intellectual disabilities services, provider organisations and local day centres. A researcher 
(LH) visited staff working in these settings to explain the study and ask if their organisation 
would be willing to support recruitment to the study.  
 
• Stage 2: Invitation to participate in the study 
If organisations and their staff were engaged and supported the study, they were provided 
with study information packs in which they were invited to disseminate to service users they 
deemed would be interested in taking part in the study. One hundred and ninety-five 
information packs were distributed between two day centres, four specialist intellectual 
disabilities services, and one provider organisation and the GCWMS. The information packs 
comprised an invitation to participate in the study and separate information sheets for 
participants, carers and relatives/welfare guardians (see appendix iii). In order to prevent 
identification of numerous potentially ineligible participants, staff were informed of the 
inclusion and exclusion criteria (although final assessment of eligibility into the study was 
made by the researcher after informed consent). On the back of the participant information 
sheet, a tear off slip was provided in which potential participants could complete, where 
appropriate supported by carers, to indicate they were interested in taking part in the study. 
Potential participants replied to the invitation to the study by FREEPOST using the self-
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addressed envelope provided, indicating whether they would like to meet the researcher to 
find out more about the study. 
 
• Stage 3: Response to invitation and assessment of eligibility 
If the participant indicated they would like to find out more information about the study, the 
researcher then made first contact with the individual to arrange an initial visit to further 
discuss the study, at a convenient time and location to the individual. This was following the 
suggestions by Foster et al. (2011) on enhancing the recruitment process by meeting 
participants face-to-face. It was also felt that this approach would provide a better rapport 
with the researcher and the recruited participants (Banks-Wallace, Enyart, & Johnson, 2004).  
At this appointment, more information about the study was discussed and potential 
participants and carers and/or relative/welfare guardians were given the opportunity to ask 
questions about the study. If the individual was willing to participate they provided informed 
consent (see section 4.5) or another meeting was scheduled to give participants time to think 
about the decision of participating. On completion of informed consent participants were 
screened for eligibility and baselines measurements obtained. 
 
• Stage 4: Initiation into intervention 
Participants were assessed individually for their eligibility, however, if participants were 
identified as living together and/or supported by the same carer, participants were 
randomised to the TAKE 5 or WWToo intervention as a cluster to prevent contamination 
between the two interventions. Participants were then contacted by the research dietitian to 
arrange their first appointment (the randomisation process is discussed further in section 
4.7).  
 
In order to evaluate the effectiveness of the recruitment process a record was kept of the 
number of potential participants who contacted the researcher from each of the recruitment 
points.  Individuals consenting to participate in the study (based on the information slips 
returned and liaising with staff at the organisation sites) were recorded. 
 
4.5 Informed consent 
A detailed protocol of consent was implemented prior to any protocol specific procedures 
being carried out.  An information sheet was read to the potential participant and adequate 
verbal explanation about the study provided to them. Potential participants were given the 
opportunity to ask questions and to clarify anything they did not understand. They were also 
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given the opportunity to decline to take part in the research study and it was emphasised that 
the participant may withdraw their consent at any time and to decline to take part in any 
particular aspect without loss of benefits to which they otherwise would be entitled.  Before 
informed consent was obtained the decision of an individual to participate in the research 
study was based on a clear understanding of what the study was about and what was 
involved.  The process of obtaining consent was conducted in accordance with the Adults 
with Incapacity Act, 2000 (Scottish Executive 2000). A carer or someone known to the 
participant, independent from the research team was witness to the consent. In circumstances 
where a participant did not have the capacity to consent to participation in the research study, 
written informed consent to participate was provided from the nearest relative or welfare 
guardian. Ongoing consent was also checked and assessed throughout the study period.  
 
4.6 Sample size 
There are few studies of randomised trials of weight management interventions involving 
adults with intellectual disabilities. Therefore, there is limited data on which to model a 
sample size calculation. The study sample size calculation of 66 participants (33 participants 
to each treatment intervention) is based on the following considerations: 
 
• To determine the probable variance of study outcomes in order to power a larger 
randomised trial. If 50 participants provide 12 month outcome data, a 90% 
confidence interval for each variance estimate will have a width of approximately 
70% of the estimate (i.e. -29% to + 41%) 
 
• To provide sufficient insight into recruitment and retention rates, which will have a 
95% confidence interval of no more than ±10% and help inform the development of 
a full-scale trial 
 
• To account for clustering of individuals (discussed in more detail in section 4.7 
Randomisation) – potential participants identified may live together and/or be 
supported by the same family or paid carers which could lead to some contamination 
between treatments and clustering of outcomes. However, there were few cluster 
randomised trials to base the likely degree of clustering, therefore the following 
assumptions were made (a conservative intra-class correlation coefficient of 0.1, and 
an average of 2 participants per cluster) to increase the sample size by 10% to give a 
sample size calculation of 56 participants 
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• To account for attrition - drop outs during the clinical trials can lead to insufficient 
data to be able to detect significant differences in outcomes. To account for this, 
studies inflate the number of participants required to prevent the trial from being 
underpowered. Review of the multi-component weight management interventions in 
adults with intellectual disabilities (chapter 3) reported variable study attrition rates, 
mean 13% (range 0% to 55.8%). Evidence from the single stranded reports of the 
TAKE 5 and WWToo studies also reported marked differences in the rate of attrition, 
5% and 48%, respectively (Jones et al., 2015; Melville et al., 2011). Therefore, taking 
the attrition rates into consideration, and differences in the delivery of the 
intervention (individual delivery in the TAKE 5 intervention versus group based 
interventions in the other studies) the sample size of this study was increased to allow 
a conservative attrition rate of 20%. This provided a final sample size calculation of 
66 participants.  
 
4.7 Randomisation 
In theory, if participants are randomised individually to a trial, there is potential that 
contamination of intervention specific information may occur between participants in 
different intervention groups. Risk of potential contamination in this study were believed to 
exist if participants had a close relationship, for example if they lived together or, due to the 
major role of social support from carers in this study, if participants were supported by the 
same carer. Thus, cluster randomisation was used in this study to prevent contamination 
between interventions, clustering of outcomes and to minimise imbalance between study 
groups. 
 
As previously discussed in chapter one, in large clinical trials the randomisation process is 
designed to prevent systematic differences in participant characteristics between intervention 
groups. However, when trials are conducted with small sample sizes, intervention groups 
may result in an unequal distribution of participant characteristics due to chance. In order to 
ensure that participant characteristics, which are likely to affect the relationship between the 
treatment and outcome, a statistical analysis technique, stratification, can be performed. In 
the single stranded feasibility study, subgroup analysis revealed that there was a trend in 
participants with Down syndrome (OR 3.50; 95% CI 0.90 to 13.66; p = 0.071) or more mild 
to moderate level of intellectual disabilities to lose weight (OR 4.08; 95% CI 0.97 to 17.21, 
p = 0.055) although results were not statistically significant (Melville et al., 2011). To 
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prevent any imbalances in this study stratification and therefore analysed with adjustment 
for presence of Down syndrome, level of intellectual disabilities and number of participants 
within a cluster was incorporated into the randomisation algorithm. 
 
Randomisation was implemented using an interactive voice response system (IVRS). This 
was hosted by the Robertson Centre for Biostatistics, University of Glasgow a separate 
department from the researcher. The researcher was blinded to participant group allocation 
by registering each participant via telephone call, providing details including the 
participant’s screen number, level of intellectual disabilities and presence of Down 
syndrome. Subsequent to registering a participant in the study, the system notified the 
principal investigator via email of the group allocation (TAKE 5 intervention or WWToo 
intervention). 
 
4.8 Study population 
Eligibility of participants was based on the following inclusion and exclusion criteria. 
 
Inclusion criteria: 
• Diagnosed with intellectual disabilities (Mild/Moderate/Severe/Profound) 
• Adults ≥ 18 years of age (no upper age limit was set in keeping with specialist 
intellectual disabilities health services in the National Health Service Greater 
Glasgow & Clyde and in accordance with the GCWMS) 
• BMI ≥ 30 kg/m2 
• Ambulatory - able to walk (with or without a walking aid) for 10 minutes at a time 
based on self/carer report 
• Not currently on a prescribed or restricted diet e.g. for phenylketonuria or diabetes  
• Not intentionally lost weight of >3kg in the previous three months. 
 
Exclusion criteria: 
• Presence of the following genetic syndromes; Prader Willi syndrome, Cohen 
syndrome or Bardet- Biedl syndrome, due to more intensive weight management 
support required 
• Currently activity involved in any other research study 
• Taking medication for the purpose of losing weight (either prescribed or over the 
counter)  
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• Individuals who were pregnant or who conceive during the study will be excluded. 
 
4.9 Interventions 
4.9.1 Intervention delivery 
The TAKE 5 and WWToo interventions were delivered by a dietitian or a health professional 
trained for the purpose of this study (the health professional received one and a half days of 
training, including instruction on the intervention content and shadowing the dietitian on 
participant appointments). Henceforth, the dietitian and the health professional will be 
denoted by the name research dietitians. The research dietitians delivered both interventions. 
To minimise contamination between the interventions, research dietitians followed a pre-set 
protocol and manual for each intervention session. The intervention sessions were delivered 
one-to-one over a 12 month period, 9-12 sessions in the weight loss phase and six sessions 
in the weight maintenance phase. This was to allow appointments to be organised flexibly 
in order to maximise the consistent involvement of family and paid carers. Each session was 
scheduled to last approximately 40 - 60 minutes. This was to account for individual needs 
and abilities of participants. If for example the session content was too intense for an 
individual, the sessions were designed flexibly to allow the content to perhaps be delivered 
over shorter additional sessions to help carers and participants develop a better 
understanding of the intervention information. Additional sessions were recorded in the 
research dietitian’s clinical notes.  
 
4.9.2 Communication and resources 
Clinical guidelines advocate that the success of behaviour change interventions is dependent 
on them being tailored to the specific needs and context experienced by the individual (NICE 
2014). Adults with intellectual disabilities have difficulties with communication and 
understanding of information, therefore in order for participants to understand the content 
on the intervention and to express their choices during the intervention, appropriate methods 
and techniques were used to facilitate augmentative communication e.g. talking mats and 
pictorial explanations (Murphy & Cameron, 2008).   
 
The resources used in both interventions had previously been piloted in the TAKE 5 single 
stranded feasibility study and in the evaluation of the WWToo intervention (Melville et al., 
2011; Jones et al., 2015) and have shown to be acceptable for adults with intellectual 
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disabilities. These resources are designed to be used flexibly for all adults with varying levels 
of intellectual disabilities and carers where appropriate.   
 
The resources were adapted to meet guidelines on images and easy read text for adults with 
intellectual disabilities (National Equalities Partnership, 2005; Department of Health, 2010). 
These included recommendations for the wording and layout, font size, and colour. 
Examples of resources for the TAKE 5 intervention and WWToo intervention are illustrated 
in appendix v.  
4.9.3 Carer involvement 
The important role of carers in supporting weight loss is highlighted by previous research 
(Fox et al.,1985; Hamilton et al., 2007; Spanos et al., 2013a). Participants were invited to 
be supported throughout the intervention by family and/or paid carers. Carers were offered 
additional one hour training session with the research dietitians on any of the components of 
the intervention. Carers were invited to attend sessions with the research dietitians to help 
with communication or where necessary behavioural change techniques for example goal 
setting and self-monitoring of the participants’ physical activity or dietary intake. 
 
4.9.4 Systematic identification of active intervention components 
In order to conduct a systematic evaluation of the effect and processes of an intervention, it 
is important to be able to identify the ‘active ingredients’ of an intervention (Abraham, Kelly, 
West, & Michie,2009; MRC, 2008; Michie, 2008). The process of extracting the components 
of interventions in particular behaviour change techniques can be facilitated using standard 
terminology and definitions (Abraham & Michie, 2008; Michie et al., 2011). Evaluation of 
the behaviour change techniques utilised in the TAKE 5 and WWToo interventions was 
conducted to explore the effective components and causal mechanisms resulting in clinically 
important outcomes such as weight loss and whether these behaviour changes were 
maintained long term. Furthermore, this aimed to provide a detailed insight into refining the 
interventions for future studies and allow the comparison of intervention components to 
previous literature on weight management interventions. The components of each 
intervention are discussed in further detail below and illustrated in Figure 3.3. The behaviour 
change techniques are coded using the CALO-RE taxonomy due to its reliability and 
applicability to dietary and physical activity interventions (Michie et al., 2011).  
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Figure 4.1. Study Design (Adapted from Harris et al., 2015). 
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4.10 TAKE 5 weight management intervention 
As described in chapter one, diet and physical activity are key components recommended by 
clinical guidelines (NICE 2014; SIGN 2010). To facilitate these healthy lifestyle changes, 
behaviour change techniques are also incorporated into weight management interventions. 
Recommendations advocate interventions should include self-monitoring, goal setting, 
problem solving, relapse prevention, and social support. Research development in behaviour 
change has led to systematic reviews and meta-analysis providing strong evidence for the 
causal mechanism of change in behaviour (Michie et al., 2009). The clarity in understanding 
the process of behaviour change has also been facilitated by standardisation of behaviour 
change taxonomies (Abraham & Michie, 2008; Michie et al., 2011). A meta-analysis of 
effective techniques in healthy eating and physical activity interventions, demonstrated that 
interventions were more effective when they included self-monitoring and at least one other 
technique from Control Theory (Carver & Scheier, 1982) in comparison to interventions not 
including these techniques (Michie et al., 2009). Control Theory proposes that the following 
techniques are fundamental to self-management and control of behaviour: goal setting, 
reviewing goals, and providing feedback on performance (Carver & Scheier, 1982). 
Therefore, evidence from clinical guidelines, and the meta-analysis of behaviour change 
techniques based on Control Theory informed the development of the TAKE 5 multi-
component weight management intervention. 
 
The TAKE 5 intervention comprises two discrete phases: 
• Phase one – an initial weight loss phase of approximately six months  
• Phase two – a weight maintenance phase of approximately six months (or an additional 
three month weight loss period if participants don’t achieve a clinically significant weight 
loss of 5% of initial body weight followed by three months weight maintenance). 
 
The key themes of the TAKE 5 weight loss and weight maintenance intervention phases are 
illustrated in Tables 3.1 and 3.2. Each session consists of a: 
 
• Weight measurement 
• Diet discussion point 
• Physical activity discussion point 
• Behavioural discussion point 
• Target setting 
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• Summary 
 
Repetition is essential to facilitate learning and understanding for adults with intellectual 
disabilities therefore reoccurring messages are implemented into each session. 
 
4.10.1 TAKE 5 intervention components 
4.10.1.1 Phase 1: Weight loss 
4.10.1.1.1 Diet 
 
To facilitate a healthy sustainable weight loss of 0.5-1 kg per week, an energy deficit of 600 
kcal per day deficit through modification of dietary intake is advocated by clinical guidelines 
(NICE 2014; SIGN 2010). This recommendation is supported by high quality evidence from 
a systematic review and meta-analysis of randomised controlled trials of dietary 
interventions (NICE 2006). Interventions were included if they had a minimum 12 months 
duration and were conducted in overweight and obese adults (BMI range 27.9 kg/m2 to 34.0 
kg/m2). The effect size was reported for studies categorised as including either a 600 kcal 
EDD or a low fat diet due to limitations in the reporting of primary studies, preventing a 
clear distinction between dietary approaches. Twelve studies were included and found that 
the WMD at 12 months between studies utilising a 600 kcal EDD or low fat diets and control 
was -5.31 kg (95% CI -5.86 kg to – 7.77 kg).  
 
Participants’ individual EDD was calculated as the estimated total energy expenditure (TEE) 
of each participant minus an energy deficit of 600kcal per day. TEE for each participant was 
calculated using the following equations: 
 
• TEE = Basal metabolic rate (BMR) x physical activity level (PAL) 
 
BMR was calculated based on age, gender, weight and height (Mifflin et al., 1990): 
 
• Females: BMR = 10 x weight (kg) + 6.25 x height (cm) – 5 x age (years) – 161. 
 
• Males: BMR = 10 x weight (kg) + 6.25 x height (cm) – 5 x age (years) + 5. 
 
The equation by Mifflin and colleagues (Mifflin, St Jeor, Hill, Scott, Daugherty, & Koh, 
1990) was used as it has been shown to more accurately estimate BMR in comparison to 
103 
 
other prediction equations when applied in overweight and obese adults (Weijis & Vansant, 
2010).  
 
A PAL of 1.3 was used as results from the pilot single stranded study of the TAKE 5 multi-
component intervention reported that individuals with intellectual disabilities and obesity 
are extremely sedentary and engage in low levels of physical activity, engaging on average 
13.1 (SD 6.2) minutes per day in moderate-to-vigorous-intensity physical activity (Melville 
et al., 2011).  Thus, it is believed that the PAL of 1.4 used in the single stranded study may 
have overestimated total energy requirements. To account for this, a PAL of 1.3 was used in 
this study which is consistent with the available evidence of another randomised controlled 
trial in the general population, examining the efficacy of a 600kcal EDD in comparison to a 
generalised 1500 kcal low-calorie diet in overweight and obese participants (Leslie, Lean, 
Baillie & Hankey, 2002). 
 
The EDD provides daily energy intake from a specified number of daily portions 
individually calculated for each participant by the research dietitians. This is based on the 
five food groups in the Eatwell plate: starchy foods such as bread, rice, potatoes and pasta; 
meat/fish and alternatives; fruit and vegetables; milk and dairy products; foods high in sugar 
and fat [Food Standards Agency (FSA), 2009].  
 
The amount of energy intake of each individual was dependent on the variables above, 
gender, age, height and weight. Therefore, larger participants consumed more calories on 
their EDD in comparison to someone of a lesser body weight. To ensure nutrient adequacy 
(NICE, 2014) the energy intake was limited to between 1200 and 3000 kcal per day. 
 
An example EDD prescribed for participants on 1500kcal energy intake and 3000 kcal 
energy intake is illustrated in Figure 4.2. This figure also presents an example of the images 
used for participants with intellectual disabilities in the TAKE 5 intervention. The five 
segments of the eat well plate indicate the amount of portions to be consumed from the diet, 
with fruit and vegetables (~30-40% of energy intake) and starchy foods (~30%) being the 
largest, followed by milk and dairy products (~10-20% of energy intake) and meat fish and 
alternatives (~10-15% of energy intake) and the smallest intake from foods high in fat and 
sugar (~5-10% of energy intake). This is based on recommendations of energy intake from 
macronutrients in the form of 50% of energy intake from carbohydrates, less than 35% from 
fat and 20% from protein (Department of Health, 1991).  
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The EDD was designed to be used flexibly with participants and carers, portions could be 
swapped for alternatives and extra kcal allowances were provided, for example to provide 
energy intake for treats at the weekend. 
 
 
 
Figure 4.2. Example of energy intake from the five food groups of participants on an energy 
prescription of 1500 kcal and 3000 kcal. Eatwell plate images from the TAKE 5 resources.  
 
4.10.1.1.2 Physical activity 
 
The physical activity component was based on health education of the benefits of being 
physically active and followed consensus guidelines on physical activity interventions for 
beginners (O’Donovan et al., 2010). The guidelines focus on supporting people to gradually 
increase their participation in physical activity and work towards achieving  health 
recommendations on the duration and intensity of physical activity (Department of Health 
2004; NHS Health Scotland 2009).  
 
Participants’ physical activity patterns were assessed at the start of the intervention and 
individualised physical activity plans made, primarily focussing on the following physical 
activities: 
 
1) Lifestyle physical activity: Physical activity that could be performed in the home 
environment such as housework, walking up stairs and following the interactive You 
Can Do It DVD 
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2) Walking: based on baseline average steps per day, individuals were encouraged to 
set targets to progressively increase walking behaviour and used pedometers to 
monitor step counts 
 
3) Sport and exercise: information was given to each participant on local leisure 
facilities and clubs with accessible sports and exercise groups/classes (Melville et 
al., 2011).  
 
Since many adults with learning disabilities have been shown to live sedentary lifestyles and 
to be less physically active compared to the general population (McGuire et al. 2007; Temple 
& Walkley, 2007), a major focus of this intervention component was also to interrupt time 
spent inactive and engaged in sedentary behaviours This was achieved throughout the 
intervention, by assessing the participants’ lifestyle habits such as watching television and 
sitting for long periods, and encouraging activity during add breaks when watching 
television such as walking or dancing when music is played. 
 
In order to discourage the participants from being physically active by overloading them 
with unachievable goals, activity was gradually increased particularly in the early stages, by 
setting achievable goals in order to build confidence and increase the participants’ 
motivation to being physically active. Furthermore, small increases in physical activity have 
shown to have health benefits independent of weight loss (NICE, 2014). 
 
4.10.1.1.3 Behaviour change techniques 
 
As previously mentioned the success of behaviour change interventions is dependent on 
them being tailored to the individual’s needs (NICE 2014). Following  recommendations by 
clinical guidelines (SIGN 2010; NICE 2014) and based on the evidence on behaviour change 
techniques based on Control Theory (Carver & Scheier, 1982), goal setting, self-monitoring, 
review of goals and feedback on performance are considered to be successful techniques in 
supporting healthy lifestyle changes (Michie et al., 2009), therefore these were used in every 
session.    
 
However, it is noted that due to the cognitive abilities of individuals with intellectual 
disabilities some of these techniques may be challenging for this population group. 
Therefore, other techniques were designed to be incorporated flexibly in relation to the needs 
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of the individual participants and included relapse prevention/coping planning and barrier 
identification/problem solving. For a full list of the behaviour change techniques utilised in 
the TAKE 5 intervention see Figure 4.3. The principal techniques are discussed in more 
detail below: 
 
4.10.1.1.3.1 Goal setting 
 
The primary goal for participants was to achieve a clinically significant weight loss of 5-
10% body weight. This was communicated with participants at the start of the intervention 
period and subsequent goals made in relation to this overall aim throughout. This was 
achieved by setting smaller achievable weight loss goals of 0.5-1kg per week. This is in 
accordance with clinical guidance (SIGN 2010; NICE 2014). Goals were set at the end of 
each session (and reviewed at the following session) and focused on dietary habits and 
physical activity. Goals were Specific, Measurable, Achievable, Relevant and Time specific 
[SMART] (Doran, 1981) to each individual. 
 
4.10.1.1.3.2 Self-monitoring 
 
Participants were encouraged to monitor their food intake with support from carers, to the 
specified number of portions of the EDD. Participants were provided with food and physical 
activity diaries and asked to record their food intake by putting a dot by the food group when 
they had consumed it. In addition, participants were given a pedometer and asked with 
support from carers to note the number of steps they performed per day and any other 
physical activities they had engaged with.  
 
4.10.1.1.3.3 Provide feedback on performance 
 
At the start of each session participants were weighed and the research dietitians provided 
participants with a record of their body weight.  
 
4.10.1.1.3.4 Relapse prevention/ coping planning 
 
Participants were prepared to deal with small lapses such as increases in weight gain 
throughout the intervention as and when the research dietitians felt appropriate. Coping 
strategies were rehearsed to prepare the participant to deal with uncertain situations such as 
eating out and when faced with unfamiliar foods. In addition, session eight devoted a focus 
to relapse prevention of weight gain. 
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4.10.1.1.3.5 Barrier identification/ problem solving 
 
Due the one to one interaction with the research dietitians in the TAKE 5 intervention, this 
allowed exploration of the participants’ individual context and environment. Any issues that 
prevented the participant form eating healthily or participating in physical activity were 
attempted to be resolved such as, engaging in physical activity due to difficulty accessing 
physical activity facilities. A solution provided was examples of lifestyle physical activity 
that can be conducted in the participant’s home environment.   
 
4.10.1.1.3.6 Stress management 
 
At each session participant’s dietary intake and physical activity were reviewed. At this point 
cues, internal or external were identified that positively or negatively influenced the 
participant’s behaviour. Any positive cues were encouraged and negative cues discussed to 
find strategies to overcome these. For example, avoiding cues that would facilitate over-
eating such as watching television and participating in sedentary behaviour.  
 
4.10.1.1.3.7 Prompt reward contingent on effort or progress towards 
behaviour 
 
Motivation was achieved through reinforcement of the diet and physical activity messages, 
and encouragement when a participant achieved a lifestyle goal or weight loss. 
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Table 4.1. TAKE 5 key themes for weight loss 
 Theme Sub-theme 
Session 1  Benefits of losing weight and motivation 
towards a healthy  
lifestyle 
 
    Introduction to TAKE 5    
    booklets 
 
    Introduction to food groups  
    that make up healthy balanced  
    diet 
 
    Set first weight loss goal  
 
Session 2 Introduction to individualised 
 energy deficit diet and the 
 importance of physical activity 
 
    Food portions 
 
    Benefits and ways to being  
    active 
 
Session 3 Principles of healthy eating and 
improving physical activity levels 
 
 
    Taking control of diet 
 
    Meals, snacks and fluid 
 
    Introduction to physical  
    activity diaries and pedometer 
 
Session 4 Healthy ways to cook and healthy 
shopping lists 
 
 
    Menu planning 
 
    Emotions and overeating 
 
Session 5 Changing behaviour and stopping  “bad 
habits” 
 
 
    Disadvantages of eating out  
    and take-aways 
 
Session 6 Coping with cravings and  
evaluating knowledge of physical activity 
 
    Techniques to help with     
    cravings 
 
    Physical activity quiz 
 
Session 7 Motivation to being active 
 
    New ways to motivate   
    physical activity 
 
    Diet myths 
 
Session 8 Relapse prevention 
 
    Lapses and ways to prevent  
    them 
 
    Coping with setbacks 
 
    Getting support from others 
 
Session 9 Review      Evaluate success in the  
    programme 
 
    Review healthy balanced diet  
    and physical activity 
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4.10.1.2 Phase 2: Weight maintenance 
4.10.1.2.1 Diet 
 
Dietary intake for the weight maintenance phase was modified based on the six month 
weight loss during the weight loss phase. If participants had lost a clinical weight loss of 5% 
of initial body weight, they were offered a personalised energy prescription diet to maintain 
their body weight. The diet followed the same dietary principles used in the weight loss 
phase, without an energy deficit of 600 kcal per day.  It was aimed to ensure a eucaloric 
dietary prescription and intake. If participants did not achieve a weight loss of 5% they were 
offered the option of continuing on their current EDD for a three month period followed by 
three months of a eucaloric energy prescribed diet to maintain their body weight. 
 
4.10.1.2.2 Physical activity 
 
The importance of physical activity was highlighted in the maintenance phase as it plays an 
important role in sustaining any reductions in body weight (Catenacci & Wyatt, 2007; SIGN 
2010; NICE 2014).  Individuals were encouraged to build on the levels of physical activity 
they achieved in phase one and continued to aim to meet clinical recommendations.  
4.10.1.2.3 Behaviour change techniques 
 
To maintain body weight loss participants were encouraged with support from carers where 
appropriate to maintain the healthy lifestyle habits from phase one. Behavioural strategies 
used in the weight loss phase were continued to be used flexibly. Specific approaches, in 
particular, relapse prevention/ coping planning and barrier identification/ problem solving 
were used to prevent large fluctuations in increased body weight and a negating of any 
benefits of the weight lost from baseline. In addition to self-monitoring of key lifestyle 
behaviours of food intake and habitual physical activity, participants were encouraged to 
self-monitor their body weight as this has been shown to help with weight maintenance 
(Wing & Phelan, 2005) and also aimed to help to imbed this as part of their routine and 
facilitate weight maintenance after the intervention has finished. 
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Table 4.2. TAKE 5 key themes for weight maintenance intervention 
 Theme Sub-theme 
Session 1  Weight maintenance and new 
individualised maintenance dietary plan 
 
    Importance of not regaining the  
    weight loss 
 
    New diet plan  
Session 2 Importance of being active and adopting 
regular eating patterns 
 
    Meal planning  
 
    Maintaining motivation for     
    physical activity and new options  
    to be active 
 
Session 3 Regular self-monitoring      Importance of food diaries and     
    monitoring physical activity (e.g.  
    step counts) 
 
    Introduction to self-weighing 
Session 4 Overview of barriers to healthy eating and 
physical activity 
 
    Strategies to choose healthy meal      
    options and saying no to  
    unhealthy food 
 
    Finding time to be active 
 
Session 5 Snacking, lapses, eating out/social 
activities 
 
    Healthy snack options 
 
    Not returning to bad / old habits 
 
    Healthy menu choices from  
    restaurants 
Session 6 Healthy menu plan and review of 
principles of weight maintenance 
 
    Overview of programme 
 
    Healthy meal plan for the future 
 
    Importance of regular self- 
    monitoring of body weight 
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4.10.1.2 TAKE 5 resources 
The TAKE 5 intervention included four information booklets, specifically designed to 
support adults with intellectual disabilities to lose weight with support from their carers. The 
acceptability and utility of the booklets was investigated in the qualitative study with family 
and paid carers (Spanos et al., 2013b) and found to be a useful source of information and 
suitable to the developmental needs of adults with intellectual disabilities. The use of images 
was highly regarded by carers who reported that all adults with intellectual disabilities could 
engage with the books irrespective of their ability to read. Further details on the title and aim 
of the booklets have been described below: 
 
Booklet 1: Eat well- Feel well: The aim of the booklet was to provide basic information 
regarding healthy eating based on the “Eat Well” plate (FSA, 2009). 
Booklet 2: You can do it: The aim of the booklet, accompanied by a DVD, aimed to 
motivate participants to improve their physical activity 
Booklet 3: How to help someone lose weight: The aim of the booklet was to motivate the 
carers to support participants who were attempting to lose weight 
Booklet 4: Get help with losing weight: The aim of the booklet was to introduce the 
importance of losing weight and the need of involving other people in this difficult process 
 
Additional resources included for the TAKE 5 intervention sessions were: 
• Food diaries – based on the Eatwell plate 
• Physical activity diaries 
• Hand-outs for each session 
 
 
4.11 WWToo comparator intervention 
WWToo was developed by a partnership group of health professionals, NHS Dietitians, 
Learning Disabilities Nursing, and Glasgow Council (Health Improvement and Glasgow 
Life). The aim of the intervention was to provide information and support on how to lose 
weight and adopt a healthier lifestyle. WWToo was developed from the original mainstream 
Waist Winners weight management programme designed to be used in adults. The content 
and resources was adapted to a more accessible format specifically for adults with 
intellectual disabilities (Jones et al., 2015).  
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WWToo was originally developed and delivered as a community group intervention with 
eight, one hour sessions delivered over seven weeks. A retrospective evaluation of the 
WWToo reported change in body weight post intervention at seven weeks, and 13 weeks 
(follow up) from baseline. Participants significantly decreased body weight -1.67 kg (95% 
CI -2.65 kg to -0.69 kg; p = 0.002) and -2.48 kg (95% CI -4.70 kg to -0.25 kg; p = 0.032), 
respectively. Five participants (36%) out of the 29 participants achieved a clinically 
important weight loss at the 13 week follow up appointment. Significant reductions in the 
health risk factors BMI and waist circumference were also illustrated at follow up time points 
(waist circumference was only measured at seven weeks). Furthermore, investigation into 
process measures demonstrated that the intervention was found to be acceptable to adults 
with intellectual disabilities and their carers.  
  
For the purpose of this research study the delivery was modified to an individualised 
intervention, delivered on a one-to-one basis.  Participants in this comparator intervention 
received the same number of sessions as participants in the TAKE 5 intervention. To retain 
participants to the study for the same duration period as those allocated to TAKE 5, a weight 
maintenance phase for WWToo was developed. 
 
4.11.1 WWToo intervention components 
4.11.1.2 Phase 1: Weight loss 
4.11.1.2.1 Diet 
 
The dietary component to the intervention focused on a health education approach. This was 
based on the principles of a health balanced diet based on the Eatwell plate (FSA, 2009). 
Food and drink was categorised as ‘healthy’ such as fruit and vegetables, ‘unhealthy’ such 
as food high in fat and sugar and other ‘healthy’ foods such as starchy foods and dairy 
products but to be had in portion controlled amounts. To facilitate understanding of 
categorisation of ‘healthy’ and ‘unhealthy’ foods, foods were coded by three colours: Red = 
unhealthy, Green = healthy and Orange = healthy but limit intake of these foods. These food 
sheets were also used to help self-monitor food intake between sessions. An overview of the 
themes of the intervention session is illustrated in Table 4.3. 
4.11.1.2.2 Physical activity 
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Physical activity was discussed based on current public health recommendations on 
increasing activity and reducing sedentary behaviour (NICE 2014). Session seven was 
devoted to education on the benefits of physical activity and at each session participants 
reviewed their current participation in physical activity and set new goals to increase 
physical activity levels.  
4.11.1.2.2 Behaviour change techniques 
 
The main focus of the intervention session was to provide educational information on healthy 
lifestyle behaviours. This was achieved by the inclusion of behaviour change techniques. 
The primary techniques included in each session were goal setting, self-monitoring and 
feedback on performance. A full list of the behaviour change techniques used is presented 
in Figure 4.3. 
4.11.1.2.2.1 Goal setting 
 
Participants set either a physical activity related goal or a dietary goal each week. These were 
based on the SMART principles (Doran, 1981). 
4.11.1.2.2.2 Self-monitoring 
 
Self-monitoring of food intake was encouraged between sessions participants recorded their 
food intake by marking a green, orange or red dot on the food sheets to indicate the unhealthy 
and healthy foods consumed. 
4.11.1.2.2.3 Provide feedback on performance 
 
At the start of each session participants were weighed and the research dietitians provided 
participants with a record of their body weight. The research dietitian also reviewed 
participant’s food charts and provided information about their food intakes and whether or 
not they had achieved a healthy or unhealthy diet.  In both cases approaches to improve 
quality and quantity of the participants overall dietary intake was provided.  
 
4.11.1.3 Phase 2: Weight maintenance 
After the initial nine sessions focussing on weight loss, participants met with the research 
dieticians a further six times. Each meeting was a session and it focussed on assisting the 
retention of knowledge delivered in the first phase of the intervention. Support was also 
provided for participants to continue to monitor their diet, physical activity and body weight.  
At each session, an opportunity for questions related to maintaining body weight was offered 
and any queries addressed. 
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Table 4.3. WWToo key themes for weight management 
 Theme Sub-theme 
Session 1  Introduction to health and weight 
 
    Food Groups – Good and bad  
    food 
 
    Energy balance 
 
    Food diaries 
 
Session 2 Planning Meals and importance of 
physical activity 
    Food groups 
 
    Portion sizes 
 
    Healthy/unhealthy snacks 
 
Session 3 Food labelling and fats     Choosing healthy food options  
    when shopping 
 
    Identifying high fat food and      
    healthier alternatives 
 
Session 4 Food labelling salt and sugar     Recognising supermarkets  
    healthy labelling range of foods 
 
    Identifying high sugar foods and  
    healthier alternatives 
 
Session 5 Shopping, budgeting, snacks, eating 
out and take-aways 
    Healthy food options in  
    restaurants and take-aways 
 
Session 6 Alcohol and other drinks     Healthy and unhealthy drink  
    options 
 
    Importance of drink enough 
 
    Effects of alcohol on weight gain 
 
Session 7 Benefits of exercise     Different types of physical  
    activity 
 
    Incorporate physical activity in   
    daily routine 
 
Session 8 Review     Review healthy food and  
    physical activity 
 
Session 9 *Evaluate what has been learned 
 
    Evaluate knowledge  
 
    Questions and feedback 
 
Weight 
Maintenance 
Weight maintenance question and 
answer session 
Address any questions regarding 
diet and physical activity 
*Additional session to maintain the same number of sessions as TAKE 5 
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4.11.1.4 WWToo resources 
 
The WWToo intervention was centred around diet sheets which illustrated how foods were 
split into red (unhealthy), yellow (healthy in moderation) and green (healthy) groups. These 
resources were piloted in the retrospective evaluation by Jones et al., (2015). Process 
evaluation with carers revealed that these diet sheets were popular and acted as a good visual 
aid. 
 
4.11.2 TAKE 5 vs WWToo intervention components 
Guidelines set out by the MRC for developing and evaluating complex interventions 
highlight it is important to establish the effective or ineffective components of an 
intervention (MRC, 2008). The two multi-component interventions under investigation are 
both made up of a diet, physical activity and behaviour change component. However, the 
distinct difference between the two interventions was based on the inclusion of the 
quantitative EDD of the TAKE 5 intervention. Based on the principles of energy balance 
this aimed to facilitate a 0.5-1 kg per week weight loss (if full compliance was achieved).  
Whereas, the diet component in the WWToo intervention is dietary advice, compliance with 
which cannot be quantified. The physical activity component of the TAKE 5 intervention is 
more comprehensive in that it included the use of pedometers and finally the behaviour 
change techniques utilised in the TAKE 5 intervention to facilitate weight loss through 
changes in diet and physical activity are more numerous and used more flexibly to meet the 
individual participants needs. Comparison of the two interventions has been illustrated in 
Figure 3.3. 
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Figure 4.3. Comparison of intervention components between groups. The components 
consistent across both interventions are colour coded in blue.  
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4.12 Outcomes 
4.12.1 Primary outcome 
The primary outcome measure was the difference in body weight at twelve months from 
baseline between the two treatment groups.  
 
4.12.2 Secondary outcomes 
Secondary outcomes include: 
• Weight loss of five percent or more of initial body weight,  
• Change in BMI, waist circumference and percentage body fat.   
• Mean percentage time per day spent engaged in moderate-vigorous intensity physical 
activity; light intensity physical activity and engagement in sedentary behaviour. 
• Change in health related Quality of Life. 
 
Change from baseline at the end of the weight loss intervention period (6 months) and end 
the intervention (12 months) will be analysed for each secondary outcome. 
 
4.13 Outcome measurements 
4.13.1 Demographic and health questionnaires 
Data on the following demographics and health were collected at baseline on the clinical 
reporting forms for the study. 
• Demographics [age (years), sex, marital status, ethnicity, Scottish Index of Multiple 
Deprivation (SIMD) decile and social support (Scottish Government, 2012)] 
• Physical and mental health questionnaires (Epilepsy, vision, hearing, mental health 
and problem behaviours). 
 
4.13.2 Level of intellectual disabilities 
The level of intellectual disabilities of participants, in keeping with the ICD-10 definition, 
was calculated from the ability and development questionnaire . The questionnaire measures 
development level through assessing participants’ ability and need for support in five key 
areas of functioning: eating and drinking, intimate care, personal safety, communication and 
decision making. A total score between 5 and 25 was obtained from the sum of the five 
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individual questions, which was then used to categorise level of intellectual disabilities, 
based on the following scores:  
 
• Mild: 5-8 
• Moderate: 9-13 
• Severe: 14-19 
• Profound: 20-25 
 
Total scores assessed by the ability and development questionnaire have shown to be highly 
associated with the Vineland’s Adaptive Behaviour Scale a validated assessment of 
functioning and ability level (Sparrow, Balla, & Cicchetti, 1984) and the questionnaire has 
been previously used as a measure of level of intellectual disabilities (Cooper,1997; Melville 
et al., 2008). 
 
4.13.3 Anthropometric outcomes 
The accurate assessment of body composition is necessary to provide valid results on the 
efficacy of the weight management interventions. The criterion methods for measuring body 
composition are considered to be complex. These include lab based methodologies such as 
doubly labelled water and dual energy X-ray absorptiometry (DEXA) (Stewart, Bramley, 
Heighton, Green, Horsman, Losowsky, & Smith, 1993; Lean Han & Deurenberg, 1996). 
These methodologies are also considered to be invasive and not commonly used in clinical 
studies. Other measures of body composition are inherently subject to methodological 
limitations and error due to the indirect nature however often offer a more practical and less 
time intensive approach (Lee & Gallagher, 2008). Anthropometric measurements provide 
an alternative methodology which are more routinely used in clinical practice. The reliability 
of anthropometric measurements is dependent on the standardisation of anatomical sites on 
the body and also the skill level of the researcher undertaking the measurements (Wang 
Thornton Kolesnik & Pierson, 2000). To ensure accuracy and reliability of measurements 
the researcher measuring outcomes undertook training to level one of the international 
society of anthropometry and kinesiology (ISAK) (Marfell-Jones, Olds, Stewart, & Carter, 
2006).  
 
Measurements of participants’ weight, height, waist circumference and triceps skinfold 
thickness measured were conducted. Measurements were made with the participant wearing 
light clothes without shoes. All measurements were made in duplicate and the final value 
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calculated as the mean of the two measurements. Weight in kilograms (kg), was measured 
to the nearest 100 grams (g), using SECA877 scales (SE approval class III; SEA Germany).  
Height in meters (m) was measured to the nearest 1mm (mm) using the SECA Leicester 
stadiometer (SECA, Germany).  
 
BMI has been utilised as an indicator of health (Sohler, Lubetkin, Levy, Soghomonian, & 
Rimmerman, 2009) and previously in randomised trials of weight management interventions 
in adults with intellectual disabilities (Bergström et al., 2013; Pett et al., 2013). BMI is 
widely used to assess weight status and categorise participants as underweight, normal 
weight, overweight and obese (WHO, 2004). BMI was calculated using the following 
equation: BMI = weight/height 2 (kg/m2). However, BMI is limited as it cannot distinguish 
between fat and fat free mass (Romero-Corral et al., 2008). Therefore, the combination of 
other anthropometric measurements girths and percentage body fat can provide additional 
information on body composition changes. Another commonly used anthropometric 
technique recommended as a measure of health and weight status is waist circumference 
(WHO, 2004). Waist circumference is a measure of the central abdominal fatness and may 
be particularly useful as a measure in adults with Down syndrome who have been reported 
to have large amounts of central adiposity (González-Agüero, Vicente-Rodríguez, Ara, 
Moreno, & Casajús, 2011). 
 
Waist circumference was measured to the nearest 0.5 centimetre (cm) at the midpoint 
between the iliac crest and the lowest rib, in full expiration whilst the participant is standing 
(WHO, 2008). This deviated from the ISAK procedure on assessment of waist 
circumference, due to difficulties in finding the midpoint on the natural contours of the body 
in adults with obesity and to allow comparison with previous research utilising the method 
by the WHO.  
 
Skinfold measurements can be used to calculate percentage body fat which has been shown 
to be a valid estimate of body composition in adults with obesity in the general population 
(Lean et al., 1996). Percentage body fat was calculated using the triceps skinfold thickness 
(mm) measured to the nearest 1 mm, waist circumference (cm) and age (years) of the 
participant.  Separate regression equations for male and female participants, developed by 
Lean et al. (1996) were used to predict body density and percentage body fat. 
 
Men 
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• Body density = 1.1554 – (0.000761 x waist) – (0.00170 x triceps) – (0.000532 x age) 
• Percentage body fat = (0.353 x waist) + (0.756 x triceps) + (0.235 x age) – 26.4 
 
Women 
• Body density = 1.1062 – (0.000482 x waist) – (0.00140 x triceps) – (0.000453 x age) 
• Percentage body fat = (0.232 x waist) + (0.657 x triceps) + (0.215 x age) -5.5 
 
4.13.4 Physical activity outcome 
Physical activity was objectively measured by accelerometers, worn by participants prior to 
the start of the intervention and at the six and 12 month data collection time points. 
Accelerometers used were small devices which measured the acceleration of the body during 
movement (Chen & Bassett, 2005). These accelerations are then converted into activity 
counts which are the interpreted by cut points or equations to provide information on the 
frequency, intensity and duration of physical activity (Hinckson & Curtis, 2013). 
Accelerometers are considered the gold standard methodology for measuring habitual 
physical activity (Lee et al., 2015) and have been used previously in studies involving adults 
with intellectual disabilities, further illustrating them to be a reliable measure of levels of 
physical activity (Temple et al., 2000; Temple & Walkley 2003). 
 
Participants were invited to wear the Actigraph GT3X+ (Manufacturing Technology inc., 
Florida), worn at the hip, attached to a belt worn round the waist  and worn for a seven day 
period at each time point. Participants were instructed to wear the Actigraph during all 
waking hours; except when showering, bathing or swimming.  
 
In order to ensure the validity of the accelerometer data, the minimum data requirement was 
set at six hours of data, on at least three days from seven (Penpraze, Reilly, MacLean, 
Montgomery, Kelly, Paton, & Grant, 2006). If this requirement was not met, the 
accelerometer data were considered invalid and excluded in the analysis. The accelerometers 
were set to record activity over 15 second intervals (epochs). The activity counts for four 
consecutive epochs summed to give activity counts per minute (cpm). This was the 
categorised as four levels of activity intensity based on recommendations from previous 
studies (Atkin et al., 2012): 
 
• sedentary behaviour 0 – 99 cpm 
• light intensity activity 100 – 1951 cpm  
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• moderate intensity activity 1952 – 5724 cpm 
• vigorous intensity activity greater than 5725 cpm.   
 
The accelerometer data were used to calculate the mean time (minutes), and the percentage 
time per day, spent in each level of activity. 
 
4.13.5 Health related quality of life 
The EQ-5D questionnaire was used to measure health related quality of life (Brooks, 1996). 
The EQ-5D consists of two parts the EQ-5D descriptive systems and the visual analogue 
scale (EQ VAS). The descriptive system was based on five dimensions: mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression. Participants were required to rate 
each domain based on three levels: no problems, some problems or extreme problems. The 
EQ VAS requires participants to self-report their health on a vertical scale ranging from 
‘worst imaginable health state’ to ‘best imaginable health state’. The EQ-5D has been shown 
to be reliable, valid and sensitive to change in adults with obesity (Sach, Barton, Doherty, 
Muir, Jenkinson, & Avery, 2007).  
 
Due to the difficulties adults with intellectual disabilities are reported to experience in terms 
of communication and level of understanding the youth version of the EQ-5D was used as it 
is aimed at young people aged seven years and older, which corresponded approximately to 
the developmental level of adults with mild/ moderate intellectual disabilities.  
 
Carers were also asked to rate their opinion of the participant’s health on the five domains 
of the EQ-5D and the EQ VAS. This was then compared with the responses of participants 
classified as having mild intellectual disabilities and the level of agreement between the two 
responses assessed.  
 
4.13.6 Process evaluation measures 
There are a number of frameworks and methodological approaches to conducting process 
evaluations.  There is overlap between process evaluation frameworks, for example, the 
measure of fidelity or implementation is commonly measured (Moore et al., 2015). Other 
frameworks recommended by the MRC guidelines exist, including the RE-AIM framework 
(Glasgow et al., 1999). However, the aim of this framework was to support translation of 
research into practice (Glasgow et al., 1999) which is not consistent with the aim of this 
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study at this stage of the research process.  Process evaluation components were guided by 
the framework of Linnan & Steckler., (2002) as this has been shown to be the most 
comprehensive process evaluation including seven key process domains and is particularly 
relevant to measuring the feasibility and fidelity of complex interventions. Research 
questions were developed in accordance with each of the seven key process evaluation 
components: context, reach, dose delivered, dose received, fidelity, implementation and 
recruitment. As this process evaluation was designed subsequent to the start of the 
intervention, data collection methods were selected on their feasibility within the scope of 
the trial. Both qualitative and quantitative methods are used in combination to provide a 
detailed insight into the above processes (Moore et al., 2015). The key components and the 
data collection methods used for analysis discussed in more detail below. There is some 
similarity and overlap of the definitions of the process evaluation components, in particular 
the reach, dose delivered and fidelity. 
 
4.13.6.1 Context 
Context related to environmental factors that may have affected the implementation of the 
intervention. It also incorporates contextual aspects which may have influenced study 
outcomes such as the setting in which the intervention was delivered. To explore this 
domain, information on participants’ geographical location and level of social deprivation 
was obtained from the case reporting forms. A record of the location of the delivery of the 
sessions was also recorded from the therapists’ notes. Furthermore, investigation into 
contextual barriers was explored in the qualitative interviews with the research dietitians.  
 
4.13.6.2 Reach 
Reach is a measure of the extent of which the intended population, adults with intellectual 
disabilities and obesity participate in the intervention. This is measured by attendance at the 
intervention based on the research dietitians’ session attendance records for participants. 
Barriers to participants participating in the intervention were also explored in the qualitative 
interviews with the research dietitians. 
 
4.13.6.3 Fidelity 
Fidelity is defined as the extent to which the intervention was implemented by the research 
dietitians as intended.  Information on the research dietitians delivering the information in 
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terms of qualifications, relevant experience and training needs was captured by the 
qualitative interviews. 
 
Fidelity of the intervention was explored by post-evaluation of the intervention session 
manuals. The research dietitians were directed to at the end of each session complete a 
checklist of the components delivered in each session. They also noted any deviation from 
the manual for example if content was left out or if new information was provided with 
rationale. This method is reported as a more feasible approach to monitoring fidelity (Linnan 
& Steckler, 2002) and was selected over the criterion method of direct observation (Hill, 
Maucione, & Hood, 2007) as it was felt that having additional unknown researchers would 
negatively affect the relationship between the participant and research dietitians which is 
fundamental to the delivery of the intervention. Furthermore, in the qualitative interviews, 
adaptations to the intervention and challenges faced with implementation the intervention as 
planned were explored. 
 
4.13.6.4 Dose delivered 
Dose delivered is the number of intended sessions that were delivered to the participants and 
the number of each intervention component delivered. This is a measure of the research 
dietitians’ efforts to deliver the intervention. Data were obtained from the attendance records 
and checklists. 
 
4.13.6.5 Dose received 
Dose delivered is the extent to which participants engage with the content of the intervention 
they received. This includes materials or resources and the extent to which they implement 
these as they are intended. This was explored in the qualitative interviews to assess if the 
content of the intervention and mode of delivery worked for this population group. As 
described above attendance records were obtained by the research dietitians. In addition, the 
research dietitians recorded clinical notes at the end of each session, detailing what parts of 
the session were well received and any difficulties experienced. 
 
4.13.6.6 Implementation 
Implementation represented a combination of the extent to which the intervention was 
delivered as intended (fidelity) and received by participants (dose received). 
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4.13.6.7 Recruitment 
Recruitment related to the procedures and strategies used to approach and identify potential 
participants to enrol in the study. Recruitment strategies have been reported from a narrative 
perspective by the researcher (LH) from information provided through liaising with health 
professionals, community organisations and day centre staff during the multi-point 
recruitment strategy. Furthermore, information was collected through receipt of invitations 
to participate in the intervention. A record of participants was kept from each recruitment 
site. Information on retention rates was noted when participants dropped out from the 
intervention. 
 
4.14 Data analysis 
4.14.6 Quantitative data analysis 
4.14.6.1 Analysis principles  
The primary analysis in this thesis were conducted as a completers intention to treat (ITT) 
analysis and exploratory analysis was conducted as per-protocol analysis. ITT is considered 
the gold standard statistical approach in clinical trials (Gupta, 2011; Hollis & Campbell, 
1999). ITT aimed to eliminate potential bias associated with drop outs, missing data or 
deviations from the initial sample size calculation. ITT analysis was defined as analysing 
participants according to initial randomisation, irrespective of what happened to the 
participant after this point, i.e., whether they complied with the intervention or dropped out 
from the study). There are several advantages to ITT as it aims to emulate the effects of 
treatments in the ‘real world’ (Gupta, 2011). Thus, it provides a more realistic estimate of 
the intervention effect as it allowed for dropouts and non-compliance of interventions which 
occurred in everyday life. Furthermore, ITT analysis, maintained the integrity of the 
randomisation process and thus the validity of the results. This allowed interpretation of any 
post-treatment differences between interventions to be attributed to the treatments and not 
due to differences in participant characteristics. 
 
An additional analytic approach in clinical trials is per-protocol analysis. This can be defined 
as participants considered to have complied with the intervention protocol and further 
defined as having adhered to a specific dose of the intervention, i.e. attendance at 75% of 
intervention sessions. Participants were defined as completing the intervention if they 
attended 75% of the total sessions. This statistical approach can be used to further explore 
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the efficacy of the interventions, by examining the difference in treatment effects under 
conditions which participants fully adhered to the intervention. Descriptive statistics were 
used for participant demographics and all outcome measures. Results have been presented 
as means and SD for baseline continuous variables (Anthropometric outcomes, physical 
activity outcomes and health related quality of life) and frequencies and percentages (%) for 
categorical variables (Demographics, Ability and development, Health conditions). 
 
Mixed linear models were used to examine the potential efficacy of primary and secondary 
outcomes. Mixed linear models were selected due to their capabilities over general linear 
models as mixed models may have accounted for correlated data or data with unequal 
variances which can arise from hierarchical data. For example, and relevant to this study 
mixed models can analyse data for individuals who have been selected from a cluster of 
participants.  
To differentiate the proportion of the variance that is due to between cluster variation an 
interclass correlation (ICC) was calculated. The ICC was calculated as the proportion of total 
variance that is due to between cluster variation from the following equation:  
𝜎𝑏2/(𝜎𝑏2+𝜎𝑤2) 
Where 𝜎𝑏2 is the variance due to differences between clusters and 𝜎𝑤2 is the variance due 
to differences between individuals within clusters. An ICC of less than 5% indicates there 
is no meaningful difference between clusters (Tabecjnick & Fidell, 2007).  
Analysis was conducted to assess normal distributions of the data. Each variable was 
assessed graphically using a histogram with normal distribution curves, boxplots and Q-Q 
residual plots. In addition to visual inspection of these plots for normal distribution, 
skewness and kurtosis were tested using z-scores with < 1.96 representing normally 
distributed data. In circumstances that data were considered not normally distributed, factors 
affecting this were explored. Outliers were identified by examining residual Q-Q plots. Data 
points classified as outliers were assessed for their potential to influence results and therefore 
study conclusions. Sensitivity analyses were conducted to compare results with and without 
outlier(s). Discrepancies between the two analyses are reported and discussed in chapters 
five and six. In addition to examining the data with and without outliers, in some cases 
transformation of the data were assessed using logarithmic and square root transformations 
and normality reassessed.  
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All statistical analyses were carried out in accordance with a pre-specified SAP. The 
objective of the SAP was to provide detailed analysis of each outcome; this is presented in 
Appendix vii. All statistical data were analysed using SPSS 21 IBM statistical package 
(SPSS IBM, New York, NY, USA). 
 
4.14.6.2 Primary outcomes 
A mixed effects model was used to determine the mean difference in weight loss at the end 
of the intervention period (~12 months) from baseline, between TAKE 5 and WWToo. The 
mixed effects model accounted for the effects of clustering of participants (stratified by level 
of intellectual disability, number of participants within a cluster and presence of Down 
syndrome) and was adjusted for baseline weight. Within group analysis was also investigated 
from the mixed models. The ICC, adjusted mean difference (95% confidence interval (CI) 
and p-value are reported.  
 
4.14.6.3 Secondary outcomes 
Continuous secondary outcomes were analysed and reported similarly as described above. 
A logistic regression model was fitted for the categorical outcome, weight loss of 5% or 
more of initial body weight taking account of clustering and baseline adjustments listed 
above. 
 
4.14.6.4 Process outcomes 
Descriptive statistics were used to assess process measures such as attendance to sessions 
for each treatment group. Independent sample t-tests were performed to determine if there 
were any differences between the treatment groups. 
 
4.14.6.5 Serious adverse events 
Serious adverse events (SAE) were defined as an adverse event (an injury or newly 
diagnosed health condition) that induced hospitalisation or prolonged hospitalisation, results 
in persistent/significant disability or incapacity or is life-threatening or fatal. SAE were 
recorded after baseline visits by the researcher at follow up visits. Incidence of SAE were 
recorded for each treatment group. 
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4.14.7 Qualitative data analysis 
In addition to the quantitative data collection methods, qualitative interviews were conducted 
with the research dietitians. The interviews with the dietitians were conducted 
retrospectively on completion of delivery of the intervention sessions and 12 month data 
collection. The interviews were conducted by an independent researcher with experience in 
conducting qualitative research and not otherwise involved in the study. The main aim of 
the qualitative interviews was to elicit the research dietitian’s views of the interventions, the 
practicalities of delivering the intervention and any challenges to implementing the 
intervention as intended. The interview consisted of semi-structured questions and is 
presented in appendix vii. The interviews were audio-recorded using Olympus DSS player 
2300. The interviews lasted between 45 minutes and one hour. The interviews were 
transcribed and analysed guided by the thematic analysis framework by Braun & Clarke, 
(2006). This consists of an outline of the following six steps: 
 
1. Familiarisation of transcribed data: 
The researcher familiarised oneself with the data through repetition of reading the 
transcribed data and noting initial ideas that emerged. 
2. Initial coding of data: 
Initial coding of data, identifying relevant data extracts to support codes 
3. Theme searches: 
The data were grouped together into potential themes and sub-themes with supporting 
evidence. 
 
4. Theme revisions 
Themes were reviewed against codes and relevant themes were modelled in relation to 
each other in a thematic map. 
5. Theme definitions 
The specifics of each theme were defined, themes were discarded if no longer relevant 
in order to form a coherent collection of themes. 
 
6. Final analysis: 
128 
 
Confirmation of data extracts were selected for evidence of themes. Reflection of the 
research question, analysis and coding of results. 
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_____________________________________________________________________ 
Chapter 5: Results 
_____________________________________________________________________ 
 
5.1 Introduction 
The primary aim of this study was to investigate the feasibility of a full-scale clinical trial of 
a multi-component weight management intervention (TAKE 5) in comparison to an active 
comparator intervention (WWToo). The main results from the completers ITT analysis and 
exploratory analysis (per-protocol) are presented in this thesis chapter. 
 
5.2 Participant characteristics 
Fifty adults (Mean age: 42 years; range: 18-71 years) with intellectual disabilities and obesity 
(Mean BMI: 40.7 kg/m2, range 30.7-65.8 kg/m2) were randomised to the study. Participants’ 
level of intellectual disabilities were mild (28.0 %), moderate (42.0 %), severe (22.0 % and 
profound (8.0 %).  Eight participants had Down syndrome as their diagnosis of intellectual 
disabilities and two participants were diagnosed with Fragile X Syndrome. 
 
Participants demographic and health characteristics are presented in Table 5.1, by 
intervention group and overall. In addition to obesity, participants were reported to have 
other chronic conditions and health issues including type II diabetes; high blood pressure; 
asthma; rheumatoid arthritis; underactive thyroid and depression. 
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Table 5.1. Baseline characteristics of participants by randomised group and overall (ITT). 
Values represent number (%), means (SD). SIMD; Scottish Index of Multiple Deprivation. 
 
 
Characteristic TAKE 5 
(n = 26) 
WWTOO 
(n = 24) 
Total 
(n = 50) 
Age (years) Mean (SD) 40.6 (15.0) 43.6 (14.0) 42.0 (14.5) 
 Gender n (%)    
Males  8 (30.8) 10 (41.7) 18 (36.0) 
Females  18 (69.2) 14 (58.3) 32 (64.0) 
Ethnicity n (%)   
 
 
Caucasian  
 
26 (100.0) 
 
22 (91.7) 
 
48 (96.0) 
 Other Asian Background  0 (0.0) 2 (8.3) 2 (4.0) 
 Marital Status n (%) 
 
 
 
 
 
 
 Married/Live with a 
partner  
1 (3.8) 
 
0 (0.0) 
 
1 (2.0) 
 Separated/Divorced  
 
1 (3.8) 
 
0 (0.0) 
 
1 (2.0) 
 Single  24 (92.3) 24 (100.0) 48 (96.0) 
 SIMD (% living in quintiles)  
 
 
 
 
 
1 (most deprived) 12 (46.2) 
 
9 (37.5) 
 
21 (42.0) 
 2 6 (23.1) 
 
5 (20.8) 
 
11 (22.0) 
 3 2 (7.7) 
 
4 (16.7) 
 
6 (12.0) 
 4 5 (19.2) 
 
5 (20.8) 
 
10 (20.0) 
 5 (least deprived) 1 (3.8) 1 (4.2) 2 (4.0) 
 Social Support n (%) 
 
  
 
 
 Lives Independently 
 
10 (28.4) 
 
8 (33.3) 
 
18 (36.0) 
 Family Carer 
 
8 (30.8) 
 
8 (33.3) 
 
16 (32.0) 
 Paid Carer  
8 (30.8) 
8 (33.3) 
 
16 (32.0) 
 Level of Intellectual Disabilities n (%) 
 
 
 
 
 
 Mild 
 
8 (30.8) 
 
6 (25.0) 
 
14 (8.0) 
 Moderate 
 
11 (42.3) 
 
10 (41.7) 
 
21 (42.0) 
 Severe 
 
4 (15.4) 
 
7 (29.2) 
 
11 (22.0) 
 Profound 3 (11.5) 
 
1 (4.2) 4 (8.0) 
Down Syndrome n (%) 4 (15.4) 4 (16.7) 8 (16.0) 
Health n (%) 
 
   
Epilepsy, Seizures or Fits 
 
6 (23.1) 
 
5 (20.8) 
 
11 (22.0) 
 Vision impairment 
 
16 (61.5) 
 
9 (37.5) 
 
25 (50.0) 
 Hearing Impairment 
 
6 (23.1%) 3 (12.5%) 9 (18.0%) 
Mental Health Problems 
 
6 (23.1) 
 
3 (12.5) 
 
9 (18.0) 
 Problem Behaviour 
 
10 (38.5) 
 
9 (37.5) 
 
19 (38.0) 
 High Blood Pressure 
 
12 (46.2) 11 (45.8) 23 (46.0) 
Type II Diabetes 1 (3.8%) 3 (12.5%) 4 (8.0%) 
 
 
 
 
EQ-5D index 0.8 (0.3) 0.7 (0.3) 0.7 (0.3) 
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5.3 Feasibility outcomes 
5.3.1 Recruitment 
Recruitment of participants to the study was conducted between February to October 2014. 
A total of 76 participants returned an information slip expressing their interest in finding out 
more information about the study. Six individuals returned the slip indicating they did not 
want to find out further information. No contact with these individuals was made by the 
researcher. Of the 76 individuals, 69 were assessed for their eligibility to participate. Four 
participants expressed interest after the target sample size was reached and therefore were 
not assessed for eligibility and three participants were excluded as they were identified as a 
cluster after a participant had been randomised and therefore their participation would have 
been exempt from inclusion in the analysis. Of the individuals screened, eight did not meet 
the inclusion criteria, three declined to participate and eight reported other reasons such as 
commitment issues to the project and illness that prevented them from participating in the 
study. Fifty participants in total of the 69 individuals screened met the eligibility criteria, 
provided informed consent, baseline measures and were enrolled in the study. Study 
screening, recruitment and retention is illustrated in Figure 5.1. Participants were recruited 
using a multi-point recruitment strategy from a primary health care service, the GCWMS (n 
= 4); specialist intellectual disabilities health services across GG&C (n = 24); community 
provider organisation (n = 4) and day centres for adults with intellectual disabilities (n = 15). 
Participants were also identified as a cluster upon a screening visit for another participant 
involved in the study (n = 3). There were five clusters in total, with two participants in each 
(two cluster of siblings, two clusters of participants living in the same household, and one 
cluster of individuals with intellectual disabilities supported by the same carer; SAP Table 
1.5). The recruited of 50 participants is short of the projected sample size calculated of 66 
participants. The recruitment period was not extended to achieve the full sample size due to 
the limited demand capacity of the research dietitians in terms of scheduling participant 
appointments. Further time restrictions to the recruitment period were introduced due to the 
time constraints of the author of this thesis PhD restrictions, in completing the study within 
a set timeframe (4 years including recruitment, data collection, interpretation, and write up 
of results). 
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Figure 5.1. Study screening, recruitment and retention. 
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5.3.2 Retention 
Retention to the 12 month interventions was high with 45 (90%) out of the 50 participants 
randomised to the study, completing both interventions. During the study period only five 
(10%) participants withdrew from taking part in the interventions. All five participants 
withdrew before the six month follow up due to the following reasons, one did not want to 
lose weight, one withdrew due to illness and three participants were withdrawn at the 
discretion of their carers. Of the five participants who dropped out of the interventions 
(TAKE 5 n = 2; WWToo n = 3), only two were considered lost to follow up and outcome 
data were not available for these participants at six and 12 months. In the WWToo 
intervention, two participants were lost to follow up at six months and outcome assessments 
were not taken due to concerns over ethical considerations in measuring outcomes if the 
participants were no longer involved in the intervention. This was clarified with ethics 
committee and protocol of consent and participants who were happy to continue to take part 
in the study outcomes were assessed at 12 months. Primary outcome measurements were 
collected for 46 participants (92%) at six months and for 48 participants (96%) at 12 months.  
 
5.3.3 Adherence 
Overall adherence to intervention sessions was high in both interventions in those who had 
not withdrawn, with session adherence ≥75% in both interventions (range: 75% - 100%). 
Attendance at each intervention sessions is presented in the SAP Table 1.3 (Appendix vii). 
Attendance rate decreased slightly in the first weight maintenance session after the weight 
loss phase (82.2%) overall, and increased to 93.3% at the end of the intervention. The 
average attendance rate was 86.4% in both intervention groups. Excluding those who 
dropped out of the intervention 26.7% attended all intervention sessions, 31.1% attended 
90% and 80% of the sessions, with 2.2% attending 70% of the intervention. The lowest 
attendance recorded was an attendance rate of 60% with 8.9% of the participants attending 
9 out of the 15 sessions. Session attendance by intervention group is illustrated in Table 5.2.  
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Table 5.2. Number of participants attending all sessions, by randomized group and overall. 
Percentage attendance at all 
appointments 
TAKE 5 
(n=24) 
WWTOO 
(n=21) 
TOTAL 
(n=45) 
100% 7 (29.1%) 5 (23.8%) 12 (26.7%) 
90% 6 (25.0%) 8 (38.1%) 14 (31.1%) 
80% 8 (33.3%) 6 (28.6%) 14 (31.1%) 
70% 1 (4.2%) 0 (0.0%) 1 (2.2%) 
60% 2 (8.3%) 2 (9.5%) 4 (8.9%) 
Note: Percentage of attendance of participants excluding participants who dropped out of 
the intervention. 
 
Participants were defined as completing the intervention if they attended 75% of the total. 
Ten (20%) participants did not meet this definition and were considered non-completers. 
The baseline characteristics of participants defined as completers and non-completers by 
treatment group are presented in the SAP Tables 2.1.1-2.1.2. (appendix vii). There was no 
significant difference in continuous outcomes (age or anthropometric characteristics) 
between the two groups (independent sample t-tests; p > 0.05). Baseline categorical 
outcomes (gender, level of intellectual disabilities, ethnicity, marital status, SIMD and level 
of social support) were also not significantly different between completers and non-
completers (Fisher’s exact test; p > 0.05).    
 
 
5.4 Potential Efficacy outcomes (ITT) 
The baseline outcome measurements, anthropometry and physical activity, are illustrated in 
Tables 5.3-5.4. Health related quality of life, as measured by the EQ-5D index are presented 
in Table 5.1. 
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Table 5.3. Baseline anthropometric outcomes by group and overall (ITT).  
Values represent mean (SD) BMI; Body Mass Index. 
*Waist circumference TAKE 5 n = 24 WWTOO n = 23 Total n = 47 
*Percentage Body Fat TAKE 5 n = 24 WWTOO n = 19 Total n = 43 
 
Table 5.4. Baseline objectively measured physical activity by group and overall (ITT) 
Physical activity/Sedentary 
behaviour outcome 
TAKE 5 
(n = 25) 
WWTOO 
(n = 22) 
Total 
(n = 47) 
Average Wear Time (minutes/day) 677.9 (130.9) 713.5 (208.0) 694.5 (170.3) 
CPM 276.9 (122.9) 292.0 (155.7) 284.0 (137.9) 
Step Count (per day) 4880 (2185) 4875 (2315) 4877 (2222) 
Light PA (minutes/day) 147.9 (47.0) 159.6 (77.2) 153.4 (62.5) 
Light PA (% time spent/day) 21.8 (6.2) 22.3 (8.0) 22.1 (7.0) 
MVPA (minutes/day) 28.8 (16.9) 31.6 (22.5) 30.1 (19.6) 
MVPA (% time spent/day) 4.5 (2.7) 4.7 (3.8) 4.6 (3.2) 
Total PA (minutes/day) 176.8 (53.3) 191.2 (85.1) 183.5 (69.6) 
Total PA (% time spent/day) 26.3 (7.6) 27.0 (9.7) 26.7 (8.6) 
Sedentary Behaviour 
(minutes/day) 
501.1 (125.9) 522.3 (165.3) 511.0 (144.4) 
Sedentary Behaviour (% time 
spent/day) 
73.7 (7.6) 73.0 (9.7) 73.3 (8.6) 
Values represent means (SD) CPM; Counts per minute, MVPA; Moderate to vigorous 
physical activity, PA; Physical activity 
  
Anthropometric 
Outcomes 
 
TAKE 5 
(n = 26) 
WWTOO 
(n = 24) 
Total 
(n = 50) 
Weight (kg) 
 
102.3 (25.4) 
 
104.1 (28.9) 
 
103.1 (26.9) 
 Height (cm) 
 
158.4 (10.6) 
 
158.5 (13.7) 
 
158.4 (12.1) 
 BMI (kg/m2) 
 
40.2 (6.8) 
 
41.2 (8.1) 
 
40.7 (7.4) 
 Waist Circumference 
(cm)* 
 
121.9 (14.0) 
 
122.2 (16.1) 
 
122.0 (14.9) 
 
Percentage Body Fat (%)* 49.3 (9.1) 51.7 (8.5) 50.3 (8.4) 
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The primary efficacy analysis was an ITT analysis conducted using a mixed model, adjusting 
for baseline variables and accounting for clustering of participants (stratified by number of 
participants within a cluster, level of intellectual disability and presence of Down syndrome). 
This was a completers ITT analysis (only participants providing outcome data at follow up 
assessments were included) as no missing data were imputed in any of the analysis. 
Exploratory analysis was also conducted to further investigate the potential efficacy of the 
weight management interventions when full compliance is achieved. This was completed for 
all outcomes. The results for the participants who completed the intervention sessions (per-
protocol analysis: attendance at greater than 75% of sessions) are presented in tables 
alongside the main analysis to facilitate comparison. The results are presented as within and 
between group mean change in outcome variables with 95% CI and adjusted for the 
covariates above. Absolute mean values at all time points baseline, six and 12 months are 
presented in the SAP Tables (3.1.1-3.18.1). 
 
5.4.1 Primary outcome   
The primary outcome for this study was change in mean weight change post intervention, 
12 months from baseline (Table 5.5). The weight loss pre-post intervention at 12 months in 
TAKE 5 was significantly different from baseline (-3.55 kg 95% CI -5.59 kg to -1.52 kg), 
however there was no significant difference in body weight in the comparator intervention, 
WWToo (-1.66 kg 95% CI -3.69 kg to 0.38 kg). Although, participants in the TAKE 5 
intervention achieved a significant weight loss at 12 months, there was no significant 
difference in weight loss between participants in the TAKE 5 intervention in comparison to 
participants in the WWToo intervention (mean difference in weight loss between groups -
1.90 kg; 95% CI -4.80 kg to 1.01 kg; p = 0.195). There was no evidence of clustering (ICC 
= 0.000). 
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Table 5.5. Change in anthropometric outcomes from baseline (ITT) 
 TAKE 5 (n = 26) WWTOO (n = 24) Difference between groups 
 
Anthropometric 
outcomes 
N Mean (95% CI) *  N Mean (95% CI) * Mean (95% CI) * p-value ICC 
Change in weight (kg) 
6 months 24 -2.93 (-4.42 to -1.44) 22 -1.26 (-2.82 to 0.30) -1.67 (-3.84 to 0.50) 0.126 0.059 
12 months 24 -3.55 (-5.59 to -1.52) 24 -1.66 (-3.69 to 0.38) -1.90 (-4.80 to 1.01) 0.195 0.000 
Change in BMI (kg/m2) 
6 months 24 -1.19 (-1.77 to -0.62) 22 -0.46 (-1.06 to 0.15) -0.74 (-1.58 to 0.11) 0.085 0.000 
12 months 24 -1.48 (-2.29 to -0.66) 24 -0.59 (-1.41 to 0.23) -0.89 (-2.05 to 0.28)  0.134 0.000 
Change in waist circumference (cm) 
6 months 22 -3.15 (-4.91 to -1.40) 20 -1.45 (-3.29 to 0.40) -1.71 (-4.28 to 0.86) 0.186 0.176 
12 months 22 -3.60 (-5.99 to -1.21) 21 -1.83 (-4.24 to 0.58) -1.77 (-5.20 to 1.67) 0.304 0.267 
Change in percentage body fat (%) 
6 months 22 -1.79 (-3.08 to -0.50) 18 -1.02 (-2.45 to 0.41) -0.77 (-2.72 to 1.19) 0.430 0.187 
12 months 22 -2.23 (-3.95 to -0.51) 18 -0.65 (-2.56 to 1.26) -1.58 (-4.21 to 1.05) 0.231 0.000 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). CI = Confidence interval; ICC = Interclass correlation coefficient. 
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5.4.2 Secondary anthropometric outcomes 
Secondary outcomes included change in body weight and other anthropometric variables, 
physical activity outcomes and health related quality of life are reported six months and 12 
months from baseline. The results are presented in the following Tables 4.5-4.9. 
 
5.4.2.1 Weight (six months) 
The pattern in weight loss within each intervention, replicated similar effects at six months 
as observed at 12 months, in that participants in the TAKE 5 intervention lost a significant 
amount of weight from baseline (-2.93 kg; 95% CI -4.42 kg to -1.44 kg), whereas as 
participants in the WWTOO intervention did not (-1.26 kg; -2.82 kg to 0.30 kg). The between 
intervention effect at six months, did not result in a significant effect on body weight (-1.67 
kg; 95% CI -3.48 kg to 0.50 kg; p = 0.126). Although there was no indication of clustering 
in change in body weight, 12 months from baseline, there was some evidence of clustering 
in change in body weight at six months (ICC = 0.059). 
 
5.4.2.2 Percentage weight change 
Table 5.6 illustrates the number of participants achieving a clinically significant weight loss 
at six months and 12 months, between the intervention groups. Based on the definitions for 
weight loss maintenance by Stevens et al., (2006) (chapter two, section 2.4.6 clinical 
effectiveness), the participants’ percentage weight change from phase one (end of the weight 
loss phase) to phase two (end of the weight the weight maintenance phase and end of the 12 
month intervention period) have been reported. This was categorised into weight loss (≥ 
3%), weight maintenance (±2.99%) and weight gain (≥ 3%). There was no difference in the 
number of participants achieving 5% weight loss between intervention groups at six months 
(OR 2.70; 95% CI 0.44 to 16.59; p = 0.275). At 12 months more participants in the TAKE 5 
intervention (50.0%) achieved a clinically important weight loss than the comparator 
intervention (20.8%) (OR 3.76; 95% CI 0.92 to 15.30; 0.064). During the weight 
maintenance phase the majority of participants in both interventions maintained their weight 
(58.3%, 68.2%, TAKE 5 and WWToo respectively) within ± 3% of initial body weight. 
Seven (29.2%) participants in the TAKE 5 intervention and four participants in the WWToo 
intervention (18.2%) continued to lose weight and three participants in both intervention 
groups gained weight. There was no significant difference in percentage weight change in 
the weight maintenance phase between intervention groups. 
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Table 5.6. Secondary outcome: Change in percentage weight change at 6 and 12 months 
from baseline. Odds ratio (95% confidence interval) and p-value (ITT).  
Percentage 
weight 
change 
TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Odds ratio  
(95% CI)* 
p-value 
Weight loss phase (0-6 months) 
Weight loss 
>5% 
5 (20.8) 2 (9.1) 7 (15.2) 2.70 (0.44 to 16.59) 0.275 
Weight loss 
<5% 
19 (79.2) 20 (90.9) 39 (84.8) Referent  
Weight maintenance phase (6 -12 months) 
Weight loss 
>3% 
7 (29.2) 4 (18.2) 11 (23.9) 1.57 (0.18 to 13.90) 0.679 
Weight 
maintenance  
14 (58.3) 15 (68.2) 29 (63.0) 0.92 (0.14 to 5.91) 0.924 
Weight gain 
>3% 
3 (12.5) 3 (13.6) 6 (13.0) Referent  
Post intervention (12 months) 
Weight loss 
>5% 
12 (50.0) 5 (20.8) 17 (35.4) 3.76 (0.92 to 15.30) 0.064 
Weight loss 
<5% 
12 (50.0) 19 (79.2) 31 (64.6) Referent  
Note: At 6 months from baseline TAKE n = 24, WWTOO n = 22, TOTAL n = 46 
          At 12 months from baseline TAKE 5 n = 24, WWTOO n = 24, TOTAL n = 48 
 
*Results are presented as adjusted Odds Ratio (OR) for effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and 
presence of Down syndrome).  
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5.4.2.3 BMI 
The analysis on BMI was performed similarly to the model fitted for the primary analysis 
on change in body weight using a mixed effects model, adjusting for baseline BMI. Change 
in BMI at six and 12 months from baseline revealed that, participants in the TAKE 5 
intervention, had a significant reduction in BMI pre-post intervention at both six months (-
1.19 kg/m2; 95% CI -1.77 kg/m2 to -0.62 kg/m2) and 12 months (-1.48 kg/m2; -2.29 kg/m2 to 
-0.66 kg/m2). There was not a significant reduction reported for change in BMI for 
participants in the WWToo intervention at either time points (6 months -0.46 kg/m2; 95% 
CI -1.06 kg/m2 to 0.15 kg/m2 and 12 months -0.59 kg/m2; 95% CI -1.41 kg/m2 to 0.23 kg/m2). 
Despite the significant effect of the TAKE 5 intervention on the reduction in BMI, there was 
no significant intervention effect between participants in the TAKE 5 and WWToo 
intervention (six months: -0.74 kg/m2; 95% CI -1.58 kg/m2 to 0.11 kg/m2; p = 0.085 and 12 
months: -0.89 kg/m2; 95% CI -2.05 kg/m2 to 0.28 kg/m2; p = 0.134). There was no effect of 
clustering on change in BMI at either six or 12 months (ICC = 0.000).  
 
5.4.2.4 Waist circumference  
Participants in both interventions had a significant reduction in waist circumference at six 
months. Participants in the TAKE 5 intervention lost -3.15 cm (95% CI -4.91 cm to -1.40 
cm) and participants in the WWToo intervention lost -1.45 cm (95% CI -3.29 cm to 0.40 
cm). However, this significant difference was only maintained in participants in the TAKE 
5 (-3.60 cm; 95% CI -5.99 cm to -1.21 cm) intervention at 12 months, with no significant 
difference in the WWToo intervention (-1.83 cm; 95% CI -4.24 cm to 0.58 cm). Adjusting 
for baseline waist circumference, there was no significant difference between the two 
interventions at six months (-1.71 cm; 95% CI -4.28 cm to 0.86 cm; p = 0.186) and 12 months 
(-1.77 cm; 95% CI -5.20 cm to 1.67 cm; p = 0.304). There was some effect of clustering on 
waist circumference at both six months and 12 months (ICC = 0.176 and ICC = 0.267, 
respectively).  
 
5.4.2.5 Percentage body fat 
Percentage body fat was significantly reduced in participants in the TAKE 5 intervention at 
both six months (-1.79%; 95% CI -3.08% to -0.50%) and 12 months (-2.23%; 95% CI -
3.95% to -0.51%). Participants in the WWToo intervention showed no significant change in 
percentage body fat at either time point (six months -1.02%; 95% CI -2.45% to 0.41% and 
12 months -0.65%; 95% CI -2.56% to 1.26%). There was no significant between intervention 
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effect in change in percentage body fat at either six or 12 months (-0.77%; 95% CI -2.72% 
to 1.19%; p = 0.430 and -1.58%; 95% CI -4.21% to 1.05%; p = 0.231, respectively). There 
was some indication of clustering on change in percentage body fat at six months from 
baseline (ICC = 0.147), however, this was not evident at 12 months (ICC = 0.000). 
 
5.4.3 Physical activity outcomes 
Valid measure of physical activity through accelerometer data collection was available for 
35 participants and 29 participants at 6 months and 12 months, respectively. Of the five 
participants who dropped out, only one participant wore the accelerometer at all three time 
points. The remaining missing data were due to five participants not having worn the 
accelerometer for the minimum duration of three days and six hours for valid data (Penpraze 
et al., 2006); nine participants did not wear the accelerometer (one at baseline, seven at six 
months and nine at 12 months); and three monitors did not collect data due to a fault with 
the monitor. 
 
The average wear time significantly decreased in the TAKE 5 intervention at six (-53.4 
minutes; 95% CI -96.8 minutes to -9.9 minutes) and 12 months (-88.3 minutes; 95% CI -
145.8 minutes to -31.4 minutes) and in the WWToo intervention at 12 months (-65.0 
minutes; 95% CI -126.1 minutes to -3.8 minutes). Therefore, the time spent in light, MVPA, 
total physical activity and sedentary behaviour also decreased from baseline and should be 
considered when interpreting the results for change in physical activity data in time spent in 
minutes/day. To adjust/account for the difference in accelerometer wear time, percentage 
time spent in physical activity at different intensities and percentage time spent in sedentary 
behaviour has been reported. Objective physical activity outcomes are presented in Table 
5.7 and change in sedentary behaviour in table 5.8 for the primary ITT. 
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Table 5.7. Change in objectively measured sedentary behaviour from baseline (ITT) 
Sedentary behaviour 
outcomes 
TAKE 5  WWTOO  Difference between groups 
 
 Mean (95% CI) * Mean (95% CI) * Mean (95% CI) * p-value ICC 
Sedentary behaviour (minutes/day) 
6 months -27.64 (-66.48 to 11.20) 21.69 (-22.33 to 65.70) -49.33 (-108.78 to 10.12) 0.100 0.547 
12 months -64.72 (-108.24 to -21.19) -46.42 (-93.19 to 0.35) -18.30 (-83.70 to 47.10) 0.568 0.961 
Sedentary behaviour (% time spent/day) 
6 months -2.08 (-4.43 to 0.27) -2.00 (-4.67 to 0.67) -0.09 (-3.67 to 3.50) 0.962 0.450 
12 months -0.91 (-4.05 to 2.24) 1.05 (-2.33 to 4.42) -1.95 (-6.61 to 2.70) 0.394 0.994 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). 6 months TAKE 5 n = 20 WWTOO n = 15; 12 months TAKE 5 n = 16 
WWTOO n = 13. CI = Confidence interval; ICC = Interclass correlation coefficient. 
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Table 5.8. Change in objectively measured physical activity from baseline (ITT) 
Physical activity 
outcomes 
TAKE 5  WWTOO  Difference between groups 
 
 Mean (95% CI) * Mean (95% CI) * Mean (95% CI) * p-value ICC 
Average Wear Time (minutes/day) 
6 months -53.35 (-96.78 to -9.92) 10.90 (-39.66 to 61.46) -64.25 (-132.72 to 4.21) 0.065 0.000 
12 months -88.34 (-145.28 to -31.40) -64.97 (-126.14 to -3.81) -23.37 (-108.84 to 62.11) 0.576 0.979 
CPM 
6 months -11.33 (-51.16 to 28.50) -27.83 (-72.59 to 16.94) 16.50 (-43.49 to 76.48) 0.58 0.924 
12 months 7.71 (-30.62 to 46.03) -0.82 (-42.03 to 40.40) 8.53 (-48.33 to 65.38) 0.76 0.910 
Step count (per day) 
6 months -652 (-1291 to -13) -556 (-1298 to 185) -95 (-1080 to 899) 0.846 0.000 
12 months -454 (-1466 to 558) -580 (-1666 to 505) 126 (-1371 to 1624) 0.863 0.997 
Light PA (minutes/day) 
6 months -23.84 (-37.28 to -10.39) -5.00 (-20.64 to 10.63) -18.83 (-39.91 to 2.25) 0.078 0.000 
12 months -14.93 (-42.53 to 12.66) -22.71 (-52.31 to 6.88) 7.78 (-33.15 to 48.71) 0.697 0.999 
Light PA (% time spent/day) 
6 months -1.79 (-3.69 to 0.11) -1.22 (-3.40 to 0.96) -0.57 (-3.50 to 2.35) 0.692 0.164 
12 months 0.79 (-2.22 to 3.81) -0.92 (-4.15 to 2.31) 1.71 (-2.75 to 6.17) 0.434 0.994 
MVPA (minutes/day) 
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6 months -4.26 (-8.49 to -0.03) -6.00 (-10.75 to -1.25) 1.74 (-4.62 to 8.11) 0.579 0.999 
12 months -1.85 (-9.16 to 5.46) -3.59 (-11.49 to 4.30) 1.74 (-9.16 to 12.64) 0.744 0.871 
MVPA (% time spent/day) 
6 months -0.32 (-1.17 to 0.54) -0.81 (-1.77 to 0.15) 0.50 (-0.79 to 1.78) 0.434 0.895 
12 months 0.10 (-0.94 to 1.13) -0.17 (-1.28 to 0.95) 0.26 (-1.28 to 1.80) 0.726 0.818 
Total PA (minutes/day) 
6 months -28.76 (-43.84 to -13.69) -10.76 (-28.29 to 6.76) -18.00 (-41.64 to 5.64) 0.130 0.000 
12 months -17.05 (-48.53 to 14.44) -25.55 (-59.34 to 8.25) 8.50 (-38.26 to 55.26) 0.710 0.994 
Total (% time spent/day) 
6 months 2.08 (-0.27 to 4.43) 2.00 (-0.67 to 4.67) 0.09 (-3.50 to 3.60) 0.962 0.449 
12 months 0.91 (-2.24 to 4.05) -1.05 (-4.42 to 2.33) 1.95 (-2.70 to 6.61) 0.39 0.994 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). 6 months TAKE 5 n = 20 WWTOO n = 15; 12 months TAKE 5 n = 16 
WWTOO n = 13. CI = Confidence Interval; ICC = Interclass Correlation Coefficient; CPM = Counts per minute; MVPA = Moderate to vigorous 
physical activity; PA = Physical activity. 
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5.4.3.1 Sedentary behaviour 
Participants with intellectual disabilities in this study engaged in high levels of physical 
inactivity and time spent a majority of time in sedentary behaviour. At baseline, all 
participants spent on average 511.0 minutes (SD 144.4 minutes) and 73.7% (SD 7.63%) of 
their time sedentary. Participation in either weight management intervention did not have a 
significant effect on decreasing time spent in sedentary behaviour at the end of the weight 
loss phase (TAKE 5 -27.6 minutes; 95% CI -66.5 minutes to 11.2 minutes; WWToo 21.7 
minutes; 95% CI -22.3 minutes to 65.7 minutes). However, at the end of the weight 
maintenance phase, participants in the TAKE 5 intervention significantly decreased time 
spent sedentary by -64.7 minutes (95% CI -108.2 minutes to -21.2 minutes). Although there 
was a trend for participants in the WWToo intervention also to decrease time spent sedentary 
this was not significant -46.4 minutes (95% CI -93.2 minutes to 0.4 minutes). There was no 
significant between group differences as six or 12 months (-49.3 minutes; 95% CI -108.8 
minutes to 10.1 minutes; p = 0.100 and -18.3 minutes; 95% CI -83.7 minutes to 47.1 minutes; 
p = 0.568, respectively). There was an effect of clustering on time spent in sedentary 
behaviour at both six months (IC = 0.547) and 12 months (ICC = 0.961). It is important to 
note that although time spent in sedentary behaviour in minutes was significantly reduced 
after completion of the TAKE 5 intervention at 12 months, this finding was not replicated 
when accounting for time spent wearing the physical activity monitor and has been reported 
as percentage time spent/day (-0.9%; 95% CI -4.1% to 2.2%). 
 
5.4.3.2 Light intensity physical activity 
Participation in light physical activity was the most common form of physical activity in 
adults with intellectual disabilities and obesity. At baseline, participants engaged in 153.4 
minutes (SD 62.5 minutes) per day which is equivalent to 22.1% (SD 7.0%) of monitor wear 
time. The aim of the intervention was to examine the potential efficacy of the weight 
management interventions on increasing physical activity and in particular aiming to 
increase and build on levels of light intensity physical activity which is believed to be more 
feasible for this population group. Participation in either weight management intervention 
did not significantly increase light intensity physical activity in minutes per day (TAKE 5 -
23.8 minutes; 95% CI -37.3 minutes to -10.4 minutes; WWToo -5.0 minutes; 95% CI -20.6 
minutes to 10.6 minutes) or percentage time spent in light intensity physical activity (TAKE 
5 1.8%; 95% CI -3.7% to 0.1%; WWToo -1.2%; 95% CI -3.4% to 1.0%) at the end of the 
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weight loss phase. The pattern of no significant change in time spent in light physical activity 
was also evident at 12 months for both interventions (TAKE 5 -14.9 minutes 95% CI -42.7 
minutes to 12.7 minutes; WWToo -22.7 minutes; 95% CI -52.3 minutes to 6.9 minutes). 
Adjusting for wear time also did not result in any significant results for the TAKE 5 
intervention (0.8% 95% CI -2.2% to 3.8%) or the WWToo intervention (-0.9%; 95% CI -
4.2% to 2.3%). There was no between group effect sizes with comparisons at six months or 
12 months (table 5.8). There was evidence of clustering for all comparisons with the 
exception of change in time spent (minutes) in light physical activity at six months. 
 
5.4.3.3 Moderate to vigorous intensity physical activity 
At baseline mean time spent in moderate to vigorous physical activity for all participants 
was 30.1 minutes (SD 19.5 minutes) per day. Participants engaged in physical activities of 
moderate to vigorous less frequently than light intensity physical activity, 4.6% (SD 3.2%) 
of wear time per day. At six months, participants in the TAKE 5 intervention significantly 
decreased time spent in moderate to vigorous physical activity (-4.3 minutes; 95% CI -8.5 
minutes to -0.0 minutes). A decrease in time spent in moderate to vigorous physical activity 
was also found in participants in the WWToo intervention at the end of the weight loss phase 
(-6.0 minutes; 95% CI -10.8 minutes to -1.3 minutes). However, adjusting for wear time, 
these significant reductions were not replicated in percentage time spent in moderate to 
vigorous physical activity at six months (TAKE 5 -0.3%; 95% CI-1.2% to 0.5%; WWToo -
0.8% 95% CI -1.8% to 0.2%). There was no between group difference in time spent in 
minutes (1.7 minutes; 95% CI -4.6 minutes to 8.1 minutes; p = 0.579) and percentage time 
spent at six months (0.5%; 95% CI -0.8% to 1.8%; p = 0.434). At the end of the intervention 
period at 12 months, although time spent in both interventions was shown to decrease, this 
was not significant in either the TAKE 5 intervention (1.9 minutes; 95% CI -9.2 minutes to 
5.5 minutes) or the WWToo intervention (-3.6 minutes; 95% CI -11.5 minutes to 4.3 
minutes). There was also no between group effect 1.7 minutes (95% CI -9.2 minutes to 12.6 
minutes; p = 0.871). There was evidence of clustering for all moderate to vigorous physical 
between group comparisons (ICC = 0.818 to 0.999). 
 
5.4.3.4 Total physical activity 
At baseline participants engaged in an accumulation of light and moderate to vigorous 
physical activity to achieve an average of 183.5 minutes (SD 69.6 minutes) per day in total. 
This is equivalent to only 26.5% (SD 8.6%) of wear time per day. Participants in the TAKE 
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5 intervention significantly decreased the time spent in total physical activity per day at six 
months (-28.8 minutes; 95% CI -43.8 minutes to -13.7 minutes). At 12 months participants 
in the TAKE 5 intervention continued to report a reduction on accumulated total physical 
activity, however, this was not a significant change (-17.1 minutes; 95% CI-48.5 minutes to 
14.4 minutes). Due to the reduction in wear time across time points as previously reported, 
adjustment for this did not support a significant reduction in total physical activity. Change 
in percentage time spent in total physical activity was in contrast to time spent in minutes as 
this was increased by 2.1% (95% CI -0.3% to 4.4%), however, this was not a significant 
change. Participants in the WWToo intervention, demonstrated a reduction in time spent in 
total physical activity at both six (-10.8 minutes; 95% CI -28.2 minutes to 6.8 minutes) and 
12 months (-25.6 minutes; 95% CI -59.3 minutes to 8.3 minutes), however, this was not a 
significant reduction. There was no between group effect on change in total physical activity 
at six months (-18.0 minutes; 95% CI -41.6 minutes to 5.6 minutes; p = 0.130) or 12 months 
(8.5 minutes; 95% CI -38.3 minutes to 55.3 minutes; p = 0.710).  
 
5.4.4 Health related quality of life 
Health related quality of life was assessed by the EQ-5D questionnaire. The results are 
presented as the EQ-5D index which is a summary index of the five health domains 
(mobility, self-care, usual activities, pain/discomfort and anxiety/depression; baseline values 
are presented in the SAP table 2.10). Presentation as a single index value allowed 
comparison with previous research measuring health related quality of life in adults with 
intellectual disabilities (Melville et al., 2015). A high proportion of participants reported to 
be in a good health state (EQ-5D index for all participants 0.7 (SD 0.3). There was no change 
in health related quality of life at six months from baseline in either the TAKE 5 (0.07; 95% 
CI -0.03 to 0.17) intervention or the WWToo intervention (0.04; 95% CI -0.07 to 0.14). 
Completion of the 12 month weight management interventions also did not change health 
related quality of life in adults with intellectual disabilities from (TAKE 5: 0.00; 95% CI -
0.14 to 0.14; WWToo: -0.04; -0.18 to 0.10).  
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Table 5.9. Change in health related quality of life from baseline (ITT) 
 TAKE 5 (n = 26) WWTOO (n = 24) Difference between groups 
 
EQ-5D 
outcomes 
N Mean (95% CI)*  N Mean (95% CI) * Mean (95% CI)* p-value ICC 
Change in EQ-5D index 
6 months 24 0.07 (-0.03 to 0.17) 22 0.04 (-0.07 to 0.14) 0.03 (-0.12 to 0.18)  0.652 0.118 
12 months 24 0.00 (-0.14 to 0.14) 24 -0.04(-0.18 to 0.10) 0.04 (-0.16 to 0.24) 0.675 0.000 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). CI = Confidence Interval; ICC = Interclass Correlation Coefficient. 
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5.5 Exploratory analysis 
5.5.1 Per-protocol analysis 
To investigate the effect of the weight management intervention under ideal circumstances, 
per-protocol analysis was conducted when participants adhered to the intervention (defined 
as attendance at 75% of intervention sessions). The baseline outcome measurements for 
completers (anthropometry, physical activity and health related quality of life) are illustrated 
in Tables 5.10-5.11. Baseline health related quality of life, is presented in the SAP (Table 
2.11.1), as this did not differentiate from the ITT results 
 
Table 5.10. Baseline anthropometric outcomes by group and overall (Completers).  
Values represent mean (SD) BMI = Body Mass Index. 
*Waist circumference Completers TAKE 5 n = 19 WWTOO n = 18 Total n = 37 
*Percentage Body Fat Completers TAKE 5 n = 19 WWTOO n = 15 Total n = 34 
  
 
 
 
 
 
 
 
 
 
 
 
Anthropometric 
Outcomes 
 
TAKE 5 
(n = 21) 
WWTOO 
(n = 19) 
Total 
(n = 40) 
Weight (kg) 
 
102.7 (25.1) 101.9 (18.1) 102.3 (21.8) 
Height (cm) 
 
158.2 (10.4) 157.0 (13.9) 157.7 (12.0) 
BMI (kg/m2) 
 
40.6 (7.1) 41.5 (6.2) 41.0 (6.6) 
Waist Circumference 
(cm)* 
 
121.7 (14.1) 121.0 (13.3) 121.4 (13.5) 
Percentage Body Fat (%)* 49.3 (10.0) 51.0 (5.8) 50.1 (8.4) 
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Table 5.11. Baseline objectively measured physical activity by group and overall 
(Completers) 
Physical activity/Sedentary 
behaviour outcome 
TAKE 5 
(n = 20) 
WWTOO 
(n = 17) 
Total 
(n = 47) 
Average Wear Time (minutes/day) 686.1 (142.2) 716.5 (227.6) 700.1 (184.2) 
CPM 276.7 (123.6) 265.6 (134.2) 271.6 (126.9) 
Step Count (per day) 4974 (2066) 4416 (2311) 4718 (2170) 
Light PA (minutes/day) 150.9 (51.9) 159.4 (87.0) 154.8 (69.3) 
Light PA (% time spent/day) 21.9 (6.6) 22.1 (9.0) 22.0 (7.7) 
MVPA (minutes/day) 28.9 (17.1) 27.9 (19.8) 28.4 (18.1) 
MVPA (% time spent/day) 4.5 (2.7) 4.0 (2.9) 4.3 (2.8) 
Total PA (minutes/day) 179.7 (57.5) 187.3 (96.0) 183.2 (76.5) 
Total PA (% time spent/day) 26.4 (7.8) 26.1 (10.0) 26.2 (8.8) 
Sedentary Behaviour 
(minutes/day) 
506.4 (133.5) 529.1 (173.8) 516.8 (151.6) 
Sedentary Behaviour (% time 
spent/day) 
73.6 (7.8) 73.9 (10.0) 73.8 (8.8) 
Values represent means (SD) CPM = Counts per minute; MVPA = Moderate to vigorous 
physical activity; PA = Physical activity 
 
5.5.1.1 Primary outcome 
The results of the per-protocol analysis for the primary outcome, change in body weight at 
12 months from baseline are in agreement with the ITT results. Participants in the TAKE 5 
intervention demonstrated a significant reduction in body weight pre-post intervention (-3.75 
kg; 95% CI -6.06 kg to -1.45 kg). There was no significant change in body weight in the 
WWToo intervention (-1.30 kg; 95% CI -3.72 kg to 1.13 kg). As in the ITT analysis, despite 
the significant change in body weight in the TAKE 5 intervention, there was no significant 
between group differences for participants defined as adhering to the intervention in full (-
2.46 kg; 95% -5.84 kg to 0.93 kg; p = 0.150). There was no evidence of clustering (ICC = 
0.000). Per-protocol results for the primary outcome and secondary anthropometric 
outcomes are illustrated in Table 5.12.
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Table 5.12. Change in anthropometric outcomes from baseline (Completers). 
Anthropometric 
outcomes 
TAKE 5 (n = 21) WWTOO (n = 19) Difference between groups 
 
 N Mean (95% CI) * N Mean (95% CI) *  Mean (95% CI) * p-value ICC 
Change in weight (kg) 
6 months 21 -3.24 (-4.93 to -1.54) 19 -1.35 (-3.13 to 0.44) -1.89 (-4.38 to 0.59) 0.130 0.096 
12 months 21 -3.75 (-6.06 to -1.45) 19 -1.30 (-3.72 to 1.13) -2.46 (-5.84 to 0.93) 0.150 0.000 
Change in BMI (kg/m2) 
6 months 21 -1.34 (-2.00 to -0.67) 19 -0.47 (-1.17 to 0.23) -0.87 (-1.84 to 0.11)  0.078 0.078 
12 months 21 -1.56 (-2.49 to -0.63) 19 -0.50 (-1.48 to 0.49) -1.06 (-2.44 to 0.31) 0.125 0.000 
Change in waist circumference (cm) 
6 months 19 -3.54 (-5.48 to -1.59) 17 -1.48 (-3.54 to 0.59) -2.06 (-4.93 to 0.81) 0.152 0.194 
12 months 19 -3.87 (-6.56 to -1.18) 16 -1.37 (-4.25 to 1.51) -2.49 (-6.48 to 1.49)  0.211 0.263 
Change in percentage body fat (%) 
6 months 19 -1.94 (-3.38 to -0.51) 15 -1.23 (-2.86 to 0.39) -0.71 (-2.91 to 1.49) 0.512 0.177 
12 months 19 -2.16 (-4.09 to -0.24) 14 -0.49 (-2.75 to 1.77) -1.68 (-4.72 to 1.36) 0.268 0.000 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). CI = Confidence Interval; ICC = Interclass Correlation Coefficient. 
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5.5.1.2 Secondary anthropometric outcomes 
The exploratory analysis on other anthropometric outcomes including change in body weight 
at six months and BMI, waist circumference and percentage body fat (at six and 12 months) 
resulted in similar effect sizes for within group and between group analysis. Participants 
defined as completers in the TAKE 5 intervention had a significant reduction in all of the 
above anthropometric outcomes at six and 12 months from baseline, whereas participation 
in the WWToo intervention had no significant effect on the anthropometric outcomes of 
adults with intellectual disabilities. These results provide further evidence of the potential 
efficacy for the TAKE 5 intervention, illustrating under ‘real life’ and full adherence that 
participants can achieve significant improvements in weight, BMI, waist circumference and 
percentage body fat.  
 
5.5.1.3 Sedentary behaviour 
Change in physical activity and sedentary behaviour was assessed in individuals who 
adhered to the intervention. The primary finding of the per-protocol analysis was that there 
was a significant between group effect in time spent per day in sedentary behaviour at six 
months (-71.88 minutes; 95% CI -136.40 minutes to -7.37 minutes; p = 0.031). This resulted 
as the between group effect size for the TAKE 5 intervention further reduced time spent 
sedentary from -27.64 minutes (95% CI -66.48 minutes to 11.20 minutes) in the ITT analysis 
to -38.60 minutes (-79.75 minutes to 2.49 minutes) in the per-protocol analysis, with a 
concomitant increase in time spent sedentary in the WWToo intervention from 21.69 
minutes (95% CI -22.33 minutes to 65.70 minutes) to 33.25 minutes (95% CI-71.88 minutes 
(-136.40 minutes to -7.37 minutes), ITT analysis and per-protocol analysis, respectively. The 
between group effects in sedentary behaviour were not significant. Caution over the 
interpretation of these results in warranted as these findings are not adjusted for wear time 
and not replicated in the change in percentage time spent in sedentary behaviour. Indeed, the 
per-protocol analysis resulted in between group differences for TAKE 5 and WWToo, 
although not statistically significant, illustrate an increase in percentage time spent in 
sedentary behaviour. This suggests that full adherence to either weight management 
intervention was not effective in interrupting the lifestyle habits of adults with intellectual 
disabilities in terms of reducing time spent sedentary. 
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5.5.1.4 Physical activity outcomes 
Investigation into whether participants adhered to the intervention, did not result in any 
significant within group or between group difference in change in physical activity 
outcomes. Results of the per-protocol analysis for objectively measured physical activity 
outcomes and sedentary behaviour are illustrated in Tables 5.13-5.14. 
 
5.5.1.5 Health related quality of life 
Data analysis from the 40 participants who adhered to the intervention had no effect on 
health related quality of life. Change in the EQ-5D index between group or within group at 
six or 12 months was not different from the ITT analysis. The results for the per-protocol 
analysis on EQ-5D index are presented in Table 5.15. 
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Table 5.13. Change in objectively measured sedentary behaviour from baseline (Completers) 
Sedentary behaviour 
outcomes 
TAKE 5  WWTOO  Difference between groups 
 
 Mean (95% CI) * Mean (95% CI) * Mean (95% CI) * p-value ICC 
Sedentary behaviour (minutes/day) 
6 months -38.60 (-79.75 to 2.49) 33.25 (-14.68 to 81.18) -71.88 (-136.40 to -7.37) 0.031 0.525 
12 months -80.00 (-127.27 to -31.74) -43.03 (-95.93 to 9.88) -36.98 (-110.95 to 37.00) 0.305 0.934 
Sedentary behaviour (% time spent/day) 
6 months 1.76 (-1.05 to 4.57) 2.32 (-0.95 to 5.59) 2.09 (-4.90 to 3.78) 0.792 0.481 
12 months -0.44 (-3.93 to 3.05) -0.60 (-4.42 to 3.21) 2.46 (-5.05 to 5.37) 0.949 0.994 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). 6 months TAKE 5 n = 17 WWTOO n = 12; 12 months TAKE 5 n = 13 
WWTOO n = 10. CI = Confidence Interval; ICC = Interclass Correlation Coefficient. 
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Table 5.14. Change in objectively measured physical activity from baseline (Completers) 
Physical activity 
outcomes 
TAKE 5 WWToo Difference between groups 
 
 Mean (95% CI) * Mean (95% CI) * Mean (95% CI)* p-value ICC 
Average Wear Time (minutes/day) 
6 months -64.34 (-110.20 to -18.47) 23.34 (-31.95 to 78.64) -87.68 (-162.04 to -13.32) 0.023 0.000 
12 months -105.15 (-170.16 to -40.14) -52.59 (-123.76 to 18.58) -52.56 (-151.41 to 46.30) 0.276 0.972 
CPM 
6 months 5.95 (-41.78 to 53.69) -30.10 (-64.86 to 24.66) 35.18 (-36.89 to 109.00) 0.317 0.942 
12 months 2.38 (-39.80 to 44.56) 36.68 (-9.21 to 82.57) 29.86 (-97.80 to 29.21) 0.268 0.935 
Step count (per day) 
6 months -458 (-1229 to 313) -399 (-1323 to 526) 594 (-1287 to 1169) 0.922 0.000 
12 months -187 (-1473 to 1100.00) -264 (-1668 to 1141) 904 (-1837 to 1991) 0.933 1.000 
Light PA (minutes/day) 
6 months -26.61 (-41.91 to -11.32) -5.07 (-23.56 to 13.32) -21.55 (-46.13 to 3.04) 0.083 0.000 
12 months -18.66 (-52.03 to 14.72) -17.36 (-53.81 to 19.06) -1.28 (-51.14 to 48.58) 0.957 1.000 
Light PA (% time spent/ day) 
6 months -1.95 (-4.16 to 0.25) -1.53 (-4.13 to 1.08) 1.67 (-3.89 to 3.04) 0.801 0.133 
12 months -18.66 (-52.03 to 14.72) -17.38 (-53.81 to 19.06) -1.28 (-51.14 to 48.58) 0.957 0.994 
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MVPA (minutes/day) 
6 months -2.43 (-7.58 to 2.73) -5.10 (-11.01 to 0.82) 2.67 (-5.17 to 10.51) 0.487 1.000 
12 months -1.18 (-9.81 to 7.44) 1.24 (-8.19 to 10.66) 6.05 (-15.30 to 10.46) 0.695 0.719 
MVPA (% time spent/day) 
6 months 0.06 (-0.94 to 1.06) -0.74 (-1.89 to 0.41) 0.75 (-0.75 to 2.35) 0.296 0.904 
12 months -0.10 (-1.17 to 0.97) 0.79 (-0.38 to 1.96) 0.76 (-0.73 to 2.51) 0.260 0.732 
Total PA (minutes/day) 
6 months -29.65 (-47.20 to -12.09) -10.08 (-31.16 to 11.01) 13.59 (-47.68 to 8.54) 0.163 0.000 
12 months -19.12 (-57.84 to 19.60) -15.99 (-58.30 to 26.32) 27.25 (-60.96 to 54.70) 0.910 0.995 
Total PA (% time spent/day) 
6 months -1.76 (-4.57 to 1.05) -2.32 (-5.59 to 0.95) 2.09 (-3.78 to 4.90) 0.792 0.481 
12 months 0.44 (-3.05 to 3.93) 0.60 (-3.21 to 4.42) 2.46 (-5.37 to 5.05) 0.949 0.994 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). 6 months TAKE 5 n = 17 WWTOO n = 12; 12 months TAKE 5 n = 13 
WWTOO n = 10. CPM = CI = Confidence Interval; ICC = Interclass Correlation Coefficient; Counts per minute; MVPA = Moderate to vigorous 
physical activity; PA = Physical activity. 
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Table 5.15. Change in health related QOL from baseline (Completers) 
EQ-5D 
outcomes 
TAKE 5 (n = 26) WWTOO (n = 24) Difference between groups 
 
 N Mean (95% CI)*  N Mean (95% CI) * Mean (95% CI)* p-value ICC 
Change in EQ-5D index 
6 months 24 0.08 (-0.04 to 0.1) 22 0.07 (-0.11 to 0.13) 0.07 (-0.10 to 0.24)  0.393 0.341 
12 months 24 -0.03 (-0.19 t 0.13) 24 -0.05 (-0.22 to 0.11) 0.02 (-0.21 to 0.25)  0.851 0.059 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants (stratified by number of participants within a 
cluster, level of intellectual disability and presence of Down syndrome). CI = Confidence Interval; ICC = Interclass Correlation Coefficient. 
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5.6 Sensitivity analysis  
Mixed models were selected due to their advantages over general linear models (see section 
4.16.1.1). For these models to produce valid results, data must meet the assumption of a 
normal distribution. Undertaking the analysis revealed that in some circumstances outliers 
(identified based on visual inspection of normality plots and Q-Q plots) affected the 
distribution of the data. Data points classified as outliers were assessed for their potential to 
influence results and therefore study conclusions. Sensitivity analysed was conducted to 
compare results with and without outlier(s). Important discrepancies between the two 
analyses are reported and full results of the sensitivity analysis can be found in the SAP in 
appendix vii.  In circumstances where data were affected by multiple data points deviating 
from the normal distribution curve, transformation of the data were assessed using 
logarithmic and square root transformations to try and improve the distribution.  
 
5.6.1 Primary outcomes ITT 
The baseline distribution of body weight was considered to be normally distributed, 
however, one participant had a higher baseline weight which was classified as an outlier 
(212 kg). This participants’ body composition in terms of BMI, waist circumference and 
percentage body fat was also considered to be outside the normal distribution of the 
remaining participants (the effect on secondary anthropometric outcomes will be discussed 
below). To test the effects of this participant on the analysis of change in body weight at 12 
months, mixed linear models were run with (Between group effect: -1.90 kg; 95% CI -4.80 
kg to 1.01 kg; p = 0.195) and without (Between group effect: -2.16 kg; 95% CI -5.08 kg to 
0.76 kg; p = 0.143; SAP table 3.1.1.1) the inclusion of the participant. The exclusion of this 
participant did not result in a significant between group effect and thus did not change the 
study conclusion for the primary outcome. Further analysis revealed that although the 
participant discussed above was considered an outlier at baseline, this was not evident in 
change in body weight at six months from baseline (SAP Tables 3.2.1.1 to 3.5.3.1).  
 
Outliers in change in body weight at 12 months were also investigated. At twelve months a 
participant in the WWToo intervention lost -15.10 kg (mean -1.6 kg; SD 5.03 kg) and was 
also identified as an outlier. Analysis without this participant (SAP Table 3.1.2.1) resulted 
in a significant between group effect -3.26 kg (95% CI -6.42 kg to -0.10 kg; p = 0.044). 
Further, investigation through the process evaluation revealed that this participant had lost 
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weight following a serious adverse event unrelated to participation in the study. It was noted 
in the research dietitian’s clinical notes that they were advised to consume a liquid diet and 
therefore, it can be assumed that the weight loss may not have been due to participating in 
the intervention. This provides further support for the potential efficacy of the TAKE 5 
weight management intervention. 
 
5.6.2 Secondary anthropometric outcomes ITT 
The participant defined as an outlier at baseline with a body weight of 212 kg in comparison 
to the mean body weight of the remaining participants, also extended to other body 
composition measurements including BMI, waist circumference and percentage body fat. 
However, exclusion of this participant from the analysis did not result in any significant 
differences in change in body composition measurements at six and 12 months. However, 
exclusion of both participants described as outliers above resulted in a significant between 
group effect for change in BMI at 12 months (-1.29 kg/m2; 95% CI -2.35 kg/m2 to -0.24 
kg/m2; p = 0.018). Another participant in the WWToo intervention, at six months lost -11 
kg, which was distinct from the mean weight loss of -1.4 kg (SD 3.60 kg). Analysis with and 
without this participant (plus the participant identified as an outlier at baseline) resulted in a 
between group difference tending to be in favour of the TAKE 5 intervention, however this 
did not reach statistical significance (Between group difference: -2.02 kg (95% CI -4.13 kg 
to 0.08 kg; p = 0.059). This change in body weight was not evident at 12 months when the 
participant regained the weight loss. 
 
Sensitivity analyses were also completed to assess the validity of the per-protocol results. 
Similar outliers arose in terms of deviations from the mean change in outcome variable. At 
12 months, change in weight and BMI was considered not normally distributed by the same 
participant described in section 5.6.1 above and who lost -15.10 kg and received and liquid 
diet. Between group differences for change in body weight (-3.26 kg; 95% CI -6.42 to -0.10 
kg; p = 0.044) and BMI (-1.39 kg/m2; -2.63 kg/m2 to -0.16 kg/m2; p = 0.028) were 
statistically significant at 12 months from baseline. This provided further evidence of the 
potential efficacy of the TAKE 5 intervention under conditions in which participants adhered 
to 75% or more of the intervention. 
 
160 
 
 
This was repeated for all anthropometric outcome measures, however, exclusion of outliers 
did not affect the interpretation or conclusion of the results. Full details of the analysis are 
presented in the SAP (Tables 3.1.1.1 to 3.5.4.1) in appendix vii. 
 
5.6.3 Physical activity outcomes 
The classification of participants as outliers, affected the normal distribution of 
accelerometer data in some cases at baseline and for change in the physical activity variable 
at six and 12 months. Differences in physical activity measured were considered outliers 
when for example, participants completed a higher or lower than average level of time spent 
engaged in physical activity. These values however, were not removed from the analysis for 
the following reasons: results were due to naturally occurring variation in physical activity 
and sedentary behaviour as the data were not spurious or subject to measurement error (data 
were double entered), and the small sample size meant that normal distribution can be hard 
to determine and thus fulfil the statistical test assumptions. Another approach in analysis of 
clinical trial data can be to use transformation of data to facilitate inclusion of all data points. 
Attempts at using logarithmic and square root transformations were conducted however, this 
did not improve the overall fit of the data and compromised variables in the mixed model 
which was originally normally distributed. Therefore, based on the above justification and 
to facilitate comparison between intensities of physical activity results are presented as ITT 
and per-protocol above using parametric mixed models.  
 
5.6.4 Health related quality of life 
The results for the change in EQ-5D were also considered to be not normally distributed. 
This was primarily due to kurtosis in the distribution of data, resulting from a lack of change 
in health related quality of life. Standard transformations did not improve the fit of the data, 
therefore, to examine the validity of no significant change in EQ-5D index, change in the 
domains that make up this health profile were explored. The improvement of each of the 
health domains; mobility, self-care, usual activities, pain/discomfort and anxiety/depression 
was categorised as improved or no improvement/deteriorated. The findings are in support of 
no change in the EQ-5D index with no significant change in outcomes at six months or 12 
months. The results for the dichotomous outcomes are reported in the SAP Tables 3.19 and 
3.20.  
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5.7 Adverse events 
Eleven serious adverse events in total were reported (four in the TAKE intervention and 
seven in the WWToo intervention), seven recorded in the weight loss phase and a further 
four in the weight maintenance phase. Four were due to exacerbation of pre-existing health 
conditions, two were surgical procedures (one routine), two were presentations of new 
medical conditions, two were the result of falls and one was an adverse reaction to change 
in medication. The weight management interventions are considered as safe as none of the 
above serious adverse events were considered to be the result of taking part in the study. 
 
5.8 Process evaluation outcomes 
To enhance understanding of the quantitative results, exploration of key processes including 
the fidelity of the intervention, implementation and effective and ineffective components are 
presented below. The results are collated from a number of methodologies including, clinical 
notes, case reporting forms, checklists and enriched from qualitative interviews with the 
research dietitians with experience and insight into weight management in this population 
group. A summary of the key themes identified in the qualitative interviews with the research 
dietitians are presented in Table 5.16. 
 
Table 5.16. Key themes and subthemes from interviews with research dietitians 
Key themes Subthemes  
Intervention delivery Participant appointments and logistics 
 Fidelity 
Intervention content Abstraction and complexity of behaviour 
change techniques 
Mediators of weight management Professional motivation 
 Support from carers 
 Barriers to behaviour change 
Context Socio environmental barriers and 
facilitators 
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5.8.1 Dose delivered 
The intervention was delivered by a dietitian and a health professional. Both had experience 
working with adults with intellectual disabilities. The dietitian had experience in obesity 
management and had a previous employment role at the Glasgow Clyde and Weight 
Management Service, which TAKE 5 has been adapted from. Furthermore, the dietitian 
devised and delivered the WWToo intervention in its original group format. Therefore, the 
dietitian had extensive experience in the delivery of both interventions. The health 
professional was also qualified to degree level, in the area of health and physical activity. 
The health professional had experience as a lifestyle counsellor on a number of physical 
activity intervention studies and therefore both were suitably qualified for the role.  
 
Research dietitians delivered both interventions on a one-to-one basis to the participants 
and/or carers where applicable. The research dietitians were asked about the feasibility of 
delivering the intervention, their demand capacity to facilitate delivery and any challenges 
they experienced in delivering the intervention. 
 
Both research dietitians were employed on a 0.5 full time equivalent contract. At the start of 
the intervention only one dietitian was employed until it was highlighted that to complete 
the intervention within the desired time frame (February 2014- October 2015) additional 
resource was required.  
 
‘I was employed two and a half days per week so at the beginning that was full and I probably 
did a bit more than two and half days a week because we didn’t know how much time would 
be taken up.  So the first three or four months it was more like full time, maybe four or five 
days at the beginning and then we managed to get RD2 on so that helped a lot, so then it 
went down to two and half days.’ RD1 
 
The decision to recruit another research dietitian reduced the workload for the first research 
dietitian, however both research dietitians continued to report pressure in delivering the 
volume of appointments to participants, particularly during the weight loss phase where 
appointments were scheduled for every two-three weeks.  
 
‘The time pressure in the beginning was stressful.’ RD1 
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However, the flexibility of the working hours also suited the research dietitians as they could 
organise appointments around their schedule. 
 
‘Although there were days I was doing a lot, but perhaps that was because I wanted to do a 
lot on those days as well.  It could have been more spread out, no I found it was fine I didn’t 
find it a problem at all.’ RD2 
 
The research dietitians were asked to identify any challenges to delivering the intervention. 
The practicalities of delivering the intervention sessions to participants who were recruited 
from different geographical locations across GG&C was reported as challenging. 
 
‘The actual practicalities are one thing that would help if we did do things in the same 
postcodes.  I figured that out in a couple of months because we had people in different areas 
at the time we were going from the East End to Barrhead, so I was booking appointments to 
suit the people, which might mean 9 o’clock in the East End and 11 o’clock in Barrhead and 
1 o’clock East End a total pain, so very soon I realised not to do that and I would do my 
mornings in East End and afternoons in Barrhead so that wouldn’t happen and people fitted 
into that fine.’ RD1 
 
5.8.2 Fidelity 
The fidelity for the duration of the intervention sessions was not met at the start of the 
intervention where sessions were delivered by only one research dietitian and had to be 
condensed to meet the demands of the number of participants. Although the duration of the 
intervention sessions was reduced to regulate the demand from participants, the recruitment 
of a second research dietitian resolved this issue and it was found that in fact the time to 
deliver the content of each session did not require the full time allocated. 
 
‘Duration was much more rushed, and where RD2 made it easier and things could be longer 
it was rare especially with WWToo that was an hour session for a group so quite often not 
so much discussion but you would need that one to one.  With Take 5 the first few sessions 
were longer so the first few sessions were maybe needing a good hour but after that the 
sessions were shorter.’ RD1 
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Despite deviations in the duration of the intervention fidelity of the intervention content was 
ensured as the intervention sessions were manualised. This meant that the intervention 
content was not compromised and delivered as intended.  
 
‘I found it fine before I went in I always had my files ready.  I would know what I was going 
to be presenting, I would run through the protocols as I went through… I would always be 
looking at my book any way to check I had covered everything.’ RD2 
 
Adherence to the delivery of the content was measured on completing of a checklist of the 
intervention content. Fidelity was reported to be high, with the only deviations from the 
intervention were due to unnecessary delivery of session content such as the exclusion of 
information on alcohol intake due to the participant not engaging reporting consuming 
alcohol. Adaptations also arose when session content was moved between sessions to 
facilitate the needs of participants. For example, it was identified in the clinical notes and 
from the qualitative interviews that one participant had problems with binge eating. Binge 
eating was an element within session seven and was moved to an earlier session (session 
three) as the problem was identified. Barrier identification/problem solving and stress 
management/emotional control training were behaviour change techniques used to help 
alleviate this issue. 
 
‘I would sometimes swap sessions around so when Laura for example went on holiday in 
session two she talked about she used to binge eat a lot so we covered binge eating, which 
wasn’t meant to be covered until way late in Session seven or eight so we covered that in 
Session two it would have been silly to wait months when there was an issue there.’ RD1 
 
5.8.3 Context 
This was an individualised intervention and the majority of sessions were conducted in 
participants’ homes (92.0%). In four cases participants met with the research dietitians at 
another location convenient to them. This was the community day centre where the 
participants attended. One participant had to be weighed at the GCWMS to allow accurate 
assessment of their body weight which was in excess of 200 kg and thus exceeded the limits 
of the scales used for measurement of body weight used in this study. To ensure valid and 
reliable measures of this participants’ body weight, all measurements were conducted 
(research dietitian and researcher conducting outcome assessments) at this site. 
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In cases where the research dietitians reflected on any negative cases, i.e. cases where 
participants did not meet their goals, it was reported that in some circumstances participants 
were limited by contextual factors such as the area they lived in. Setting goals around the 
most popular activity, walking, for this population was limited as the area in which 
participants lived was considered unsafe/not suitable. The SIMD scores are presented in 
table 5.1. It has been documented that participants 42.0% lived in the most deprived areas. 
 
‘He couldn’t walk around because it was a bad area.  That has been an issue for a lot of 
people where they live and they can’t go walks.’ RD2 
 
5.8.4 Dose received 
The research dietitians provided an insight into how each of the interventions were received 
and highlighted the successful and unsuccessful components. Both interventions were 
reported to be well received by participants and carers. It was noted in particular, that the 
structured format of the TAKE 5 session and the reputability of the TAKE 5 intervention 
was highly regarded by carers. 
 
‘I think carers liked the structure, TAKE 5 was very structured and I told them as well that 
this what they would be getting if they didn’t have intellectual disabilities and that it was the 
same programme as the Weight Management Service.  So I think a lot liked that because 
they felt they weren’t getting a dampened down version it was equal.’  RD1 
 
Successful receipt of the components of the intervention was dependent on the resources and 
methods of communication being tailored to the individual needs of participants. A method 
of communication utilised and found to be effective in both interventions, was the use of 
visual aids, in particular in the TAKE 5 intervention the use of fat and sugar models to 
illustrate the quantities in food products was considered a powerful technique in facilitating 
understanding of key nutrition messages. 
 
‘I think the sugar test tubes and the fat test tubes to me they were just a godsend people 
would say“ have you got your test tubes again” They would go “I can’t believe that a 
McDonalds has got so much fat in it and it’s all visual stuff. I know a lot of them will still 
think about that.’ RD2 
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5.8.5 Intervention components 
There is a degree of overlap between the components of both interventions (see figure 4.3). 
The successful components identified in both interventions were discussed by the research 
dietitians. 
 
5.8.5.1 Diet 
In both interventions participants with support from carers were asked to complete food 
diaries. The format of the food diaries were different across interventions. In TAKE 5 this 
was in the form of ticking off food portions based on the EatWell plate and in WWToo this 
was based on the traffic light system (Detailed description of food diaries is discussed in the 
methods sections 4.10; 4.11). Both formats were reported to be successful for some 
participants. 
 
‘They liked doing the diaries, writing it down, showing people, and showing me and the 
carers, well these were the ones who could do it and I think it probably opens up 
conversation that they would be able to discuss their weight or being a point of interest to 
them, and something that is theirs.’ RD1 
 
The research dietitians were asked to identify any aspects of the intervention sessions that 
were considered as challenging or ineffective. The absence of quantitative dietary advice in 
WWToo was highlighted by one research dietitian as an issue in that it was harder to monitor 
participants’ dietary changes and progress. 
 
‘There were no proper amounts of calories that weren’t worked out for example. So it was 
harder for me to see improvements or to see where things could change.’  RD1 
 
5.8.5.2 Physical activity 
Support to increase physical activity was well received and changes in this behaviour were 
observed. Although it was reported that small changes in physical activity did occur, they 
might not have been sufficient to have a significant effect on the outcomes of the study. 
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‘Other things that I observed was a lot more exercise, people dancing in their bedroom that 
seems to be really really good for a lot of people, which is fab.  That was mostly in Take 5 
with the pedometers so they could record their steps, so were trying to reach a given step 
count.’ RD2 
‘Physical activity definitely increased and everybody changed something a little bit.  Maybe 
it wasn’t enough but they did change something and again I think that comes down to support 
and care’.  RD2 
 
5.8.5.3 Behaviour change techniques 
A key component to the weight management interventions was the incorporation of 
behaviour change techniques goal setting and self-monitoring of diet and physical activity. 
The techniques included were adapted from mainstream interventions, however it was 
uncertain whether adults with intellectual disabilities had the cognitive abilities and skills to 
understand, reflect and implement these techniques.  
 
‘At the moment I am not convinced they were self-monitoring.’ RD1 
 
‘The only thing about being weighed was it was positive whatever. There were very few who 
understood a number as being higher or lower than a previous number.’ RD1 
 
Participants with mild to moderate intellectual disabilities were more able to implement 
these behaviour change techniques and it was reported that this was an effective component 
and was often used as a source of discussion at subsequent appointments. 
 
‘Goal setting worked, they liked doing goals they weren’t SMART goals by any sense but 
they were goals and most time they would remember their goals the next week when I would 
speak to them.’ RD1 
 
‘Being weighed definitely helped people like that, everyone liked that regardless, more than 
mainstream groups way more.’  RD1 
 
Participants with more severe or profound intellectual disabilities were reported to be unable 
to monitor their own behaviour and were therefore reliant on carers in supporting weight 
loss. These are preliminary findings, but highlight that not all individuals have the ability to 
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self-monitor their behaviour which is a key consideration when implementing weight 
management interventions in this population group.  
 
5.8.5.4 Implementation 
Factors affecting the implementation of the weight management interventions were 
explored. The research dietitian highlighted the role of carers as a key facilitator in 
implementing the behaviour changes techniques and supporting healthy lifestyle choices, 
diet and physical activity, to facilitate the weight loss. Participants supported by consistent 
and engaged carers were associated with greater weight loss 
 
‘She was a success on Take 5 and it was totally down to the staff and they stuck to their guns 
and they didn’t have to.  They could have given her chocolate for an easy life and they made 
her walk round the block despite her throwing big tantrums about it so that was good. RD1 
She did well solely because staff were good.’ RD1 
 
‘The ones with the most support I would say probably lost the most weight but that was the 
same with physical activity as well.’ RD2 
 
On the contrary, challenges that were identified in the implementation of the intervention 
sessions included the lack of support from carers. Adults with less severe intellectual 
disabilities although have the autonomy to make decisions and lived independently, it was 
observed that the additional support from carers would have been beneficial. Indeed, the lack 
of engagement from carers was identified as a barrier to achieving successful weight loss. 
 
‘I have got a few I used to go and see and there was no support and it made it more difficult’. 
RD2 
 
‘There was some people that had a mild intellectual disability but could have still done with 
carer support so sometimes I would turn up and they would be in charge of their own lives 
and how they arranged it but maybe they would have a carer once a week who would pop in 
and visit them.’  RD1 
 
‘So some carers weren’t that supportive and some family wasn’t supportive in that denying 
all knowledge of them having anything apart from fruit and veg, yet he was one of our 
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heaviest people his weight was 107kilos and he lost no weight despite his mum being 
adamant he wasn’t eating and there was clearly something going wrong.’ RD1 
 
It was also highlighted that a lack of consistency in support due to multiple carer involvement 
was perceived as a barrier. 
 
‘It was difficult when there was more than one carer involved, so sometimes I had a main 
carer who was on the ball and there from the beginning and other carers came in later on 
in the programme they didn’t know about it, it was always offered to go over but sometimes 
the carers weren’t that bothered any way.  It was always a possibility that you could speak 
and do extra carer sessions if they needed it but most didn’t want that.’  RD1 
 
In addition to the social support from carers both research dietitians agreed that their 
presence and company (professional support) at sessions was a motivational factor for 
participants to lose weight.  
 
‘The support and me turning up and the lady called Sarah, again pleasing me was quite a 
big one.’ RD1 
 
‘They just liked the company and wanted us to come round.’ RD2 
 
The dietitians were also used as motivation by carers in between appointments. 
‘And staff would use that RD1 is going to be cross with you and what would RD1 say if you 
ate that chocolate bar?’ RD1 
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_____________________________________________________________________ 
Chapter 6: Discussion 
_____________________________________________________________________ 
 
6.1 Introduction 
The management of obesity is an international health concern, particularly for adults with 
intellectual disabilities who have equivalent or greater rates of obesity in comparison to the 
general population (Melville et al., 2007; Rimmer & Yamaki, 2006). The health risks 
associated with obesity have shown to have a negative impact on the health of adults with 
intellectual disabilities, exacerbating already prevalent health conditions in this population 
and further reducing their life expectancy (Cooper et al., 2004). The level of evidence for 
the management of obesity for this population group has been identified as insufficient in 
comparison to the available literature in the general population. This is supported by 
evidence from national clinical guidelines (SIGN, 2010; NICE, 2014) and previous 
systematic reviews (Hamilton et al., 2007; Jinks et al., 2011; Spanos et al., 2013a) in 
recognising that more research is required to provide equality of service provision in the 
treatment of obesity for adults with intellectual disabilities. This thesis aimed to fulfil current 
gaps in the research by examining the effectiveness of multi-component weight management 
interventions for adults with intellectual disabilities and piloting and evaluating a 
randomised controlled trial of a multi-component weight management intervention 
consistent with clinical recommendations on the treatment of obesity. This chapter will 
provide an overview of the principal findings of the studies conducted for this thesis. The 
outcomes of the pilot randomised trial will be discussed in terms of feasibility and 
acceptability to participants, potential efficacy of outcomes, and key findings will be 
discussed in relation to previous research. In addition to the outcome evaluation, evaluation 
of the study processes including fidelity, implementation and exploring the effective and 
ineffective components will also be discussed. This chapter will conclude with 
recommendations and areas for future research. 
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6.2 Summary of principal findings 
 
6.2.1 Systematic review of multi-component weight management 
interventions in adults with intellectual disabilities 
The systematic review identified that current randomised controlled trials of multi-
component weight management interventions in adults with intellectual disabilities do not 
meet current clinical recommendations on the management of obesity. The current available 
evidence elicited a small insignificant effect on weight loss in comparison to no treatment 
and no studies reported whether participants achieved clinically important results of 5-10% 
weight loss. The interventions primarily focussed on a health education approach, and 
although one intervention appeared to potentially be efficacious, issues regarding reporting 
bias and confounding factors including differences in baseline characteristics prevented 
interpretation of results. The sustainability of changes in body weight has not been 
extensively explored in the management of obesity in adults with intellectual disabilities, 
therefore longer term studies with a distinct weight maintenance phase were recommended. 
Direct comparison of the active ingredients of multi-component weight management 
interventions revealed non-significant results. This was primarily due to the homogeneity of 
behaviour change techniques used in the interventions and also challenges with the 
identification of the active ingredients of the intervention, due to limited reporting on 
intervention components. Therefore, due to the uncertainty over the efficacy of interventions 
founded on a health education approach, recommendations from this review were for future 
weight management interventions to adhere to current UK clinical recommendations, in 
particular including an EDD, support to increase physical activity and support from carers 
in the implementation of the intervention (NICE, 2014; SIGN, 2010). The results of this 
review are in contrast to the abundance of interventions on weight management in the 
general population (Avenell et al., 2004; Loveman et al., 2011; Hartman-Boyce et al., 2014). 
Evidence in the general population provides support for the EDD approach in the treatment 
of obesity. The disparity in the evidence between the two population groups is concerning 
and may be attributed to the limited funding and resources in research involving adults with 
intellectual disabilities. 
 
172 
 
 
6.2.2 Pilot randomised controlled trial of the TAKE 5 multi-
component weight management intervention in comparison with 
an active comparator intervention.       
This is the first ever study of a randomised controlled trial of a weight management 
intervention in adults with intellectual disabilities which satisfies clinical recommendations 
on the management of obesity: including an EDD, adequate weight maintenance component 
and provided 12 month follow up to examine the potential efficacy of the intervention (NICE 
2014; SIGN 2010). This study overcame the barriers to involving adults with intellectual 
disabilities in research and demonstrated the successful recruitment and retention of adults 
with intellectual disabilities to a randomised controlled trial of two weight management 
interventions. The principal findings of this study are that an EDD approach to weight 
management is acceptable and effective when tailored to the specific needs of adults with 
intellectual disabilities. This study adds to the limited evidence of weight management 
interventions in this population group and provides preliminary evidence that an EDD 
approach to weight management may be efficacious in the treatment of obesity. Furthermore, 
this study provides additional evidence that current practice based on a health education 
approach is ineffective in the treatment of obesity in adults with intellectual disabilities.  
 
 
6.3 Feasibility of the pilot randomised controlled trial 
The TAKE 5 multi-component weight management intervention was originally developed 
by a multi-disciplinary team of researchers and health professionals to reflect the 
recommendations for weight management advocated by UK clinical guidelines. The 
GCWMS largely implemented this guidance and their service (Morrison et al., 2012; Logue 
et al., 2014) was a useful model for developing the TAKE 5 intervention.   TAKE 5 met 
clinical guidelines for multi-component weight management interventions, including an 
EDD, support to increase physical activity and behaviour change techniques (SIGN, 2010; 
NICE, 2014). An evaluation of the single stranded TAKE 5 intervention was conducted by 
Melville and colleagues (2011; Spanos et al., 2015), and demonstrated that it led to 
significant improvements in health risk factors including body weight, BMI, waist 
circumference and an increase in physical activity and reduced time spent in sedentary 
behaviour. Therefore, the benefits of the pilot intervention, provided the foundation on which 
this thesis was built and following research guidance on developing and evaluating complex 
interventions (MRC 2000; 2008). To provide a reliable and accurate investigation of the 
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potential efficacy of the TAKE 5 multi-component weight management intervention, a 
randomised controlled trial was required. This is a fairly novel design in intellectual 
disabilities research, as few randomised controlled trials of weight management 
interventions previously have been conducted (Hamilton et al., 2007; Spanos et al., 2013a). 
Therefore, prior to a full-scale trial this thesis aimed to address questions over the feasibility 
of key processes including recruitment of adults with intellectual disabilities, acceptability 
of outcomes and provide data for sample size calculations to determine whether or not a full-
scale trial could be justified.  
 
 
6.3.1 Recruitment 
The recruitment strategy was found to be effective and fifty participants were randomised to 
either intervention group. The successful recruitment to this study was better than 
anticipated. Previous research has reported minimal participation of adults with intellectual 
disabilities in research (Iacono, 2006) and is evident by the small sample sizes of weight 
management interventions in this population group identified in chapter two and previous 
systematic reviews (Hamilton et al., 2007; Jinks et al., 2011; Spanos et al., 2013a). This was 
in contrast to the evidence on weight management interventions in the general population. 
The small sample sizes may reflect the limited resources and funding available to researchers 
in this field (Lennox et al., 2005) and the challenges reported to recruiting adults with 
intellectual disabilities (Cleaver et al., 2010; Lennox et al., 2005). Recruitment in this trial 
was shown to be feasible and acceptable to adults with intellectual disabilities. This study 
utilised a multi-point recruitment strategy developed by Foster and colleagues (2011) based 
on the success of recruitment of adults with intellectual disabilities to a walking intervention 
(Mitchell et al., 2013; Melville et al., 2015). This strategy overcame the barriers and 
challenges often reported previously to recruitment such as ethical procedures consistent 
with the inability to have direct contact with participants and procedures of taking informed 
consent (Cleaver et al., 2010; Lennox et al., 2005). Barriers were overcome by utilising the 
advice from Lennox et al., (2005) and identification of a key worker/carer known to the 
potential participant with intellectual disabilities was a priority.  The personal approach to 
recruitment, achieved by meeting participants and carers in person to build up a rapport with 
participants, aimed to eliminate potential barriers to participating in a research study (Foster 
et al., 2011). Although the final sample of 50 participants were successfully recruited in this 
study, this was short of the original target sample size of 66 participants. The decision made 
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to stop recruitment at 50 participants was justified based on following reasons; the demand 
capacity of the research dietitians was near maximum and therefore, enrolling additional 
participants was believed to potentially threaten the validity of the delivery of the 
interventions; as this was a pilot trial extending the recruitment period would require 
additional resources for the researcher and the research dietitians which was not feasible and 
would prohibit completion of the trial in the desired timeframe; finally, one of the  aims of 
this study was to provide sufficient insight into the feasibility of the recruitment and retention 
rates to inform a full-scale trial and not to provide sufficient power to determine the efficacy 
of the between group differences in outcomes. This aim of this study was achieved by 
demonstrating the successful recruitment of participants from multiple organisations.  
 
It was difficult to compare the effectiveness of the recruitment strategy of this study with 
previous trials of weight management interventions as the majority of studies did not report 
how participants were recruited (chapter two). With the exception of Beeken et al., (2013), 
reporting that their recruitment strategy was based on self-referral or referral by carers or 
health professionals in response to advertisements through posters in services and day care 
facilities utilised by adults with intellectual disabilities. Fifty participants were recruited to 
this study over a 12 month period, and short of the target original sample size of 60 
participants. Full results of this study have as yet not been reported, therefore reasons for the 
shortfall in the target sample size remain unclear. However, it is postulated that this may be 
mainly due to the difficulties in recruitment as discussed above.  
 
Feasibility issues of recruitment to randomised controlled trials were also prevalent in 
clinical trials in the general population (Campbell, Snowdon, Francis, Elbourne, McDonald, 
Knight, & Grant,2007; McDonald, Knight, Campbell, Entwistle, Grant, Cook, & Snowdon, 
2006). For example, a recent review investigating recruitment strategies to enrolment in 
randomised controlled trials, revealed that of the 114 trials of lifestyle interventions included 
in this review, only 31% achieved their original target and furthermore, 45% achieved less 
than 80% of the calculated sample size (McDonald et al., 2006).  In summary, it is 
recommended that clinical trials aiming to recruit participants with intellectual disabilities 
should implement a pre-planned recruitment strategy. Future trials of multi-component 
weight management interventions should build upon the successful recruitment of this study 
in order to provide sufficient sample sizes to ensure statistical significant results for clinically 
important effects. 
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6.3.2 Retention 
Acceptability of the intervention was evident by the retention rates which were extremely 
high in this study, 90% at six months and 12 months. The retention rates were similar in both 
interventions (92.3% and 87.5%, TAKE 5 and WWToo, respectively). The retention rates in 
this study are comparable to the high retention rates in the feasibility studies of the weight 
loss (Melville et al., 2011) and weight maintenance phases (Spanos et al., 2015). As these 
were conducted separately and eligibility criteria into the second phase re-assessed, retention 
rates were 87% and 90% for the two discrete phases at six months and 18 months from 
baseline. The high retention rates are in contrast to the single stranded evaluation of the 
WWToo intervention by Jones et al., (2015), which reported only half (52%) of the 
participants enrolled in the study completed the intervention. It is speculated that this could 
be due to the group delivery of the intervention and the need to attend the sessions outside 
the home or with support from carers. Comparison of the long term retention to multi-
component weight management interventions in adults with intellectual disabilities is limited 
as only two studies examined retention rates at 12 months (Fox et al., 1984; Bergström et 
al., 2013). The results of this study and the above randomised controlled trials of multi-
component weight management interventions in adults with intellectual disabilities compare 
favourably with the retention rates of studies conducted in the general population. 
Comparison of drop-outs with weight management interventions for adults with obesity 
were 30-60% at 12 months (Douketis et al., 2005). Retention rates were higher for adults 
with intellectual disabilities and obesity in this study in comparison to clinical trials of 
weight management interventions in the general population.  
 
6.3.3 Adherence 
Acceptability of the intervention was also measured by attendance at the intervention 
sessions. Adherence to the intervention was high with greater than 75% during the weight 
loss phase and weight maintenance phase in both interventions. The one-to-one delivery of 
this intervention and the option to conduct the sessions at the participants’ location of choice 
may explain the high attendance levels. However, previous research in intellectual 
disabilities has not evaluated adherence and the process of the delivery of the intervention 
in depth. The majority of studies on weight management interventions in adults with 
intellectual disabilities delivered the interventions in a group setting and a set location, 
therefore comparison with other evaluations remains difficult (Chapter two). The high 
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attendance rate is in agreement with an individualised multi-component weight maintenance 
intervention conducted in the general population. Process evaluation with the therapists 
delivering the intervention reported that the one-to-one delivery of the intervention in person 
was higher than when the intervention was delivered by telephone and also that the 
individual delivery in the participant’s home environment prevented poor adherence to the 
intervention sessions (Simpson et al., 2015). 
 
6.4 Acceptability of outcomes 
In order to detect clinically important changes in outcomes, it is important that outcomes are 
acceptable to participants and can be measured accurately and reliably. The main outcomes 
under investigation in this study were anthropometric variables, objective assessment of 
physical activity and health related quality of life. 
 
6.4.1 Anthropometric outcomes 
Measurement of body composition was well received by participants, overall compliance to 
measurements ranged between 86% and 100% of all measurements. Body weight and height 
measurements to calculate BMI were acceptable to all participants with intellectual 
disabilities. Waist circumference could not be measured accurately in three participants with 
severe/profound intellectual disabilities at baseline due to difficulties with them moving or 
refusing to take off an outer layer of clothing by one participant. Percentage body fat was 
the most challenging methodological assessment in terms of acceptability to participants and 
accuracy of measurement. The level of compliance with the measurement was reported to 
be lower in comparison to other anthropometric assessments (86%). For example, at baseline 
seven participants reported that they did not want this measurement to be taken or the 
researcher had issues in accurately measuring triceps skinfold. Percentage body fat could not 
be measured in one participant due to clothing restrictions. It was noted that a greater 
proportion of adults with severe or profound intellectual disabilities had difficulty with the 
acceptability of this measurement technique.  
 
The results of this study on the feasibility and acceptability of anthropometric measurements 
are consistent with the available literature. For example, a study by Verstraelen and 
colleagues (Verstraelen, Maaskant, Knijff‐Raeven, Curfs, & van Schrojenstein Lantman–de 
Valk, 2009) investigated the feasibility of BMI, waist circumference and skinfold 
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measurements in 76 adults (age range 19 to 72 years) with intellectual disabilities. 
Participants were classified as underweight (14%), normal weight (50%), overweight (18%) 
and obese (18%). BMI and waist circumference were shown to be feasible in all participants, 
whereas skinfold measurements were slightly less acceptable with five participants reported 
to not be able to tolerate this measurement due to fear of the skinfold callipers. This study, 
however, did not report level of intellectual disabilities and therefore it is unclear if the lack 
of acceptability in some participants was limited to a specific subgroup of adults with 
intellectual disabilities. Furthermore, Temple & Walkley, & Greenway, (2010) investigated 
the accuracy of BMI in measuring adiposity in adults with intellectual disabilities against a 
criterion measure, DEXA. Data from 46 adults (age range 19 to 60) with mild to moderate 
intellectual disabilities was obtained. Participants again varied in their weight status from 
normal weight to morbidly obese (Mean BMI 27.7 kg/m2; range 18.4 kg/m2 to 42.3 kg/m2). 
Linear regression analysis was used to investigate the association between the two 
measurement techniques. BMI was strongly associated with direct assessment of adiposity 
(R2 = 0.83) and therefore shown to be a reliable measure of adults with intellectual 
disabilities.  
 
The feasibility of anthropometric measurements in the above research included adults with 
mild to moderate intellectual disabilities or as in the study by Vestraelen et al., (2009) the 
level of intellectual disabilities was not reported. In the current study, body composition was 
assessed in adults with all levels of intellectual disabilities and it was found that skinfold 
measurements were not feasible in adults with severe intellectual disabilities. This is in 
agreement with a previous study in adults with severe intellectual (weight status: 
underweight 4%; normal weight 65%; overweight 27% and obese 4%) and sensory 
disabilities (Waninge, Van der Weide, Evenhuis, Van Wijck, & Van der Schans,2009). 
Waninge et al., (2009) also examined the feasibility of BMI and waist circumference with 
high levels of feasibility (≥95%) whereas skinfold measurements were found to be feasible 
in 82% of measurements. An explanation for the lower level of acceptability to this 
population was due to a proportion of participants becoming agitated during the 
measurement and being unable to remain still upon feeling the pinch of the callipers. This 
limited accurate assessment of the measurement as it takes two seconds, with the callipers 
in place, before a reading of a skinfold thickness can be taken. In this current study the 
researcher was aware of these potential effects on anxiety and agitation and did not want to 
provoke these symptoms. Any signs of discomfort with the suggestion of the measurement 
or occurrence when performing the measurement, resulted in the measurement not being 
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conducted. Due to the enhanced impairment in cognitive abilities of adults with severe or 
profound intellectual disabilities, barriers with understanding their environment and/or the 
measurements being taken may limit the feasibility of skinfold measurements. Future 
research is warranted in the assessment of body fat for this subgroup of adults with 
intellectual disabilities. 
 
6.4.2 Physical activity outcomes 
Objective assessment of physical activity by accelerometers was shown to be acceptable to 
adults with intellectual disabilities. Compliance with the accelerometers was reported to be 
extremely high at baseline (94%), however, this decreased to 76% and 63% at six and 12 
months, respectively. As data were analysed retrospectively on completion of the study, 
issues regarding compliance were not identified and reasons for non-compliance were not 
formally explored. Compliance strategies were conducted throughout the study with weekly 
telephone calls facilitating as a reminder to participants and carers to encourage maximum 
wear time (Trost, McIver, & Pate, 2005). However, it was noted by the researcher that, in 
some circumstances there may have been resistance from carers to the participants wearing 
the monitors. This could perhaps be due to a lack of understanding of the importance of the 
monitors or carer’s making assumptions about the participants’ willingness to wear 
accelerometers. Since carers play an integral role in supporting this population with decision 
making, future studies should aim to educate the carers and participants on the importance 
of capturing physical activity levels through accelerometer wear. Indeed, compliance 
strategies shown to be effective in the general population include providing more education 
on the accelerometer so participants know why they are wearing them (i.e. explaining the 
output from the accelerometer) (Trost et al., 2005) and getting participants to complete an 
activity monitor log. Future studies should aim to implement these strategies with both 
participants and carers in order to maintain high rates of compliance and provide more valid 
physical activity data. 
 
6.4.3 Health related quality of life 
Due to the lack of burden to participants all questions asked in the process of this trial, all 
were found to be acceptable to adults with intellectual disabilities and their carers. The five 
dimensions of the EQ-5D were answered by all individuals or by proxy responses from 
carers (i.e. with participants with more, severe profound intellectual disabilities). However, 
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the majority of participants were unable to answer the EQ VAS. Participants who could 
answer the EQ VAS had predominantly mild intellectual disabilities. In the original analysis, 
it was proposed that ratings from individuals with mild intellectual disabilities and their 
carers would be compared. However, challenges in the interview setting in that carers would 
in some circumstances want to answer for the individual independent of level of intellectual 
disabilities meant that in some cases due to acquiescence of participants, their responses 
matched carers and vice versa. Few studies have examined the acceptability of the EQ-5D 
questionnaire in adults with intellectual disabilities. One study by Melville et al., (2015) also 
reported that participants were unable to complete the EQ-VAS and did not report the results 
of participants who were able to complete the scale, therefore comparison with other studies 
is limited. The difficulties arose in this study due to proxy response and the turnover of staff 
meant in some case measurements at all three time points were not completed by the same 
carer.  
6.5 Potential efficacy of interventions 
The primary efficacy analysis for this study was completers ITT, as this maintained the 
original treatment random allocation to the TAKE 5 intervention and the WWToo 
intervention, therefore, minimising any confounding biases such as differences between 
baseline characteristics that may influence the outcome. Exploratory analysis was conducted 
to examine the potential efficacy of the intervention under ‘ideal’ conditions in which 
participants were defined as adhering to the intervention and finally sensitivity analysis was 
also conducted to examine the validity of the results. The main discussion and conclusion 
on the potential efficacy of the TAKE 5 and WWToo interventions was based on the results 
of the completers ITT analysis, as this reflects what would happen in clinical practice. 
However, where relevant, per-protocol results and results of the sensitivity analysis will also 
be discussed. 
 
6.5.1 Weight management 
The primary results of this study provide preliminary evidence that the TAKE 5 intervention 
may be an effective weight loss strategy. The within group analysis revealed that participants 
in the TAKE 5 intervention achieved significant reductions in body weight, BMI, waist 
circumference and percentage body fat at six months and 12 months which were not found 
in participants completing the WWToo intervention. Although there was no between 
intervention effect of the TAKE 5 intervention in comparison to the WWToo intervention, 
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this was due to the small sample size of this study which was not sufficiently powered to 
detect between group differences. At 12 months the proportion of participants achieving a 
clinically important weight loss, although not statistically significant, was 50% of 
participants in the TAKE 5 intervention in comparison to 21% of the proportion of 
participants in the WWToo intervention.  This finding is extremely influential in terms of 
effective weight management approaches for adults with intellectual disabilities and 
provides preliminary evidence of the potential efficacy of the EDD as an alternative 
approach to weight management over current practice of health education interventions.  
 
6.5.1.1 Comparison with single stranded studies 
Comparison of the interventions used in this study with the original pilot investigations is 
important to determine if progress has been made in terms of the development of the 
intervention and the potential efficacy. Comparison of the weight loss results of this study 
of the TAKE 5 intervention at the end of the weight loss phase (-2.93 kg 95% CI -4.42 kg to 
-1.44 kg) with the original pilot study by Melville and colleagues (2011), (-4.47 kg 95% CI 
-5.91 kg to -3.03 kg), revealed a slightly lower absolute weight loss and clinically important 
weight loss of 5-10% of initial body weight (20.5% vs 36.2%, respectively). However, 
adhering to clinical recommendations, the true time point to examine the efficacy of an 
intervention is at 12 months. At the end of the weight maintenance phase and end of the 
intervention, participants in the TAKE 5 intervention in this study had continued to lose 
weight, (overall weight change from baseline at 12 months: -3.55 kg;-5.59 kg to -1.52 kg). 
This may reflect the design of the study, as if participants had not achieved a clinically 
significant weight loss of 5% at six months they were offered the option to continue to lose 
weight for a further three months, followed by three months of weight maintenance. This 
compares favourably to the changes in body weight in the single stranded weight 
maintenance phase in which participants did not maintain a significant reduction in body 
weight, -0.6 kg (SD 5.5 kg; p = 0.5). Based on the definitions by Stevens et al., (2006), fifty-
eight percent of participants maintained their weight loss in this study in comparison to 50% 
of participants in the single stranded study (Spanos et al., 2015). Moreover, fewer 
participants gained weight (13% vs 29%) and a higher percentage of participants continued 
to lose weight (29% vs 21%) in this study. Although, these results should be interpreted 
cautiously due to the differences in the duration of the weight maintenance period by Spanos 
et al., (2015) which was 12 months in comparison to the six months weight maintenance 
181 
 
 
phase in this study, the results suggest that TAKE 5 can achieve sustainable clinically 
important changes in body weight. 
 
Comparison of the WWToo intervention with the retrospective evaluation by Jones et al., 
(2015) is difficult as the two interventions under investigation are distinct. The WWToo 
utilised in this study was adapted from the original format in terms of the delivery of the 
intervention, from a group based to an individual based intervention with one-to-one contact 
with a dietitian; the addition of the involvement of family and paid carers in supporting 
participants to make healthy lifestyle choices; addition of a weight maintenance sessions  
and finally the increased number of sessions and duration of the intervention from eight to 
fifteen sessions and 13 weeks to 12 months. In the original group based intervention, 
participants were reported to have significant reductions in weight, BMI, waist 
circumference and 26% of participants lost 5-10% of initial body weight. It is important to 
take into consideration limitations of the single stranded observational study of the WWToo 
intervention when interpreting these results. Firstly, this study is subject to a high risk of 
detection bias as researchers collecting outcome measures were not blinded and it has been 
shown in clinical trials that unblinding of study outcomes can exaggerate the treatment effect 
(Hróbjartsson et al., 2012). Secondly, the duration of the study was very short therefore, the 
sustainability of the change in outcomes is uncertain and does not meet clinical 
recommendations on examining the efficacy of interventions for weight management. Re-
evaluation of interventions at the feasibility and piloting stage is central to informing and 
justifying a full-scale clinical trial. Based on the results of this study, it appears that even in 
a more intensive format of the WWToo intervention in terms of delivery with increased 
frequency of sessions and level of support on a one to one basis, does not support the findings 
of the original study as a potential approach to weight management in adults with intellectual 
disabilities.  
 
6.5.1.2 Comparison with randomised controlled trials in adults with 
intellectual disabilities 
This thesis identified a paucity of randomised controlled trials of weight management 
interventions in adults with intellectual disabilities. The current available evidence did not 
meet current clinical recommendations on the management of obesity and elicited small non-
significant effects on weight loss in comparison to no treatment.  Furthermore, the quality 
of the current evidence base, is subject to poorly conducted trials which in general have small 
samples sizes and were not adequately powered. Furthermore, current studies have 
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methodological limitations and risk of biases including confounding factors, selective 
reporting and attrition bias which limit the efficacy of results. This is the first ever 
randomised controlled trial to adhere to clinical recommendations. This study was carried 
out using robust methods which aimed to provide an unbiased assessment of the effect of 
the intervention.   Furthermore, this is the first study to illustrate the acceptability of an EDD 
in adults with intellectual disabilities and report clinically important weight loss. Future 
studies, should aim to emulate the high-quality design of this study, in order to evolve the 
field of weight management in adults with intellectual disabilities. 
 
6.5.2 Physical activity and sedentary behaviour 
The results of this study are consistent with previous research in that adults with intellectual 
disabilities are at increased health risk due to the adoption of sedentary lifestyles and lack of 
engagement in physical activity (Bartlo & Klein., 2011; Temple & Walkley, 2003). 
Participants in both interventions were reported to participate in 153.4 minutes/day (SD 
62.5) of light and 30.1 minutes/day (SD 19.6) of moderate to vigorous physical activity. The 
baseline results of the physical activity levels in this study are higher than the physical 
activity levels reported in the single-stranded feasibility study, with baseline moderate to 
vigorous physical activity double the level reported by Melville et al., (2011). However, this 
is still low in comparison to the evidence of physical activity in the general population and 
consistent with previous research for adults with intellectual disabilities (Phillips et al., 
2011).  
 
At 12 months the study found no effect in time spent in physical activity at either light, 
moderate or vigorous intensity or time spent sedentary. This replicated the findings found at 
the end of the weight maintenance period in the TAKE 5 weight maintenance study by 
Spanos et al., (2015). Furthermore, few of the randomised controlled trials of multi-
component weight management interventions measured the effect of the intervention using 
objective assessment of physical activity. Only one study measured physical activity by 
accelerometer (McDermott et al., 2012). Another study utilised pedometers to measure 
physical activity (Bergström et al., 2013), on the basis they had shown high agreement with 
accelerometer-measured physical activity (Le Masurier & Tudor-Locke 2003; Tudor-Locke, 
Ainsworth, B. Thompson, & Matthews 2002). McDermott et al., (2012) reported consistent 
finding with this study in that participants engaged in high levels of sedentary behaviour 
(87.4% of accelerometer wear time spent sedentary). The main physical activity outcome 
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was solely focussed on moderate to vigorous physical activity. This was shown to not to be 
significantly increased at 12 months from baseline in comparison to the control intervention. 
However, in contrast participants in the study by Bergström and colleagues (2013), reported 
a significant increase in step count at 12 months their multi-component intervention in 
comparison to no treatment control intervention (1608 steps per day; 95% CI 42 to 3137; p 
= 0.045). Although a significant increase in step count is reported this is not of significant 
magnitude to have any clinical benefits from change in physical activity levels. However, 
difficulties in making direct comparisons with the single stranded study and previous 
research due to different models of accelerometers used, different cut points used to 
categorise intensities of physical activities and uni-axial, multiple-axial devices used are 
some of the challenges in comparing data (Rothney, Apker, Song, & Chen, 2008; Thompson, 
Batterham, Markovitch, Dixon, Lund, & Walhin, 2009).  
 
Irrespective of the methodology issues in comparing objective measures of physical activity 
across studies, adults with intellectual disabilities and obesity engage in low levels of 
physical activity. The reported low levels of physical activity and adoption of sedentary 
lifestyles in this population group is largely due to the increased barriers individuals with 
intellectual disabilities face in leading physically active lifestyles. Barriers commonly 
reported for adults with intellectual disabilities include; a reduced cognitive ability to 
understand the benefits of engaging in regular physical activity and a lack of awareness of 
available physical activity options, limited time capacity and support from carers to assist 
engagement in physical activity (i.e. taking a service user for a walk) and limitations in 
transportation (Hawkins & Look, 2006; Bodde & Seo, 2009). Although, this study did not 
explore barriers to engagement in physical activity directly, it was reported in the process 
evaluation that contextual factors and the engagement of carers were influential in changing 
this behaviour. It was reported in the qualitative interviews with the research dietitians that 
physical activity goals were not achieved in some participants due to the environment and 
concerns over safety in performing physical activity outside the home. The negative impact 
of the environment can be further illustrated as 42.0% of participants lived in the most 
deprived areas of Glasgow. This is in agreement with previous research discussing the 
barriers and facilitators to engagement in physical activity by a recent study by Melville et 
al., (2015). Melville et al., (2015) attributed the ineffectiveness of their walking intervention 
in part to the unsupportive environment. If the environment in which the participants are 
resident is not supportive of physical activity, more emphasis should be placed in future 
studies on feasible home based activities and interrupting sedentary behaviour. 
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6.5.3 Health related quality of life 
 The between group differences in change in health related quality of life were negligible, 
with this pattern in small insignificant changes also evident pre-post at six months and 12 
months from baseline in both interventions. Comparison of changes in weight loss on health 
related quality of life is limited as few studies have utilised the EQ-5D in adults with 
intellectual disabilities (Riemsma, Forbes, Glanville, Eastwood, & Kleijnen, 2001). Only 
one of the multi-component weight management interventions reviewed in chapter two 
included a measure of the EQ-5D index, however, this study has not published full results 
and therefore, comparison with this study is not possible. A recent study of a physical 
activity/walking programme also found that there was no significant change in health related 
quality of life, however the intervention also had no effect on its primary outcome of change 
in physical activity (Melville et al., 2015). The limited change in this study may be due to a 
high proportion of participants reporting no problems in health profiles at baseline and 
therefore, the EQ-5D itself might not be sensitive to changes in a population classifying 
themselves or from proxy respondents as in general having no health problems. This is in 
agreement with a recent study of a weight maintenance intervention in the general population 
(Simpson et al., 2015), illustrated that participants with intellectual disabilities have 
equivalent self-reported health states as overweight and obese adults in the general 
population. 
 
In a study undertaking practice nurse health checks, the authors reported that the health 
dimensions measured which are considered important for the general population may not be 
regarded as health priorities for adults with intellectual disabilities (Cooper et al., 2014). 
Another useful tool to measure health related quality of life in weight management 
interventions in the general population is the short Form questionnaire-12 items (SF-12). 
This may provide an alternative approach to capture changes in health related quality of life. 
There are also obesity specific research tools to capture changes in health related quality of 
life following weight loss, however, the validity and interpretability of these questionnaires 
is uncertain (Duval et al., 2006). Furthermore, their applicability to the cognitive needs and 
abilities of adults with intellectual disabilities requires further investigation. As proxy 
response is an integral component to both conducting research and clinical practice involving 
adults with intellectual disabilities (Finlay & Lyons, 2001), it is important that future 
research investigates valid questionnaires or self-report/proxy response measures to 
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accurately and reliably measure health related quality of life in adults with intellectual 
disabilities. 
 
6.6 Validity of principal findings 
Validity of the results was conducted based on the sensitivity analysis. The eligibility criteria 
in this study included no upper limit on weight status (BMI > 30 kg/m2) mirroring the 
procedures in clinical practice at the GCWMS (Morrison et al., 2012; Logue et al., 2014). 
Due to the small sample size of this study one participant was identified as an outlier with a 
weight of 212 kg and distinct from the study population mean. The effect of this participant 
increased the average body weight and body composition measurement at baseline, therefore 
analysis was conducted with and without this participant. Analysis without this participant 
did not affect the overall conclusion and interpretation of the results. Indeed, it is important 
that this participant is included in the results of the intervention as morbid obesity is shown 
to further increase the risk of health inequalities associated with obesity and therefore, 
weight loss for this population group is imperative.  
 
An important finding of the sensitivity analysis is that one participant in the WWToo 
intervention was shown to lose a substantial amount of weight loss of -15 kg which was not 
replicated by other participants completing this intervention at 12 months. Exploration of 
reasons into this substantial change in body weight revealed that this was due to medical 
reasons and likely not a result of taking part in the intervention. Following the procedures of 
conducting analysis excluding outliers, the results revealed a mean weight change in the 
WWToo intervention of -0.5 kg (SD 3.5kg) and resulted in a significant between group 
difference (TAKE 5 – WWToo). This provides further evidence that the TAKE 5 intervention 
may be an effective approach to treat obesity.   
 
6.7 Comparison with the GCWMS 
Clinical services often judge the success of their intervention based on participants defined 
as completing the intervention. The GCWMS conducted a recent analysis of the efficacy of 
their tier three weight management programme at 12 months (Logue et al., 2014). A high 
proportion of missing data were reported in this study; therefore, analysis was conducted by 
last observation carried forward (LOCF) and for completers (defined as attending 50% of 
the sessions in each phase). One thousand eight hundred and thirty-eight patients were 
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included in the LOCF analysis, reporting a weight loss of -3.6 kg (95% CI -3.9 kg to -3.3 
kg) at 12 months from baseline. For completers, weight was measured directly for the 
participants who started the intervention and the absolute weight loss revealed a change of 
−7.2 kg (95% CI −8.1 kg to −6.3 kg). Furthermore, comparison of the number of participants 
achieving a clinically important weight loss increased from 24% (LOCF) to 51% for 
participants completing the intervention. The difference in results suggests that participants 
who adhere to the intervention produce greater effect sizes on change in body weight and 
clinically important weight losses. However, the interpretation of these results may be 
misleading as only 21.7% of participants had direct measurement of body weight at 12 
months and therefore it is reported that confirmation of clinically important weight losses 
can only be assured for only 12% of the patients at 12 months. This raises questions over the 
validity of their completers analysis and may ask questions about the effectiveness of the 
current service. 
 
The results of the TAKE 5 intervention compare favourably to the results in the GCWMS 
offered to the general population. Firstly, in terms of adherence to the intervention, a higher 
proportion of adults with intellectual disabilities attended the intervention sessions. Only 
20% of adults with intellectual disabilities were defined as having not completed the 
intervention in this study, which was based on a higher acceptability rate of 75% attendance 
at intervention sessions. The absolute weight loss independent of analysis conducted 
(completers ITT or per-protocol) in this study is equivalent to the LOCF analysis reported 
in the GCWMS, and results for clinically important weight losses were reported for 
approximately 50% of the participants in TAKE 5. This illustrates that adults with 
intellectual disabilities can achieve significant weight losses comparable to the general 
population. This is in agreement with the study by Spanos, Hankey, Boyle, & Melville, 
(2014) comparing the single stranded weight loss study of the TAKE 5 intervention with 
‘matched participants’ (based on gender, BMI and age) in the general population completing 
the GCWMS. The conclusions of the study reported that the TAKE 5 multi-component 
intervention was equally effective as the GCWMS in the general population. Although this 
thesis did not match participants and therefore direct comparison is limited, it appears to 
reiterate the results of Spanos et al., (2014) that adults with intellectual disabilities can lose 
an equivalent amount of weight comparable to the general population and that a personalised 
dietary approach of an EDD is an acceptable and efficacious approach to weight 
management in this population group. 
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6.8 Process evaluation 
The process evaluation was implemented to understand some of the feasibility measures 
such as recruitment and retention to the intervention, delivery and implementation of the 
intervention and the identification of effective and ineffective components. Investigation 
into these outcomes is essential to evolve intervention design and resolve any challenges or 
barriers to the research process or implementation of the intervention which might have the 
potential to be extrapolated on conducting a full-scale trial. A mixed methods design was 
utilised to address the above research questions, which were guided by the process 
evaluation framework designed by Linnan & Steckler, (2000).  
 
6.8.1 Fidelity of the intervention 
The intervention was delivered successfully by two trained health professionals (a dietitian 
and lifestyle counsellor). In general, the intervention was implemented as intended. Issues 
with study resources and capacity, at the start of the study due to the employment of only 
one research dietitian meant that in some circumstances sessions did not adhere to the time 
allocation for appointments set at 1 hour in the protocol. Delivery of session content was not 
compromised and this was resolved quickly with the appointment of a second research 
dietitian. Furthermore, it was noted that the delivery of session content did not require the 
full duration and no participants requested additional appointments to help facilitate 
understanding of session information. Duration of the intervention sessions varied 
depending on the intervention content. At the start of the TAKE 5 intervention in particular, 
sessions required the full hour to effectively communicate the information to participants.  
However, coverage of session content in other sessions did not require the full time allocated, 
and sessions lasted approximately 40 minutes. This was also found to be the case in the 
WWToo intervention, as delivering the intervention content on a one-to-one basis required 
less time than in the pilot group base study that the intervention was adapted from (Jones et 
al., 2015). One of the reasons of conducting a pilot randomised trial was to work out the 
practicalities of delivering the weight management intervention. Lessons learnt from this 
study are that a whole time equivalent dietitian is required to deliver the weight management 
intervention and that appointments should be consolidated to geographical regions to 
maximise the research dietitian’s time to see participants. 
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The fidelity of the delivery of the intervention sessions was good across both interventions 
and the research dietitians only on occasion deviated from the protocol to meet the needs of 
a participant such as rearranging session content design to be delivered later in the 
intervention to an earlier session in which it was required. Justification for changes were 
noted and within the scope of the intervention. This mirrored what would happen in clinical 
practice at the GCWMS, which the intervention aimed to replicate. As both research 
dietitians delivered both interventions, there is potential for contamination in crossing over 
of intervention content to the opposite intervention. This is a  limitation of this study was 
that fidelity of the intervention was not recorded by a criterion method of direct observation 
(Hill et al., 2007). However, research has shown that professionals alter the way they interact 
and respond when being observed and this has shown to provide an inaccurate estimate of 
implementation fidelity (Breitenstein, Gross, Garvey, Hill, Fogg, & Resnick, 2010). This 
can present, for example, either in terms of being over adherent to the protocol or if anxiety 
is provoked, this can lead to diminishing effects on protocol adherence and/or competency 
in implementing the intervention. It was also felt that either reaction would negatively affect 
the interaction between the participant and research dietitian which as previously discussed 
is shown to be a contributing factor to the successful delivery of the intervention. To 
maximise the fidelity of the intervention other measures including providing research 
dietitians with a manual of each intervention sessions and adherence to a set pre-specified 
protocol were implemented and checklists of the components delivered at each session (Hill 
et al., 2007; Linnan & Steckler, 2002). A future full scale randomised controlled trial would 
however require multiple professionals to deliver the intervention. Therefore, to ensure 
fidelity, audio recording of a selection of the sessions or alternatively having different 
research dietitians deliver each intervention would further reduce the risk of contamination 
between interventions.  
 
 
6.8.2 Implementation of the intervention 
One of the integral components of this study was the influence of social support from carers 
in supporting participants to lose weight. Successful strategies associated with 
improvements in healthy lifestyle habits in particular included, carers supporting participants 
to increase their physical activity by encouraging them to go walking or interrupt sedentary 
time by encouraging engagement in enjoyable activities such as dancing. Furthermore, 
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advising on portion control and consumption of healthy food options also played an integral 
role in helping to achieve participants weight loss targets. This is in agreement with previous 
research identifying the role of social support from carers in supporting individuals with 
intellectual disabilities (Matthews et al., 2016; Spanos et al., 2013b).  
 
The multi-component weight management interventions were based on behaviour change 
techniques recommended by clinical guidelines (NICE 2014; SIGN 2010) and research from 
high quality meta-analysis on supporting healthy eating and physical activity in the general 
population (Michie et al., 2009). However, it was identified that in some circumstances 
behaviour change techniques shown to be effective in the general population may not be 
easily implemented in adults with intellectual disabilities due to limitations in levels of 
understanding and cognitive skills. The primary behaviour change techniques utilised in the 
interventions were goal setting and self-monitoring. Preliminary results demonstrated that 
adults with severe or profound intellectual disabilities were not able to self-monitor lifestyle 
behaviours. For example, self-monitoring of physical activity involves a process of 
identification of the number of steps, reflection and understanding on the amount and 
interpretation of the results as to whether this has improved or decreased since the last time. 
The three self-monitoring behaviours changes were diet, physical activity and body weight. 
It was reported that the food diaries were more easily interpretable to adults with intellectual 
disabilities than pedometers. In circumstances where adults with intellectual disabilities 
could not process the behaviour change techniques it was associated from the research 
dietitians that carers were influential in implementing the technique. This highlighted the 
importance of consistent and continued support from carers in helping all adults with 
intellectual disabilities to lose weight. Furthermore, although adults with mild to moderate 
intellectual disabilities have shown to have more autonomy, it was proposed by the research 
dietitians that additional support from carers would have been beneficial and resulted in 
further success in changing participants’ behaviour. Previous trials reported in chapter two 
excluded adults with severe or profound intellectual disabilities. Therefore, this is the first 
study to provide weight management for all adults with intellectual disabilities and 
highlights with support from carers, this population group irrespective is severity of 
intellectual disabilities, can achieve improvements in body weight and composition. 
 
In addition, to overcome barriers in providing complex health information and to be 
inclusive of all adults with intellectual disabilities the intervention included adapted methods 
of communication such as visual aids, drawings and games. This was highlighted as another 
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key facilitator in implementing the intervention. This is supported by previous research 
illustrating that participants learn more from visual and sensory methods of communication 
rather than written exercises or solely discussions (Spanos et al., 2012; Holly & Sharp, 
2014).  
 
6.8.3 Effective and ineffective components 
In addition to the feasibility of the implementation of the intervention, the systematic coding 
and identification of behaviour change techniques allowed insight into the active ingredients 
of the intervention. The findings of this study provide exploratory information on the process 
of behaviour change in supporting participants with intellectual disabilities to lose weight. 
This study provides support for the utility of an EDD in adults with intellectual disabilities. 
The research dietitians reported that quantitative dietary advice from the EDD was easier to 
monitor and observe progress in dietary habits. Furthermore, due to the limited effect on 
increasing physical activity, the main active component in the TAKE 5 intervention can be 
attributed to the EDD along with successful implementation of behaviour change techniques 
such as feedback, goal setting, self-monitoring and social support from carers.  
 
A limiting component of this study was the lack of effect of the intervention on increasing 
physical activity or reducing sedentary behaviour. Investigation into the barriers and 
facilitators to implementation of the intervention components with the research dietitians 
provided an insight into why the process of this intervention component failed to elicit an 
effect. One explanation for this could be due to a lack of carer knowledge and education on 
the benefits of physical activity and current physical activity recommendations (Melville et 
al., 2009). Although carers were involved in the implementation of the intervention, the main 
focus was on education and engaging the participants with intellectual disabilities. Future 
trials should focus on developing further resources targeting carers to improve their 
knowledge on the benefits of physical activity and effectively engage adults with intellectual 
disabilities to improve this lifestyle behaviour. The lack of change could also be related in 
addition to socioeconomic factors discussed previously, and the challenges in adapting 
complex interventions for the needs of this population group. The behaviour change 
techniques implemented to support increases in physical activity were feedback, goal setting 
and self-monitoring. Although shown to be effective in changing dietary habits, they may 
not have been of significant magnitude to change levels of physical activity. Evidence in 
increasing physical activity in obese adults in the general population suggests that effective 
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behaviour change techniques include self-efficacy, teach to use prompts/cues, prompt 
practice, and prompt rewards contingent on process or effort (Olander et al., 2014). Future 
implementation of the intervention should take on lessons learnt from this thesis which 
included, reinforcing the strategy for engaging carers in the implementation of the 
intervention, refining the physical activity component by utilising other effective behaviour 
change techniques such as incorporating practice of physical activity into the sessions, 
providing prompts cues to stimulate increased physical activity between sessions and 
encourage peers and family and friends to engage in this lifestyle behaviour. Enhancement 
of these intervention components, in particular the support to increase physical activity in 
addition to the already positive changes achieved in diet, could provide a larger effect size 
on weight loss. 
 
6.9 Strengths and limitations 
A key strength of this research is in aiming to address the lack of evidence on the 
management of obesity in an underrepresented population in adults with intellectual 
disabilities. This thesis followed a programme of research in accordance with best practice 
guidance on examining and developing complex interventions (MRC 2000; 2008). This 
included providing an updated review of current knowledge through systematically 
reviewing the evidence base on weight management interventions in adults with intellectual 
disabilities, followed by the evaluation of a multi-component weight management 
intervention which fully adhered to clinical guidelines (NICE 2014, SIGN 2010). This 
consisted of examining the feasibility of essential processes to conducting clinical trials 
including recruitment and retention, examining the implementation and fidelity of the 
intervention and also provided insight into the mechanisms supporting behaviour change. 
Furthermore, a consistent strength throughout the studies in this thesis was reviewing and 
conducting research based on the gold standard, randomised controlled trial study design 
and finally, and most importantly providing weight management support inclusive of all 
adults with varying severity of intellectual disabilities.   
 
The pilot randomised controlled trial was conducted rigorously and aimed to reduce potential 
risks of bias identified in previous studies. However, this was a pilot study and the small 
sample size prevented any significant between group findings and prevents firm conclusions 
over the efficacy of the intervention being made. Although this study aimed to adhere to 
guidelines of examining the feasibility of complex interventions, this study did not conduct 
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pilot investigation into the cost-effectiveness of the future trial. The delivery of the 
intervention was by a highly trained and educated dietitian and health professional based on 
the evidence that these professionals can have a slight improvement on increased efficacy of 
weight loss in weight management in the general population (Hartmann-Boyce et al., 2014; 
Laws, 2004). However, the cost-effectiveness of employing dietitians to deliver weight 
management in adults with intellectual disabilities is uncertain. Furthermore, due to the 
limited funding and resources available to this population group, delivery of the intervention 
by dietitians may not be feasible on a larger scale. A future research area based on the results 
of this study in the association of successful implementation of the intervention by carers 
may include whether or not carers could be trained to effectively deliver the intervention. 
Future studies should undertake an economic evaluation of the TAKE 5 multi-component 
weight management intervention to provide evidence on whether or not the TAKE 
intervention is viable for implementation into practice.  
 
As the process evaluation was conducted prior to the start of the randomised controlled trial 
as an additional exploratory study, there are limitations in understanding some of the process 
of participating in a randomised controlled trial. In particular, a lack of the measure of 
compliance with intervention components such as the EDD, carers experiences of supporting 
individuals with intellectual disabilities in the intervention and barriers and facilitators to 
implementing the intervention. Other limitations in conducting the process evaluation of the 
study include a lack of measurement of fidelity of the behaviour change techniques 
implemented throughout the sessions, as these were not recorded. This has importance to 
gain insight into whether the intervention was implemented as planned and in identifying 
the active ingredients of the intervention. Finally, although the qualitative interviews with 
the research dietitians enriched the data to provide insight into the effective and ineffective 
components of the interventions and the implementation of the interventions, further insight 
could have been achieved by interviewing participants and carers. Participants who were 
successful or unsuccessful in terms of their compliance with the regime and weight loss may 
report differently.   
  
6.10 Research implications 
Currently in the UK, there is no formal treatment pathway within the national health service 
for the treatment of obesity for adults with intellectual disabilities. Although services exist 
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for weight management in the general population, difficulties with communication, level of 
understanding and additional support needs means that these services are not easily 
accessible or even ineffective for adults with intellectual disabilities. The disparity in the 
provision of health services available for adults with intellectual disabilities is recognised by 
clinical guidelines as a major health priority (NICE 2007). It is recognised that individuals 
with intellectual disabilities need access to health services tailored specifically to their 
cognitive and communication needs, and that training of health professionals to facilitate 
effective communication and appropriate resources designed to meet the level of intellectual 
disabilities is required in order to make services more accessible to this population group. 
This study of the TAKE 5 weight management intervention has provided evidence to 
facilitate the next step of a programme of research to examine the effectiveness of the 
intervention. This is consistent with the MRC guidelines on developing and evaluating health 
interventions. Further research is necessary to provide strong support for the future 
implementation of this intervention as a service and reduce the inequalities adults with 
intellectual disabilities receive in terms of service provision for weight management.  
 
In order to tackle the obesity epidemic in adults with intellectual disabilities, alternative 
strategies may also need to be considered. Prevention of obesity is often considered a 
desirable strategy as it is shown to be easier to prevent weight gain that to lose weight. Body 
weight has shown to increase over time (Anderson, Konz, Frederich, & Wood, 2001; 
Heitmann, & Garby, 1999) and therefore intervention strategies in the prevention of obesity 
should aim to tackle this problem at an earlier age. In the general population, the transition 
from adolescence to adulthood has been identified as a high risk period for weight gain 
(Gordon-Larsen, Nelson, & Popkin, 2004). There is also anecdotal evidence from health 
professionals that this is also a time for increased weight gain in individuals with intellectual 
disabilities. Strategies to tackle an increase in body weight vary in terms of intervention 
components (diet, physical activity and behaviour change) and there is no gold standard 
approach. Physical activity has shown to be an effective approach in preventing weight gain 
due to its role in energy balance through increased energy expenditure (Kavouras et al., 
2007; McTiernan et al., 2007), improved appetite control and reduced energy intake 
(Chaput, Klingenberg, Rosenkilde, Gilbert, Tremnlay, & Sjodin, 2011; Stubbs & Tolkamp, 
2006). In order to develop such an intervention to prevent weight gain in young adults with 
intellectual disabilities, it is important that the current evidence base is evaluated. An 
additional research question addressed by this thesis was to systematically assess the 
literature on randomised controlled trials on the effects of physical activity interventions to 
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prevent weight gain in young adults with intellectual disabilities (Harris et al., 2015). This 
review highlighted, consistent with the evidence for weight management in adults with 
intellectual disabilities, the paucity of interventions to prevent weight gain. None of the 
interventions identified had a specific focus to prevent adverse increases in body weight and 
meta-analysis reported that the physical activity interventions included did not prevent 
weight gain (WMD: -0.17 kg, 95% CI, -1.04 kg to 0.72 kg) or improve body composition. 
No effect of the interventions was found due to limitations in inadequate dose of the 
intervention with only two out of the six studies included meeting current physical activity 
recommendations to prevent weight gain. Furthermore, the duration of the interventions was 
short with the mean duration 15.3 weeks (range 10-21 weeks). This was designed to facilitate 
physiological adaptations and improvements in central aspects of fitness such as 
cardiorespiratory fitness and metabolic health, however, it was insufficient to investigate 
adaptations in body weight and no intervention adhered to clinical recommendations to 
examine the efficacy of the intervention on changes in body weight.  Based on this evidence 
synthesis of single component physical activity interventions, future research 
recommendations were established, in terms of advocating longer term physical activity 
interventions and follow up period (duration 12 months) to elucidate the effects of physical 
activity interventions on the prevention of weight gain and body composition in young adults 
with intellectual disabilities. 
6.11 Recommendations for implementing a full-scale 
randomised controlled trial 
Future research into the development of a full-scale trial of the TAKE 5 multi-component 
weight management intervention has been detailed throughout this thesis. This section aims 
to summarise these recommendations and provide a comprehensive list of recommendations 
to evolve the programme of research in examining the effectiveness of the intervention. 
6.11.1 Sufficiently powered study 
As this study was underpowered to investigate the true efficacy of the intervention, a future 
full-scale study needs to be adequately powered. Decisions over the most appropriate 
comparator intervention need to be deliberated based on the justification which formed this 
study (section 4.2 study design). For a full-scale randomised controlled trial, utilising a TAU 
comparator intervention, 56 participants per group would be required to have 90% power at 
the 5% (two-sided) significance level. Attrition in this pilot study was 10%, however, to take 
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account of a TAU design a 20% attrition rate would be required for a full-scale trial, 
increasing the sample size to 68 per group. The majority of participants in this study were 
randomised as individuals with an average cluster size of 1.11. Assuming a conservative 
ICC of 0.2 the final recommended sample size is 140. 
 
6.11.2 Intervention components 
Future replication of this study should refine the development of the physical activity 
component. Based on the high levels of physical inactivity and the barriers discussed with 
changing this behaviour, a prescriptive physical activity component focussed on home based 
physical activity and interrupting sedentary behaviour is recommended. 
6.11.3 Key role of carers 
As carers have been highlighted as having a fundamental role in supporting behaviour 
change in relation to weight loss for adults with intellectual disabilities, adaptations are 
recommended to the intervention resources. Currently the intervention resources are solely 
developed for adults with intellectual disabilities (with the exception of one booklet; How to 
help someone lose weight). Although adults with intellectual disabilities should remain the 
main focus of the intervention, additional resources specific for carers are believed to be 
beneficial. In particular, information and resources to increase carers’ knowledge on the 
importance and benefits of physical activity are recommended. As carers were also shown 
to be key facilitators in implementing the intervention, investigation into the delivery of the 
intervention by carers who already work with adults with intellectual disabilities is 
recommended. This would be after an initial training period from health professionals.  
 
6.11.4 Sustainability of weight loss 
As this was a pilot study which was conducted over a 12 month period, the sustainability of 
long term changes in body weight is uncertain. Previous research of multi-component weight 
management interventions have not been conducted for longer than 15 months. It is 
recommended that future studies, should provide long term follow up measures which would 
provide valuable insight into whether the short term changes in body weight and secondary 
outcomes persist over time. This would provide findings which are more generalizable to 
real world situations, and therefore provide evidence to support the implementation of TAKE 
5 as a weight management programme in clinical practice. 
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6.11.5 Compliance of intervention components 
It is recommended that compliance to the components of the weight management 
interventions, in particular the EDD, should be monitored. Methods to inform compliance to 
the EDD include self-monitoring in diaries completed by participants with support from 
carers. Although this was used as a behaviour change technique in the weight management 
intervention, this was not recorded as an outcome. This would identify if the components are 
received as intended. 
 
6.11.6 Fidelity of the intervention 
To ensure fidelity of the interventions it is recommended that audio recording of a selection 
of intervention sessions be used. This would allow a more accurate measure of the 
implementation of the intervention as intended by research dietitians and bring to light any 
deviations in the protocol or contamination between delivering the interventions. 
Furthermore, although the behaviour change techniques were mapped out at the start of the 
intervention, investigation into measuring the frequency and use of these techniques could 
help identify the active ingredients in supporting weight loss in this population group. 
 
6.11.7 Qualitative research 
To understand why there was a lack of change in physical activity, it is recommended that 
qualitative interviews with carers should be conducted. This would provide insight into their 
attitudes towards physical activity and the barriers and facilitators to engaging adults with 
intellectual disabilities in this component of the intervention. 
 
6.12 Future research 
The overall findings of this thesis are that there is a disparity of evidence based weight 
management interventions designed for adults with intellectual disabilities and that 
interventions based on clinical recommendations in the general population are acceptable to 
adults with intellectual disabilities. The findings of this thesis add considerably to the limited 
evidence base on the management of obesity in adults with intellectual disabilities and also 
provide new potential research areas to be considered in the future: 
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• Investigation into the importance of contextual factors formed by the social 
ecological model to assist the understanding of physical activity behaviour change 
and weight loss in adults with intellectual disabilities 
• Investigation into the development of interventions to reduce the high levels of 
sedentary behaviour in adults with intellectual disabilities 
• Investigation into alternative strategies to tackle the obesity epidemic in adults with 
intellectual disabilities. This should include strategies to prevent weight gain 
• Investigation into the applicability of behaviour change techniques in adults with 
intellectual disabilities. For example, identifying if adults with intellectual 
disabilities can self-monitor diet or physical activity behaviours.  
 
6.13 Conclusions 
This thesis has investigated an area of clinical need. It has contributed to closing the gap 
between research and providing accessible weight management services for adults with 
intellectual disabilities. This thesis has provided an update on the current evidence using 
robust systematic review techniques and demonstrated the feasibility and process of 
conducting high quality randomised controlled trials of weight management interventions. 
The principal findings offer promise in the treatment of obesity and benefits to the health of 
this underrepresented population group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
198 
 
 
_____________________________________________________________________ 
Appendices 
_____________________________________________________________________ 
Appendix i: Systematic review search strategy 
Medline search strategy used to identify multi-component weight management 
interventions in adults with intellectual disabilities and obesity. 
 
1. exp Intellectual Disability/  
2. exp Mentally Disabled Persons/ 
3. (intellectual* adj (disab* or disorder* or handicap* or impair* or deficien* or 
subnorm*)).tw. 
4. (learning adj (disab* or disorder* or impair* or difficult*)).tw. 
5. (development* adj (disab* or disorder* or handicap* or impair* or delay*)).tw. 
6. (Mental* adj (disab* or disorder* or handicap* or impair* or deficien* or subnorm* or 
retard*)).tw. 
7. 1 or 2 or 3 or 4 or 5 or 6 
 
8. exp Exercise/ 
9. exp Exercise Therapy/ 
10. exp Physical Fitness/ 
11. exp Motor Activity/ 
12. exp Sports/ 
13. exp “Physical education and training”/ 
14. (fit* adj (regime* or program*)).tw. 
15. ((moderate or vigorous*) adj3 activ*).tw. 
16. (physic* adj5 (fit* or train* or activ* or endur* or intervention*)).tw. 
17. (exercis* adj5 (aerobic* or train* or fit* or activ*or endur or intervention*)).tw. 
18. (gym* or circuit* or aqua* or walk* or jog* or run* or swim*).tw.  
19. (weight lift* or strength train* or resistance train* or circuit train* or aerob* train*).tw. 
20. ((lifestyle or life-style) adj5 (activ* or physic*)).tw. 
21. Exercise*.tw. 
22. Physical Activ*.tw. 
23. exp Diet/ 
24. exp Diet Therapy/ 
25. exp Caloric Restriction 
26. exp Diet, Fat-Restricted/ or exp Diet/ or exp Diet, Carbohydrate-Restricted/ 
27.  exp Nutrition Therapy/ 
28. exp Nutritional Support/ 
29. (nutrition* or food or carbohydrate* or protein or fat*).ti,ab. 
30. ((diet or dieting) adj5 (health* or weight*)).tw. 
31. (calorie adj3 (control or reduc* or restriction)).tw. 
32. Nutrition education.tw. 
33. diet*.tw. 
34. exp Behavior therapy/ 
35. exp cognitive therapy/ 
36. exp psychotherapy/ 
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37. exp family therapy/ 
38. (behavio* adj3 (therap* or technique* or modif* or intervention*)).tw. 
39. (cognit* adj3 (therap* or technique* or modif* or intervention*)).tw. 
40. CBT.tw. 
41. (psychotherapy* or pyscho-therapy*).tw. 
42. exp Health Promotion/ 
43. (health* adj3 (promot* or educ* or lifestyle)).tw. 
44. OR 8-43 
 
45. exp Obesity/ 
46. exp Body Weight/ 
47. exp Body Weight Changes/ 
48. exp Weight Gain/ 
49. exp Weight Loss/ 
50. exp Body Mass Index/ 
51. obes*.tw. 
52. ("weight gain" or "weight loss").tw. 
53. (overweight or "over weight" or over-weight).tw. 
54. (weight adj2 (loss or lost or losing or reduc* or change*)).tw. 
55. (body weigh* or bodyweigh* or body mass* or bodymass or body fat* or bodyfat*).tw. 
56. (bmi or "body mass index").tw. 
57. ((bmi or "body mass index") adj2 (gain or loss or change*)).tw. 
58. body composition.tw. 
59. OR 45-58 
 
60. exp Intervention studies/ 
61. exp Evaluation studies/ 
62. Randomized controlled trial.pt. 
63. Controlled clinical trial.pt. 
64. Clinical trial.pt. 
65. (randomized or randomised).ti,ab. 
66. Randomly.ti,ab. 
67. Trial.ti,ab. 
68. Groups.ti,ab. 
69. OR 60-68 
70.7 AND 44 AND 59 AND 69 
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WEIGHT LOSS AND LEARNING DISABILITIES 
 
PARTICIPANT INFORMATION SHEET 
 
We would like to invite you to take part in a research project. The 
project is to find ways to help people lose weight. The information 
sheet tells you about the project. Please read the information 
sheet, or ask someone to read it with you. This information sheet is 
for you to keep.  
 
You can talk to your family and friends about the project. Ask them 
what they think about it.  
 
What is the research project about?  
The aim of this project is to help people lose weight.  
This project will use two weight loss programs:  
• TAKE 5 
• Waist Winners Too 
Previous research projects found that TAKE 5 and Waist Winners 
Too were able to help support people to lose weight. We would like 
to see which program is better at helping people to lose weight. 
 
The weight loss programs will try and help people lose weight by 
making healthy lifestyle choices such as eating a balanced diet and 
becoming more active. People who lose weight have been shown to:  
 
• feel better 
• sleep better 
• have more energy 
• have a lower risk of getting health problems. 
 
Why do you want me to take part? 
We are inviting you to take part because you are using the learning 
disabilities services. Someone who knows you thinks you might be 
interested in losing weight. We would like 60 people who want to 
lose weight to take part. 
What will the research project involve? 
If you want to find out more a researcher will contact you and ask 
to visit you.  You do not have to meet the researcher. Please let us 
know if you do not want to see the researcher. 
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You can ask the researcher questions about the project.  The 
researcher will invite you to decide if you want to take part in the 
research project.  If you say yes, you will be asked to sign a form.  
You can keep a copy of the consent form.  
If you choose to take part, the researcher will visit you three times 
over 12 months. The meetings will be at a place that is suitable for 
you.  Each meeting will last about one hour.  The researcher will 
ask questions about:  
✓ Yourself and the things you do  
✓ What you like to eat and any physical activity you do 
✓ How you feel about losing weight. 
 
The researcher will also ask to measure your weight, height, waist 
circumference and body fat. 
You will be asked to wear a special belt for one week at the 
beginning, middle and at the end of the project. This measures how 
active you are. 
We will ask you if we can tell your GP that you are taking part in the 
project.  
After you meet with the researcher a dietician will meet you. The 
dietician will talk to you about starting a weight loss program. You 
will either get the TAKE 5 weight loss program or the Waist 
Winners Too weight loss program. The program that you get will be 
decided by a process called randomisation, which is like the toss 
of a coin. You have an equal chance of taking part in the TAKE 5 or 
Waist Winners Too. Both programs last 12 months. The first six 
months is a weight loss phase. After that there is a six month 
weight maintenance phase.  
We would like to find out what people think about the weight loss 
program they received. At the end of the 12 months the researcher 
will ask to meet you and ask you questions about the weight loss 
program. We want to know if you think it helped you. You can also 
suggest ways to make the weight loss program better. This 
meeting with the researcher will last about one hour. The 
researcher will make notes of the things you said and also record 
what you said during the meeting. If you give permission we will 
also ask a carer what they think about the weight loss program. 
 
What do the weight loss programs involve? 
In both programs a dietician will meet you: 
• Phase 1: Nine times, every two-three weeks 
• Phase 2: Six times, every month 
A carer can support you in these sessions. The carer will be invited 
to help you make a note of your diet and activities. They can also 
help you plan the changes you want to make. 
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TAKE 5  
Phase 1: Weight loss 
The meetings in the first phase of this program are to help you find 
ways to lose weight. These sessions will focus on: 
• Dietary change: The dietician will help you chose ways to 
make healthy changes to your diet. They will give you a 
Personalised Dietary Plan to help you to lose weight 
• Physical Activity: You will discuss activities that you like to 
do. The dietician will support you to increase your physical 
activity levels  
• Behaviour Change: You will be encouraged to set goals and 
keep a note of your weight and waist circumference. 
 
Phase 2: Weight maintenance 
The meetings in the second phase are to help you to learn new 
skills to keep the weight off. These sessions will focus on: 
• Behavioural methods to maintain lifestyle changes  
• Keeping a note of your body weight and food intake 
• Staying active. 
 
Waist Winners Too  
Phase 1: weight loss 
The meetings in the first phase of this program are to give you 
advice on healthy eating and how you can achieve a steady weight 
loss by making changes to your diet and lifestyle. These sessions 
will focus on: 
• Eating a balanced healthy diet – based on the Eatwell plate 
• Importance of physical activity and current recommendations 
• Goal setting and keeping a note of your weight and daily food 
intake. 
 
Phase 2: Weight maintenance 
The meetings in the second phase are to help you to remember 
what you learned in the first phase and to support you to continue 
to monitor your diet and weight. You will be able to ask questions 
about the healthy lifestyle information you received and discuss 
positive changes you have been able to make and any barriers you 
experience to making these changes. 
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If you are harmed by taking part in this research project, there are 
no special compensation arrangements.  If you are harmed due to 
someone’s negligence, then you may have grounds for a legal 
action but you may have to pay for it.  Regardless of this if you 
wish to complain about any aspect of the way you have been 
treated during the course of this project, the normal National 
Health Service complaints mechanism will be available to you. 
 
Has ethical approval been granted for this project? 
This project has been granted ethical approval by the Scotland A 
Research Ethics Committee. 
 
When will the project take place? 
This project will take place during 2014-2016. You would be involved 
for a maximum of twelve months. 
 
Will taking part in the project help me? 
If you decide to take part in the project it might help you lose weight. 
You might feel better or have more energy. However, taking part 
might not help. We want to find out if the weight loss programs work.  
 
The results of this project may help other people lose weight. All 
researchers are fully trained and qualified. We will provide feedback 
to you at the end of the project. 
 
What will happen if I decide not to take part in the project? 
You do not have to take part in this research project.  It is OK to 
say no.  If you do not want to take part, this will not affect the care 
and support you receive. 
 
What if I change my mind and do not want to take part during the 
project? 
You can change your mind about taking part, or stop, at any time.  
You do not have to give a reason.  If you change your mind this will 
not affect the care and support you receive.  
 
               Where would the interviews take place? 
If it is OK with you, the researcher will arrange to see you at your 
home.  If you want the researcher can arrange to see you somewhere 
else.  
 
What will happen to the information the researcher collects? 
All the information about you is kept safe. It will be treated with strict 
confidence. It will be kept secret. The research team will not tell 
anyone your name. The information will be kept safely on a 
computer. Only members of the research team and the sponsor for 
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the research project will have access to the information. The 
sponsor may access the information for audit purposes only. The 
Data Protection Act will be followed at all times. 
 
What will happen to the results of the project? 
When the research project is finished, the research team will write 
to you about the research findings. They will also write reports 
about the research. Your name will not be used in the reports. They 
may write about the things you said but no one will be able to tell 
from the reports that you took part in the research. The information 
will also be used as part of a PhD student project. 
 
Who is organising and funding the research? 
This project is organised by the researchers at the University of 
Glasgow.  The money to pay for the project was provided by the 
Equally Well Fund. 
 
How can I find out more about the project? 
You can ask the researcher questions about the project.  The 
name and telephone number of the researchers are shown below.  
You can contact them at any time to ask questions. 
 
You might like to speak to someone who is not a member of the research 
group. Andrew Jahoda can be contacted on the telephone. His number is 
0141 211 3878. Andrew will try and answer any questions you have. 
 
What do I do now? 
It is up to you to choose whether you want to take part in the project. 
Please fill out the reply slip on the last page. Write your name, address 
and telephone number. Let us know if you want to find out more about the 
project by ticking one of the boxes.  
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Please send the reply slip back in the FREEPOST envelope. 
 
If you tick the YES box we will contact you. 
 
If you tick the NO box we will not contact you again. 
 
 
Thank you for reading this information sheet. 
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Researcher  
Leanne Harris 
Mental Health and Wellbeing                   
Admin Building, Gartnavel Royal  
Hospital, 1055 Great Western Road,  
Glasgow, G12 0XH.  
Telephone: 0141 211 0213 
 
Research Team 
Dr. Craig Melville, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Telephone: 0141 211 3878 
 
Dr Catherine Hankey, Senior Lecturer in Human Nutrition, University of 
Glasgow. Telephone: 0141 211 5443 
 
Mrs Heather Murray, Senior Statistician, University of Glasgow. Telephone: 
0141 330 4744 
 
Dr Susan Boyle, Consultant Clinical Psychologist, Glasgow and Clyde Weight 
Loss Service. Telephone: 0141 211 1296 
 
Dr Carol Pert, Consultant Clinical Psychologist,  Learning Disabilities 
Psychology NHS GG&C. Telephone: 0141 276 2300 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Researcher 
Photo 
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WEIGHT LOSS AND LEARNING DISABILITIES 
 
 
Name ………………………………………………… 
 
 
Address ………………………………………………. 
 
……………………………………………………….. 
 
……………………………………………………….. 
 
Telephone Number ………………………………….. 
 
 
I would like to find out more about the project  Yes  
 
           No  
 
Please return this form in the FREEPOST envelope to: 
 
Researcher name: Leanne Harris 
Mental Health and Wellbeing                   
Admin Building, Gartnavel Royal  
Hospital, 1055 Great Western Road,  
Glasgow, G12 0XH.  
Telephone: 0141 211 0213 
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WEIGHT LOSS AND LEARNING DISABILITIES 
 
Carer Information Sheet 
We would like to invite the person with learning disabilities whom you support to 
take part in a research project.  Please keep this information sheet. Before the 
person you support decides it is important to understand why the research is being 
done and what it will involve. You may be able to help the person you support decide 
whether they want to take part. You will not be asked to be a participant in the 
project.  Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Thank you for reading this. 
 
 
What will the research project find out? 
The aim of this project is to compare two weight loss programs; TAKE 5 and Waist 
Winners Too, to see if they can help adults with learning disabilities lose weight. The 
weight loss programs will try and help adults with learning disabilities lose weight 
through making healthy lifestyle choices such as eating a balanced diet and 
becoming more physically active. This approach has been shown to work for adults 
who do not have learning disabilities.  
 
People who lose weight and are of a healthy weight have been shown to feel better, 
sleep better, have more energy, and have a lower risk of developing certain 
diseases (heart disease, cancer, bone diseases and diabetes). 
 
 
Why do you want the person I support to take part? 
The person with learning disabilities whom you support has been invited to take part 
in the project because he/she is using the learning disabilities services and someone 
thinks they might be interested in losing weight. We would like 60 individuals who 
want to lose weight to take part. We will look at whether this approach helps the 
person you support lose and maintain weight loss over a 12 month period. 
 
 
What will the project involve? 
If the person you support wants to find out more about the project a researcher can 
contact them to arrange a time to meet.  This meeting would be to discuss the 
project, and answer any questions about the project.  If the person you support does 
not want to meet the researcher, please let us know. Some people with learning 
disabilities are unable to consent to participation in research.  If this is the case, 
under the procedures of the Adults with Incapacity (Scotland) Act a relative, or 
welfare guardian can be asked to consider providing consent to participation. 
 
If the person you support chooses to meet the researcher, they will explain the 
project to them, and answer any questions. The person with learning disabilities you 
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support will be invited to choose whether to take part in the project. They will be 
given a copy of the consent form to keep.  The person you support does not have 
to take part in the project it is OK to say ‘no’ and this will not affect the care that the 
person you support receives from learning disabilities services.   
 
If the person you support chooses to take part in the project, they would be involved 
in the project for about 12 months. The researcher would like to arrange three 
meetings, over the 12 months. Each meeting will last about one hour.  If this seems 
too long, the person can choose shorter meetings.  At each meeting, the researcher 
would like to ask questions about: 
 
• The person and the things they do 
• What the person likes to eat and any physical activity they do 
• How the person feels about losing weight. 
 
The researcher will also ask to measure the person’s weight, height, waist 
circumference and body fat. The person you support will be asked to wear a special 
belt each day for one week at the beginning, middle and end of the project. It 
measures how active people are.  
 
The researcher will also ask for specific consent to speak to carers about the person 
with learning disabilities life and the support they receive. 
 
After the first meeting with the researcher, a research dietician will arrange to meet 
the person you support to talk about starting a weight loss program. The person you 
support will either get the TAKE 5 weight loss program or the Waist Winners Too 
weight loss program. The program that they get will be decided by a process called 
randomisation, which is like the toss of a coin. They will have an equal chance of 
taking part in the TAKE 5 or Waist Winners Too programs. Both programs last 12 
months are split into two phases: 
 
• six month weight loss phase  
• six month weight maintenance phase.  
 
We would like to find out what people think about the weight loss program they 
receive. If the person you support decides to take part the researcher will ask to 
meet them and ask them questions about the weight loss program. We want to 
know if they think it helped them. They can also suggest ways to make the weight 
loss program better. This meeting with the researcher will last about one hour. The 
researcher will make notes of the things the person you support said and also 
audio record what is said during the meeting. If the person you support gives 
permission we would also like to ask carers what they think about the weight loss 
program. 
 
 
What do the weight loss programs involve? 
TAKE 5 and Waist Winners Too have both been developed and piloted in 
Glasgow. Both programs have both been shown to be acceptable to adults with 
learning disabilities and shown to be effective in helping them to lose weight. 
 
In both programs a dietician will meet the person you support: 
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• Phase 1: Nine times, every two-three weeks 
• Phase 2: Six times, every month 
If the participant wants a carer can be involved in these sessions.  
 
TAKE 5  
Phase 1: Weight loss 
The meetings in the first phase of this program are to help the person you support 
find ways to lose weight. The research dietician will help the person you support to 
choose ways to make changes to their diet and give them a personalised dietary 
plan to help them eat less to lose weight. The person you support will also be 
encouraged to set goals and monitor their progress by measuring their own weight 
and how active they are. The research dietician will also try and help the person 
you support find ways to increase their activity.  
 
Phase 2: Weight maintenance 
The meetings in the second phase are to help the person you support to find ways 
to maintain any weight loss and help prevent weight regain. The person you 
support will learn ways to help them maintain the important changes they have 
made to their lifestyle, to monitor their food intake and weight and also ways to 
continue to be more active. 
 
Waist Winners Too  
Phase 1: Weight loss 
The meetings in the first phase of this program are to give the person you support 
advice on healthy eating and how they can achieve a steady weight loss by 
making changes to their diet and lifestyle. The research dietician will talk about 
eating a balanced diet and the person you support will learn to make better food 
choices. They will also learn about the importance of physical activity. The 
research dietician will help the person you support set goals and monitor their 
progress in making healthy lifestyle choices. 
 
Phase 2: Weight maintenance 
 The meetings in the second phase are to help the person you support maintain 
any weight loss, they will review the important topics that they have already 
learned in phase one and be given support to continue monitoring of their diet and 
weight. 
 
If the person you support is harmed by taking part in this research project, there 
are no special compensation arrangements.  If they are harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have to pay 
for it.  Regardless of this if you, or the person you support, wish to complain about 
any aspect of the way you have been treated during the course of this project, the 
normal National Health Service complaints mechanism will be available. 
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What is the role of carers in the project? 
If the person with learning disabilities decides to take part they will be invited to 
choose if they want carers to support them. The carers could be asked to support 
the person with learning disabilities during the research interviews and during the 
sessions with the research dietician. Family carers and paid carers can be involved 
in supporting the person. 
 
There are some questionnaires for carers to complete. These ask the carer their 
views on weight loss, healthy eating and physical activities of the person with 
learning disabilities. 
 
During the 12 month period the carers will be invited to support the person with 
learning disabilities to gradually lose weight. As well as giving general support to the 
person with learning disabilities, the carers will be asked to help them answer the 
questions, make a note of their activities and help make choices about how to eat 
healthier. 
 
Will taking part in the project help me, or the person I support? 
If the person you support decides to take part, they may benefit from losing weight. 
Other studies have found that losing weight helps people feel better. However, there 
is no guarantee the weight loss program will help the person you support do lose 
weight. We want to find out if the weight loss programs work.  
 
What will happen if the person I support decides not to take part in the 
project? 
The person with learning disabilities whom you support does not have to take part 
in this research project.  It is OK to say ‘no’.  If he/she decides not to take part in the 
project this will not affect the care that the person you support receives from anybody 
who provides care or support to that person.  
 
What if the person I support changes his/her mind about taking part during 
the project? 
The person you support can change his/her mind about taking part, or stop, at any 
time.  He/she does not have to give a reason for changing their mind.  If he/she 
changes their mind about taking part in the project this will not affect the care the 
person you support receives from the services. 
 
Where will the sessions take place? 
The researcher, and research dietician, will arrange to meet with the person with 
learning disabilities at a place that is convenient for them.  He/she can choose 
where they want to meet with the researcher, and research dietician.  The 
researcher, and research dietician, could meet at the home of the person you 
support.  If this is not suitable, the researcher, and research dietician, will arrange 
to meet somewhere that is suitable for the person you support.  The person you 
support will be invited to choose if they would like someone to support them during 
the interviews. 
 
What will happen to the information the research team collect? 
The research team will keep all the information provided in strict confidence.  Only 
members of the research team and the sponsor of the research project will have 
access to the information provided.  The sponsor may access the information for the 
223 
 
 
purpose of audit only.  The information will be kept very safely on a computer 
database.  The Data Protection Act will be adhered to at all times. 
 
Who is organising and funding the research? 
This research project is organised by researchers at the University of Glasgow. 
The research team have organised other studies that adults with learning 
disabilities have participated in. The money to pay for the project was provided by 
the Equally Well Fund. 
 
Has ethical approval been granted for this project? 
This project has been granted ethical approval by the Scotland A Research Ethics 
Committee. 
 
When will the project take place? 
This project will take place in 2014-2016 but the involvement of the person you 
support will only be for 12 months. 
 
What will happen to the results of the project? 
After the project is finished, we will post out information about the findings of this 
research project to everyone who takes part.  Findings of this project will also be 
given to managers of learning disabilities health and social work services.  The 
research findings will be written into reports which will be published. Quotes from 
the interviews may also be published.  It will not be possible to identify any of the 
individuals who take part in the project from the reports, as all the information will 
be anonymised, with information from many individuals grouped together. The 
information will also be used as part of a PhD student project. 
 
How can I find out more about this project? 
If you would like to discuss any aspect of this project, or wish to ask any questions 
please ask the researcher, or contact members of the research team, at any stage 
of the project. 
 
If you want to talk to someone independent of the research project please contact 
Professor Andrew Jahoda (Telephone: 0141 211 3878). Professor Jahoda will try 
and answer any questions you have about the project. 
 
Thank you for taking the time to read this information sheet. 
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WEIGHT LOSS AND LEARNING DISABILITIES 
 
RELATIVE/ WELFARE GUARDIAN INFORMATION SHEET 
 
We would like to invite the person with learning disabilities whom you support to 
take part in a research project.  We do not think that this person has the capacity to 
consent to participate in research.  However, under the provisions of the Adults with 
Incapacity (Scotland) Act you are able to provide consent. We are inviting you to 
provide consent on behalf of the person with learning disabilities, having considered 
what you think they would want you to do. Before you make your decision about 
whether to give consent for them to participate in this project, it is important that you 
understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with the person with learning 
disabilities whom you support, and others if you wish.  Ask us if there is anything 
that is not clear or if you would like more information.  Please keep this information 
sheet. Thank you for reading this information sheet. 
 
What will the research project find out? 
The aim of this project is to compare two weight loss programs; TAKE 5 and Waist 
Winners Too, to see if they can help adults with learning disabilities lose weight. The 
weight loss programs will try and help adults with learning disabilities lose weight 
through making healthy lifestyle choices such as eating a balanced diet and 
becoming more physically active. This approach has been shown to work for adults 
who do not have learning disabilities.  
 
People who lose weight and are of a healthy weight have been shown to feel better, 
sleep better, have more energy, and have a lower risk of developing certain 
diseases (heart disease, cancer, bone diseases and diabetes). 
 
Why do you want the person I support to take part? 
The person with learning disabilities whom you support has been invited to take part 
in the project because he/she is using the learning disabilities services and someone 
thinks they might be interested in losing weight. We would like 60 individuals who 
want to lose weight to take part. We will look at whether this approach helps the 
person you support lose and maintain weight loss over a 12 month period. 
 
What will the project involve? 
If the person you support wants to find out more about the project a researcher can 
contact them to arrange a time to meet.  This meeting would be to discuss the 
project, and answer any questions about the project.  If the person you support does 
not want to meet the researcher, please let us know. Some people with learning 
disabilities are unable to consent to participation in research.   
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If the person with learning disabilities is not able to consent a nearest relative or 
welfare guardian can be asked to provide consent not the adult themselves, under 
the Adults with Incapacity (Scotland) Act.  
 
If the person you support chooses to meet the researcher, they will explain the 
project to them, and answer any questions. The person with learning disabilities you 
support will be invited to choose whether to take part in the project. They will be 
given a copy of the consent form to keep.  The person you support does not have 
to take part in the project it is OK to say ‘no’ and this will not affect the care that the 
person you support receives from learning disabilities services.   
 
If the person you support chooses to take part in the project, they would be involved 
in the project for about 12 months. The researcher would like to arrange three 
meetings, over the 12 months. Each meeting will last about one hour.  If this seems 
too long, the person can choose shorter meetings.  At each meeting, the researcher 
would like to ask questions about: 
 
• The person and the things they do 
• What the person likes to eat and any physical activity they do 
• How the person feels about losing weight. 
 
The researcher will also ask to measure the person’s weight, height, waist 
circumference and body fat. The person you support will be asked to wear a special 
belt each day for one week at the beginning, middle and end of the project. It 
measures how active people are.  
 
The researcher will also ask for specific consent to speak to carers about the person 
with learning disabilities life and the support they receive. 
 
After the first meeting with the researcher, a research dietician will arrange to meet 
the person you support to talk about starting a weight loss program. The person you 
support will either get the TAKE 5 weight loss program or the Waist Winners Too 
weight loss program. The program that they get will be decided by a process called 
randomisation, which is like the toss of a coin. They will have an equal chance of 
taking part in the TAKE 5 or Waist Winners Too programs. Both programs last 12 
months are split into two phases: 
 
• six month weight loss phase  
• six month weight maintenance phase.  
 
We would like to find out what people think about the weight loss program they 
receive. If the person you support decides to take part the researcher will ask to 
meet them and ask them questions about the weight loss program. We want to 
know if they think it helped them. They can also suggest ways to make the weight 
loss program better. This meeting with the researcher will last about one hour. The 
researcher will make notes of the things the person you support said and also 
audio record what is said during the meeting. If the person you support gives 
permission we would also like to ask carers what they think about the weight loss 
program. 
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What do the weight loss programs involve? 
TAKE 5 and Waist Winners Too have both been developed and piloted in 
Glasgow. Both programs have both been shown to be acceptable to adults with 
learning disabilities and shown to be effective in helping them to lose weight. 
 
In both programs a dietician will meet the person you support: 
• Phase 1: Nine times, every two-three weeks 
• Phase 2: Six times, every month 
If the participant wants a carer can be involved in these sessions.  
 
TAKE 5  
Phase 1: Weight loss 
The meetings in the first phase of this program are to help the person you support 
find ways to lose weight. The research dietician will help the person you support to 
choose ways to make changes to their diet and give them a personalised dietary 
plan to help them eat less to lose weight. The person you support will also be 
encouraged to set goals and monitor their progress by measuring their own weight 
and how active they are. The research dietician will also try and help the person 
you support find ways to increase their activity.  
 
Phase 2: Weight maintenance 
The meetings in the second phase are to help the person you support to find ways 
to maintain any weight loss and help prevent weight regain. The person you 
support will learn ways to help them maintain the important changes they have 
made to their lifestyle, to monitor their food intake and weight and also ways to 
continue to be more active. 
 
Waist Winners Too  
Phase 1: Weight loss 
The meetings in the first phase of this program are to give the person you support 
advice on healthy eating and how they can achieve a steady weight loss by 
making changes to their diet and lifestyle. The research dietician will talk about 
eating a balanced diet and the person you support will learn to make better food 
choices. They will also learn about the importance of physical activity. The 
research dietician will help the person you support set goals and monitor their 
progress in making healthy lifestyle choices. 
 
Phase 2: Weight maintenance 
 The meetings in the second phase are to help the person you support maintain 
any weight loss, they will review the important topics that they have already 
learned in phase one and be given support to continue monitoring of their diet and 
weight. 
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If the person you support is harmed by taking part in this research project, there 
are no special compensation arrangements.  If they are harmed due to someone’s 
negligence, then you may have grounds for a legal action but you may have to pay 
for it.  Regardless of this if you, or the person you support, wish to complain about 
any aspect of the way you have been treated during the course of this project, the 
normal National Health Service complaints mechanism will be available. 
 
What is the role of carers in the project? 
If the person with learning disabilities decides to take part they will be invited to 
choose if they want carers to support them. The carers could be asked to support 
the person with learning disabilities during the research interviews and during the 
sessions with the research dietician. Family carers and paid carers can be involved 
in supporting the person. 
 
There are some questionnaires for carers to complete. These ask the carer their 
views on weight loss, healthy eating and physical activities of the person with 
learning disabilities. 
 
During the 12 month period the carers will be invited to support the person with 
learning disabilities to gradually lose weight. As well as giving general support to the 
person with learning disabilities, the carers will be asked to help them answer the 
questions, make a note of their activities and help make choices about how to eat 
healthier. 
 
Will taking part in the project help me, or the person I support? 
If the person you support decides to take part, they may benefit from losing weight. 
Other studies have found that losing weight helps people feel better. However, there 
is no guarantee the weight loss program will help the person you support do lose 
weight. We want to find out if the weight loss programs work.  
 
What will happen if the person I support decides not to take part in the 
project? 
The person with learning disabilities whom you support does not have to take part 
in this research project.  It is OK to say ‘no’.  If he/she decides not to take part in the 
project this will not affect the care that the person you support receives from anybody 
who provides care or support to that person.  
 
What if the person I support changes his/her mind about taking part during 
the project? 
The person you support can change his/her mind about taking part, or stop, at any 
time.  He/she does not have to give a reason for changing their mind.  If he/she 
changes their mind about taking part in the project this will not affect the care the 
person you support receives from the services. 
 
Where will the sessions take place? 
The researcher, and research dietician, will arrange to meet with the person with 
learning disabilities at a place that is convenient for them.  He/she can choose 
where they want to meet with the researcher, and research dietician.  The 
researcher, and research dietician, could meet at the home of the person you 
support.  If this is not suitable, the researcher, and research dietician, will arrange 
to meet somewhere that is suitable for the person you support.  The person you 
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support will be invited to choose if they would like someone to support them during 
the interviews. 
 
What will happen to the information the research team collect? 
The research team will keep all the information provided in strict confidence.  Only 
members of the research team and the sponsor of the research project will have 
access to the information provided.  The sponsor may access the information for the 
purpose of audit only.  The information will be kept very safely on a computer 
database.  The Data Protection Act will be adhered to at all times. 
 
Who is organising and funding the research? 
This research project is organised by researchers at the University of Glasgow. 
The research team have organised other studies that adults with learning 
disabilities have participated in. The money to pay for the project was provided by 
the Equally Well Fund. 
 
Has ethical approval been granted for this project? 
This project has been granted ethical approval by the Scotland A Research Ethics 
Committee. 
 
When will the project take place? 
This project will take place in 2014-2016 but the involvement of the person you 
support will only be for 12 months. 
 
What will happen to the results of the project? 
After the project is finished, we will post out information about the findings of this 
research project to everyone who takes part.  Findings of this project will also be 
given to managers of learning disabilities health and social work services.  The 
research findings will be written into reports which will be published. Quotes from 
the interviews may also be published.  It will not be possible to identify any of the 
individuals who take part in the project from the reports, as all the information will 
be anonymised, with information from many individuals grouped together. The 
information will also be used as part of a PhD student project. 
 
 
How can I find out more about this project? 
If you would like to discuss any aspect of this project, or wish to ask any questions 
please ask the researcher, or contact members of the research team, at any stage 
of the project. 
 
If you want to talk to someone independent of the research project please contact 
Professor Andrew Jahoda (Telephone: 0141 211 3878). Professor Jahoda will try 
and answer any questions you have about the project. 
 
Thank you for taking the time to read this information sheet. 
 
 
Researcher  
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Appendix iv: Study Consent Forms 
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Appendix v: TAKE 5 and WWToo Resources 
 
TAKE 5 Resources 
 
What activities can I do? 
        
At home on my own 
      
 
 
 
 
 
With other people 
 
 
 
 
 
 
Classes or sports or groups  
 
 
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What? 
When? 
 Where? 
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Coping with Cravings 
 
Sometimes we went to eat something but we are not 
really hungry. 
 
We may even get a craving after we have eaten a meal. 
 
Cravings you think about in your head 
 
 
 
 
You feel hungry in your tummy 
 
 
 
If you get a craving try to: 
 
• Do something else for 20 minutes.  What 
could you do?        
• Look at your target sheet 
• Talk to someone about it 
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Practical tips 
 
How many of these tips can you try?  
Tick them off as you do them. 
 
1. Make a healthy packed lunch or healthy snack  
every day for a week 
 
2. Use less or no oil or butter in your meals 
3. Freeze or bin leftovers 
4. Use a smaller plate 
5. Have fruit or vegetables rather than crisps 
6. Plan the next day’s food 
7. Make a healthy shopping list and go shopping 
8. Do a new activity  
9. Cover half your dinner plate with salad or vegetables 
10. Add frozen vegetables to your meals 
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WWToo Resources 
Food versus Exercise 
      
100       = 30 mile    
   =  30 minute    
   =  40 minute    
   =  10 minute    
 
   =  50 minute    
 
   =  70 minute  
 
   =  45 minute    
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   =  20 minute    
 
How to use up 100 calories 
 
 
     
    15 minutes 
   20 minutes 
 
    10 minutes 
 
   15 minutes 
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    10 minutes 
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Appendix vi: Process evaluation semi-
structured interview 
 
 
Interview schedule for staff implementing the weight management interventions 
 
 
The aim of this interview is to gain an insight into what worked well and did not work well 
with the WELLDO study. Any insight that you have about the positive and negative aspects 
of the study could help inform future trials.  
 
 
1. Could you briefly summarise your role in the implementation of the weight 
management interventions used in this trial? 
 
2. Can you briefly summarise your qualifications and experience relevant to your 
role? 
 
3. What was your demand capacity to deliver the intervention? 
 
4. Did you have any training needs to be able to deliver the interventions? If yes, how 
were these met? 
 
5. What did you think of the standard of training you received to deliver the weight 
management interventions? How fully did it meet your needs? Were there any gaps 
or anything unnecessary delivered?  
 
6. Could you have been supported in any other way to improve the delivery of the 
intervention?  
 
Implementation  
 
7. What were the practicalities of implementing the planned interventions (TAKE 5/ 
WWToo) in practice?  
 
8. Were any adaptations to the interventions required or did it go to plan? If so why 
were the adaptations required? 
 
9. Were there any additional training needs of people supporting participants (i.e. day 
centre staff/ family or paid carers)? How did you address these? 
 
10. Could participants/carers have been supported in any other way to improve the 
intervention? 
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11. There are no formal results as yet, but what in your opinion are the changes in 
outcomes you have observed overall in the participants you have seen? 
 
12. Are there any positive cases (participants you regard as achieving their targets) you 
can describe? Why do you think it worked for the participant(s)? 
 
13. Are there any negative cases (participants you regard as not achieving their targets) 
you can describe? Why do you think it didn’t work for the participant(s)? 
 
Weight management sessions (TAKE 5/ WWToo) 
 
We would like to find out more about how well the two interventions were received, 
starting with TAKE 5 followed by the same question repeated for WWToo. 
 
14. What is your general insight into how well the intervention sessions were received? 
 
15. What components (Diet/PA/Behaviour change techniques) worked well within the 
sessions? 
 
16. Where there any challenges to delivering the sessions? 
 
17. What types of communication techniques were used most often to communicate 
with this population group? 
18. Are carers actively involved in the intervention sessions? If so how do they 
help facilitate the session?  
 
19. Did any aspect of the sessions not work well with most of this group of 
participants? 
 
20. Did sessions adhere to the content, duration and quality as initially set out in the 
protocol? If not, why did this deviate? How often did this deviation take place and 
how did you manage any deviations? 
 
21. Can you describe any adaptations that were required to the sessions? 
 
22. Where and when was flexibility needed?  
 
General 
The aim of this interview is to gain an insight into specific positive and negative issues 
about the WELLDO project in order to inform future trials.  
 
23. What if anything do you think could be done for future studies to improve the 
implementation of the weight management interventions? 
 
24. Finally, do you have any additional comments you would like to add based on your 
experience of taking part in this trial and delivery of the interventions? 
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Appendix vii: Statistical Analysis Plan 
WEight Loss in Learning Disabilities and Obesity Study (WELLDO) 
 
Statistical Analysis Plan (SAP) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Title: Weight Loss in Learning Disabilities and Obesity (WELLDO): A 
single-blind randomised trial of a weight loss intervention for adults 
with learning disabilities and obesity. 
Short Title: WELLDO 
Trial 
Registration: 
ISRCTN52903778 
Sponsors: NHS Greater Glasgow and Clyde 
Funded by: Scottish Government, The Equally Well Fund 
Protocol 
Version: 
1.2 
SAP Version: Final 1.0 
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Abbreviations 
 
BMI Body Mass Index 
CI Confidence Interval 
CONSORT Consolidated Standards of Reporting Trials 
EQ-5D-Y EuroQol (Youth) 
ICC Intraclass correlation 
IVRS Interactive Voice Response System 
RCB the Robertson Centre for Biostatistics 
SAE Serious Adverse Event 
SAP Statistical Analysis Plan 
SIMD Scottish Index of Multiple Deviation 
SD Standard Deviation 
VAS Visual Analogue Scale 
 
1.0 Introduction 
1.1. Background 
 
Individuals with intellectual disabilities have consistently reported to have higher rates of 
obesity than the general population. Despite the negative impact of obesity on health there 
is a limited evidence base to inform the management of obesity in this population. Clinical 
guidelines recommend multi-component weight management interventions to support 
individuals who are overweight or obese to achieve a clinically significant weight loss. The 
aim of this study is to add to the limited evidence base by examining the feasibility of a full-
scale clinical trial of the TAKE 5 multi-component weight management intervention in 
comparison with an active comparator intervention.       
 
1.2 Purpose of Analysis 
The objective of this SAP is to describe the statistical analysis to be carried out for the 
WELLDO study. 
 
1.3 Study Objectives 
 
1. Can adults with intellectual disabilities and obesity be recruited to a randomised study of 
the TAKE 5 intervention versus a health education control intervention? 
 
2. What attrition rates are observed at 6 and 12 months post-randomisation? 
 
3. Are the patient centred outcome measures acceptable to the participants and can they be 
measured reliably to detect clinically important changes? 
 
 
2.0 Study Methods 
2.1 Study Design 
 
This study was a single-centre, randomised trial. Participants were randomised in clusters to 
a multi-component weight management (TAKE 5) intervention or an active comparator 
intervention (WWToo) (Figure 1). 
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Figure 1. Study Design (Adapted from Harris et al., 2015). 
 
2.2 Study Population 
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The target population for this study is adults with intellectual disabilities and obesity (BMI 
≥ 30lg/m2). A multi-point recruitment strategy will be used to identify potential participants 
from adults with intellectual disabilities: 
• attending local authority day centres  
• receiving support from provider organisations  
• using services provided by Area Intellectual Disabilities Teams, in the catchment 
area of NHS Greater Glasgow and Clyde. 
 
Participants will be considered eligible to take part in the study if they are adults (≥18 years) 
with intellectual disabilities, obese (BMI ≥ 30 kg/m2), ambulatory (able to walk with or 
without a walking aid for 10 minutes), not currently on a prescribed or restricted diet e.g. for 
phenylketonuria or diabetes and not intentionally lost weight of >3kg in the previous three 
months. Participants will be excluded in they have the following genetic syndromes; Prader 
Willi syndrome, Cohen syndrome or Bardet- Biedl syndrome, taking medication for the 
purpose of losing weight (either prescribed or over the counter) and individuals who are 
pregnant or who conceived during the study will be excluded. 
 
2.3 Randomisation and Blinding 
Once informed consent is obtained, participants will undergo baseline assessments. For 
clusters of participants, the baseline data for all participants in the cluster will be collected 
before randomisation. Participants will be allocated to one of the two study groups, using a 
mixed randomisation/minimisation approach. 
 
The researcher will telephone an Interactive Voice Response System (IVRS) created and 
maintained by the Robertson Centre for Biostatistics (RCB). The researcher will log onto 
the system with a user ID and PIN, and provide the screening number and age of the 
participant for identification, as well as level of intellectual disabilities and presence of 
Down Syndrome for use in the adaptive minimisation algorithm (designed to ensure that 
none of these factors is imbalanced between the two study groups). The IVRS will not reveal 
the random allocation to the researcher, but notified the study coordinator, who will contact 
the research dietitians to arrange subsequent study visits. The researcher will be blinded to 
study group allocation. 
 
2.4 Sample Size and Power 
There is limited data from controlled trials of weight management involving adults with 
intellectual disabilities on which to base a sample size calculation. This study is designed to 
estimate recruitment and retention rates for a full-scale clinical trial; it is not powered to 
detect a difference between study groups. Sixty-six participants will be recruited (33 to each 
treatment arm). This will provide sufficient insight into recruitment and retention rates, 
which will have a 95% confidence interval of no more than ±10%. The sample size will 
allow for a possible attrition rate of 20%. This study also aims to determine likely variance 
of study outcomes in order to power a larger randomised trial; if 50 participants provide 
outcome data at 12 months, a 90% confidence interval for each variance estimate will have 
a width of approximately 70% of the estimate (i.e. −26% to +44%). 
 
2.5 Study Variables 
 
Outcome variables will be measured at three time points (table 1), baseline, ≈ 6 and 12 
months from baseline. 
 
Table 1: Schedule of outcome measure assessments 
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Outcome measure Baseline Time 1 (≈ 6 
months from 
baseline) 
Time 2 (≈ 12 
months from 
baseline) 
Demographic & 
health 
questionnaires 
x X X 
Height, weight, 
waist 
circumference, and 
triceps skinfold 
thickness 
x X X 
Quality of life 
measures 
x X X 
 
 
• Age, physical activity objective accelerometer data – Items measured on a 
continuous scale 
• Anthropometric variables – Items measured on a continuous scale. Items will be 
measured twice and the average for each item reported as the summary statistic 
• Demographics, marital status, ethnicity, social support, lifestyle habits, physical 
activity and mental health 
• SIMD is calculated from participants’ postcodes. Items are ordered categorically into 
quintiles for which 1 = most deprived and 5 = least deprived 
• Ability and development – Items are measured on a 1-5 ordered categorical scale for 
which 1 = total independent, 2 = minimum assistance, 5 = regular supervision, 4 = 
1:1 support and 5 = totally dependent. A total score 5-25 is calculated form the 5 
questions 
• Quality of life (EQ-5D-Y) – Items are measured on a 1-3 categorical scale for which 
1 = no problems, 2 = some problems and 3 = extreme problems for each dimension 
• Quality of life (EQ VAS) – Items are measured on a 0-100 visual analogue scale 
(VAS) for which 0 = worst imaginable health state and 100 = the best imaginable 
health state 
• EQ-5D index. 
 
2.6 General Considerations 
 
Analysis is based on the intention to treat (ITT) principle. Per-protocol analyses, including 
only those participants who engaged with the programme, will also used to test the sensitivity 
of the ITT results. 
 
Analysis will be conducted to assess normal distributions of the data. Each variable will be 
assessed graphically using a histogram with normal distribution curves, boxplots and Q-Q 
residual plots. In addition to visual inspection of these plots for normal distribution, 
skewness and kurtosis will be tested using z-scores with < 1.96 representing normally 
distributed data. In circumstances if data are considered not normally distributed, factors 
affecting this will be explored. Outliers will be identified by examining residual Q-Q plots. 
Data points classified as outliers will be assessed for their potential to influence results and 
therefore study conclusions. Sensitivity analysed will be conducted to compare results with 
and without outlier(s). Any discrepancies between the two analyses will be reported and 
discussed. In addition to examining the data with and without outliers, transformation of the 
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data will be assessed using logarithmic and square root transformations and normality 
reassessed.  
 
Descriptive statistics will be used for participant demographics and all outcome measures. 
Results will be presented as means and standard deviations (SD) for continuous variables 
(Anthropometric outcomes, physical activity outcomes) and frequencies and percentages 
(%) for categorical variables (Demographics, Ability and development, Health, QOL). 
 
2.7 Primary Outcome 
The primary outcome measure is the mean difference in body weight (kilograms (kg)) at 
twelve months from baseline between the two treatment groups.  
 
2.8 Secondary Outcomes 
Secondary outcomes include: 
• Weight loss of five percent or more of initial body weight,  
• Change in BMI, waist circumference and percentage body fat.   
• Mean percentage time per day spent engaged in moderate-vigorous intensity physical 
activity; light intensity physical activity and engagement in sedentary behaviour. 
• Change in health related Quality of Life. 
 
Change from baseline at the end of the weight loss intervention period (6 months) and end 
the intervention (12 months) will be analysed for each secondary outcome. 
 
2.9 Derived Variables 
BMI will be calculated by the equation weight/height 2 (kg/m2). 
 
Percentage body fat will be calculated using the triceps skinfold thickness (mm) measured 
to the nearest 1 mm, waist circumference (cm) and age (years) of the participant. Separate 
regression equations for male and female participants, developed by Lean et al. (1996) will 
be used to predict body density (BD) and percentage body fat (BF%). 
 
Men 
BD = 1.1554 – (0.000761 x waist) – (0.00170 x triceps) – (0.000532 x age) 
BF% = (0.353 x waist) + (0.756 x triceps) + (0.235 x age) – 26.4 
 
Women 
BD = 1.1062 – (0.000482 x waist) – (0.00140 x triceps) – (0.000453 x age) 
BF% = (0.232 x waist) + (0.657 x triceps) + (0.215 x age) -5.5 
 
Level of intellectual disabilities will be calculated by the adding the scores (total score 5-
25) from the five key areas of functioning: eating and drinking, intimate care, personal 
safety, communication and decision making. 
 
 
3.0 Analysis 
 
All statistical data will be analysed using SPSS 21 IBM statistical package (SPSS IBM, New 
York, NY, USA). 
3.1 Participant Disposition 
A summary of the characteristics of the participants randomised to each treatment group 
(TAKE 5 or WWToo) and lost to follow-up will be provided overall and by randomised 
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group. This will be illustrated following Consolidated Standards of Reporting Trials 
(CONSORT) flow diagram (Figure 2). 
 
 
 
Figure 2. CONSORT flow diagram. 
 
3.2 Baseline Characteristics 
A summary of baseline characteristics for each randomised treatment group and overall will 
be reported: 
 
 
• Demographics (age (years), sex, martial status, ethnicity, SIMD decile and social 
support) 
• Anthropometry measurements (weight (kg), height (cm), body mass index (BMI) 
(kg/m2) and, waist circumference (cm) and percentage body fat (%) 
• Ability and development  
• Physical and mental health questionnaires 
• Lifestyle habits 
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• Physical activity (Accelerometer data) 
• Quality of life (EQ-5D-Y)  
 
3.3 Concurrent Illness and Medical Conditions 
Physical and mental health conditions: Epilepsy, vision, hearing, mental health and 
problem behaviours will be reported as in accordance with the summary statistics. Further 
health problems such as diabetes and high blood pressure will be added from health 
problems or diagnosis questionnaire.  
 
3.4 Treatment Compliance 
Treatment compliance will be assessed by attendance to the intervention sessions.  
 
3.5 Potential efficacy Analysis 
3.5.1 Primary Outcome 
A mixed effects model will be used to determine the mean difference in weight change at 
the end of the intervention period (~12 months) from baseline, between TAKE 5 and 
WWToo. The mixed effects model will take into account of clustering of participants 
(stratified by level of intellectual disabilities, number of participants in a cluster and presence 
of Down syndrome) and will adjust for baseline weight. The Interclass correlation coefficient 
(ICC), adjusted mean difference ((95% confidence interval (CI)) and p-value will be 
reported. 
 
3.5.2 Secondary Outcome 
Continuous secondary outcomes will be analysed and reported similarly as described above. 
A logistic regression model will be fitted for the categorical outcome, weight loss of 5% or 
more of initial body weight taking account of clustering and baseline adjustments listed 
above. 
 
3.6 Process Measures 
Descriptive statistics will be used to assess process measures such as attendance to sessions 
for each treatment group. Independent sample t-tests will be performed to determine if there 
are any differences between the treatment groups. 
 
 
3.7 Missing Data 
Missing data will not be imputed for any of the analysis. 
 
3.8 Serious Adverse Events 
Serious adverse events (SAE) are defined as an adverse event (an injury or newly 
diagnosed health condition) that induced hospitalisation or prolonged hospitalisation, 
results in persistent/significant disability or incapacity or is life-threatening or fatal. SAE 
will be recorded after baseline visits by the researcher at follow up visits. Incidence of SAE 
will be recorded for each treatment group. 
 
4.0 Listing of Tables and Figures 
Table 1.1. Subject disposition and reasons for withdrawal. 
Table 1.2. Number of participants attending each visit, by randomised group and overall. 
Table 1.3. Number of participants attending each intervention session, by randomised group 
and overall. 
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Table 1.4. Number of participants attending all sessions, by randomised group and overall. 
Table 1.5. Summary of clusters, by randomised group and overall. 
Table 2.1. Summary of demographic and baseline characteristics, by randomised group and 
overall (ITT). 
Table 2.1.1. Summary of demographic and baseline characteristics, by randomised group 
and overall (Completers). 
Table 2.1.2. Summary of demographic and baseline characteristics, by randomised group 
and overall (Non-completers). 
Table 2.2. Summary of baseline anthropometry measurements, by randomised group and 
overall (ITT). 
Table 2.2.1. Summary of baseline anthropometry measurements, by randomised group and 
overall (Completers). 
Table 2.2.2. Summary of baseline anthropometry measurements, by randomised group and 
overall (Non-completers). 
Table 2.3. Summary of baseline ability and development, by randomised group and overall 
(ITT). 
Table 2.3.1. Summary of baseline ability and development, by randomised group and overall 
(Completers). 
Table 2.3.2. Summary of baseline ability and development, by randomised group and overall 
(Non-completers). 
Table 2.4. Summary of baseline level of intellectual disabilities, by randomized group and 
overall (ITT). 
Table 2.4.1. Summary of baseline level of intellectual disabilities, by randomized group and 
overall (Completers). 
Table 2.4.2. Summary of baseline level of intellectual disabilities, by randomized group and 
overall (Non-completers). 
Table 2.5. Summary of baseline physical and mental health, by randomised group and 
overall (ITT). 
Table 2.5.1. Summary of baseline physical and mental health, by randomised group and 
overall (Completers). 
Table 2.6. Summary of baseline lifestyle habits, by randomised group and overall (ITT). 
Table 2.6.1. Summary of baseline lifestyle habits, by randomised group and overall 
(Completers). 
Table 2.7. Summary of baseline accelerometer data (minutes/day), by randomised group 
and overall (ITT). 
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Table 2.7.1. Summary of baseline accelerometer data (minutes/day), by randomised group 
and overall (Completers). 
Table 2.8. Summary of baseline accelerometer data (percentage time spent/day), by 
randomised group and overall (ITT). 
Table 2.8.1. Summary of baseline accelerometer data (percentage time spent/day), by 
randomised group and overall (Completers). 
Table 2.9. Summary of baseline EQ domain, by randomised group and overall (ITT). 
Table 2.9.1. Summary of baseline EQ domain, by randomised group and overall 
(Completers). 
Table 2.10. Summary of baseline EQ-5D-Y index, by randomised group and overall (ITT). 
Table 2.10.1. Summary of baseline EQ-5D-Y index, by randomised group and overall 
(Completers). 
Table 3.1.1. Primary outcome: Change in average weight (kg) at 12 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Table 3.1.1.1. Sensitivity analysis - primary outcome: Change in average weight (kg) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 
5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.1.1.2. Sensitivity analysis - primary outcome: Change in average weight (kg) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 
5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.1.2. Primary outcome: Change in average weight (kg) at 12 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Table 3.1.2.1. Sensitivity analysis - primary outcome: Change in average weight (kg) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 
5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.2.1. Secondary outcome: Change in average weight (kg) at 6 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Table 3.2.1.1. Sensitivity analysis - secondary outcome: Change in average weight (kg) at 6 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 
5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.2.1.2. Sensitivity analysis - secondary outcome: Change in average weight (kg) at 6 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 
5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.2.2. Secondary outcome: Change in average weight (kg) at 6 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
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Table 3.3.1. Secondary outcome: Change in average BMI (kg/m2) at 6 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Table 3.3.1.1. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 
6 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.3.2. Secondary outcome: Change in average BMI (kg/m2) at 6 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Table 3.3.3. Secondary outcome: Change in average BMI (kg/m2) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Table 3.3.3.1. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 
12 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.3.3.2. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 
12 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.3.4. Secondary outcome: Change in average BMI (kg/m2) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (Completers). 
Table 3.3.4.1. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 
12 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.4.1. Secondary outcome: Change in average waist circumference (cm) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.4.1.1. Sensitivity analysis - secondary outcome: Change in average waist 
circumference (cm) at 6 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.4.1.2. Sensitivity analysis - secondary outcome: Change in average waist 
circumference (cm) at 6 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.4.2. Secondary outcome: Change in average waist circumference (cm) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.4.2.1. Sensitivity analysis - secondary outcome: Change in average waist 
circumference (cm) at 6 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
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Table 3.4.3. Secondary outcome: Change in average waist circumference (cm) at 12 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.4.3.1 Sensitivity analysis - secondary outcome: Change in average waist 
circumference (cm) at 12 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.4.4. Secondary outcome: Change in average waist circumference (cm) at 12 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.5.1. Secondary outcome: Change in average percentage body fat (%) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.5.1.1. Sensitivity analysis -secondary outcome: Change in average percentage body 
fat (%) at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.5.1.2 Sensitivity analysis - secondary outcome: Change in average percentage body 
fat (%) at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.5.2. Secondary outcome: Change in average percentage body fat (%) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.5.2.1 Sensitivity analysis - secondary outcome: Change in average percentage body 
fat (%) at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.5.3. Secondary outcome: Change in average percentage body fat (%) at 12 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.5.3.1. Sensitivity analysis - secondary outcome: Change in average percentage body 
fat (%) at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.5.3.2. Sensitivity analysis - secondary outcome: Change in average percentage body 
fat (%) at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.5.4. Secondary outcome: Change in average percentage body fat (%) at 12 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.5.4.1. Sensitivity analysis - secondary outcome: Change in average percentage body 
fat (%) at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
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Table 3.6. Secondary outcome: Change in percentage weight change at 6 and 12 months 
from baseline. Odds ratio (95% confidence interval) and p-value (ITT).  
 
Table 3.6.1. Secondary outcome: Change in percentage weight change at 6 and 12 months 
from baseline. Odds ratio (95% confidence interval) and p-value (Completers).  
Table 3.7. Secondary outcome: Change in average step count at 6 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Table 3.7.1. Secondary outcome: Change in average step count at 6 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Table 3.8. Secondary outcome: Change in average step count at 12 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Table 3.8.1. Secondary outcome: Change in average step count at 12 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Table 3.9. Secondary outcome: Change in average number of minutes spent in light physical 
activity per day at 6 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.9.1. Secondary outcome: Change in average number of minutes spent in light 
physical activity per day at 6 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.9.2. Secondary outcome: Change in percentage time spent in light physical activity 
per day at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.9.3 Secondary outcome: Change in percentage time spent in light physical activity 
per day at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.10. Secondary outcome: Change in average number of minutes spent in light 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Table 3.10.1. Secondary outcome: Change in average number of minutes spent in light 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.10.2. Secondary outcome: Change in percentage time spent in light physical activity 
per day at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
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Table 3.10.3 Secondary outcome: Change in percentage time spent in light physical activity 
per day at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.11. Secondary outcome: Change in average number of minutes spent in moderate 
to vigorous physical activity per day at 6 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (ITT). 
Table 3.11.1. Secondary outcome: Change in average number of minutes spent in moderate 
to vigorous physical activity per day at 6 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (Completers). 
Table 3.11.2. Secondary outcome: Change in percentage time spent in moderate to vigorous 
physical activity per day at 6 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Table 3.11.3 Secondary outcome: Change in percentage time spent in moderate to vigorous 
physical activity per day at 6 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.12. Secondary outcome: Change in average number of minutes spent in moderate 
to vigorous physical activity per day at 12 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (ITT). 
Table 3.12.1. Secondary outcome: Change in average number of minutes spent in moderate 
to vigorous physical activity per day at 12 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (Completers). 
Table 3.12.2. Secondary outcome: Change in percentage time spent in moderate to vigorous 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Table 3.12.3 Secondary outcome: Change in percentage time spent in moderate to vigorous 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.13. Secondary outcome: Change in average number of minutes spent in any physical 
activity per day at 6 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.13.1. Secondary outcome: Change in average number of minutes spent in any 
physical activity per day at 6 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
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Table 3.13.2. Secondary outcome: Change in percentage time spent in any physical activity 
per day at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.13.3 Secondary outcome: Change in percentage time spent in any physical activity 
per day at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.14. Secondary outcome: Change in average number of minutes spent in any physical 
activity per day at 12 months from baseline, by intervention group and overall.  Adjusted 
mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.14.1. Secondary outcome: Change in average number of minutes spent in any 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.14.2. Secondary outcome: Change in percentage time spent in any physical activity 
per day at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Table 3.14.3 Secondary outcome: Change in percentage time spent in any physical activity 
per day at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Table 3.15. Secondary outcome: Change in average number of minutes spent in sedentary 
behaviour physical activity per day at 6 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (ITT). 
Table 3.15.1. Secondary outcome: Change in average number of minutes spent in sedentary 
behaviour physical activity per day at 6 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (Completers). 
Table 3.15.2. Secondary outcome: Change in percentage time spent in sedentary behaviour 
physical activity per day at 6 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Table 3.15.3 Secondary outcome: Change in percentage time spent in sedentary behaviour 
physical activity per day at 6 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.16. Secondary outcome: Change in average number of minutes spent in sedentary 
behaviour physical activity per day at 12 months from baseline, by intervention group and 
overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (ITT). 
Table 3.16.1. Secondary outcome: Change in average number of minutes spent in sedentary 
behaviour physical activity per day at 12 months from baseline, by intervention group and 
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overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value 
and ICC (Completers). 
Table 3.16.2. Secondary outcome: Change in percentage time spent in sedentary behaviour 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Table 3.16.3 Secondary outcome: Change in percentage time spent in sedentary behaviour 
physical activity per day at 12 months from baseline, by intervention group and overall.  
Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Table 3.17. Secondary outcome: Change in average EQ-5D index at 6 months from baseline, 
by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Table 3.17.1 Secondary outcome: Change in average EQ-5D index at 6 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (Completers). 
Table 3.18. Secondary outcome: Change in average EQ-5D index at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Table 3.18.1 Secondary outcome: Change in average EQ-5D index at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (Completers). 
Table 3.19. Secondary outcome: Change in EQ-5D-Y domain at 6 months from baseline. 
Adjusted odds ratio (95% confidence interval) and p-value (ITT).  
Table 3.20. Secondary outcome: Change in EQ-5D-Y domain at 12 months from baseline. 
Adjusted odds ratio (95% confidence interval) and p-value (ITT).  
 
4.1 Figures 
No figures with exception of the skeleton CONSORT flow diagram was documented in 
this SAP. 
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5.0 Tables 
Table 1.1. Subject disposition and reasons for withdrawal. 
Disposition TAKE 5 
 
WWTOO TOTAL 
Screened participants N/A N/A 69 
    
Randomised participants 26 24 50 (100.0%) 
    
Completed study 24 (92.3%) 21 (87.5%) 45 (90.0%) 
    
Withdrawals from study 2 (7.7%) 3 (12.5%) 5 (10.0%) 
Reasons for withdrawal    
  Adverse event (non-serious) 0 (0.0%) 1 (33.3%) 1 (20.0%) 
  Participant unwilling to continue in study activities 0 (0.0%) 1 (33.3%) 1 (20.0%) 
  Participant withdrew consent 0 (0.0%) 0 (0.0%) 0 (0.0%) 
  Participant withdrew on advice of investigator 0 (0.0%) 0 (0.0%) 0 (0.0%) 
  Carer or next of kin withdrew consent 1 (50.0%) 1 (33.3%) 2 (40.0%) 
  Participant lost to follow-up 1 (50.0%) 0 (0.0%) 1 (20.0%) 
  Inclusion / exclusion criteria not met  0 (0.0%) 0 (0.0%) 0 (0.0%) 
  Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
    
Table 1.2. Number of participants attending each visit, by randomised group and overall. 
Visit TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Screening  26 (100.0%) 24 (100.0%) 50 (100.0%) 
Baseline  26 (100.0%) 24 (100.0%) 50 (100.0%) 
6 months 24 (92.3%) 22 (91.7%) 46 (92.0%) 
12 months 24 (92.3%) 24 (100.0%) 48 (96.0%) 
Table 1.3. Number of participants attending each intervention session, by randomised group and overall.  
TAKE 5 session N TAKE 5 
(n=26) 
N WWTOO 
(n=24) 
N TOTAL 
(n=50) 
Weight Loss 1 26 26 (100.0%) 24 24 (100.0%) 50 50 (100.0%) 
Weight Loss 2 26 26 (100.0%) 24 19 (79.2%) 50 45 (90.0%) 
Weight Loss 3 26 24 (92.3%) 24 20 (83.3%) 50 44 (88.0%) 
Weight Loss 4 26 24 (92.3%) 23 19 (82.6%) 49 43 (87.8%) 
Weight Loss 5 26 20 (76.9%) 23 23 (100.0) 49 43 (87.8%) 
Weight Loss 6 25 22 (88.0%) 23 18 (78.3%) 48 40 (83.3%) 
Weight Loss 7 25 22 (88.0%) 22 21 (95.5%) 47 43 (91.5%) 
Weight Loss 8 24 23 (95.8%) 21 18 (85.7%) 45 41 (91.1%) 
Weight Loss 9 24 22 (91.7%) 21 20 (95.2%) 45 42 (93.3%) 
Weight Maintenance 1 24 18 (75.0%) 21 19 (90.5%) 45 37 (82.2%) 
Weight Maintenance 2 24 20 (83.3%) 21 16 (76.2%) 45 36 (80.0%) 
Weight Maintenance 3 24 21 (87.5%) 21 18 (85.7%) 45 39 (86.7%) 
Weight Maintenance 4 24 19 (79.2%) 21 19 (90.5%) 45 38 (84.4%) 
Weight Maintenance 5 24 20 (83.3%) 21 18 (85.7%) 45 38 (84.4%) 
Weight Maintenance 6 24 21 (87.5%) 21 21 (100.0%) 45 42 (93.3%) 
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Table 1.4. Number of participants attending all sessions, by randomized group and overall. 
Percentage attendance at all appointments TAKE 5 
(n=24) 
WWTOO 
(n=21) 
TOTAL 
(n=45) 
100% 7 (29.1%) 5 (23.8%) 12 (26.7%) 
90% 6 (25.0%) 8 (38.1%) 14 (31.1%) 
80% 8 (33.3%) 6 (28.6%) 14 (31.1%) 
70% 1 (4.2%) 0 (0.0%) 1 (2.2%) 
60% 2 (8.3%) 2 (9.5%) 4 (8.9%) 
Note: Percentage of attendance of participants excluding participants who dropped out of the intervention. 
 
Table 1.5. Summary of clusters, by randomised group and overall. 
 TAKE 5 
 
WWTOO 
 
TOTAL 
 
Number of clusters 3 2 5  
     
Size of clusters N 26 24 50 
 Mean 1.2 1.2 1.2 
 Std Dev 0.43 0.38 0.40 
 Median 1.0 1.0 1.0 
 Min-Max 1-2 1-2 1-2 
 Interquartile range 1 1 1 
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Table 2.1. Summary of demographic and baseline characteristics, by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Age (years)  N 26 24 50 
 Mean 40.6 43.6 42.0 
 Std Dev 14.98 13.99 14.45 
 Median 42.5 45.5 44.5 
 Min-Max 18-71 23-66 18-71 
 Interquartile range 26-53 29-54 29-53 
 Missing 0 0 0 
Gender N 26 24 50 
 Male 8 (30.8%) 10 (41.7%) 18 (36.0%) 
 Female 18 (69.2%) 14 (58.3%) 32 (64.0%) 
 Missing 0 0 0 
Marital status N 26 24 50 
 Married/live in 
partner 
1 (3.8%) 0 (0.0%) 1 (2.0%) 
 Separated/ divorced 1 (3.8%) 0 (0.0%) 1 (2.0%) 
 Single 24 (92.3%) 24 (100.0%) 48 (96.0%) 
 Widow/er 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Ethnicity N 26 24 50 
 White 26 (100.0%) 22 (91.7%) 48 (96.0%) 
 Asian 0 (0.0%) 2 (8.3%) 2 (4.0%) 
 Black 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Mixed 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
SIMD decile (% 
living in quintiles) 
N 26 24 50 
 1 (most deprived) 12 (46.2%) 9 (37.5%) 21 (42.0%) 
 2 6 (23.1%) 5 (20.8%) 11 (22.0%) 
 3 2 (7.7%) 4 (16.7%) 6 (12.0%) 
 4 5 (19.2%) 5 (20.8%) 10 (20.0%) 
 5 (least deprived) 1 (3.8%) 1 (4.2%) 2 (4.0%) 
 Missing 0 0 0 
Where does 
participant live? 
N 26 24 50 
 Parents home 7 (26.9%) 7 (29.2%) 14 (28.0%) 
 Other family carers 
home 
1 (3.8%) 1 (4.2%) 2 (4.0%) 
 Lives independently 
+/- children 
1 (3.8%) 3 (12.5%) 4 (8.0%) 
 Lives independently 
with spouse 
1 (3.8%) 0 (0.0%) 1 (2.0%) 
 Lives independently 
with paid support 
8 (30.8%) 5 (20.8%) 13 (26.0%) 
 Supported group 
living 
5 (19.2%) 6 (25.0%) 11 (22.0%) 
 Supported living - 
individual 
2 (7.7%) 1 (4.2%) 3 (6.0%) 
 Residential care 1 (3.8%) 1 (4.2%) 2 (4.0%) 
 Nursing home 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 NHS accommodation 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
If supported, how 
much? 
N 16 13 29 
 Part-time support 
(less than daily) 
3 (18.8%) 0 (0.0%) 3 (10.3%) 
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 Part-time support 
(daily) 
6 (37.5%) 3 (23.1%) 9 (31.0%) 
 24 hour support, 
sleep-in nights 
7 (43.8%) 10 (76.9%) 17 (58.6%) 
 24 hour support, 
including wake at 
night 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.1.1. Summary of demographic and baseline characteristics, by randomised group and overall 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Age (years)  N 21 19 40 
 Mean 40.9 42.6 41.7 
 Std Dev 13.54 13.91 13.57 
 Median 44.0 45.0 44.5 
 Min-Max 18-61 23-65 18-65 
 Interquartile range 28-53 29-52 29-52 
 Missing 0 0 0 
Gender N 21 19 40 
 Male 7 (33.3%) 7 (36.8%) 14 (35.0%) 
 Female 14 (66.7%) 12 (63.2%) 26 (65.0%) 
 Missing 0 0 0 
Marital status N 21 10 40 
 Married/live in 
partner 
1 (4.8%) 0 1 (2.5%) 
 Separated/ divorced 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Single 20 (95.2%) 19 (100%) 39 (97.5%) 
 Widow/er 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Ethnicity N 21 19 40 
 White 21 (100%) 17 (89.5%) 38 (95.0%) 
 Asian 0 (0.0%) 2 (10.5%) 2 (5.0%) 
 Black 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Mixed 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
SIMD decile (% 
living in quintiles) 
N 21 19 40 
 1 (most deprived) 7 (33.3%) 8 (42.1%) 15 (37.5%) 
 2 6 (28.6%) 5 (26.3%) 11 (27.5) 
 3 2 (9.5%) 0 (0.0%) 2 (5%) 
 4 5 (23.8%) 5 (26.3%) 10 (25.0%) 
 5 (least deprived) 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 Missing 0 0 0 
Where does 
participant live? 
N 21 19 40 
 Parents home 5 (23.8%) 6 (31.6%) 11 (27.5%) 
 Other family carers 
home 
1 (4.8%) 1 (5.3%) 2 (5.0%) 
 Lives independently 
+/- children 
1 (4.8%) 2 (10.5%) 3 (7.5%) 
 Lives independently 
with spouse 
1 (4.8%) 0 (0.0%) 1 (2.5%) 
 Lives independently 
with paid support 
6 (28.6%) 4 (21.1%) 10 (25.0%) 
 Supported group 
living 
5 (23.8%) 5 (26.3%) 10 (25.0%) 
 Supported living - 
individual 
1 (4.8%) 0 (0.0%) 1 (2.5%) 
 Residential care 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 Nursing home 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 NHS accommodation 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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If supported, how 
much? 
N 13 10 23 
 Part-time support 
(less than daily) 
1 (7.7%) 0 (0.0%) 1 (4.3%) 
 Part-time support 
(daily) 
6 (46.2%) 2 (20.0%) 8 (34.8%) 
 24 hour support, 
sleep-in nights 
6 (46.2%) 8 (80.0%) 14 (60.9%) 
 24 hour support, 
including wake at 
night 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.1.2 Summary of demographic and baseline characteristics, by randomised group and overall (Non-
completers). 
Variable Statistic TAKE 5 
(n=5) 
WWTOO 
(n=5) 
TOTAL 
(n=10) 
Age (years)  N 5 5 10 
 Mean 39.2 47.6 43.4 
 Std Dev 21.97 15.14 18.33 
 Median 32.0 50.0 46.5 
 Min-Max 19-71 25-66 19-71 
 Interquartile range 21-62 34-60 24-57 
 Missing 0 0 0 
Gender N 5 5 10 
 Male 1 (20.0%) 3 (60.0%) 4 (40.0%) 
 Female 4 (80.0%) 2 (40.0%) 6 (60.0%) 
 Missing 0 0 0 
Marital status N 5 5 10 
 Married/live in 
partner 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Separated/ divorced 1 (20.0%) 0 (0.0%) 1 (10.0%) 
 Single 4 (80.0%) 5 (100.0%) 9 (90.0%) 
 Widow/er 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Ethnicity N 5 5 10 
 White 5 (100.0%) 5 (100.0%) 10 (100.0%) 
 Asian 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Black 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Mixed 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 (0.0%) 0 (0.0%) 0 (0.0%) 
SIMD decile (% 
living in quintiles) 
N 5 5 10 
 1 (most deprived) 5 (100.0%) 1 (20.0%) 6 (60.0%) 
 2 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 3 0 (0.0%) 4 (80.0%) 4 (40.0%) 
 4 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 5 (least deprived) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Where does 
participant live? 
N 5 5 10 
 Parents home 2 (40.0%) 1 (20.0%) 3 (30.0%) 
 Other family carers 
home 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Lives independently 
+/- children 
0 (0.0%) 1 (20.0%) 1 (10.0%) 
 Lives independently 
with spouse 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Lives independently 
with paid support 
2 (40.0%) 1 (20.0%) 3 (30.0%) 
 Supported group 
living 
0 (0.0%) 1 (20.0%) 1 (10.0%) 
 Supported living - 
individual 
1 (20.0%) 1 (20.0%) 2 (20.0%) 
 Residential care 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Nursing home 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 NHS accommodation 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
If supported, how 
much? 
N 3 3 6 
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 Part-time support 
(less than daily) 
2 (66.7%) 0 (0.0%) 2 (33.3%) 
 Part-time support 
(daily) 
0 (0.0%) 1 (33.3%) 1 (16.7%) 
 24 hour support, 
sleep-in nights 
1 (33.3%) 2 (66.7%) 3 (50.0%) 
 24 hour support, 
including wake at 
night 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.2. Summary of baseline anthropometry measurements, by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Height (cm)  N 26 24 50 
 Mean 158.4 158.5 158.4 
 Std Dev 10.64 13.65 12.05 
 Median 157.5 157.5 157.5 
 Min-Max 137-175 132-181 1322-181 
 Interquartile range 151-167 149-172 150-168 
 Missing 0 0 0 
Weight (kg)  N 26 24 50 
 Mean 102.3 104.1 103.1 
 Std Dev 25.40 28.86 26.85 
 Median 102.3 100.4 100.7 
 Min-Max 59-149 72-212. 59-212 
 Interquartile range 84-126 87-111 867-122 
 Missing 0 0 0 
BMI (kg/m2)  N 26 24 50 
 Mean 40.2 41.2 40.7 
 Std Dev 6.84 8.14 7.43 
 Median 40.4 39.0 39.6 
 Min-Max 31-54 32-66 31-66 
 Interquartile range 33-45 34-46 34-45 
 Missing 0 0 0 
Waist 
circumference (cm) 
N 24 23 47 
 Mean 121.9 122.2 122.0 
 Std Dev 14.02 16.12 14.92 
 Median 121.5 121.1 121.1 
 Min-Max 95-143 98-171 95-171 
 Interquartile range 111-136 109-130 110-132 
 Missing 2 1 3 
Percentage body fat 
(%) 
N 24 19 43 
 Mean 49.3 51.7 50.3 
 Std Dev 9.11 8.55 8.84 
 Median 48.9 49.6 49.5 
 Min-Max 33-68 41-79 33-79 
 Interquartile range 
45-55 47-55 
46-55 
 Missing 2 5 7 
Note: Summaries are the average of two measurements taken for each participant.   
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Table 2.2.1 Summary of baseline anthropometry measurements, by randomised group and overall 
(Completers) 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Height (cm)  N 21 19 40 
 Mean 158.2 157.0 157.7 
 Std Dev 10.37 13.85 12.00 
 Median 157.9 156.2 157.2 
 Min-Max 137-175 132-181 132-181 
 Interquartile range 151-165 147-168 149-166 
 Missing 0 0 0 
Weight (kg)  N 21 19 40 
 Mean 102.7 101.9 102.3 
 Std Dev 25.10 18.05 21.77 
 Median 100.5 100.9 100.7 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 87-126 88-112 87-119 
 Missing 0 0 0 
BMI (kg/m2)  N 21 19 40 
 Mean 40.6 41.5 41.0 
 Std Dev 7.06 6.19 6.59 
 Median 39.6 42.9 40.4 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 34-46 35-46 35-46 
 Missing 0 0 0 
Waist 
circumference (cm) 
N 19 18 37 
 Mean 121.7 121.0 121.4 
 Std Dev 14.11 13.28 13.53 
 Median 120.5 121.4 121.1 
 Min-Max 95-143 98-149 95-149 
 Interquartile range 111-136 109-130 110-133 
 Missing 2 1 3 
Percentage body fat 
(%) 
N 19 15 34 
 Mean 49.3 51.0 50.1 
 Std Dev 10.02 5.79 8.35 
 Median 49.9 51.3 50.1 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 40-55 47-55 46-55 
 Missing 2 4 6 
Note: Summaries are the average of two measurements taken for each participant.   
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Table 2.2.2 Summary of baseline anthropometry measurements, by randomised group and overall (Non-
completers) 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Height (cm)  N 5 5 10 
 Mean 159.0 164.2 161.6 
 Std Dev 13.04 12.55 12.37 
 Median 157.1 162.7 159.9 
 Min-Max 139-173 150-180 139-180 
 Interquartile range 148-171 152-177 154-174 
 Missing 0 0 0 
Weight (kg)  N 5 5 10 
 Mean 100.4 112.2 106.3 
 Std Dev 29.58 56.73 43.11 
 Median 104.1 86.8 95.3 
 Min-Max 65-132 77-212 65-212 
 Interquartile range 70-129 79-158 77-127 
 Missing 0 0 0 
BMI (kg/m2)  N 5 5 10 
 Mean 38.9 40.3 39.6 
 Std Dev 6.40 14.37 10.51 
 Median 42.2 34.3 35.3 
 Min-Max 31-44 32-66 31-66 
 Interquartile range 32-44 32-51 33-44 
 Missing 0 0 0 
Waist 
circumference (cm) 
N 5 5 5 
 Mean 122.5 126.3 124.4 
 Std Dev 15.26 25.52 19.92 
 Median 128.6 118.4 120.0 
 Min-Max 105-141 105-171 105-171 
 Interquartile range 107-135 111-146 108-132 
 Missing 0 0 0 
Percentage body fat 
(%) 
N 5 4 9 
 Mean 49.2 54.3 51.4 
 Std Dev 5.05 16.46 11.03 
 Median 48.1 47.3 48.1 
 Min-Max 45-58 44-79 44-79 
 Interquartile range 46-53 44-71 45-54 
 Missing 0 1 1 
Note: Summaries are the average of two measurements taken for each participant.   
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Table 2.3. Summary of baseline ability and development, by randomised group and overall (ITT). 
How much support 
does the participant 
need with 
Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Eating and drinking N 26 24 50 
 Totally independent 18 (69.2%) 16 (66.7%) 34 (68.0%) 
 Minimum assistance 3 (11.5%) 7 (29.2%) 10 (20.0%) 
 Regular 
prompting/supervision 
3 (11.5%) 1 (4.2%) 4 (8.0%) 
 1:1 support required 2 (7.7%) 0 (0.0%) 2 (4.0%) 
 1:1 support required 
and special equipment 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Intimate care N 26 24 50 
 Fully independent 10 (38.5%) 9 (16.7%) 19 (38.0%) 
 Minimum assistance 7 (26.9%) 4 (16.7%) 11 (22.0%) 
 Regular 
prompting/supervision 
3 (11.5%) 2 (8.3%) 5 (10.0%) 
 1:1 support required 5 (19.2%) 8 (33.3%) 13 (26.0%) 
 1:1 support required 
and totally dependent 
1 (3.8%) 1 (4.2%) 2 (4.0%) 
 Missing 0 0 0 
Personal safety N 26 24 50 
 Totally independent 6 (23.1%) 5 (20.8%) 11 (22.0%) 
 Minimum assistance 6 (23.1%) 5 (20.8%) 11 (22.0%) 
 Some 
awareness/supervision 
8 (30.8%) 5 (20.8%) 13 (26.0%) 
 Constant supervision 3 (11.5%) 4 (16.7%) 7 (14.0%) 
 Totally dependent 3 (11.5%) 5 (20.8%) 8 (16.0%) 
 Missing 0 0 0 
Communication N 26 24 50 
 Totally independent 14 (53.8%) 12 (50.0%) 26 (52.0%) 
 Reasonably clearly, 
sign/aids 
4 (15.4%) 3 (12.5%) 7 (14.0%) 
 Staff support 2 (7.7%) 4 (16.7%) 6 (12.0%) 
 Time required 
understand 
3 (11.5%) 1 (4.2%) 4 (8.0%) 
 Extremely limited  3 (11.5%) 4 (16.7%) 7 (14.0%) 
 Missing 0 0 0 
Decision making N 26 24 50 
 Totally independent 4 (15.4%) 3 (12.5%) 7 (14.0%) 
 Minimum support 9 (34.6%) 6 (25.0%) 15 (30.0%) 
 Some 
choices/decisions 
8 (30.8%) 12 (50.0%) 20 (40.0%) 
 Support required 3 (11.5%) 1 (4.2%) 4 (8.0%) 
 Totally dependent 2 (7.7%) 2 (8.3%) 4 (8.0%) 
 Missing 0 0 0 
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Table 2.3.1. Summary of baseline ability and development, by randomised group and overall (Completers). 
How much support 
does the participant 
need with 
Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Eating and drinking N 21 19 40 
 Totally independent 15 (71.4%) 13 (68.4%) 28 (70.0%) 
 Minimum assistance 3 (14.3%) 5 (26.3%) 8 (20.0%) 
 Regular 
prompting/supervision 
1 (4.8%) 1 (5.3%) 2 (5.0%) 
 1:1 support required 2 (9.5%) 0 (0.0%) 2 (5.0%) 
 1:1 support required 
and special equipment 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Intimate care N 21 19 40 
 Fully independent 8 (38.1%) 7 (36.8%) 15 (37.5%) 
 Minimum assistance 6 (28.6%) 3 (15.8%) 9 (22.5%) 
 Regular 
prompting/supervision 
3 (14.3%) 1 (5.3%) 4 (10.0%) 
 1:1 support required 4 (19.0%) 7 (36.8%) 11 (27.5%) 
 1:1 support required 
and totally dependent 
0 (0.0%) 1 (5.3%) 1 (2.5%) 
 Missing 0 0 0 
Personal safety N 21 19 40 
 Totally independent 5 (23.8%) 4 (21.1%) 9 (22.5%) 
 Minimum assistance 6 (28.6%) 4 (21.1%) 10 (25.0%) 
 Some 
awareness/supervision 
6 (28.6%) 3 (15.8%) 9 (22.5%) 
 Constant supervision 2 (9.5%) 4 (21.1%) 6 (15.0%) 
 Totally dependent 2 (9.5%) 4 (21.1%) 6 (15.0%) 
 Missing 0 0 0 
Communication N 21 19 40 
 Totally independent 12 (57.1%) 9 (47.4%) 21 (52.5%) 
 Reasonably clearly, 
sign/aids 
4 (19.0%) 3 (15.8%) 7 (17.5%) 
 Staff support 0 (0.0%) 3 (15.8%) 3 (7.5%) 
 Time required 
understand 
2 (9.5%) 1 (5.3%) 3 (7.5%) 
 Extremely limited  3 (14.3%) 3 (15.8%) 6 (15.0%) 
 Missing 0 0 0 
Decision making N 21 19 40 
 Totally independent 3 (14.3%) 2 (10.5%) 5 (12.5%) 
 Minimum support 8 (38.1%) 5 (26.3%) 13 (32.5%) 
 Some 
choices/decisions 
6 (28.6%) 9 (47.4%) 15 (37.5%) 
 Support required 3 (14.3%) 1 (5.3%) 4 (10.0%) 
 Totally dependent 1 (4.8%) 2 (10.5%) 3 (7.5%) 
 Missing 0 0 0 
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Table 2.3.2. Summary of baseline ability and development, by randomised group and overall (Non-
completers). 
How much support 
does the participant 
need with 
Statistic TAKE 5 
(n=5) 
WWTOO 
(n=5) 
TOTAL 
(n=10) 
Eating and drinking N 5 5 10 
 Totally independent 3 (60.0%) 3 (60.0%) 6 (60.0%) 
 Minimum assistance 0 (0.0%) 2 (40.0%) 2 (20.0%) 
 Regular 
prompting/supervision 
2 (40.0%) 0 (0.0%) 2 (20.0%) 
 1:1 support required 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1:1 support required 
and special equipment 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Intimate care N 5 5 10 
 Fully independent 2 (40.0%) 2 (40.0%) 4 (40.0%) 
 Minimum assistance 1 (20.0%) 1 (20.0%) 2 (20.0%) 
 Regular 
prompting/supervision 
0 (0.0%) 1 (20.0%) 1 (10.0%) 
 1:1 support required 1 (20.0%) 1 (20.0%) 2 (20.0%) 
 1:1 support required 
and totally dependent 
1 (20.0%) 0 (0.0%) 1 (10.0%) 
 Missing 0 0 0 
Personal safety N 5 5 10 
 Totally independent 1 (20.0%) 1 (20.0%) 2 (20.0%) 
 Minimum assistance 0 (0.0%) 1 (20.0%) 1 (10.0%) 
 Some 
awareness/supervision 
2 (40.0%) 2 (40.0%) 4 (40.0%) 
 Constant supervision 1 (20.0%) 0 (0.0%) 1 (10.0%) 
 Totally dependent 1 (20.0%) 1 (20.0%) 2 (20.0%) 
 Missing 0 0 0 
Communication N 5 5 10 
 Totally independent 2 (40.0%) 3 (60.0%) 5 (50.0%) 
 Reasonably clearly, 
sign/aids 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Staff support 2 (40.0%) 1 (20.0%) 3 (30.0%) 
 Time required 
understand 
1 (20.0%) 0 (0.0%) 1 (10.0%) 
 Extremely limited  0 (0.0%) 1 (20.0%) 1 (10.0%) 
 Missing 0 0 0 
Decision making N 5 5 10 
 Totally independent 1 (20.0%) 1 (20.0%) 2 (20.0%) 
 Minimum support 1 (20.0%) 1 (20.0%) 2 (20.0%) 
 Some 
choices/decisions 
2 (40.0%) 3 (60.0%) 5 (50.0%) 
 Support required 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Totally dependent 1 (20.0%) 0 (0.0%) 1 (10.0%) 
 Missing 0 0 0 
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Table 2.4. Summary of baseline level of intellectual disabilities, by randomized group and overall (ITT). 
Variable TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Mild 8 (30.8%) 6 (25.0%) 14 (28.0%) 
Moderate 11 (42.3%) 10 (41.7%) 21 (42.0%) 
Severe 4 (15.4%) 7 (29.2%) 11 (22.0%) 
Profound 3 (11.5%) 1 (4.2%) 4 (8.0%) 
 
Table 2.4.1. Summary of baseline level of intellectual disabilities, by randomized group and overall 
(Completers). 
Variable TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) Mild 6 (28.6%) 5 (26.3%) 11 (27.5%) 
Moderate 11 (52.4%) 7 (36.8%) 8 (45.0%) 
Severe 2 (9.5%) 6 (31.6%) 8 (20.0%) 
Profound 2 (9.5%) 1 (5.3%) 3 (7.5%) 
 
Table 2.4.2 Summary of baseline level of intellectual disabilities, by randomized group and overall (Non-
completers). 
Variable TAKE 5 
(n=5) 
WWTOO 
(n=5) 
TOTAL 
(n=10) Mild 2 (40.0%) 1 (20.0%) 3 (30.0%) 
Moderate 0 (0.0%) 3 (60.0%) 3 (30.0%) 
Severe 2 (40.0%) 1 (20.0%) 3 (30.0%) 
Profound 1 (20.0%) 0 (0.0%) 1 (10.0%) 
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Table 2.5. Summary of baseline physical and mental health, by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Epilepsy N 26 24 50 
 Yes 6 (23.1%) 5 (20.8%) 11 (22.0%) 
 No 20 (76.9%) 19 (79.2%) 39 (78.0%) 
 Missing 0 0 0 
Vision N 26 24 50 
 Yes 16 (61.5%) 9 (37.5%) 25 (50.0%) 
 No 10 (38.5%) 14 (58.3%) 24 (48.0%) 
 Don’t know 0 (0.0%) 1 (4.2%) 1 (2.0%) 
 Missing 0 0 0 
Hearing N 26 24 50 
 Yes 6 (23.1%) 3 (12.5%) 9 (18.0%) 
 No 20 (76.9%) 21 (87.5%) 41 (82.0%) 
 Missing 0 0 0 
Mental Health Issues N 26 24 50 
 Yes 10 (38.5%) 9 (37.5%) 19 (38.0%) 
 No 15 (57.7%) 14 (58.3%) 29 (58.0%) 
 Not sure 1 (3.8%) 1 (4.2%) 2 (4.0%) 
 Missing 0 0 0 
Problem behaviours N 26 24 50 
 Yes 12 (46.2%) 11 (45.8%) 23 (46.0%) 
 No 14 (53.8%) 13 (54.2%) 27 (54.0%) 
 Missing 0 0 0 
High Blood Pressure N 26 24 50 
 Yes 5 (19.2%) 2 (8.3%) 7 (14.0%) 
 No 21 (80.8%) 22 (91.7%) 43 (86.0%) 
 Missing 0 0 0 
Type II Diabetes N 26 24 50 
 Yes 1 (3.8%) 3 (12.5%) 4 (8.0%) 
 No 25 (96.2%) 21 (87.5%) 46 (92.0%) 
 Missing 0 0 0 
Underactive Thyroid N 26 24 50 
 Yes 2 (7.7%) 1 (4.2%) 3 (6.0%) 
 No 24 (92.3%) 23 (95.8%) 47 (94.0%) 
 Missing 0 0 0 
Rheumatoid Arthritis  N 26 24 50 
 Yes 3 (11.5%) 2 (8.3%) 5 (10.0%) 
 No 23 (88.5%) 22 (91.7%) 45 (90.0%) 
 Missing 0 0 0 
Asthma N 26 24 50 
 Yes 4 (15.4%) 3 (12.5%) 7 (14.0%) 
 No 22 (84.6%) 21 (87.5%) 43 (86.0%) 
 Missing 0 0 0 
Depression N 26 24 50 
 Yes 3 (11.5%) 3 (12.5%) 6 (12.0%) 
 No 23 (88.5%) 21 (87.5%) 44 (88.0%) 
 Missing 0 0 0 
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Table 2.5.1. Summary of baseline physical and mental health, by randomised group and overall (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Epilepsy N 21 19 40 
 Yes 4 (19.0%) 3 (15.8%) 7 (17.5%) 
 No 17 (81.0%) 16 (84.2%) 33 (82.5%) 
 Missing 0 0 0 
Vision N 21 19 40 
 Yes 11 (52.4%) 7 (36.8%) 18 (45.0%) 
 No 10 (47.6%) 12 (63.2%) 22 (55.0%) 
 Don’t know 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Hearing N 21 19 40 
 Yes 6 (28.6%) 2 (10.5%) 8 (20.0%) 
 No 15 (71.4%) 17 (89.5%) 32 (80.0%) 
 Missing 0 0 0 
Mental Health Issues N 21 19 40 
 Yes 8 (38.1%) 7 (36.8%) 15 (37.5%) 
 No 12 (57.1%) 11 (57.9%) 23 (57.5%) 
 Not sure 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 Missing 0 0 0 
Problem behaviours N 21 19 40 
 Yes 10 (47.6%) 8 (42.1%) 18 (45.0%) 
 No 11 (52.4%) 11 (57.9%) 22 (55.0%) 
 Missing 0 0 0 
High Blood Pressure N 21 19 40 
 Yes 4 (19.0%) 2 (10.5%) 6 (15.0%) 
 No 17 (81.0%) 17 (89.5%) 34 (85.0%) 
 Missing 0 0 0 
Type II Diabetes N 21 19 40 
 Yes 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 No 20 (95.2%) 18 (94.7%) 38 (95.0%) 
 Missing 0 0 0 
Underactive Thyroid N 21 19 40 
 Yes 2 (9.5%) 1 (5.3%) 3 (7.5%) 
 No 19 (90.5%) 18 (94.7%) 37 (92.5%) 
 Missing 0 0 0 
Rheumatoid Arthritis  N 21 19 40 
 Yes 1 (4.8%) 2 (10.5%) 3 (7.5%) 
 No 20 (95.2%) 17 (89.5%) 37 (92.5%) 
 Missing 0 0 0 
Asthma N 21 19 40 
 Yes 3 (14.3%) 2 (10.5%) 5 (12.5%) 
 No 18 (85.7%) 17 (89.5%) 35 (87.5%) 
 Missing 0 0 0 
Depression N 21 19 40 
 Yes 3 (14.3%) 3 (15.8%) 6 (15.0%) 
 No 18 (85.7%) 16 (84.2%) 34 (85.0%) 
 Missing 0 0 0 
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Table 2.6. Summary of baseline lifestyle habits, by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Hours watching TV, 
DVDs or videos 
N 26 24 50 
 Does not watch TV 2 (7.7%) 0 (0.0%) 2 (4.0%) 
 1-3 hours month 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1 hour a week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 2-4 hours a week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 5-6 hours a week 0 (0.0%) 1 (4.2%) 1 (2.0%) 
 1 hour a day 2 (7.7%) 3 (12.5%) 5 (10.0%) 
 2-3 hours a day 10 (38.5%) 5 (20.8%) 15 (30.0%) 
 4-5 hours a day 7 (26.9%) 8 (33.3%) 15 (30.0%) 
 6+ hours a day 5 (19.2%) 7 (29.2%) 12 (24.0%) 
 Missing 0 0 0 
Hours using computers N 26 24 50 
 Does not use computers 10 (38.5%) 14 (58.3%) 24 (48.0%) 
 1-3 hours month 3 (11.5%) 2(8.3%) 5 (10.0%) 
 1 hour a week 2 (7.7%) 4 (16.7%) 6 (12.0%) 
 2-4 hours a week 1 (3.8%) 1 (4.2%) 2 (4.0%) 
 5-6 hours a week 1 (3.8%) 0 (0.0%) 1 (2.0%) 
 1 hour a day 2 (7.7%) 1 (4.2%) 3 (6.0%) 
 2-3 hours a day 7 (26.9%) 0 (0.0%) 7 (14.0%) 
 4-5 hours a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 6+ hours a day 0 (0.0%) 2 (8.3%) 2 (4.0%) 
 Missing 0 0 0 
Number of cigarettes 
smoked 
N 26 24 50 
 None, does not smoke 26 (100.0%) 21 (87.5%) 47 (94.0%) 
 Less than 1 cigarette a month 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1-3 cigarettes a month 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1-6 cigarettes a week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1-3 cigarettes a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 4-10 cigarettes a day 0 (0.0%) 1 (4.2%) 1 (2.0%) 
 11-20 cigarettes a day 0 (0.0%) 2 (8.3%) 2 (4.0%) 
 21-39 cigarettes a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 40+ cigarettes a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.6.1. Summary of baseline lifestyle habits, by randomised group and overall (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Hours watching TV, 
DVDs or videos 
N 21 19 40 
 Does not watch TV 2 (9.5%) 0 (0.0%) 2 (5.0%) 
 1-3 hours month 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1 hour a week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 2-4 hours a week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 5-6 hours a week 0 (0.0%) 1 (5.3%) 1 (2.5%) 
 1 hour a day 2 (9.5%) 3 (15.8%) 5 (12.5%) 
 2-3 hours a day 10 (47.6%) 4 (21.1%) 14 (35.0%) 
 4-5 hours a day 3 (14.3%) 6 (31.6%) 9 (22.5%) 
 6+ hours a day 4 (19.0%) 5 (26.3%) 9 (22.5%) 
 Missing 0 0 0 
Hours using computers N 21 19 40 
 Does not use computers 9 (42.9%) 10 (52.6%) 19 (47.5%) 
 1-3 hours month 3 (14.3%) 2 (10.5%) 5 (12.5%) 
 1 hour a week 2 (9.5%) 3 (15.8%) 5 (12.5%) 
 2-4 hours a week 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 5-6 hours a week 1 (4.8%) 0 (0.0%) 1 (2.5%) 
 1 hour a day 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 2-3 hours a day 4 (19.0%) 0 (0.0%) 4 (10.0%) 
 4-5 hours a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 6+ hours a day 0 (0.0%) 2 (10.5%) 2 (5.0%) 
 Missing 0 0 0 
Number of cigarettes 
smoked 
N 21 19 40 
 None, does not smoke 21 (100.0%) 17 (89.5%) 38 (95.0%) 
 Less than 1 cigarette a month 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1-3 cigarettes a month 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1-6 cigarettes a week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 1-3 cigarettes a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 4-10 cigarettes a day 0 (0.0%) 1 (5.3%) 1 (2.5%) 
 11-20 cigarettes a day 0 (0.0%) 1 (5.3%) 1 (2.5%) 
 21-39 cigarettes a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 40+ cigarettes a day 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.8. Summary of baseline accelerometer data (minutes/day), by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Steps N 25 22 47 
 Mean 4880 4875 4877 
 Std Dev 2184.72 2315.32 2222.06 
 Median 4652 5077 4705 
 Min-Max 1422-10062 1246-9207 1246-10062 
 Interquartile range 3578-6371 2757-6591 3055-6490 
 Missing 1 2 3 
Light PA (minutes/day) N 25 22 47 
 Mean 147.9 159.6 153.4 
 Std Dev 47.01 77.19 62.51 
 Median 141.9 143.7 141.9 
 Min-Max 49-268 75-382 49-382 
 Interquartile range 124-180 101.3-194.8 105-183 
 Missing 1 2 3 
MVPA (minutes/day) N 25 22 47 
 Mean 28.8 31.6 30.1 
 Std Dev 16.90 22.52 19.56 
 Median 23.5 23.0 23.5 
 Min-Max 2-64 5-89 2-89 
 Interquartile range 17-42 17-39 17-40 
 Missing 1 2 3 
Total PA (minutes/day) N 25 22 47 
 Mean 176.8 191.2 183.5 
 Std Dev 53.25 85.09 69.55 
 Median 175.2 184.0 176.9 
 Min-Max 68-331 93-420 68-420 
 Interquartile range 145-203 112-229 136-212 
 Missing 1 2 3 
Sedentary Behaviour 
(minutes/day) 
N 25 22 47 
 Mean 501.1 522.3 511.0 
 Std Dev 125.88 165.29 144.41 
 Median 475.7 496.6 479.6 
 Min-Max 353-945 268-915 268-945 
 Interquartile range 411-583 410-671 412-593 
 Missing 1 2 3 
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Table 2.8.1. Summary of baseline accelerometer data (minutes/day), by randomised group and overall 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Steps N 20 17 37 
 Mean 4974 4416 4718 
 Std Dev 2066.43 2311.27 2169.62 
 Median 4673 3939 4652 
 Min-Max 1599-10062 1246-8130 1246-10062 
 Interquartile range 3752-6426 2360-6671 2982-6562 
 Missing 1 2 3 
Light PA (minutes/day) N 20 17 37 
 Mean 150.9 159.4 154.8 
 Std Dev 51.85 86.97 69.28 
 Median 150.7 118.9 144.7 
 Min-Max 49-268 75-382 49-382 
 Interquartile range 127-183 95-210 103-187 
 Missing 1 2 3 
MVPA (minutes/day) N 20 17 37 
 Mean 28.9 27.9 28.4 
 Std Dev 17.09 19.81 18.14 
 Median 21.5 22.2 22.2 
 Min-Max 4-64 5-89 4-89 
 Interquartile range 17-43 16-37 17-39 
 Missing 1 2 3 
Total PA (minutes/day) N 20 17 37 
 Mean 179.7 187.3 183.2 
 Std Dev 57.47 96.04 76.54 
 Median 176.1 170.1 175.2 
 Min-Max 68-331 93-420 68-420 
 Interquartile range 150-219 108-239 122-219 
 Missing 1 2 3 
Sedentary Behaviour 
(minutes/day) 
N 20 17 37 
 Mean 506.4 529.1 516.8 
 Std Dev 133.54 173.84 151.57 
 Median 459.3 479.6 475.7 
 Min-Max 374-945 268-915 268-945 
 Interquartile range 416-586 407-684 412-609 
 Missing 1 2 3 
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Table 2.9. Summary of baseline accelerometer data (percentage time spent/day), by randomised group and 
overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Light PA (% time 
spent/day) 
N 25 22 47 
 Mean 21.8 22.3 22.1 
 Std Dev 6.22 8.01 7.04 
 Median 21.2 20.2 20.9 
 Min-Max 10-38 12-39 10-39 
 Interquartile range 18-26 16-29 17-26 
 Missing 1 2 3 
MVPA (% time spent 
/day) 
N 25 22 47 
 Mean 4.5 4.7 4.6 
 Std Dev 2.73 3.78 3.23 
 Median 4.1 3.8 3.9 
 Min-Max 0-9 1-15 0-15 
 Interquartile range 2-6 2-6 2-6 
 Missing 1 2 3 
Total PA (% time spent 
/day) 
N 25 22 47 
 Mean 26.3 27.0 26.7 
 Std Dev 7.63 9.72 8.6 
 Median 25.5 25.0 25.5 
 Min-Max 14-47 15-45 14-47 
 Interquartile range 21-30 19-32 20-31 
 Missing 1 2 3 
Sedentary Behaviour (% 
time spent /day) 
N 25 22 47 
 Mean 73.7 73.0 73.3 
 Std Dev 7.63 9.72 8.58 
 Median 74.5 75.0 74.5 
 Min-Max 53-86 55-85 53-86 
 Interquartile range 70-79 68-81 69-80 
 Missing 1 2 3 
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Table 2.9.1. Summary of baseline accelerometer data, by randomised group and overall (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) Light PA (% time 
spent/day) 
N 20 17 37 
 Mean 21.9 22.1 22.0 
 Std Dev 6.62 8.96 7.67 
 Median 21.3 17.2 20.6 
 Min-Max 10-38 12-39 10-39 
 Interquartile range 18-26 15-30 16-27 
 Missing 1 2 3 
MVPA (% time spent 
/day) 
N 20 17 37 
 Mean 4.5 4.0 4.3 
 Std Dev 2.70 2.91 2.77 
 Median 3.6 3.4 3.4 
 Min-Max 0-9 0-14 0-14 
 Interquartile range 2-6 2-5 2-6 
 Missing 1 2 3 
Total PA (% time spent 
/day) 
N 20 17 37 
 Mean 26.4 26.1 26.2 
 Std Dev 7.80 10.03 8.77 
 Median 25.3 20.6 25.1 
 Min-Max 14-47 15-44 14-47 
 Interquartile range 22-30 18-33 20-31 
 Missing 1 2 3 
Sedentary Behaviour (% 
time spent /day) 
N 20 17 37 
 Mean 73.6 73.9 73.8 
 Std Dev 7.80 10.03 8.77 
 Median 74.7 79.4 74.9 
 Min-Max 53-86 56-85 53-86 
 Interquartile range 70-78 67-82 69-80 
 Missing 1 2 3 
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Table 2.10. Summary of baseline EQ-5D-Y domain, by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
EQ-5D Dimension     
Mobility N 26 24 50 
 No problems 21 (80.8%) 16 (66.7%) 37 (74.0%) 
 Some problems 3 (11.5%) 7 (29.2%) 10 (20.0%) 
 Extreme problems 2 (7.7%) 1 (4.2%) 3 (6.0%) 
 Missing 0 0 0 
Self-care N 26 24 50 
 No problems 18 (69.2%) 15 (62.5%) 33 (66.0%) 
 Some problems 5 (19.2%) 2 (8.3%) 7 (14.0%) 
 Extreme problems 3 (11.5%) 7 (29.2%) 10 (20.0%) 
 Missing 0 0 0 
Usual activities N 26 24 50 
 No problems 23 (88.5%) 22 (91.7%) 45 (90.0%) 
 Some problems 3 (11.5%) 2 (8.3%) 5 (10.0%) 
 Extreme problems 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Pain/discomfort N 26 24 50 
 No problems 21 (80.8%) 19 (79.2%) 40 (80.0%) 
 Some problems 4 (15.4%) 4 (16.7%) 8 (16.0%) 
 Extreme problems 1 (3.8%) 1 (4.2%) 2 (4.0%) 
 Missing 0 0 0 
Anxiety/depression N 26 24 50 
 No problems 21 (80.8%) 20 (83.3%) 41 (82.0%) 
 Some problems 5 (19.2%) 4 (16.7%) 9 (18.0%) 
 Extreme problems 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.10.1. Summary of baseline EQ-5D-Y domain, by randomised group and overall (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
EQ-5D Dimension     
Mobility N 21 19 40 
 No problems 17 (81.0%) 13 (68.4%) 30 (75.0%) 
 Some problems 2 (9.5%) 5 (26.3%) 7 (17.5%) 
 Extreme problems 2 (9.5%) 1 (5.3%) 3 (7.5%) 
 Missing 0 0 0 
Self-care N 21 19 40 
 No problems 15 (71.4%) 12 (63.2%) 27 (67.5%) 
 Some problems 4 (19.0%) 2 (10.5%) 6 (15.0%) 
 Extreme problems 2 (9.5%) 5 (26.3%) 7 (17.5%) 
 Missing 0 0 0 
Usual activities N 21 19 40 
 No problems 20 (95.2%) 18 (94.7%) 28 (95.0%) 
 Some problems 1 (4.8%) 1 (5.3%) 2 (5.0%) 
 Extreme problems 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
Pain/discomfort N 21 19 40 
 No problems 18 (85.7%) 16 (84.2%) 34 (85.0%) 
 Some problems 2 (9.5%) 3 (15.8%) 5 (12.5%) 
 Extreme problems 1 (4.8%) 0 (0.0%) 1 (2.5%) 
 Missing 0 0 0 
Anxiety/depression N 21 19 40 
 No problems 17 (81.0%) 17 (89.5%) 34 (85.0%) 
 Some problems 4 (19.0%) 2 (10.5%) 6 (15.0%) 
 Extreme problems 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Missing 0 0 0 
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Table 2.11. Summary of baseline EQ-5D-Y index, by randomised group and overall (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
EQ-5D Index N 26 24 50 
 Mean 0.8 0.7 0.7 
 Std Dev 0.27 0.32 0.29 
 Median 0.8 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 0 0 0 
Table 2.11.1. Summary of baseline EQ-5D-Y index, by randomised group and overall (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
EQ-5D Index N 21 19 40 
 Mean 0.8 0.8 0.8 
 Std Dev 0.28 0.28 0.28 
 Median 0.8 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 0 0 0 
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Table 3.1.1.  Primary outcome: Change in average weight (kg) at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT) 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 24 48 
 Mean 101.3 104.1 102.7 
 Std Dev 26.02 28.86 27.22 
 Median 98.0 100.4 100.2 
 Min-Max 59-149 72-212 59-212 
 Interquartile range 78-126 87-111 86-119 
 Missing 2 0 2 
 12 months N 24 24 48 
 Mean 97.7 102.4 100.1 
 Std Dev 26.65 26.88 26.59 
 Median 97.7 97.1 97.2 
 Min-Max 58-149 73.5-199.4 58.3-199.4 
 Interquartile range 74-122 85.8-107.9 85.5-113.1 
 Missing 2 0 2 
Change at 12 months N 24 24 48 
 Mean -3.6 -1.6 -2.6 
 Std Dev 5.16 5.03 5.14 
 Median -4.3 -0.8 -1.7 
 Min-Max -13-5 -15-4 -15-5 
 Interquartile range -7-1 -5-2 -6-2 
 Missing 2 0 2 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.90 (-4.80 
to 1.01) 
 
 
p = 0.195 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.1.1.1. Sensitivity analysis - primary outcome: Change in average weight (kg) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 23 47 
 Mean 101.3 99.4 100.3 
 Std Dev 26.02 17.82 22.16 
 Median 98.0 99.8 99.8 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 78-126 87-110 86-114 
 Missing 2 1 1 
 12 months N 24 23 47 
 Mean 97.7 98.2 97.9 
 Std Dev 26.65 17.60 22.43 
 Median 97.7 97.0 97.2 
 Min-Max 58-149 74-146 58-149 
 Interquartile range 74-122 86-107 96-113 
 Missing 2 1 1 
Change at 12 months N 24 23 47 
 Mean -3.6 -1.1 -2.4 
 Std Dev 5.16 4.55 4.97 
 Median -4.3 -0.4 -1.5 
 Min-Max -13-5 -15-4 -15-5 
 Interquartile range -7-1 -3-2 -6-2 
 Missing 2 1 1 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.16 (-5.08 
to 0.76) 
 
 
p = 0.143 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.1.1.2. Sensitivity analysis - primary outcome: Change in average weight (kg) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 22 46 
 Mean 101.3 99.3 100.3 
 Std Dev 26.02 18.24 22.41 
 Median 98.0 96.5 97.7 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 78-126 86-110 86-116 
 Missing 2 2 4 
 12 months N 24 22 46 
 Mean 97.7 98.8 98.2 
 Std Dev 26.65 17.80 22.61 
 Median 97.7 97.1 97.2 
 Min-Max 58-149 74-146 58-149 
 Interquartile range 74-122 86-107 85-113 
 Missing 2 2 4 
Change at 12 months N 24 22 46 
 Mean -3.6 -0.5 -2.1 
 Std Dev 5.16 3.46 4.65 
 Median -4.3 0.1 -1.4 
 Min-Max -13-5 -8-4 -13-5 
 Interquartile range -7-1 -2-2 -6-2 
 Missing 2 2 4 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.93 (-5.65 
to -0.20) 
 
 
p = 0.036 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.1.2. Primary outcome: Change in average weight (kg) at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 19 40 
 Mean 102.7 101.9 102.3 
 Std Dev 25.10 18.05 21.77 
 Median 100.5 100.9 100.7 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 87-126 88-112 87-119 
 Missing 0 0 0 
 12 months N 21 19 40 
 Mean 98.9 100.7 99.8 
 Std Dev 25.48 18.22 22.07 
 Median 98.3 97.3 97.8 
 Min-Max 58-149 74-146 58-149 
 Interquartile range 83-120 86-108 86-113 
 Missing 0 0 0 
Change at 12 months N 21 19 40 
 Mean -3.8 -1.2 -2.6 
 Std Dev 5.40 4.71 5.18 
 Median -4.9 -0.4 -1.4 
 Min-Max -13-5 -15-4 -15-5 
 Interquartile range -8-1 -2-2 -6-2 
 Missing 0 0 0 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.46 (-5.84 
to 0.93) 
 
 
p = 0.150 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.1.2.1. Sensitivity analysis - primary outcome: Change in average weight (kg) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 18 39 
 Mean 102.7 102.0 102.4 
 Std Dev 25.10 18.57 22.05 
 Median 100.5 100.5 100.5 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 87-126 88-113 87-121 
 Missing 0 1 1 
 12 months N 21 18 39 
 Mean 98.9 101.5 100.1 
 Std Dev 25.48 18.37 22.2 
 Median 98.3 99.0 98.3 
 Min-Max 58-149 74-146 58-149 
 Interquartile range 83-120 86-109 86-113 
 Missing 0 1 1 
Change at 12 months N 21 18 39 
 Mean -3.8 -0.5 -2.3 
 Std Dev 5.40 3.4 4.83 
 Median -4.9 0.1 -1.3 
 Min-Max -13-5 -8-4 -13-5 
 Interquartile range -8-1 -2-2 -6-2 
 Missing 0 1 1 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-3.26 (-6.42 
to -0.10) 
 
 
 
p = 0.044 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.2.1. Secondary outcome: Change in average weight (kg) at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 22 46 
 Mean 101.3 105.1 103.1 
 Std Dev 26.02 29.78 27.63 
 Median 98.0 100.4 100.2 
 Min-Max 59-149 72-212 59-212 
 Interquartile range 78-126 87-113 87-122 
 Missing 2 2 4 
 6 months N 24 22 46 
 Mean 98.4 103.7 101.0 
 Std Dev 26.75 28.77 27.6 
 Median 95.6 98.8 98.1 
 Min-Max 58-144 71-211 58-211 
 Interquartile range 77-122 86-109 85-119 
 Missing 2 2 4 
Change at 6 months N 24 22 46 
 Mean -2.8 -1.4 -2.1 
 Std Dev 3.76 3.34 3.60 
 Median -2.4 -1.4 -1.6 
 Min-Max -12-5 -11-6 -12-6 
 Interquartile range -6-0 -3-1 -4-0 
 Missing 2 2 4 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.67 (-3.84 
to 0.50) 
 
 
p = 0.126 
 
 
 
0.059 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.2.1.1. Sensitivity analysis - secondary outcome: Change in average weight (kg) at 6 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 21 45 
 Mean 101.3 100.0 100.7 
 Std Dev 26.02 18.22 22.47 
 Median 98.0 99.8 99.8 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 78-126 87-111 86-118 
 Missing 2 3 5 
 6 months N 24 21 45 
 Mean 98.4 98.7 98.5 
 Std Dev 26.75 16.50 22.31 
 Median 95.6 98.6 97.6 
 Min-Max 58-144 71-135 58-144 
 Interquartile range 77-122 86-107 85-114 
 Missing 2 3 5 
Change at 6 months N 24 21 45 
 Mean -2.8 -1.4 -2.1 
 Std Dev 3.76 3.42 3.64 
 Median -2.4 -1.4 -1.7 
 Min-Max -12-5 -11-6 -12-6 
 Interquartile range -6-0 -3-1 -4-0 
 Missing 2 3 5 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.55 (-3.76 
to 0.66) 
 
 
 
p = 0.162 
 
 
 
 
0.072 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
 
 
 
 
 
 
 
 
 
 
 
294 
 
 
Table 3.2.1.2. Sensitivity analysis - secondary outcome: Change in average weight (kg) at 6 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 20 44 
 Mean 101.3 97.8 99.7 
 Std Dev 26.02 15.41 21.68 
 Median 98.0 96.5 97.7 
 Min-Max 59-149 72-130 59-149 
 Interquartile range 78-126 87-108 86-114 
 Missing 2 4 6 
 6 months N 24 20 44 
 Mean 98.4 96.9 97.7 
 Std Dev 26.75 14.68 21.88 
 Median 95.6 98.1 96.9 
 Min-Max 58-144 71-129 58-144 
 Interquartile range 77-122 86-105 84-110 
 Missing 2 4 6 
Change at 6 months N 24 20 44 
 Mean -2.8 -0.9 -2.0 
 Std Dev 3.76 2.78 3.45 
 Median -2.4 -0.9 -1.6 
 Min-Max -12-5 -6-6 -12-6 
 Interquartile range -6-0 -3-1 -4-0 
 Missing 2 4 6 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.02 (-4.13 
to 0.08) 
 
 
 
p = 0.059 
 
 
 
 
0.033 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.2.2. Secondary outcome: Change in average weight (kg) at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 19 40 
 Mean 102.7 101.9 102.3 
 Std Dev 25.10 18.05 21.77 
 Median 100.5 100.9 100.7 
 Min-Max 59-149 72-145 59-149 
 Interquartile range 87-126 88-112 87-119 
 Missing 0 0 0 
 6 months N 21 19 40 
 Mean 99.6 100.5 100.0 
 Std Dev 25.98 16.29 21.66 
 Median 96.2 99.0 98.7 
 Min-Max 58-144 71-135 58-144 
 Interquartile range 85-121 86-108 87-116 
 Missing 0 0 0 
Change at 6 months N 21 19 40 
 Mean -3.1 -1.4 -2.3 
 Std Dev 3.91 3.48 3.76 
 Median -3.6 -1.4 -2.0 
 Min-Max -12-5 -11-6 -12-6 
 Interquartile range -6-0 -3-0 -4-0 
 Missing 0 0 0 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.89 (-4.38 
to 0.59) 
 
 
p = 0.130 
 
 
 
 
0.096 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.1. Secondary outcome: Change in average BMI (kg/m2) at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 22 46 
 Mean 40.0 41.8 40.8 
 Std Dev 7.06 8.29 7.64 
 Median 39.6 41.3 39.6 
 Min-Max 31-54 32-66 31-66 
 Interquartile range 33-45 35-46 34-46 
 Missing 2 2 4 
 6 months N 24 22 46 
 Mean 38.8 41.3 40.0 
 Std Dev 7.53 8.21 7.88 
 Median 38.5 40.8 39.6 
 Min-Max 27-55 32-65 27-65 
 Interquartile range 33-45 34-46 33-45 
 Missing 2 2 4 
Change at 6 months N 24 22 46 
 Mean -1.2 -0.5 -0.8 
 Std Dev 1.57 1.20 1.43 
 Median -1.1 -0.6 -0.7 
 Min-Max -5-2 -3-2 -5-2 
 Interquartile range -2-0 -1-0 -2-0 
 Missing 2 2 4 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.74 (-1.58 
to 0.11) 
 
 
p = 0.085 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.1.1. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 6 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 21 45 
 Mean 40.0 40.6 40.3 
 Std Dev 7.06 6.47 6.73 
 Median 39.6 39.6 39.6 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 33-45 35-46 34-46 
 Missing 2 3 5 
 6 months N 24 21 45 
 Mean 38.8 40.2 39.4 
 Std Dev 7.53 6.36 6.97 
 Median 38.5 40.4 39.6 
 Min-Max 27-55 32-52 27-55 
 Interquartile range 33-45 34-45 33-45 
 Missing 2 3 5 
Change at 6 months N 24 21 45 
 Mean -1.2 -1.0 -0.8 
 Std Dev 1.57 1.23 1.45 
 Median -1.1 -0.7 -0.7 
 Min-Max -5-2 -3-2 -5-2 
 Interquartile range -2-0 -1-0 -2-0 
 Missing 2 3 5 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.74 (-1.61 
to 0.12) 
 
 
 
p = 0.090 
 
 
 
 
0.006 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.2. Secondary outcome: Change in average BMI (kg/m2) at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 19 40 
 Mean 40.6 41.5 41.0 
 Std Dev 7.06 6.19 6.59 
 Median 39.6 42.9 40.4 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 34-46 35-46 35-46 
 Missing 0 0 0 
 6 months N 21 19 40 
 Mean 39.3 41.0 40.1 
 Std Dev 7.63 6.11 6.92 
 Median 39.1 41.1 39.6 
 Min-Max 27-55 32-52 27-55 
 Interquartile range 34-46 35-45 34-45 
 Missing 0 0 0 
Change at 6 months N 21 19 40 
 Mean -1.3 -0.5 -0.9 
 Std Dev 1.63 1.24 1.50 
 Median -1.3 -0.7 -0.8 
 Min-Max -5-2 -3-2 -5-2 
 Interquartile range -3-0 -1-0 -2-0 
 Missing 0 0 0 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.87 (-1.84 
to 0.11)  
 
 
p = 0.078 
 
 
 
 
0.078 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.3. Secondary outcome: Change in average BMI (kg/m2) at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 24 48 
 Mean 40.0 41.2 40.6 
 Std Dev 7.06 8.14 7.56 
 Median 39.6 39.0 39.6 
 Min-Max 31-54 32-66 31-66 
 Interquartile range 33-45 35-46 34-46 
 Missing 2 0 2 
 12 months N 24 24 48 
 Mean 38.5 40.7 39.6 
 Std Dev 7.30 7.73 7.51 
 Median 38.2 38.2 38.2 
 Min-Max 27-50 32-62 27-62 
 Interquartile range 32-44 35-46 33-45 
 Missing 2 0 2 
Change at 12 months N 24 24 48 
 Mean -1.5 -0.6 -1.0 
 Std Dev 2.06 1.97 2.04 
 Median -1.8 -0.3 -0.7 
 Min-Max -6-2 -7-2 -7-2 
 Interquartile range -3-0 -2-1 -2-1 
 Missing 2 0 2 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.89 (-2.05 
to 0.28) 
 
 
p = 0.134 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.3.1. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 23 47 
 Mean 40.0 40.2 40.1 
 Std Dev 7.06 6.37 6.66 
 Median 39.6 38.3 39.5 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 33-45 34-46 34-45 
 Missing 2 1 3 
 12 months N 24 23 47 
 Mean 38.5 39.7 39.1 
 Std Dev 7.30 6.41 6.83 
 Median 38.2 37.6 37.9 
 Min-Max 27-50 32-52 27-52 
 Interquartile range 32-44 35-45 33-44 
 Missing 2 1 3 
Change at 12 months N 24 23 47 
 Mean -1.5 -0.4 -1.0 
 Std Dev 2.06 1.88 2.02 
 Median -1.8 -0.2 -0.5 
 Min-Max -6-2 -7-2 -7-2 
 Interquartile range -3-0 -1-1 -2-1 
 Missing 2 1 3 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.00 (-2.15 
to 0.20) 
 
 
 
p = 0.100 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
 
 
 
 
 
 
 
 
 
 
 
 
 
301 
 
 
Table 3.3.3.2. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 22 46 
 Mean 40.0 39.9 40.0 
 Std Dev 7.06 6.40 6.68 
 Median 39.6 38.2 38.9 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 33-45 34-45 34-45 
 Missing 2 2 4 
 12 months N 24 22 46 
 Mean 38.5 39.8 39.1 
 Std Dev 7.30 6.55 6.91 
 Median 38.2 37.5 37.7 
 Min-Max 27-50 32-52 27-52 
 Interquartile range 32-44 34-45 33-45 
 Missing 2 2 4 
Change at 12 months N 24 22 46 
 Mean -1.5 -0.1 -0.8 
 Std Dev 2.06 1.29 1.84 
 Median -1.8 0.0 -0.5 
 Min-Max -6-2 -3-2 -6-2 
 Interquartile range -3-0 -1-1 -2-1 
 Missing 2 2 4 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.29 (-2.35 
to -0.24) 
 
 
 
p = 0.018 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.4. Secondary outcome: Change in average BMI (kg/m2) at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 19 40 
 Mean 40.6 41.5 41.0 
 Std Dev 7.06 6.19 6.59 
 Median 39.6 42.9 40.4 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 34-46 35-46 35-46 
 Missing 0 0 0 
 12 months N 21 19 40 
 Mean 39.0 41.0 40.0 
 Std Dev 7.2 6.29 6.79 
 Median 38.5 40.4 39.6 
 Min-Max 27-50 32-52 27-52 
 Interquartile range 33-46 35-47 35-46 
 Missing 0 0 0 
Change at 12 months N 21 19 40 
 Mean -1.6 -0.5 -1.1 
 Std Dev 2.15 1.97 2.11 
 Median -2.3 -0.2 -0.5 
 Min-Max -6-2 -7-2 -7-2 
 Interquartile range -3-0 -1-0 -3-1 
 Missing 0 0 0 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.06 (-2.44 
to 0.31) 
 
 
 
p = 0.125 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.3.4.1. Sensitivity analysis - secondary outcome: Change in average BMI (kg/m2) at 12 months from 
baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence 
interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 18 39 
 Mean 40.6 41.3 40.9 
 Std Dev 7.06 6.29 6.63 
 Median 39.6 41.3 39.6 
 Min-Max 31-54 32-52 31-54 
 Interquartile range 34-46 35-46 35-46 
 Missing 0 1 1 
 12 months N 21 18 39 
 Mean 39.0 41.1 40.0 
 Std Dev 7.2 6.46 6.87 
 Median 38.5 40.5 40.4 
 Min-Max 27-50 32-52 27-52 
 Interquartile range 33-46 35-47 35-47 
 Missing 0 1 1 
Change at 12 months N 21 18 39 
 Mean -1.6 -0.2 -0.9 
 Std Dev 2.15 1.27 1.91 
 Median -2.3 0.0 -0.5 
 Min-Max -6-2 -3-2 -6-2 
 Interquartile range -3-0 -1-1 -3-1 
 Missing 0 1 1 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.39 (-2.63 
to -0.16) 
 
 
 
p = 0.028 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.1. Secondary outcome: Change in average waist circumference (cm) at 6 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 20 42 
 Mean 121.2 123.7 122.4 
 Std Dev 14.49 16.30 15.24 
 Median 120.0 121.4 120.8 
 Min-Max 95-143 103-171 95-171 
 Interquartile range 110-136 109-131 110-135 
 Missing 4 4 8 
 6 months N 22 20 42 
 Mean 118.5 121.9 120.1 
 Std Dev 14.94 15.34 15.05 
 Median 117.2 120.6 118.4 
 Min-Max 91-142 102-170 91-170 
 Interquartile range 108-132 110-125 109-131 
 Missing 4 4 8 
Change at 6 months N 22 20 42 
 Mean -2.8 -1.8 -2.3 
 Std Dev 4.35 3.65 4.01 
 Median -1.9 -1.5 -1.6 
 Min-Max -11-5 -12-4 -12-5 
 Interquartile range -6-0 -4-0 -5-0 
 Missing 4 4 8 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.71 (-4.28 
to 0.86) 
 
 
p = 0.186 
 
 
 
0.176 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.1.1. Sensitivity analysis - secondary outcome: Change in average waist circumference (cm) at 6 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 19 41 
 Mean 121.2 121.2 121.2 
 Std Dev 14.49 12.34 13.37 
 Median 120.0 121.1 120.5 
 Min-Max 95-143 103-149 95-149 
 Interquartile range 110-136 109-130 109-133 
 Missing 4 5 9 
 6 months N 22 19 41 
 Mean 118.5 119.4 118.9 
 Std Dev 14.94 10.63 12.97 
 Median 117.2 119.9 118.2 
 Min-Max 91-142 103-140 91-142 
 Interquartile range 108-132 109-125 109-130 
 Missing 4 5 9 
Change at 6 months N 22 19 41 
 Mean -2.8 -1.9 -2.4 
 Std Dev 4.35 3.74 4.05 
 Median -1.9 -1.6 -1.7 
 Min-Max -11-5 -12-4 -12-5 
 Interquartile range -6-0 -4-0 -5-0 
 Missing 4 5 9 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis) 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.48 (-4.05 
to 1.09) 
 
 
 
p = 0.249 
 
 
 
 
0.147 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.1.2. Sensitivity analysis - secondary outcome: Change in average waist circumference (cm) at 6 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 18 40 
 Mean 121.2 119.7 120.6 
 Std Dev 14.49 10.65 12.77 
 Median 120.0 120.6 120.3 
 Min-Max 95-143 103-139 95-143 
 Interquartile range 110-136 109-128 109-132 
 Missing 4 6 10 
 6 months N 22 18 40 
 Mean 118.5 118.4 118.4 
 Std Dev 14.94 10.00 12.80 
 Median 117.2 119.2 118.0 
 Min-Max 91-142 103-140 91-142 
 Interquartile range 108-132 109-125 109-128 
 Missing 4 6 10 
Change at 6 months N 22 18 40 
 Mean -2.8 -1.3 -2.1 
 Std Dev 4.35 2.93 3.80 
 Median -1.9 -1.5 -1.6 
 Min-Max -11-5 -6-4 -11-5 
 Interquartile range -6-0 -3-1 -4-0 
 Missing 4 6 10 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.00 (-4.48 
to 0.47) 
 
 
 
p = 0.109 
 
 
 
 
0.179 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.2. Secondary outcome: Change in average waist circumference (cm) at 6 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 19 17 36 
 Mean 121.7 122.4 122.0 
 Std Dev 14.11 12.33 13.12 
 Median 120.5 121.7 121.4 
 Min-Max 95-143 103-149 95-149 
 Interquartile range 111-136 109-130 111-134 
 Missing 2 2 4 
 6 months N 19 17 36 
 Mean 118.6 120.5 119.5 
 Std Dev 14.59 10.62 12.73 
 Median 117.9 121.3 119.2 
 Min-Max 91-142 103-140 91-142 
 Interquartile range 109-132 110-125 109-130 
 Missing 2 2 4 
Change at 6 months N 19 17 36 
 Mean -3.1 -1.9 -2.5 
 Std Dev 4.58 3.73 4.19 
 Median -2.5 -1.6 -1.7 
 Min-Max -12-5 -12-4 -12-5 
 Interquartile range -7-0 -4-0 -5-0 
 Missing 2 2 4 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.06 (-4.93 
to 0.81) 
 
 
 
p = 0.152 
 
 
 
 
0.194 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.2.1. Sensitivity analysis - secondary outcome: Change in average waist circumference (cm) at 6 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 19 16 35 
 Mean 121.7 120.7 121.3 
 Std Dev 14.11 10.59 12.46 
 Median 120.5 121.4 121.1 
 Min-Max 95-143 103-139 95-143 
 Interquartile range 111-136 109-129 111-132 
 Missing 2 3 5 
 6 months N 19 16 35 
 Mean 118.6 119.5 119.0 
 Std Dev 14.59 10.04 12.54 
 Median 117.9 120.6 118.6 
 Min-Max 91-142 103-140 91-142 
 Interquartile range 109-132 110-125 109-129 
 Missing 2 3 5 
Change at 6 months N 19 16 35 
 Mean -3.1 -1.3 -2.3 
 Std Dev 4.58 2.79 3.93 
 Median -2.5 -1.5 -1.7 
 Min-Max -12-5 -6-4 -12-5 
 Interquartile range -7-0 -3-0 -5-0 
 Missing 2 3 5 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.64 (-5.38 
to 0.10) 
 
 
 
p = 0.059 
 
 
 
 
0.224 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.3. Secondary outcome: Change in average waist circumference (cm) at 12 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 21 43 
 Mean 121.2 123.4 122.3 
 Std Dev 14.49 15.96 15.08 
 Median 120.0 121.6 120.5 
 Min-Max 95-143 103-171 95-171 
 Interquartile range 110-136 109-130 110-134 
 Missing 4 3 7 
 12 months N 22 21 43 
 Mean 117.9 121.4 119.6 
 Std Dev 15.05 14.17 14.56 
 Median 117.4 118.9 118.3 
 Min-Max 93-145 106-156 93-156 
 Interquartile range 105-129 110-126 109-128 
 Missing 4 3 7 
Change at 12 months N 22 21 43 
 Mean -3.4 -2.0 -2.7 
 Std Dev 5.65 5.59 5.60 
 Median -3.3 -1.2 -2.5 
 Min-Max -15-6 -15-9 -15-9 
 Interquartile range -8-1 -5-1 -6-1 
 Missing 4 3 7 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.77 (-5.20 
to 1.67) 
 
 
p = 0.304 
 
 
 
0.267 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.3.1 Sensitivity analysis - secondary outcome: Change in average waist circumference (cm) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 20 42 
 Mean 121.2 121.0 121.1 
 Std Dev 14.49 12.06 13.22 
 Median 120.0 120.9 120.3 
 Min-Max 95-143 103-149 95-149 
 Interquartile range 110-136 109-129 110-133 
 Missing 4 4 8 
 12 months N 22 20 42 
 Mean 117.9 119.7 118.8 
 Std Dev 15.05 12.09 13.59 
 Median 117.4 118.6 118.0 
 Min-Max 93-145 106-150 93-150 
 Interquartile range 105-129 110-125 108-127 
 Missing 4 4 8 
Change at 12 months N 22 20 42 
 Mean -3.4 -1.3 -2.4 
 Std Dev 5.65 4.89 5.34 
 Median -3.3 -0.9 -2.2 
 Min-Max -15-6 -11-9 -15-9 
 Interquartile range -8-1 -4-2 -6-1 
 Missing 4 4 8 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.08 (-5.48 
to 1.32) 
 
 
 
p = 0.223 
 
 
 
 
0.163 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.4.4. Secondary outcome: Change in average waist circumference (cm) at 12 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 19 16 35 
 Mean 121.7 122.5 122.1 
 Std Dev 14.11 12.73 13.31 
 Median 120.5 123.0 121.7 
 Min-Max 95-143 103-149 95-149 
 Interquartile range 111-136 109-131 111-134 
 Missing 2 3 5 
 12 months N 19 16 35 
 Mean 118.1 120.9 119.4 
 Std Dev 14.06 13.18 13.54 
 Median 117.7 120.0 118.4 
 Min-Max 93-142 106-150 93-150 
 Interquartile range 109-128 108-127 109-128 
 Missing 2 3 5 
Change at 12 months N 19 16 35 
 Mean -3.6 -1.5 -2.7 
 Std Dev 5.87 5.09 5.55 
 Median -2.7 -0.9 -2.0 
 Min-Max -15-6 -11-9 -15-9 
 Interquartile range -8-1 -4-2 -8-1 
 Missing 2 3 5 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.49 (-6.48 
to 1.49) 
 
 
 
p = 0.211 
 
 
 
 
0.263 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.1. Secondary outcome: Change in average percentage body fat (%) at 6 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 18 40 
 Mean 49.5 51.8 50.5 
 Std Dev 9.52 8.78 9.15 
 Median 49.7 49.4 49.7 
 Min-Max 33-68 41-79 33-79 
 Interquartile range 44-56 46-55 45-55 
 Missing 4 6 10 
 6 months N 22 18 40 
 Mean 47.9 50.5 49.1 
 Std Dev 9.22 8.87 9.04 
 Median 48.9 49.4 48.9 
 Min-Max 28-66 40-78 28-78 
 Interquartile range 44-55 44-54 44-55 
 Missing 4 6 10 
Change at 6 months N 22 18 40 
 Mean -1.5 -1.3 -1.4 
 Std Dev 2.92 2.82 2.84 
 Median -1.6 -0.9 -1.2 
 Min-Max -11-4 -10-3 -11-4 
 Interquartile range -3-0 -3-0 -3-0 
 Missing 4 6 10 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.77 (-2.72 
to 1.19) 
 
 
 
p = 0.430 
 
 
 
 
0.187 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.1.1. Sensitivity analysis -secondary outcome: Change in average percentage body fat (%) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 17 39 
 Mean 49.5 50.2 49.8 
 Std Dev 9.52 5.84 8.03 
 Median 49.7 47.4 49.5 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 44-56 46-55 45-55 
 Missing 4 7 11 
 6 months N 22 17 39 
 Mean 47.9 48.9 48.3 
 Std Dev 9.22 5.82 7.84 
 Median 48.9 48.4 48.7 
 Min-Max 28-66 40-59 28-66 
 Interquartile range 44-55 44-53 44-54 
 Missing 4 7 11 
Change at 6 months N 22 17 39 
 Mean -1.5 -1.3 -1.4 
 Std Dev 2.92 2.91 2.88 
 Median -1.6 -1.1 -1.3 
 Min-Max -11-4 -10-3 -11-4 
 Interquartile range -3-0 -3-0 -3-0 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.64 (-2.61 
to 1.33) 
 
 
 
p = 0.510 
 
 
 
 
0.140 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.1.2 Sensitivity analysis - secondary outcome: Change in average percentage body fat (%) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 21 16 37 
 Mean 48.7 49.5 49.0 
 Std Dev 9.10 5.26 7.60 
 Median 49.5 47.3 48.4 
 Min-Max 33-68 41-59 33-68 
 Interquartile range 42-55 45-55 45-55 
 Missing 5 8 13 
 6 months N 21 16 37 
 Mean 47.6 48.7 48.1 
 Std Dev 9.35 5.97 7.98 
 Median 48.7 47.8 48.4 
 Min-Max 28-66 40-59 28-66 
 Interquartile range 43-55 44-54 44-54 
 Missing 5 8 13 
Change at 6 months N 21 16 37 
 Mean -1.1 -0.8 -1.0 
 Std Dev 2.10 2.02 2.04 
 Median -1.5 -0.8 -1.1 
 Min-Max -5-4 -4-3 -5-4 
 Interquartile range -2-2 -3-0 -2-0 
 Missing 5 8 13 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.61 (-2.08 
to 0.85) 
 
 
 
p = 0.399 
 
 
 
 
0.112 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.2. Secondary outcome: Change in average percentage body fat (%) at 6 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 19 15 34 
 Mean 49.3 51.0 50.1 
 Std Dev 10.02 5.79 8.35 
 Median 49.9 51.3 50.1 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 40-55 47-55 46-55 
 Missing 2 4 6 
 6 months N 19 15 34 
 Mean 47.6 49.5 48.4 
 Std Dev 9.63 5.76 8.10 
 Median 49.1 50.4 49.5 
 Min-Max 28-66 40-59 28-66 
 Interquartile range 43-55 45-54 44-54 
 Missing 2 4 6 
Change at 6 months N 19 15 34 
 Mean -1.7 -1.5 -1.6 
 Std Dev 3.11 2.76 2.92 
 Median -2.0 -1.1 -1.4 
 Min-Max -11-4 -10-2 -11-4 
 Interquartile range -3-0 -3-0 -3-0 
 Missing 2 4 6 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.71 (-2.91 
to 1.49) 
 
 
 
p = 0.512 
 
 
 
 
0.177 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.2.1 Sensitivity analysis - secondary outcome: Change in average percentage body fat (%) at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 18 14 32 
 Mean 48.5 50.2 49.2 
 Std Dev 9.57 5.22 7.90 
 Median 49.7 49.4 49.7 
 Min-Max 33-68 41-59 33-68 
 Interquartile range 39-55 47-55 46-55 
 Missing 3 5 8 
 6 months N 18 14 32 
 Mean 47.3 49.3 48.2 
 Std Dev 9.79 5.94 8.27 
 Median 48.9 48.8 48.9 
 Min-Max 28-66 40-59 28-66 
 Interquartile range 41-55 44-54 44-55 
 Missing 3 5 8 
Change at 6 months N 18 14 32 
 Mean -1.2 -0.9 -1.1 
 Std Dev 2.24 1.65 1.98 
 Median -1.8 -0.8 -1.2 
 Min-Max -5-4 -4-2 -5-4 
 Interquartile range -3-0 -2-0 -2-0 
 Missing 3 5 8 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.60 (-2.16 
to 0.95) 
 
 
 
p = 0.432 
 
 
 
 
0.113 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.3. Secondary outcome: Change in average percentage body fat (%) at 12 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 18 40 
 Mean 49.5 51.8 50.5 
 Std Dev 9.52 8.78 9.15 
 Median 49.7 49.4 49.7 
 Min-Max 33-68 41-79 33-79 
 Interquartile range 44-56 46-55 45-55 
 Missing 4 6 10 
 12 months N 22 18 40 
 Mean 47.6 50.9 49.1 
 Std Dev 9.47 8.38 9.04 
 Median 48.2 50.2 48.6 
 Min-Max 27-65 39-70 27-70 
 Interquartile range 42-56 44-57 43-56 
 Missing 4 6 10 
Change at 12 months N 22 18 40 
 Mean -1.9 -1.0 -1.5 
 Std Dev 3.98 4.04 3.98 
 Median -2.2 -0.6 -1.3 
 Min-Max -14-4 -9-6 -14-6 
 Interquartile range -4-1 -4-2 -3-1 
 Missing 4 6 10 
Statistical Analysis     
Mixed effects model 
(ITT) 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.58 (-4.21 
to 1.05) 
 
 
 
p = 0.231 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.3.1. Sensitivity analysis - secondary outcome: Change in average percentage body fat (%) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 22 17 39 
 Mean 49.5 50.4 49.9 
 Std Dev 9.52 5.79 8.02 
 Median 49.7 49.6 49.6 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 44-56 46-55 45-55 
 Missing 4 7 11 
 12 months N 22 17 39 
 Mean 47.6 49.8 48.5 
 Std Dev 9.47 7.14 8.50 
 Median 48.2 49.7 48.2 
 Min-Max 27-65 39-62 27-65 
 Interquartile range 42-56 44-56 43-55 
 Missing 4 7 11 
Change at 12 months N 22 17 39 
 Mean -1.9 -0.6 -1.3 
 Std Dev 3.98 3.64 3.84 
 Median -2.2 -0.5 -0.7 
 Min-Max -14-4 -7-6 -14-6 
 Interquartile range -4-1 -3-2 -3-1 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Sensitivity-analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.76 (-4.39 
to 0.87) 
 
 
 
p = 0.182 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
 
 
 
 
 
 
 
 
 
 
 
 
319 
 
 
Table 3.5.3.2. Sensitivity analysis - secondary outcome: Change in average percentage body fat (%) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 21 17 38 
 Mean 48.7 50.4 49.5 
 Std Dev 9.10 5.79 7.74 
 Median 49.5 49.6 49.6 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 42-55 46-55 45-55 
 Missing 5 7 12 
 12 months N 21 17 38 
 Mean 47.4 49.8 48.5 
 Std Dev 9.68 7.14 8.61 
 Median 48.2 49.7 48.2 
 Min-Max 27-65 39-62 27-65 
 Interquartile range 42-56 44-56 43-55 
 Missing 5 7 12 
Change at 12 months N 21 17 38 
 Mean -1.3 -0.6 -1.0 
 Std Dev 2.89 3.64 3.22 
 Median -2.0 -0.5 -0.7 
 Min-Max -5-4 -7-6 -7-6 
 Interquartile range -3-1 -3-2 -3-1 
 Missing 5 7 12 
Statistical Analysis     
Mixed effects model 
(Sensitivity-analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.00 (-3.28 
to 1.28) 
 
 
 
p = 0.378 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.4. Secondary outcome: Change in average percentage body fat (%) at 12 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 19 14 33 
 Mean 49.3 51.3 50.2 
 Std Dev 10.02 5.90 8.46 
 Median 49.9 51.9 50.4 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 40-55 47-55 46-55 
 Missing 2 5 7 
 12 months N 19 14 33 
 Mean 47.4 50.5 48.7 
 Std Dev 9.72 7.50 8.85 
 Median 48.2 50.2 49.0 
 Min-Max 27-65 39-62 27-65 
 Interquartile range 43-55 44-57 43-56 
 Missing 2 5 7 
Change at 12 months N 19 14 33 
 Mean -3.9 -0.8 -1.5 
 Std Dev 4.19 3.52 3.90 
 Median -2.0 -0.2 -0.7 
 Min-Max -14-4 -7-6 -14-6 
 Interquartile range -4-0 -4-2 -4-1 
 Missing 2 5 7 
Statistical Analysis     
Mixed effects model 
(Per-protocol) 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.68 (-4.72 
to 1.36) 
 
 
 
p = 0.268 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.5.4.1. Sensitivity analysis - secondary outcome: Change in average percentage body fat (%) at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 18 14 32 
 Mean 48.5 51.3 49.7 
 Std Dev 9.57 5.90 8.17 
 Median 49.7 51.9 50.1 
 Min-Max 33-68 41-61 33-68 
 Interquartile range 39-55 47-55 46-55 
 Missing 3 5 8 
 12 months N 18 14 32 
 Mean 47.2 50.5 48.7 
 Std Dev 9.97 7.50 8.99 
 Median 48.2 50.2 48.6 
 Min-Max 27-65 39-62 27-65 
 Interquartile range 41-56 44-57 43-56 
 Missing 3 5 8 
Change at 12 months N 18 14 32 
 Mean -1.2 -0.8 -1.0 
 Std Dev 2.97 3.52 3.17 
 Median -1.3 -0.2 -0.6 
 Min-Max -5-4 -7-6 -7-6 
 Interquartile range -4-1 -4-2 -3-1 
 Missing 3 5 8 
Statistical Analysis     
Mixed effects model 
(Sensitivity analysis)* 
 
 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.71 (-3.29 
to 1.86) 
 
 
 
p = 0.575 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.6. Secondary outcome: Change in percentage weight change at 6 and 12 months from baseline. Odds 
ratio (95% confidence interval) and p-value (ITT).  
Percentage 
weight change 
TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Odds ratio  
(95% CI)* 
P-value 
Weight loss phase (6 months)     
>5% 5 (20.8) 2 (9.1) 7 (15.2) 2.70 (0.44 to 16.59) 0.275 
<5% 19 (79.2) 20 (90.9) 39 (84.8) Referent  
Weight maintenance phase (6 months – 12 months)    
Weight loss >3% 7 (29.2) 4 (18.2) 11 (23.9) 1.57 (0.18 to 13.90) 0.679 
Weight 
maintenance  
14 (58.3) 15 (68.2) 29 (63.0) 0.92 (0.14 to 5.91) 0.924 
Weight gain >3% 3 (12.5) 3 (13.6) 6 (13.0) Referent  
Post intervention (12 months)     
>5% 12 (50.0) 5 (20.8) 17 (35.4) 3.76 (0.92 to 15.30) 0.064 
<5% 12 (50.0) 19 (79.2) 31 (64.6) Referent  
Note: At 6 months from baseline TAKE n = 24, WWTOO n = 22, TOTAL n = 46 
          At 12 months from baseline TAKE 5 n = 24, WWTOO n = 24, TOTAL n = 48 
 
*Results are presented as adjusted Odds Ratio (OR) for effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and 
presence of Down syndrome). CI = Confidence Interval. 
 
Table 3.6.1. Secondary outcome: Change in percentage weight change at 6 and 12 months from baseline. 
Odds ratio (95% confidence interval) and p-value (Completers).  
Percentage 
weight change 
TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Odds ratio 
(95% CI)* 
P-value 
Weight loss phase (6 months)     
>5% 5 (23.8%) 2 (10.5%) 7 (17.5%) 2.84 (0.39 to 
20.56) 
0.291 
<5% 16 (76.2%) 17 (89.5%) 33 (82.5%) Referent  
Weight maintenance phase (6 
months – 12 months) 
    
Weight loss >3% 3 (14.3%) 3 (15.8%) 6 (15.0%) 1.37 (0.13 to 
14.64) 
0.788 
Weight 
maintenance  
13 (61.9%) 13 (68.4%) 26 (65.0%) 0.97 (0.14 to 
6.69) 
0.972 
Weight gain >3% 5 (23.8%) 3 (15.8%) 8 (20.0%) Referent  
Post intervention (12 months)     
>5% 10 (47.6%) 3 (15.8%) 13 (32.5%) 4.93 (0.95 to 
25.58) 
0.057 
<5% 11 (52.4%) 16 (84.2%) 27 (67.5%) Referent  
*Results are presented as adjusted Odds Ratio (OR) for effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and 
presence of Down syndrome). CI = Confidence Interval. 
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Table 3.7. Secondary outcome: Change in average step count at 6 months from baseline, by intervention group 
and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 5002 5311 5135 
 Std Dev 2319.90 2308.58 2286.10 
 Median 4673 5584 4882 
 Min-Max 1422-10062 1850-9207 1422-10062 
 Interquartile range 3752-6783 3055-6892 3751-6892 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 4304 4817 4524 
 Std Dev 2311.59 1894.16 2128.30 
 Median 4245 4757 4421 
 Min-Max 1249-8293 2001-7361 1249-8293 
 Interquartile range 2022-5831 2914-7126 2452-5869 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -697 -495 -611 
 Std Dev 1637.73 1446.41 1540 
 Median -847 -769 -769 
 Min-Max -3024-4083 -3574-2164 -3574-4083 
 Interquartile range -1767-92 -1321-704 -1761-208 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT) 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-95.48 (-
1089.66 to 
898.69) 
 
 
p = 0.846 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.7.1. Secondary outcome: Change in average step count at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 4940 4805 4884 
 Std Dev 2173.11 2215.02 2151.88 
 Median 4652 5090 4695 
 Min-Max 1599-10062 1850-8130 1599-10062 
 Interquartile range 3753-6348 2318-6782 3534-6671 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 4355 4587 4451 
 Std Dev 2387 1991.10 2197 
 Median 4105 4589 4384 
 Min-Max 1249-8293 2001-7361 1249-8293 
 Interquartile range 2053-6233 2568-6757 2284-6233 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -585 -218 -433 
 Std Dev 1682.93 1475.74 1583.65 
 Median -709 -483 -497 
 Min-Max -3024-4083 -3574-2164 -3024-4083 
 Interquartile range -1765-157 -1055-789 -1447-410 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol) 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-59.10 (-
1287.03 to 
1168.83)  
 
 
 
p = 0.922 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.8. Secondary outcome: Change in average step count at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 4710 5211 4935 
 Std Dev 2354.11 2469.19 2376.16 
 Median 4342 5584 4705 
 Min-Max 1422-10062 1850-9207 1422-10062 
 Interquartile range 3426-5969 2564-7183 3186-6583 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 4157 4505 4313 
 Std Dev 2450.50 2295.81 2346.65 
 Median 3451 3741 3595 
 Min-Max 1076-8951 1857-9314 1076--9314 
 Interquartile range 2276-5643 2631-6905 2344-6372 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean -553 -707 -622 
 Std Dev 1673.48 2087.43 1836.78 
 Median -395 -526 -438 
 Min-Max -3578-2774 -5090-3730 -5090-3730 
 Interquartile range -1815-258 -2136-78 -1957-176 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
126.40 (-
1371.07 to 
1623.87) 
 
 
p = 0.863 
 
 
 
0.997 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.8.1. Secondary outcome: Change in average step count at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 4563 4574 4567 
 Std Dev 2147.57 2363.71 2191.19 
 Median 4033 4322 4033 
 Min-Max 1599-10062 1850-8130 1599-10062 
 Interquartile range 3534-5383 2064-7037 3055-5675 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 4121 4325 4210 
 Std Dev 2617.42 2509.44 2514.70 
 Median 3441 3531 3441 
 Min-Max 1076-8951 1857-9314 1076-9314 
 Interquartile range 2340-6104 2212-6898 2221-6882 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -441 -249 -358 
 Std Dev 1609.11 2188.54 1838.82 
 Median -438 -142 -351 
 Min-Max -2675-2774 -5090-3730 -5090-3730 
 Interquartile range -1709-240 -892-452 -1288-203 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
76.93 (-
1837.01 to 
1990.88) 
 
 
 
p = 0.933 
 
 
 
 
1.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.9. Secondary outcome: Change in average number of minutes spent in light physical activity per day 
at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 150.7 172.7 160.2 
 Std Dev 49.27 84.77 66.61 
 Median 150.7 149.9 149.9 
 Min-Max 49-268 80-382 49-3812 
 Interquartile range 127-181 104-233 122-183 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 128.5 165.6 144.4 
 Std Dev 41.55 72.24 58.83 
 Median 124.3 141.6 131.2 
 Min-Max 46-224 78-318 46-318 
 Interquartile range 105-153 111-242 111-160 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -22.3 -7.1 -15.8 
 Std Dev 29.16 36.22 32.76 
 Median -16.3 -7.4 -9.7 
 Min-Max -91-13 -81-34 -91-34 
 Interquartile range -39 to -3 -32-30 -33-8 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-18.83 (-
39.91 to 
2.25) 
 
 
p = 0.078 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.9.1. Secondary outcome: Change in average number of minutes spent in light physical activity per day 
at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 152.6 178.7 163.4 
 Std Dev 53.03 94.51 72.71 
 Median 156.7 150.0 150.1 
 Min-Max 49-268 80-382 49-382 
 Interquartile range 129-182 98-152 111-1187 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 128.0 170.9 145.7 
 Std Dev 44.61 78.37 63.35 
 Median 125.3 136.4 131.2 
 Min-Max 46-224 78-318 46-318 
 Interquartile range 96-151 112-256 108-167 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -24.7 -7.8 -17.7 
 Std Dev 30.83 37.57 34.19 
 Median -19.4 -7.8 -13.3 
 Min-Max -91-13 -81-34 -91-34 
 Interquartile range -46 to -5 -29-30 -38-9 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-21.55 (-
46.13 to 
3.04) 
 
 
 
p = 0.083 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.9.2. Secondary outcome: Change in percentage time spent in light physical activity per day at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 22.4 23.5 22.9 
 Std Dev 6.10 8.85 7.30 
 Median 21.3 22.0 21.3 
 Min-Max 10-38 12-39 10-39 
 Interquartile range 20-26 16-29 17-27 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 20.7 22.1 21.3 
 Std Dev 5.50 6.97 6.12 
 Median 20.6 19.9 20.4 
 Min-Max 10-34 11-38 10-38 
 Interquartile range 16-24 18-25 18-25 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -1.7 -1.4 -1.6 
 Std Dev 3.80 5.63 4.60 
 Median -1.7 -0.1 -0.9 
 Min-Max -12-5 -20-3 -20-5 
 Interquartile range -4-0 -2-2 -4-1 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.57 (-3.50 
to 2.35) 
 
 
 
P = 0.692 
 
 
 
 
0.164 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.9.3 Secondary outcome: Change in percentage time spent in light physical activity per day at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 22.4 23.3 22.8 
 Std Dev 6.36 9.78 7.80 
 Median 21.3 20.2 21.3 
 Min-Max 10-38 12-39 10-39 
 Interquartile range 20-26 15-33 17-27 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 20.5 21.6 21.0 
 Std Dev 5.51 7.53 6.32 
 Median 20.5 19.3 19.9 
 Min-Max 10-34 11-38 10-38 
 Interquartile range 16-24 18-25 17-24 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -1.9 -1.7 -1.8 
 Std Dev 3.89 6.28 4.92 
 Median -1.8 -0.4 -1.0 
 Min-Max -12-5 -20-3 -20-5 
 Interquartile range -4-0 -3-2 -4-1 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.43 (-3.89 
to 3.04) 
 
 
 
p = 0.801 
 
 
 
 
0.133 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
331 
 
 
Table 3.10. Secondary outcome: Change in average number of minutes spent in light physical activity per day 
at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 151.8 169.9 159.9 
 Std Dev 52.05 89.62 70.55 
 Median 157.4 148.2 150.1 
 Min-Max 49-268 81-382 49-382 
 Interquartile range 123-181 100-222 111-182 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 137.0 145.0 140.6 
 Std Dev 54.94 71.90 62.04 
 Median 131.4 133.5 132.3 
 Min-Max 61-261 44.8-291.1 44.8-291.1 
 Interquartile range 91-162 87-197 87-164 
 Missing 10 11 21 
 
 
Change at 12 months 
N 16 13 29 
Mean -14.7 -24.8 -19.3 
 Std Dev 42.17 71.66 56.39 
 Median -25.4 -9.4 -16.6 
 Min-Max -75-69 -228-57 -228-69 
 Interquartile range -39-19 -26-9 -33-11 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
7.78 (-33.15 
to 48.71) 
 
 
p = 0.697 
 
 
 
0.999 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.10.1. Secondary outcome: Change in average number of minutes spent in light physical activity per 
day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 154.5 176.2 163.9 
 Std Dev 57.30 102.4 78.77 
 Median 158.1 134.5 156.7 
 Min-Max 49-268 80-382 49-382 
 Interquartile range 115-182 95-267 103-186 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 137.1 155.3 145.0 
 Std Dev 60.57 74.42 65.97 
 Median 130.6 143.8 133.5 
 Min-Max 61-261 72-291 61-291 
 Interquartile range 86-160 87-229 87-65 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -17.4 -21.0 -19.0 
 Std Dev 43.93 77.56 59.30 
 Median -30.0 -8.9 -9.4 
 Min-Max -75-69 -228-57 -228-69 
 Interquartile range -55-17 -23-17 -36-12 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.28 (-51.14 
to 48.58) 
 
 
 
p = 0.957 
 
 
 
 
0.999 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.10.2. Secondary outcome: Change in percentage time spent in light physical activity per day at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 22.4 22.3 22.3 
 Std Dev 6.30 8.37 7.16 
 Median 21.0 20.9 20.9 
 Min-Max 10-38 12-39 10-39 
 Interquartile range 19-26 15-29 17-27 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 22.2 22.1 22.1 
 Std Dev 8.29 9.35 8.62 
 Median 21.8 23.8 22.2 
 Min-Max 123-45 8-37 8-45 
 Interquartile range 15-24 13-31 15-27 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean -0.2 -0.2 -0.2 
 Std Dev 6.03 5.48 5.69 
 Median 2.1 0.7 1.8 
 Min-Max -12-7 -13-9 -13-9 
 Interquartile range -5-5 -3-3 -4-4 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
1.71 (-2.75 to 
6.17) 
 
 
 
P = 0.434 
 
 
 
 
0.993 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.10.3 Secondary outcome: Change in percentage time spent in light physical activity per day at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=29) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 22.4 21.8 22.1 
 Std Dev 6.69 9.34 7.76 
 Median 21.3 17.2 20.6 
 Min-Max 10-38 12-39 10-39 
 Interquartile range 19-26 15-30 16-26 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 21.8 22.3 22.0 
 Std Dev 8.55 9.06 8.57 
 Median 21.3 22.5 21.3 
 Min-Max 13-45 12-37 12-45 
 Interquartile range 15-24 14-30 15-26 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -0.6 0.5 -0.1 
 Std Dev 6.28 4.47 5.48 
 Median 2.1 0.0 0.7 
 Min-Max -12-7 -6-9 -12-9 
 Interquartile range -5-3 -2-3 -4-3 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.55 (-4.32 to 
5.42) 
 
 
 
p = 0.814 
 
 
 
 
0.994 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.11. Secondary outcome: Change in average number of minutes spent in moderate to vigorous physical 
activity per day at 6 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 28.4 33.7 30.6 
 Std Dev 17.97 19.77 18.67 
 Median 21.5 33.2 23.5 
 Min-Max 2-64 11-83 2-83 
 Interquartile range 17-43 20-39 17-42 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 24.4 26.6 25.4 
 Std Dev 16.37 13.75 15.13 
 Median 21.0 26.2 23.7 
 Min-Max 2-62 4-60 2-62 
 Interquartile range 11-36 19-31 14-31 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -3.9 -7.1 -5.3 
 Std Dev 9.50 10.45 9.89 
 Median -1.9 -7.7 -5.7 
 Min-Max -24-19 -23-8 -24-19 
 Interquartile range -10-2 -15-3 -13-2 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
1.74 (-4.62 to 
8.12) 
 
 
p = 0.579 
 
 
 
0.999 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.11.1. Secondary outcome: Change in average number of minutes spent in moderate to vigorous 
physical activity per day at 6 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 28.0 27.2 27.7 
 Std Dev 17.46 12.42 15.33 
 Median 19.4 22.3 22.2 
 Min-Max 4-64 11-52 4-64 
 Interquartile range 17-42 18-38 17-39 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 25.1 22.1 23.8 
 Std Dev 16.77 8.73 13.89 
 Median 21.0 25.2 21.2 
 Min-Max 6-62 4-32 4-62 
 Interquartile range 12-38 15-28 13-30 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -3.0 -5.1 -3.9 
 Std Dev 9.4 10.30 9.67 
 Median -0.6 -6.8 -3.3 
 Min-Max -24-19 -21-8 -24-19 
 Interquartile range -9-2 -13-7 -11-2 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
2.67 (-5.17 to 
10.51) 
 
 
 
p = 0.487 
 
 
 
 
1.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.11.2. Secondary outcome: Change in percentage time spent in moderate to vigorous physical activity 
per day at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 4.4 4.9 4.6 
 Std Dev 2.80 3.58 3.11 
 Median 3.6 3.7 3.7 
 Min-Max 0-9 2-16 0-16 
 Interquartile range 2-6 3-6 3-6 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 4.1 3.9 4.0 
 Std Dev 2.88 2.92 2.86 
 Median 3.6 3.3 3.4 
 Min-Max 0-12 1-11 0-12 
 Interquartile range 2-5 2-4 2-5 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -0.3 -1.0 -0.6 
 Std Dev 1.91 1.70 1.83 
 Median -0.2 -0.8 -0.7 
 Min-Max -4-5 -4-1 -4-5 
 Interquartile range -2-1 -2-1 -2-1 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.50 (-0.79 to 
1.78) 
 
 
 
p = 0.434 
 
 
 
 
0.895 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.11.3. Secondary outcome: Change in percentage time spent in moderate to vigorous physical activity 
per day at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 4.3 3.6 4.0 
 Std Dev 2.63 1.49 2.23 
 Median 3.2 3.1 3.2 
 Min-Max 0-9 2-6 0-9 
 Interquartile range 2-6 2-5 2-6 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 4.3 2.9 3.7 
 Std Dev 2.97 1.21 2.47 
 Median 3.5 3.0 3.4 
 Min-Max 1-12 1-5 1-12 
 Interquartile range 2-6 2-4 2-5 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -0.1 -0.7 -0.3 
 Std Dev 1.89 1.54 1.76 
 Median -0.2 -0.8 -0.6 
 Min-Max -4-5 -4-1 -4-5 
 Interquartile range -1-1 -2-1 -1-1 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.80 (-0.75 to 
2.35) 
 
 
 
p = 0.296 
 
 
 
 
0.904 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.12. Secondary outcome: Change in average number of minutes spent in moderate to vigorous physical 
activity per day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 25.2 33.5 28.9 
 Std Dev 18.05 21.34 19.68 
 Median 18.5 22.4 20.2 
 Min-Max 2-64 11-83 2-83 
 Interquartile range 16-42 19-46 17-41 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 24.3 26.7 25.4 
 Std Dev 22.86 13.77 19.04 
 Median 13.4 22.9 18.0 
 Min-Max 4-78 8-52 4-78 
 Interquartile range 8-41 15-39 11-40 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean -0.9 -6.8 -3.6 
 Std Dev 12.85 15.75 14.28 
 Median -2.6 -5.8 -4.5 
 Min-Max -18-35 -31-20 -31-35 
 Interquartile range -9-4 -17-4 -11-3 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
1.74 (-9.16 to 
12.64) 
 
 
p = 0.744 
 
 
 
0.871 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.12.1. Secondary outcome: Change in average number of minutes spent in moderate to vigorous 
physical activity per day at 12 months from baseline, by intervention group and overall.  Adjusted mean 
difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 24.0 25.7 24.8 
 Std Dev 17.19 13.17 15.26 
 Median 17.8 21.2 19.4 
 Min-Max 4-64 11-52 4-64 
 Interquartile range 16-33 17-39 16-39 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 23.5 24.1 23.7 
 Std Dev 24.03 12.98 19.60 
 Median 12.4 20.4 15.0 
 Min-Max 5-78 8-44 5-78 
 Interquartile range 9-34 14-37 11-36 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -0.6 -1.6 -1.0 
 Std Dev 13.96 12.96 13.23 
 Median -3.0 -5.6 -3.4 
 Min-Max -18-35 -24-21 -24-35 
 Interquartile range -9-4 -9-9 -8-4 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-2.42 (-15.30 
to 10.46) 
 
 
 
p = 0.695 
 
 
 
 
0.823 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.12.2. Secondary outcome: Change in percentage time spent in moderate to vigorous physical activity 
per day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 3.9 4.8 4.3 
 Std Dev 2.87 3.85 3.31 
 Median 3.1 3.4 3.2 
 Min-Max 0-9 2-15 0-16 
 Interquartile range 2-6 2-5 2-6 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 4.1 4.2 4.2 
 Std Dev 3.87 2.46 3.26 
 Median 2.2 3.5 2.7 
 Min-Max 1-13 2-10 1-13 
 Interquartile range 1-8 2-6 2-6 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean 0.2 -0.6 -0.2 
 Std Dev 2.10 2.03 2.06 
 Median -0.1 -0.5 -0.2 
 Min-Max -2-7 -5-2 -5-7 
 Interquartile range -1-1 -1-1 -1-0 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.26 (-1.28 to 
1.80) 
 
 
 
p = 0.726 
 
 
 
 
0.818 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.12.3. Secondary outcome: Change in percentage time spent in moderate to vigorous physical activity 
per day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 3.7 3.2 3.5 
 Std Dev 2.63 1.31 2.13 
 Median 3.0 2.8 2.9 
 Min-Max 0-9 2-6 0-9 
 Interquartile range 2-5 2-4 2-4 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 3.8 3.4 3.7 
 Std Dev 3.89 1.75 3.09 
 Median 2.1 2.8 2.2 
 Min-Max 1-13 2-6 1-13 
 Interquartile range 1-6 2-6 2-6 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean 0.1 0.2 0.2 
 Std Dev 2.34 1.11 1.87 
 Median -0.3 -0.2 -0.2 
 Min-Max -2-7 -1-2 -2-7 
 Interquartile range -1-1 -1-1 -1-1 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.89 (-2.51 
to 0.73) 
 
 
 
p = 0.260 
 
 
 
 
0.732 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.13. Secondary outcome: Change in average number of minutes spent in physical activity of any 
intensity per day at 6 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 179.1 206.4 190.8 
 Std Dev 56.94 93.80 74.99 
 Median 177.0 185.9 180.6 
 Min-Max 68-331 94-420 68-420 
 Interquartile range 150-206 124-266 141-226 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 152.9 192.2 169.7 
 Std Dev 48.98 76.19 64.20 
 Median 146.0 167.8 159.6 
 Min-Max 68-274.0 88-346 68-346 
 Interquartile range 124-180 137-267 129-187 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -26.2 -14.2 -21.0 
 Std Dev 31.10 43.94 37.05 
 Median -23.1 -18.1 -21.9 
 Min-Max -90-30.0 -99-42 -99-42 
 Interquartile range -45 to -2 -54-29 -45-2 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-18.00 
(41.64 to 
5.64) 
 
 
 
p = 0.130 
 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
 
 
 
 
 
 
 
 
 
 
 
 
344 
 
 
Table 3.13.1 Secondary outcome: Change in average number of minutes spent in physical activity of any 
intensity per day at 6 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 180.7 205.9 191.1 
 Std Dev 60.02 105.01 80.93 
 Median 177.0 178.0 177.0 
 Min-Max 68-331 94-420 68-420 
 Interquartile range 150-211 116-289 133-227 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 153.1 193.0 169.6 
 Std Dev 52.27 84.12 68.86 
 Median 146.3 163.8 159.6 
 Min-Max 68-274 88-346 68-346 
 Interquartile range 118-178 135-286 126-184 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -27.6 -12.9 -21.5 
 Std Dev 33.16 46.31 39.05 
 Median -22.1 -11.2 -18.1 
 Min-Max -90-30 -99-42 -99-42 
 Interquartile range -49 to -3 -48-34 -49-4 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-19.57 (-
47.68 to 
8.54) 
 
 
 
p = 0.163 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.13.2 Secondary outcome: Change in percentage time spent in physical activity of any intensity per day 
at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 26.8 28.4 27.5 
 Std Dev 7.63 10.83 9.03 
 Median 26.0 28.1 26.4 
 Min-Max 15-47 15-45 15-47 
 Interquartile range 22-30 19-40 20-32 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 24.8 26.0 25.3 
 Std Dev 6.86 8.43 7.48 
 Median 23.8 24.2 23.9 
 Min-Max 15-41 13-42 13-42 
 Interquartile range 20-28 20-31 20-28 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -2.1 -2.3 -2.2 
 Std Dev 4.67 6.82 5.60 
 Median -2.7 -1.1 -1.9 
 Min-Max -12-10 -24-4 -24-10 
 Interquartile range -5-0 -4-2 -5-1 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.09 (-3.6 to 
3.50) 
 
 
 
p = 0.962 
 
 
 
 
0.449 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.13.3 Secondary outcome: Change in percentage time spent in physical activity of any intensity per day 
at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 26.8 26.9 26.8 
 Std Dev 7.61 10.99 8.97 
 Median 25.5 24.3 25.5 
 Min-Max 15-47 15-44 15-47 
 Interquartile range 22-30 17-38 20-31 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 24.8 24.5 24.7 
 Std Dev 6.93 8.21 7.34 
 Median 23.9 21.9 23.8 
 Min-Max 15-41 13-42 13-42 
 Interquartile range 20-28 20-27 20-27 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -2.0 -2.4 -2.2 
 Std Dev 4.81 7.63 6.01 
 Median -2.3 -1.5 -1.9 
 Min-Max -12-10 -24-4 -24-10 
 Interquartile range -5-0 -4-3 -5-1 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.56 (-3.78 to 
4.90) 
 
 
 
p = 0.792 
 
 
 
 
0.481 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.14. Secondary outcome: Change in average number of minutes spent in physical activity of any 
intensity per day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 177.0 203.4 188.8 
 Std Dev 58.50 99.63 79.16 
 Median 176.1 182.1 176.9 
 Min-Max 68-331 94-420 68-420 
 Interquartile range 139-206 119-269 130-218 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 161.4 171.7 166.0 
 Std Dev 62.04 81.68 70.35 
 Median 159.5 151.4 156.8 
 Min-Max 72-308 67-335 67-335 
 Interquartile range 106-188 104-243 107-208 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean -15.6 -31.7 -22.8 
 Std Dev 44.01 80.73 62.43 
 Median -29.1 -22.3 -22.45 
 Min-Max -78-86 -251-72 -251-86 
 Interquartile range -40-18 -40-3  
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
8.50 (-38.26 
to 55.26) 
 
 
 
p = 0.710 
 
 
 
 
0.994 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.14.1. Secondary outcome: Change in average number of minutes spent in physical activity of any 
intensity per day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference 
(TAKE 5-WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 178.5 201.9 188.7 
 Std Dev 62.91 114.09 87.31 
 Median 175.2 155.6 174.5 
 Min-Max 68-331 94-420 68-420 
 Interquartile range 142-211 111-309 124-226 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 160.5 179.4 168.7 
 Std Dev 69.27 85.56 75.52 
 Median 151.1 158.5 151.1 
 Min-Max 72-308 80-335 72-335 
 Interquartile range 102-206 107-267 104-222 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -18.0 -22.5 -20.0 
 Std Dev 45.48 88.25 65.72 
 Median -34.7 -14.6 -22.3 
 Min-Max -78-86 -251-72 -251-86 
 Interquartile range -49-14 -31-28 -37-17 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-3.13 (-60.96 
to 54.70) 
 
 
 
p = 0.910 
 
 
 
 
0.995 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.14.2. Secondary outcome: Change in percentage time spent in physical activity of any intensity per 
day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 26.3 27.1 26.7 
 Std Dev 7.67 10.66 8.97 
 Median 24.4 25.7 25.1 
 Min-Max 15-47 15-45 15-47 
 Interquartile range 22-30 18-36 20-32 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 26.3 26.3 26.3 
 Std Dev 10.15 11.11 10.39 
 Median 24.2 27.5 24.3 
 Min-Max 14-53 12-43 12-53 
 Interquartile range 20-31 15-36 17.5-32.3 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean 0.0 -0.8 -0.4 
 Std Dev 5.89 5.8 5.77 
 Median 1.5 -1.8 0.4 
 Min-Max -12-8 -14-11 -14-11 
 Interquartile range -4-5 -3-2 -3-3 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
1.95 (-2.70 to 
6.61) 
 
 
 
p = 0.394 
 
 
 
 
0.994 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.14.3. Secondary outcome: Change in percentage time spent in physical activity of any intensity per 
day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 26.1 25.0 25.6 
 Std Dev 7.64 10.44 8.76 
 Median 23.7 20.0 23.7 
 Min-Max 15-47 15-44 15-47 
 Interquartile range 22-29 17-34 19-30 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 25.6 25.7 25.6 
 Std Dev 10.27 10.51 10.14 
 Median 24.3 24.8 24.3 
 Min-Max 14-53 13-42 13-53 
 Interquartile range 18-31 15-34 17-32 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -0.5 0.7 0.0 
 Std Dev 6.06 4.90 5.50 
 Median 1.0 0.1 1.0 
 Min-Max -12-8 -5-11 -12-11 
 Interquartile range -5-3 -3-3 -3-3 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.16 (-5.37 
to 5.05) 
 
 
 
p = 0.949 
 
 
 
 
0.994 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.15. Secondary outcome: Change in average number of minutes spent on sedentary behaviour per day 
at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 485.5 533.7 506.1 
 Std Dev 89.69 184.02 137.93 
 Median 482.5 513.7 489.3 
 Min-Max 353.1-662.2 267.5-915.4 267.5-915.4 
 Interquartile range 404.8-571.9 412.5-705.7 411.6-588.0 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 464.2 550.9 501.4 
 Std Dev 91.84 159.73 130.81 
 Median 466.4 556.0 492.1 
 Min-Max 316.5-605.2 323.8-926.2 316.5-926.2 
 Interquartile range 388.1-555.2 432.5-639.2 393.8-592.5 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean -21.2 17.2 -4.8 
 Std Dev 85.32 82.77 85.21 
 Median -26.3 20.4 -9.4 
 Min-Max -173.9-
129.5 
-109.2-178.0 -173.9-178.0 
 Interquartile range -74.2-51.0 -37.8-66.9 -57.6-61.4 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-49.33 (-
108.78 to 
10.12) 
 
 
p = 0.100 
 
 
 
0.547 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.15.1 Secondary outcome: Change in average number of minutes spent in sedentary behaviour per day 
at 6 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 489.0 562.4 519.4 
 Std Dev 90.41 190.26 142.29 
 Median 475.7 521.9 489.3 
 Min-Max 374-662 268-915 268-915 
 Interquartile range 407-583 425-708 412-613 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 462.3 584.4 512.8 
 Std Dev 91.07 147.41 130.46 
 Median 460.0 580.4 500.0 
 Min-Max 317-605 399-926 317-926 
 Interquartile range 390-554 464-667 413-586 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean -26.6 22.0 -6.5 
 Std Dev 86.27 83.28 87.02 
 Median -27.4 15.6 -21.6 
 Min-Max -174-130 -99-178 -174-178 
 Interquartile range -88-41 -36-61 -48-52 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-71.88 (-
136.40 to -
7.37) 
 
 
 
p = 0.031 
 
 
 
 
0.525 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.15.2. Secondary outcome: Change in percentage time spent in sedentary behaviour per day at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 20 15 35 
 Mean 73.2 71.6 72.5 
 Std Dev 7.63 10.83 9.03 
 Median 74.04 71.9 73.6 
 Min-Max 53-86 55-85 53-86 
 Interquartile range 70-78 60-81 68-80 
 Missing 6 9 15 
 6 months N 20 15 35 
 Mean 75.2 74.0 74.7 
 Std Dev 6.86 8.43 7.48 
 Median 76.2 75.8 76.1 
 Min-Max 59-85 58-87 58-87 
 Interquartile range 72-80 69-80 72-80 
 Missing 6 9 15 
Change at 6 months N 20 15 35 
 Mean 2.1 2.3 2.2 
 Std Dev 4.67 6.82 5.60 
 Median 2.7 1.1 1.9 
 Min-Max -10-12 -4-24 -10-24 
 Interquartile range 0-5 -2-4 -1-5 
 Missing 6 9 15 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.09 (-3.50 to 
3.67) 
 
 
 
p = 0.962 
 
 
 
 
0.449 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.15.3. Secondary outcome: Change in percentage time spent in sedentary behaviour per day at 6 months 
from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 17 12 29 
 Mean 73.2 73.1 73.2 
 Std Dev 7.61 10.99 8.97 
 Median 74.5 75.7 74.5 
 Min-Max 53-86 56-85 53-86 
 Interquartile range 70-78 62-83 69-80 
 Missing 4 7 11 
 6 months N 17 12 29 
 Mean 75.2 75.5 75.3 
 Std Dev 6.93 8.21 7.34 
 Median 76.1 78.1 76.2 
 Min-Max 59-85 58-87 58-87 
 Interquartile range 72-80 73-80 73-80 
 Missing 4 7 11 
Change at 6 months N 17 12 29 
 Mean 2.0 2.4 2.2 
 Std Dev 4.81 7.63 6.01 
 Median 2.3 1.5 1.9 
 Min-Max -10-12 -4-24 -10-24 
 Interquartile range 0-5 -3-4 -1-5 
 Missing 4 7 11 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-0.56 (-4.90 
to 3.78) 
 
 
 
p = 0.792 
 
 
 
 
0.481 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.16. Secondary outcome: Change in average number of minutes spent on sedentary behaviours per day 
at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 
95% confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 493.4 554.7 520.9 
 Std Dev 96.96 187.65 145.24 
 Median 489.9 526.3 492.3 
 Min-Max 353.1-662.2 267.5-915.4 267.5-915.4 
 Interquartile range 404.8-585.7 422.7-707.2 412.0-612.6 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 458.7 479.0 467.8 
 Std Dev 108.40 102.93 104.60 
 Median 475.9 456.1 470.0 
 Min-Max 234.5-602.9 295.4-648.3 234.5-648.3 
 Interquartile range 390.4-558.6 420.9-547.4 403.6-551.9 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean -34.7 -75.8 -53.1 
 Std Dev 73.57 149.36 113.55 
 Median -21.6 -57.6 -28.4 
 Min-Max -192.1-70.8 -469.5-156.4 -469.5-156.4 
 Interquartile range -102.4-32.1 -129.9-7.3 -99.8-12.7 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-18.30 (-
83.70 to 
47.10) 
 
 
p = 0.568 
 
 
 
0.961 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.16.1. Secondary outcome: Change in average number of minutes spent in sedentary behaviours per 
day at 12 months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-
WWTOO), 95% confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 499.8 595.5 541.4 
 Std Dev 98.95 189.77 149.75 
 Median 489.3 596.20 513.7 
 Min-Max 374-662 268-915 268-915 
 Interquartile range 407-593 463-721 412-662 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 462.3 508.3 482.3 
 Std Dev 95.58 87.82 93.18 
 Median 470.0 489.7 470.0 
 Min-Max 269-603 418-648 269-648 
 Interquartile range 392-558 428-572 418-556 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean -37.5 -87.2 -59.1 
 Std Dev 72.28 169.69 123.55 
 Median -23.8 -59.0 -28.4 
 Min-Max -192-46 -470-156 -470-156 
 Interquartile range -100-24 -190-17 -105-17 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-36.98 (-
110.95 to 
37.00) 
 
 
 
p = 0.305 
 
 
 
 
0.946 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.16.2. Secondary outcome: Change in percentage time spent in sedentary behaviours per day at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 16 13 29 
 Mean 73.7 72.9 73.3 
 Std Dev 7.67 10.66 8.97 
 Median 75.6 74.3 74.9 
 Min-Max 53-86 55-85 53-86 
 Interquartile range 70-78 64-82 69-80 
 Missing 10 11 21 
 12 months N 16 13 29 
 Mean 73.7 73.7 73.7 
 Std Dev 10.15 11.11 10.39 
 Median 75.8 72.5 75.7 
 Min-Max 47-86 57-88 47-88 
 Interquartile range 69-80 64-85 68-83 
 Missing 10 11 21 
Change at 12 months N 16 13 29 
 Mean 0.0 0.8 0.4 
 Std Dev 5.89 5.83 5.77 
 Median -1.5 1.8 -0.4 
 Min-Max -8-12 -11-14 -11-14 
 Interquartile range -4-4 -2-3 -3-3 
 Missing 10 11 21 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
-1.95 (-6.61 
to 2.70) 
 
 
 
p = 0.394 
 
 
 
 
0.994 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.16.3. Secondary outcome: Change in percentage time spent in sedentary behaviours per day at 12 
months from baseline, by intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% 
confidence interval, p-value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 13 10 23 
 Mean 73.9 75.0 74.4 
 Std Dev 7.64 10.44 8.76 
 Median 76.3 80.0 76.4 
 Min-Max 53-86 56-85 53-86 
 Interquartile range 71-78 66-83 70-81 
 Missing 8 9 17 
 12 months N 13 10 23 
 Mean 74.4 74.3 74.4 
 Std Dev 10.27 10.51 10.14 
 Median 75.7 75.2 75.7 
 Min-Max 47-86 58-87 47-87 
 Interquartile range 70-82 66-85 68-83 
 Missing 8 9 17 
Change at 12 months N 13 10 23 
 Mean 0.5 -0.7 0.0 
 Std Dev 6.06 4.90 5.50 
 Median -1.0 -0.1 -1.0 
 Min-Max -8-12 -11-5 -11-12 
 Interquartile range -3-5 -3-3 -3-3 
 Missing 8 9 17 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.16 (-5.05 to 
5.37) 
 
 
 
p = 0.949 
 
 
 
 
0.994 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.17. Secondary outcome: Change in average EQ-5D index at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
Total 
(n=50) 
Baseline N 24 22 46 
 Mean 0.8 0.7 0.8 
 Std Dev 0.27 0.33 0.29 
 Median 0.8 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 2 2 4 
 6 months N 24 22 46 
 Mean 0.8 0.8 0.8 
 Std Dev 0.29 0.25 0.27 
 Median 1.0 0.8 0.9 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 1-1 1-1 
 Missing 2 2 4 
Change at 6 months N 24 22 46 
 Mean 0.1 0.0 0.1 
 Std Dev 0.28 0.32 0.29 
 Median 0.0 0.0 0.0 
 Min-Max -1-1 -1-1 -1-1 
 Interquartile range 0-0 0-0 0-0 
 Missing 2 2 4 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.03 (-0.12 to 
0.18) 
 
 
p = 0.652 
 
 
 
0.118 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.17.1. Secondary outcome: Change in average EQ-5D index at 6 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
Total 
(n=40) 
Baseline N 21 19 40 
 Mean 0.8 0.8 0.8 
 Std Dev 0.28 0.28 0.28 
 Median 0.8 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 0 0 0 
 6 months N 21 19 40 
 Mean 0.9 0.8 0.8 
 Std Dev 0.30 0.26 0.28 
 Median 1.0 0.8 0.9 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 0 0 0 
Change at 6 months N 21 19 40 
 Mean 0.1 0.0 0.0 
 Std Dev 0.28 0.23 0.26 
 Median 0.0 0.1 0.0 
 Min-Max -1-1 -1-0 -1-1 
 Interquartile range 0-1 0-0 0-0 
 Missing 0 0 0 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.07 (-0.10 to 
0.24) 
 
 
 
p = 0.393 
 
 
 
 
0.341 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 6 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.18. Secondary outcome: Change in average EQ-5D index at 12 months from baseline, by intervention 
group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-value and ICC 
(ITT). 
Variable Statistic TAKE 5 
(n=26) 
WWTOO 
(n=24) 
TOTAL 
(n=50) 
Baseline N 24 24 48 
 Mean 0.8 0.7 0.8 
 Std Dev 0.27 0.32 0.29 
 Median 0.8 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 2 0 2 
 12 months N 24 24 48 
 Mean 0.8 0.7 0.7 
 Std Dev 0.39 0.30 0.35 
 Median 1.0 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 2 0 2 
Change at 12 months N 24 24 48 
 Mean -0.0 -0.0 -0.0 
 Std Dev 0.39 0.37 0.38 
 Median 0.0 0.0 0.0 
 Min-Max -1-1 -1-1 -1-1 
 Interquartile range 0-0 0-0 0-0 
 Missing 2 0 2 
Statistical Analysis     
Mixed effects model 
(ITT)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.04 (-0.16 to 
0.24) 
 
 
p = 0.675 
 
 
 
0.000 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.18.1. Secondary outcome: Change in average EQ-5D index at 12 months from baseline, by 
intervention group and overall.  Adjusted mean difference (TAKE 5-WWTOO), 95% confidence interval, p-
value and ICC (Completers). 
Variable Statistic TAKE 5 
(n=21) 
WWTOO 
(n=19) 
TOTAL 
(n=40) 
Baseline N 21 19 40 
 Mean 0.8 0.8 0.8 
 Std Dev 0.28 0.28 0.28 
 Median 0.8 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 1-1 
 Missing 0 0 0 
 12 months N 21 19 40 
 Mean 0.8 0.7 0.7 
 Std Dev 0.41 0.31 0.36 
 Median 1.0 0.8 0.8 
 Min-Max 0-1 0-1 0-1 
 Interquartile range 1-1 0-1 0-1 
 Missing 0 0 0 
Change at 12 months N 21 19 40 
 Mean 0.0 0.0 0.0 
 Std Dev 0.41 0.28 0.35 
 Median 0.0 0.0 0.0 
 Min-Max -1-1 -1-0 -1-1 
 Interquartile range 0-0 0-0 0-0 
 Missing 0 0 0 
Statistical Analysis     
Mixed effects model 
(Per-protocol)* 
Intervention effect (95% 
CI)  
 
P-value 
ICC 
0.02 (-0.21 to 
0.25) 
 
 
 
p = 0.851 
 
 
 
 
0.059 
CI= Confidence Interval; ICC = Intraclass correlation.  
Data only reported for participants with data at both baseline and 12 months 
*Results are presented as adjusted means for baseline variable and effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and presence of Down 
syndrome). 
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Table 3.19. Secondary outcome: Change in EQ-5D-Y domain at 6 months from baseline. Odds ratio (95% 
confidence interval) and p-value (ITT).  
EQ-5D 
Domain 
Change in EQ-5D 
Domain 
TAKE 5 
(n=24) 
WWTOO 
(n=22) 
TOTAL 
(n=46) 
Odds ratio (95% 
CI)* 
P-
value 
Mobility Improvement  3 (12.5%) 7 (31.8%) 10 (21.7%) 0.34 (0.07 to 1.67) 0.179 
No improvement/ 
Deteriorated 
21 (87.5%) 15 (68.2%) 36 (78.3%) Referent  
Self-care Improvement  2 (8.3%) 3 (13.6%) 5 (10.9%) 0.63 (0.09 to 4.41) 0.633 
No improvement/ 
Deteriorated 
22 (91.7%) 19 (86.4%) 41 (89.1%) Referent  
Usual 
activities 
Improvement  1 (4.2%) 1 (4.5%) 2 (4.3%) 0.92 (0.07 to 12.17) 0.951 
No improvement/ 
Deteriorated 
23 (95.8%) 21 (95.5%) 44 (95.7%) Referent  
Pain 
discomfort 
Improvement  3 (12.5%) 4 (18.2%) 7 (15.2%) 0.66 (0.11 to 4.02) 0.646 
No improvement/ 
Deteriorated 
21 (87.5%) 18 (81.8%) 39 (84.8%) Referent  
Anxiety/ 
depression 
Improvement  3 (12.5%) 4 (18.2%) 7 (15.2%) 0.58 (0.09 to 3.72) 0.555 
No improvement/ 
Deteriorated 
21 (87.5%) 18 (81.8%) 39 (84.8%) Referent  
*Results are presented as adjusted Odds Ratio (OR) for effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and 
presence of Down syndrome). CI = Confidence Interval. 
 
Table 3.20. Secondary outcome: Change in EQ-5D-Y domain at 12 months from baseline. Odds ratio (95% 
confidence interval) and p-value (ITT).  
EQ-5D 
Domain 
Change in EQ-5D 
Domain 
TAKE 5 
(n=24) 
WWTOO 
(n=24) 
TOTAL 
(n=48) 
Odds ratio (95% 
CI)* 
P-
value 
Mobility Improvement  3 (12.5%) 5 (20.8%) 8 (16.7%) 0.65 (0.11 to 3.87) 0.630 
No improvement/ 
Deteriorated 
21 (87.5%) 19 (79.2%) 40 (83.3%) Referent  
Self-care Improvement  2 (8.3%) 4 (16.7%) 6 (15.2%) 0.58 (0.09 to 3.80) 0.562 
No improvement/ 
Deteriorated 
22 (91.7%) 20 (83.3%) 42 (91.3%) Referent  
Usual 
activities 
Improvement  1 (4.2%) 2 (8.3%) 3 (6.3%) 0.57 (0.08 to 5.70) 0.626 
No improvement/ 
Deteriorated 
23 (95.8%) 22 (91.7%) 45 (97.8%) Referent  
Pain 
discomfort 
Improvement  3 (12.5%) 3 (12.5%) 6 (12.5%) 0.98 (0.16 to 5.93) 0.985 
No improvement/ 
Deteriorated 
21 (87.5%) 21 (87.5%) 42 (91.3%) Referent  
Anxiety/ 
depression 
Improvement  3 (12.5%) 4 (16.7%) 7 (14.6%) 0.65 (0.10 to 4.11) 0.637 
No improvement/ 
Deteriorated 
21 (87.5%) 20 (83.3%) 41 (89.1%) Referent  
*Results are presented as adjusted Odds Ratio (OR) for effect of clustering of participants 
(stratified by number of participants within a cluster, level of intellectual disability and 
presence of Down syndrome). CI = Confidence Interval. 
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Appendix Viii: Publications arising from this thesis 
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